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Photoredox/nickel Dual Catalysis On Functionalization Of Unsaturated Systems 
Abstract 
Alkene functional groups are ubiquitous, and development of olefin functionalization transformations 
provides a unique opportunity to install Csp3 centers with great atom- and step-efficiency. Many elegant 
strategies have been developed toward this goal, however, the selective functionalization of unactivated 
olefins still remains underdeveloped. By fulfilling single electron processes under mild conditions, the 
emergence of photoredox/Ni dual catalysis has significantly expanded the alkyl nucleophile repertoire in 
C-C bond constructions. Applying this concept in C=C and C=X functionalization thus possesses great 
potential. 
Both photoredox/Ni dual catalysis and reductive coupling transpire via single electron pathways. Although 
the reductive coupling requires a stoichiometric amount of reductant, photoredox/Ni dual catalysis may 
fulfill similar transformations in a redox-neutral form, potentially improving both atom economy and 
reproducibility. To take advantage of this concept, an amidation reaction using organic isocyanates and 
alkylsilicates was developed. Through a Csp2-Csp3 bond construction approach, various alkyl amides 
were synthesized with good functional group tolerance, and thanks to the mild conditions, the deleterious 
CO extrusion reactivity was avoided. 
Heterocarbofunctionalization of olefins has great potential of rapidly building molecular complexity, 
however, very few mild and selective approaches have been reported. Through a photoredox proton-
coupled electron transfer (PCET) pathway, reactive amidyl radicals were generated mildly to facilitate a 
cascade amidoarylation/nickel-catalyzed cross-coupling of unactivated olefins. This new technology 
grants access to an array of complex molecules containing a privileged pyrrolidinone core from alkenyl 
amides and aryl- and heteroaryl bromides. Notably, not only amides, but carbamates and ureas were also 
used. Subsequently, carbonyl-type electrophiles, such as acyl (pseudo)halides and in situ-activated 
carboxylic acids, were incorporated in a highly diastereoselective amidoacylation reaction. Mechanistic 
studies, including hydrogen-bond affinity constants, cyclization rate measurements, quenching studies, 
cyclic voltammetry, isomerization experiments, as well as computational studies, were central to 
comprehend the subtleties contributing to the integration of the two catalytic cycles and the origin of the 
high diastereoselectivity. 
Finally, a method for Csp3-Csp3 and Csp3-X bond construction was developed by implementing 
photoredox/Ni dual catalysis into a Tsuji-Trost-type alkylation of allyl alcohol-derived partners. This 
transformation transpires with high linear and E-selectivity, avoiding the normal requirement for harsh 
conditions (e.g., strong base, elevated temperature). Additionally, using aryl sulfinate salts as radical 
precursors, allyl sulfones can also be obtained. Kinetic isotope effect experiments implicated oxidative 
addition of the nickel catalyst to the allylic electrophile as the turnover-limiting step, supporting previous 
computational studies. 
In summary, photoredox/Ni dual catalysis has proven enabling toward functionalization of unsaturated 
systems. Through different approaches, the unsaturated systems can be implemented as electrophiles 
(allyl alcohols, isocyanates) or radical precursors (pendant olefins). Various connections that are pivotal 
for synthetic chemistry have been demonstrated, such as Csp2-Csp3, Csp3-Csp3, Csp3-S and Csp3-N 
bonds, delivering a series of complex structures, such as functionalized monosaccharides, 
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PHOTOREDOX/NICKEL DUAL CATALYSIS ON FUNCTIONALIZATION OF 
UNSATURATED SYSTEMS 
Shuai Zheng 
Gary A. Molander 
Alkene functional groups are ubiquitous, and development of olefin functionalization 
transformations provides a unique opportunity to install Csp3 centers with great atom- and step-
efficiency. Many elegant strategies have been developed toward this goal, however, the selective 
functionalization of unactivated olefins still remains underdeveloped. By fulfilling single electron 
processes under mild conditions, the emergence of photoredox/Ni dual catalysis has significantly 
expanded the alkyl nucleophile repertoire in C-C bond constructions. Applying this concept in C=C 
and C=X functionalization thus possesses great potential. 
Both photoredox/Ni dual catalysis and reductive coupling transpire via single electron 
pathways. Although the reductive coupling requires a stoichiometric amount of reductant, 
photoredox/Ni dual catalysis may fulfill similar transformations in a redox-neutral form, potentially 
improving both atom economy and reproducibility. To take advantage of this concept, an amidation 
reaction using organic isocyanates and alkylsilicates was developed. Through a Csp2-Csp3 bond 
construction approach, various alkyl amides were synthesized with good functional group tolerance, 
and thanks to the mild conditions, the deleterious CO extrusion reactivity was avoided.  
Heterocarbofunctionalization of olefins has great potential of rapidly building molecular 
complexity, however, very few mild and selective approaches have been reported. Through a 
photoredox proton-coupled electron transfer (PCET) pathway, reactive amidyl radicals were 
generated mildly to facilitate a cascade amidoarylation/nickel-catalyzed cross-coupling of 
unactivated olefins.  This new technology grants access to an array of complex molecules 
containing a privileged pyrrolidinone core from alkenyl amides and aryl- and heteroaryl bromides. 
 vii 
Notably, not only amides, but carbamates and ureas were also used. Subsequently, carbonyl-type 
electrophiles, such as acyl (pseudo)halides and in situ-activated carboxylic acids, were incorporated 
in a highly diastereoselective amidoacylation reaction. Mechanistic studies, including hydrogen-
bond affinity constants, cyclization rate measurements, quenching studies, cyclic voltammetry, 
isomerization experiments, as well as computational studies, were central to comprehend the 
subtleties contributing to the integration of the two catalytic cycles and the origin of the high 
diastereoselectivity. 
Finally, a method for Csp3-Csp3 and Csp3-X bond construction was developed by 
implementing photoredox/Ni dual catalysis into a Tsuji-Trost-type alkylation of allyl alcohol-
derived partners. This transformation transpires with high linear and E-selectivity, avoiding the 
normal requirement for harsh conditions (e.g., strong base, elevated temperature). Additionally, 
using aryl sulfinate salts as radical precursors, allyl sulfones can also be obtained. Kinetic isotope 
effect experiments implicated oxidative addition of the nickel catalyst to the allylic electrophile as 
the turnover-limiting step, supporting previous computational studies. 
In summary, photoredox/Ni dual catalysis has proven enabling toward functionalization of 
unsaturated systems. Through different approaches, the unsaturated systems can be implemented 
as electrophiles (allyl alcohols, isocyanates) or radical precursors (pendant olefins). Various 
connections that are pivotal for synthetic chemistry have been demonstrated, such as Csp2-Csp3, Csp3-
Csp3, Csp3-S and Csp3-N bonds, delivering a series of complex structures, such as functionalized 
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Chapter 1. Transition Metal-Catalyzed Functionalization of C=C and C=X Double Bond: 
Conventional and Photoredox Approaches toward Regio- and Stereoselectivity 
1.1 Transition Metal-Catalyzed Olefin Functionalization: Hydroarylation, Hydroalkylation 
and Difunctionalization 
1.1.1 Strategies for Olefin Hydrofunctionalization  
Alkene functional groups are present in a variety of commodity chemicals as well as 
bioactive molecules. Development of olefin functionalization reactions will not only greatly 
enhance molecular diversity, but also provide vast opportunities for rapid manipulation of complex 
molecules. Moreover, addition and/or formal C-H functionalization reactions of olefins have been 
considered a great way to enhance synthesis efficiency.1 To this end, great efforts have been made 
using transition-metal catalysis methods, and the Mizoroki-Heck reaction is one such example 
(Figure 1.1). This transformation enables direct cross-coupling between olefins and various aryl, 
alkenyl and benzyl (pseudo)halides,2 and has realized the convenient synthesis of many highly-
functionalized olefin species.3 Indeed, together with other cross-coupling reactions, Mizoroki-Heck 
coupling has enabled numerous transformations that are otherwise challenging, and this was 
recognized in the presentation of the shared 2010 Nobel Prize of Chemistry to Richard Heck, its 
developer.4 Over the years, the continuous development of such reactions has expanded the scope 
into net-oxidative5 and dehydrogenative6 cross-coupling, and by manipulation of the ligand system, 
linear vs. branched selectivities have been achieved.2 Finally, utilization of the cheaper and less 
toxic first-row Group10 metal nickel led to much milder reaction conditions and incorporation of 




Figure 1.1. Mizoroki-Heck vs. Reductive Heck Coupling Reactions 
Despite the great molecular diversity that they have enabled, as with other transformations, 
Heck couplings have mostly been limited to construction of Csp2-Csp2 bonds. Medicinal chemists, 
on the other hand, have identified the significant benefits of increasing the 3D complexity of 
molecules in the process of drug discovery.8 Methods of installing Csp3 centers are therefore highly 
desired, yet unfortunately the available toolbox is hardly sufficient. Considering the abundance of 
alkene-containing compounds, olefins have the potential to become a great repertoire for Csp3 
building blocks because of their availability and stability, especially compared to the conventional 
alkyl coupling partners, such as alkyl halides and reactive organometallic reagents. To this end, the 
reductive Heck coupling is one of the earliest approaches using olefin to install alkyl functional 
groups on aryl halides. First discovered in the 1980s, this transformation rendered the 
hydroarylation of olefin species by an eventual reductive elimination of the palladium hydride 
intermediate (Figure 1.1), instead of having the β-hydride elimination as the final step. A hydride 
source (“reductant”) is therefore required. Because of the difficulties in catalyst development, 
although discovered several decades ago, the reductive Heck coupling has remained rather 
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underdeveloped and is restricted to tethered and/or activated alkenes. Recently, this reaction was 
finally expanded to unactivated olefins.9  
To achieve the goal of using alkenes as Csp3 building blocks, several other strategies were 
developed toward selective hydroarylation of olefin, namely nucleopalladation-
protodepalladation,10 a dual-catalytic approach with metal hydride-mediated transformations,11 and 
involvement of alternative metal/catalysis principles (Figure 1.2).12 The nucleopalladation 
approach utilizes a nucleophile (e.g., enol,13 aryl boronic acids,14 and arylsilanes15) via either an 
inner-sphere or outer-sphere nucleophilic attack to functionalize the C=C double bond, followed 
by protodepalladation (Figure 1.2a). Such transformations are overall redox-neutral, and have 
enabled not only Csp2-Csp3 but also Csp3-Csp3 constructions.
16  The direct utilization of such an 
approach is usually limited to tethered or activated alkenes, and unactivated olefins would require 
a special means of activation. Utilizing directing groups can enhance the selectivity, although 
elevated temperatures are still required.16-17 Alternatively, in situ generated copper hydrides have 
also been applied to activate the olefins via hydrometalation, followed by transmetalation to the Pd 
catalyst center for further steps (Figure 1.2b).11,18 Such a dual-catalytic strategy generally allows 
milder reaction conditions, and in certain occasions, an appropriate catalyst, such as Ni-H, can take 
on the roles of both alkene hydrometallation and cross-coupling with aryl halides.19 Finally, when 
using alternative metals, the hydrometalation process leads to single-electron species, and the 
resulting alkyl radical species can be further utilized in either a Minisci-type reaction20 on 
heteroarenes or engaged with nickel catalysis21 for a dual-catalyzed hydroarylation (Figure 1.2c). 
It is noteworthy that, in many cases where metal hydride species are utilized to activate olefins, 
potent hydride sources, such as silanes, have to be applied as the hydride donor to recover M-H 




Figure 1.2. Strategies for Olefin Hydroalkylation and Hydroarylation 
1.1.2 Transition Metal-Catalyzed Difunctionalization of Olefins 
Hydrofunctionalization of olefins is powerful and enabling for organic synthesis. However, 
it has thus far failed to fully use the alkene moiety to generate connections that addition of C=C 
bond should, in theory, provide. If two distinct functional groups could be installed in one reaction, 
one could build molecular complexity in an even more rapid fashion. When transition metal 
catalysis is involved, such difunctionalizations are usually realized by different mechanisms: via 
migratory insertion of organometallic intermediates, outer-sphere nucleometalation, or trapping the 
radical species after a polarity reversal process (Figure 1.3). 
 




Thanks to the systematic study of Mizoroki-Heck coupling, the migratory insertion of [M]-
aryl species into C=C bonds is very well understood. Indeed, many dicarbofunctionalization and 
heterocarbofunctionalization transformations have been carried out by intercepting the Heck-type 
intermediate. By utilizing a variety of directing groups to enhance both reactivity and selectivity, a 
series of dicarbo- and heterocarbofunctionalizations have been realized. For example, by utilizing 
a Ni(0)-Ni(II) catalytic cycle, diarylation and alkylarylation were conducted using either a classical 
8-aminoquinoline (Figure 1.4a)22 or a more removable imine (Figure 1.4b)23 directing group. 
Although the aryl halides and aryl-/alkylzinc reagents were utilized, the potential side reaction of 
competitive Negishi coupling was avoided. Similarly, by switching the nucleophile to boronic acid 
or silyl species, both carboborylation and carbosilylation are achievable under Pd catalysis (Figure 
1.4a).24  
 
Figure 1.4. Dicarbofunctionalization and Carboboration/Silylation via M-C Migratory Insertion 
As Pd-alkyl species are known to undergo β-hydride elimination, a “remote” 
aminoarylation of (ortho-hydroxy)aryl tethered unactivated olefins through a β-H elimination-
reinsertion pathway has been reported. Alkene aminoarylations adding two functional groups to 
the 1,n-positions (n ranges from 3 to 11), with amino groups ending up at benzylic position, have 
been achieved (Figure 1.5b). 25 Interestingly, when using an electrophilic amino source, R2N-OBz, 
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and R1ZnX carbonucleophile under a similar Ni(0)-Ni(II) cycle, the migratory insertion preferred 
the initial formation of the C-C bond (Figure 1.5a).26 
 
Figure 1.5. Carboamination via M-C Migratory Insertion 
Migratory insertions from metal-heteroatom complexes are also capable of taking part in 
heterocarbofunctionalization reactions. With a pendant hydroxy or amino group, the migratory 
insertion of Pd-N and Pd-O bonds into C=C bonds are demonstrated with the help of an appropriate 
base.27 The resulting intermediate then undergoes reductive elimination to render the corresponding 
aminoarylation28 and oxyarylation29 products (Figure 1.6a). Here, although the pendant amino and 
hydroxy groups are required, such transformations provide a great way to synthesize densely 
functionalized heterocycles, pivotal substructures for drug discovery.30 Although 1,2-
carboborylation via Cu-catalysis is achievable through a Cu-Bpin intermediate generated with 
B2pin2,
31 it is more interesting to see that, by utilizing an appropriate ligand system, Ni catalysts 
can also affect a remote carboboration similar to Pd catalysis, via elimination-reinsertion pathway 
(Figure 1.6b).32 
 




In addition to the “inner-sphere” 1,2-migratory insertion on a C=C bond, olefin 
difunctionalizations may also be initiated via an “outer-sphere” nucleophilic attack of the alkene 
functional group. With proper design, this mechanistic step can cause different regioselectivity 
compared to the migratory insertion pathway. Within a Pd(II)-Pd(IV) catalytic cycle, a variety of 
C-and N-centered nucleophiles, including indole, 1,3-diketyl, phenol, as well as amido/imido and 
tosylamido species, can be incorporated (Figure 1.7).33 In each case, the nucleophile initially attacks 
the double bond after the alkenyl substrate coordinates the Pd catalyst. Therefore, in contrast to the 
migratory insertion pathway, the nucleophile would be added to the terminal position of the double 
bond. 
 
Figure 1.7. Olefin Difunctionalization via Nucleometalation 
Trapping Alkyl Radical 
Single electron species are useful intermediates, capable of fulfilling many useful 
transformations. In fact, the radical polymerization of olefins is one of the most important methods 
to generate polymers, and this process has been studied for decades.34 However, probably because 
such polymerization reactivities are hard to avoid, radical functionalization of olefins has remained 
relatively scarce until recently. Inspired by reductive coupling reactions, where alkyl radicals are 
reductively generated from alkyl halides, pioneering research was done initially using a 
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difluoroalkyl radical, an activated olefin, and aryl boronates (Figure 1.8).35 Although the 
mechanism remained unclear, the available evidence supported the generation of a difluoroalkyl 
radical, and the selectivity was proposed to arise by transforming a reactive electrophilic radical 
into a stabilized and nucleophilic α-nitrogen radical, which is more suitable for Ni-catalyzed cross-
coupling. To engage unactivated olefins, two strategies were applied: 1) tethering the alkyl bromide 
to forge an intramolecular addition (Figure 1.9a),36 and 2) taking advantage of the difficulties faced 
in tertiary alkyl Csp2-Csp3 coupling (Figure 1.9b).
37  
 
Figure 1.8. Ni-Catalyzed Single-Electron Olefin Aryldifluoroalkylation 
 
Figure 1.9. Ni-Catalyzed Reductive Dicarbofunctionalization of Unactivated Olefins 
Heterocarbofunctionalizations via radical pathways have also been conducted using 
different metal catalysts. Thus, catalyzed by Cu, oxytrifluoromethylation38 and 
aminotrifluoromethylation39 were achieved (Figure 1.10). Although the mechanism of the final ring 
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closure step remains unclear, it is very clear that radical species are involved and that copper plays 
a vital role. 
 
Figure 1.10. Cu-Catalyzed Oxytrifluoromethylation and Aminotrifluoromethylation 
1.2 Recent Advances on Functionalization of Cumulenes  
 Cumulenes contain at least three contiguous atoms connected with double bonds. From 
many of these species, allenes, ketenes, isocyanates, carbodiimides as well as carbon dioxide have 
received significant attention because of their synthetic utility. They contain at least one Csp center 
and, except for allene, consist of at least one polarized bond, which leads to some very interesting 
reactivity. Because of the unique structure features of allenes40 and the environmental implications 
of CO2,
41 both systems have received significant attention, while carbodiimide species are 
identified as one of the most common reagents for amide condensation reactions42 and are found in 
helical polymer synthesis.43 
Ketenes, however, remain underrepresented in transition-metal catalysis. On the one hand, 
their well-established electrophilic reactivities have side reactions that are hard to avoid; on the 
other, both functional groups have two binding modes (Figure 1.11a), and the more useful bonding 
structure would actually lead to a C-C or C-N cleavage to form an inert M-CO species, 
decomposing the substrate and shutting down the catalyst at the same time (Figure 1.11a).44 
Because of this, many of the initial research efforts involving transition metals were 
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stoichiometric.45 Among the few examples, reactions of allylic acetates and carbonates with ketenes 
have been attempted through Pd catalysis (Figure 1.11b).46 With allyl acetates, 1,3-dienes were 
obtained via the decarbonylation pathway, while the reductive elimination with the MeO group 
outcompeted the CO extrusion in an appropriate solvent, thus forming a γ,δ-unsaturated ester. More 
recently, a Ni-catalyzed [2+2+2] cycloaddition involving ketene was disclosed (Figure 1.11c).47 
With dppb as a ligand, the decarbonylative pathway was completely avoided, generating a series 
of ketone structures with α-quaternary carbons.  
 
Figure 1.11. Transition Metal-Catalyzed Ketene Functionalization 
The functionalization of isocyanates faces a similar challenge to that of decarbonylation of 
a ketene, rendering the undesired metal-imides and metal-carbonyl complexes, among other side 
products.48 However, with the distinctive electrophilic sp-hybridized carbon center, 
functionalization of organic isocyanates provides great potential for amide bond construction via 
an unconventional C-C bond-formation pathway.49 It is noteworthy that amides are ubiquitous in 
bioactive molecules,50 and amide constructions are among the most heavily used transformations 
for medicinal chemists.50 Thanks to the development of Csp2-Csp2 cross-coupling, early development 
of amide synthesis with isocyanates mainly used nucleophilic aryl coupling partners with Cu,51 
Pd,52 and Rh53 catalysis (Figure 1.12a).  However, harsh conditions have to be applied, and the 
synthesis of alkyl amides is limited to specific substrates such as α,β-unsaturated esters (with help 
of a hydride source)54 and allylic species,55 and these reactions often suffered from various 
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selectivity issues (Figure 1.12b). By taking the reductive coupling approach, this challenge was 
solved by using alkyl bromide under rather mild conditions, although a superstoichiometric amount 
of Zn has to be applied (Figure 1.12c).56  
 
Figure 1.12. Amidation Transformations using Isocyanates 
1.3 Photoredox-Mediated Approaches toward Olefin Functionalization 
1.3.1 Introduction to Photoredox Catalysis 
Radical intermediates are pivotal in organic synthesis and catalysis, and often provide 
complementary reactivity when compared to two-electron transformations.57 However, the lack of 
mild and general methods for C-centered radical generation has significantly limited their 
application. On the other hand, several organometallic species have been extensively studied for 
their excited state single-electron transfer reactivities.58 Represented by polypyridyl ruthenium 
complexes, these compounds can harness over 50 kcal/mol of energy upon excitation by visible 
light, exciting one HOMO electron into the ground state LUMO of the complex, creating two 
SOMOs.  Therefore, the complex becomes both a potent oxidant and a potent reductant (Figure 
1.13a).59 Although the application of Ru(bpy)3 complex into organic synthesis dates back to the 
1980s, when Pshorr cyclizations,60 reductive dehalogenations,61 as well as olefin hydrogenations62 
were reported(Figure 1.13b), the concept of photoredox catalysis did not become extensively 
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implemented in organic synthesis until about a decade ago, when the first example of combining 
organic catalysis with photoredox was reported.63  
 
Figure 1.13. Principle of Photoredox Catalysis and Early Efforts on Synthesis Application 
Great progress has been made since then. Thanks to much interest of 
organometallic/organic fluorophores, a wide range of photoexcitable compounds have been 
synthesized, exhibiting diverse photophysical and redox properties that may be suitable for 
different applications in catalysis (Figure 1.14a). Especially, in terms of Csp3 center installation, 
photoredox catalysis has enabled mild and controllable alkyl radical generation, and has therefore 
significantly expanded the repertoire of many useful reactions, such as the Minisci reaction64 and 
Giese additions65 (Figure 1.14b). Various bench-stable and relatively redox-inert substrates, such 
as carboxylic acids,66 alkyl halides,63,67 alkyl trifluoroborates,65 alkyl bis(catecholato)silicates,68 
alkyl 1,4-dihydropyridines,69 as well as activated70 and unactivated C-H bonds,71 have proven 




Figure 1.14. Photocatalytic Pathways toward Alkyl Radical Generation 
To this end, one major breakthrough is the confluence of photoredox catalysis and Ni-
catalyzed cross-coupling reactions (Figure 1.15). As is mentioned in Section 1.1, although cross-
coupling reactions are the most popular method for C-C bond construction, significant limitations 
remain in terms of Csp2-Csp3 and Csp3-Csp3 coupling, for such transformations would conventionally 
require harsh reaction conditions, air-sensitve organometallic reagents,72 or highly toxic 
organostannanes.73 Photoredox/Ni dual catalysis provided a solution by taking advantage of the 
mild conditions of visible-light photocatalysis, the well-defined single-electron reactivity, as well 
as the reduced risk of β-H elimination from the use of nickel. This reaction design has permitted a 
previously rather challenging transformation to proceed under very mild reaction conditions, and 
has demonstrated great versatility and compatibility since then, utilizing many different 




Figure 1.15. Photoredox-Nickel Dual-Catalyzed Cross-Coupling 
1.3.2 Strategies of Olefin Functionalization using Photoredox Catalysis 
For photocatalytic olefin functionalizations, radical/polar crossover has been used as a 
general strategy. It can be categorized to two ways: nucleophilic radical addition onto an electron-
deficient double bond followed by reduction to form carbanion (Figure 1.16, Pathway A), or 
electrophilic radical addition to transform the C=C bond into a carbocation (Figure 1.16, Pathway 
B). These transformations are usually driven by the generation of a stabilized radical before the 
subsequent oxidation/reduction step. In fact, several early works have extensively utilized the 
addition of nucleophilic radicals onto electron-deficient conjugated olefins (e.g., α,β-unsaturated 
ketones, esters and amides), rendering the hydroalkylation product or Giese-type addition (Figure 
1.14b).65,68  This transformation is useful for constructing various Csp3-Csp3
65,68,75 and Csp3-S
76 bonds, 
although the olefin scope is limited to conjugated or electron-deficient alkenes. Difunctionalization 
of olefins under this principle is relatively rare, with only several cyclopropanations reported,77 




Figure 1.16. Olefin Difunctionalization via Photocatalytic Radical-Polar Crossover 
Pathway B has facilitated a significant number of olefin difunctionalization 
transformations. On one hand, the electrophilic radicals are more available via oxidative quenching 
(e.g., perfluoroalkyl halides,78 aryl diazonium salts,79 Umemoto reagents,78 etc.), leaving the overall 
transformation redox neutral; on the other hand, a series of nucleophiles have proven feasible to 
quench the resulting carbocations, including alcohols,80 halide anions,81 as well as organic nitriles82 
(via a Ritter-type reaction). As a few representative examples, aminotrifluoromethylation83 and 
aryltrifluoromethylation84 were disclosed using “+CF3” sources and various amines as well as 
electron-rich (hetero)arenes (Figure 1.17), while aminoarylation and oxyarylation were enabled 
using aryl radicals generated from hypervalent iodine complexes80 or aryl diazonium salts85 (Figure 
1.17).    
 
Figure 17. Radical-Polar Crossover via Oxidative Quenching 
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Interestingly, functionalization of olefins can also be achieved by the oxidation of the C=C 
bond itself. Although the redox potential is as high as 2.0 V (vs. SCE),86 the oxidation of aliphatic 
olefins could still be accessed by some strongly oxidizing photocatalysts, such as photoexcited 
MesAcr+ (Figure 1.14a). The resulting radical cation would subsequently react under a “polar-
radical” fashion: the cationic reactivity with nucleophiles first, followed by transformations 
involving the alkyl radical. Hydroetherification87 and hydroamination88 were achieved with anti-
Markovnikov selectivity (Figure 1.18a), while heterocarbofunctionalizations were also achieved 
with pendant olefins (Figure 1.18b).89 
 
Figure 1.18. Photocatalytic “Polar-Radical” Crossover for Olefin Difunctionalization 
1.3.3 Strategies of Olefin Difunctionalization via Photoredox/Ni Dual-Catalysis 
Although utilizing photoredox/Ni dual catalysis in olefin difunctionalization is a very 
appealing approach for the rapid synthesis of complex molecules, the selectivity between olefin 
difunctionalization and aryl-alkyl cross-coupling is hard to achieve, because most of the efficient 
olefinic alkyl radical acceptors would lead to less nucleophilic radicals, which would suffer from 
competitive radical-polar crossover, generating carbanions. Therefore, even though photoredox/Ni 
dual catalysis was reported to create indoline backbones using unactivated olefins, this 
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transformation utilized a migratory insertion mechanism for olefin difunctionalization and thus 
would not be generally applicable (Figure 1.19a).90 Not until very recently have suitable olefinic 
acceptors for this transformation finally been identified, namely vinyl boronic esters91 and vinyl 
carboxylic esters92 (Figure 1.19b). Although a good variety of radical sources have been utilized in 
these processes, it is noteworthy that, in most cases, tertiary radicals, which are known as 
challenging Csp2-Csp3 cross-coupling partners,
93 have to be employed to enhance the selectivity. 
 
Figure 1.19. Ni/Photoredox Dual-Catalyzed Olefin Difunctionalization 
1.4. Conclusion and Outlook 
Over the past few decades, tremendous efforts have been made toward utilizing transition-
metal catalysis for functionalization of C-C or C-X double bond manifolds. Such transformations 
have emerged as a powerful way to utilize naturally abundant olefin moieties as Csp3 building 
blocks, and are a great way to achieve high molecular complexity in a step- and atom-economic 
fashion. Starting from a reductive Heck coupling, where the migratory insertion intermediate was 
intercepted with a hydride source, various alternative approaches have been explored and fulfilled, 
including nucleometalation, metal-hydride olefin activation for either single- or dual-catalysis, as 
well as single-electron transfer (SET) processes by metal hydride hydrogen atom transfer (MHAT) 
to generate alkyl radicals from olefins.  
Guided by the development of hydrofunctionalization, various carbon- and heteroatom-
based nucleophiles and electrophiles have been utilized to achieve dicarbofunctionalization, 
aminoarylation, and carboborylation, etc. Directing groups are often engaged to boost selectivity 
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and reactivity, and the SET principle was also utilized in either a polarity reversal or a reductive 
coupling design. Because of their interesting reactivity profile and synthetic utility, cumulative 
systems containing heterocycles, such as ketenes and isocyanates, are also involved in various 
catalysis studies, with ketenes delivering various quaternary carbon centers, and isocyanates 
achieving amide synthesis through C-C formation.  
Last but not least, photoredox catalysis has also emerged as a powerful tool for olefin 
functionalization. Using the radical-polar crossover approach via reductive quenching, a 
tremendous amount of research has been disclosed using various radical precursors for 
hydroalkylation and cyclopropanation of electron deficient olefins, while the oxidative quenching 
pathway of photoredox radical-polar crossover leads to various hetero-carbofunctionalizations. 
Olefin difunctionalization via photoredox/Ni dual catalysis has been challenging to achieve because 
of selectivity issues, yet through an alternative mechanistic approach or by using reasonably 
activated olefins, amidoarylation and dicarbofunctionalization have been demonstrated. 
With these great efforts, a great deal of chemical space still remains unexplored. For highly 
activated unsaturated systems, such as isocyanates, although great achievements have been made 
by reductive coupling, the use of metal reductants raises concerns of sustainability and 
reproducibility. For unactivated olefins, more versatile transformations still need to be developed. 
Traceless directing groups are enabling, but compromise atom economy, and reactive 
organometallic reagents and harsh conditions are still often required. Transformations that may 
engage reactive radical species, such as trifluoromethyl radical, are useful but highly specialized. 
Photocatalysis has demonstrated its power in functionalizing styrene and α,β-unsaturated carbonyl 
structures, however, little has been discovered for the modification of inert olefin species. Of 
particular note, the highly enabling photoredox/Ni dual catalysis is still rather underrepresented in 
this realm. Therefore, it will be highly meaningful to develop C-C or C-X double bond motifs as 
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Chapter 2. Photoredox/Nickel-Catalyzed Amidation via Alkylsilicates and Isocyanates 
2.1 Introduction 
Amides are highly prevalent in biomedically related molecules.† In fact, over 30% of bond-
forming reactions in medicinal chemistry publications are amidations.1 Despite the fact that 
amidation methods are well represented, most of them are constructed by C-N bond formation. The 
application of isocyanates in amide synthesis allows an unconventional C-C formation approach;2 
however, many of these are predicated on sensitive reagents, harsh conditions, or stoichiometric 
amounts of activating agents.3 As a representative example, in a contribution from Bode et al. 
(Figure 2.1a),4 alkyl- and aryl isocyanates reacted with Grignard reagents to form sterically 
hindered amides. Unfortunately, utilization of organometallic reagents limits the functional group 
tolerance of this approach. In a seminal work disclosed by Martin et al., the formation of amides 
was achieved from alkyl halides and isocyanates in a reductive cross-coupling manner (Figure 
2.1b).5  
 
Figure 2.1. Previous Research of Amide Synthesis with Isocyanates4,5 
Indeed, reductive coupling has become a powerful tool for the construction of a variety of 
structures, including Csp
2-Csp
3 bonds.6 Compared to conventional cross-coupling reactions,7 
reductive cross-coupling generates “radical nucleophiles” from the corresponding halides and often 
results in milder yield and better functional group tolerance. Despite this clear advantage, the need 
 
 
† Reproduced in part from Zheng, S.; Primer, D. N.; Molander, G. A.; ACS Catal. 2017, 7, 7957 
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for a sacrificial amount of a stoichiometric reductant (hydride sources, metals, etc.) is a systematic 
drawback regarding atom-economy, sustainability, and sometimes reproducibility, which limits the 
widespread implementation of reductive couplings. 
The widely accepted hypothesis of a single-electron transfer (SET) process in reductive 
coupling indicates an intrinsic mechanistic similarity between reductive and photoredox/Ni dual-
catalyzed cross-coupling,8 in which a radical is generated via photoredox catalysis before oxidative 
capture by the metal center, generating a Ni(III) intermediate I that is common to both approaches 
(Figure 2.2).9,10 Given the mechanistic similarities between these two emerging fields, it seemed 
reasonable to explore whether other electrophilic partners previously employed in reductive 
coupling processes could be translationally applied to unexplored photoredox systems.6c The main 
advantage here would be the possibilities of a redox-neutral reaction – the reduced photocatalyst 
formed upon reductive quenching would turn over the nickel catalytic cycle, obviating the need for 
a  sacrificial reductant.  
 
Figure 2.2. Mechanistic Similarities between Reductive and Photoredox Cross-coupling and 
Proposed Transformation 
Several electrophiles have been incorporated within photoredox cross-coupling, including 
aryl (pseudo)halides,10a,10c-e,11 alkenyl halides,12 acyl chlorides,13 acyl imides,14 and activated 
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carboxylic acids.15 However, unsaturated carbonyl-type or cumulative unsaturated electrophiles 
have not been explored extensively, with most efforts focusing on CO2.
16 Therefore, we decided to 
explore the ability of isocyanates to be engaged in a Ni/photoredox dual catalytic cycle to generate 
amide bonds.  
2.2 Results and Discussion 
To begin our investigation, we selected cyclohexyl bis(catecholato)silicate (1a) and 
phenethyl isocyanate (1b) as radical partner and electrophile, respectively. Use of [Ru(bpy)3][PF6]2 
as a photocatalyst and [(dtbbpy)Ni(H2O)4]Cl2 as the nickel precatalyst afforded the desired amide 
product in 46% yield (Table 1, entry 1). For organosilicates, the use of i-Pr2NH2
+ as a counterion 
proved detrimental because of the tendency of the associated conjugate base to form an N,N-
diisopropyl urea upon reaction with the isocyanates, resulting in lower yields (Figure 2.3, entry 2). 
This problem was circumvented by altering the silicate counterion to Et3NH
+ or Me3NH
+, the 
conjugate bases of which are non-nucleophilic. At this point, a rigorous optimization effort of 
solvent and ligand for nickel was carried out, utilizing high throughput experimentation.17 
Unsurprisingly, the choice of ligand for the Ni catalyst exerted a significant influence in the reaction 
outcome. Whereas bidentate phosphine ligands afforded poor yields (entries 4 and 16), with a 
significant amount of radical homocoupling byproducts, bispyridyl-type ligands (entries 1-3) gave 
better results. It came to our attention that use of the flexible dtbbpy ligand afforded modest yields 
(entries 1-2), whereas the previously employed 6-Mebpy5 gave only a 15% yield (entry 3). Given 
that substitution at the 6-position of the bpy ligand should cause distortion of the backbone,5 this 
suggested that a more rigid system might be beneficial for this catalysis. In this vein, the use of 
phenanthroline resulted in quantitative product formation, while successfully suppressing the 
formation of off-cycle products (entry 5). To improve the operational simplicity, the use of 
preformed (Phen)NiCl2 led to similar results (entry 12). Further optimization of catalyst loading 
indicated the feasibility of reducing the catalyst loading to 2.5 mol % of Ni-precatalyst and 1.5 mol 
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% of the Ru-photocatalyst in DMF. Other radical precursors such as 4-alkyl-1,4-dihydropyridines 
and alkyltrifluoroborates were also attempted under the conditions developed for the alkylsilicates 




Figure 2.3. Optimization of Reaction Conditions. a1a (0.1 mmol, 1.0 equiv), 1b (0.2 mmol, 2.0 
equiv), photocatalyst (1.5 mol %), [M] (2.5 mol %), ligand (2.5 mol %), DMF (1 mL, 0.1 M) at rt 
under blue LED irradiation. bHPLC yield. cUsing diisopropylammonium 
cyclohexylbis(catecholato)silicate as radical precursor. d4CzIPN = 1,2,3,5-tetrakis(carbazol-9-yl)-
4,6-dicyanobenzene. e[Ir] = {Ir[dF(CF3)ppy]2[bpy]}[PF6]. 
fIn the dark. g 1.0 equiv of TEMPO was 
added. hUsing diethyl 4-cyclohexyl-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate as radical 





Encouraged by these results, we explored the substrate scope. As shown in Figure 2.4, 
primary (1), secondary (2) and tertiary (3) isocyanate species all afforded comparable yields, 
indicating the low influence of steric factors regarding the isocyanate counterpart. Notably, even 
for a sterically demanding 2,6-diisopropylphenyl isocyanate (8), the yield was not compromised. 
When using aromatic isocyanates, only one equivalent was required to obtain comparable yields 
(14), likely because of their enhanced stability under the reaction conditions. Concerning the 
alkylsilicates, both primary and secondary alkylsilicates worked well, with slightly higher yields 
using secondary alkylsilicates, probably as a consequence of the higher stability of the intermediate 
radical. A gram-scale reaction generating 14 was also carried out, and a comparable yield of 69% 
was observed, indicating that this reaction is scalable. 
 
Figure 2.4. Scope of isocyanates. a 2.0 equiv for alkyl isocyanates, 0.5 mmol, 1.0 equiv for aryl 




A variety of functional groups were well accommodated on both the silicate and isocyanate 
coupling partners. According to results presented in Tables 2 and 3, enolizable ketones (9), esters 
(4, 21 and 24), ethers (20), fluorides (18, 19), alkyl- and aryl nitriles (12, 16) and ureas (22) were 
incorporated in moderate to good yields. These functional groups were not tolerated under 
previously reported protocols.4 Isothiocyanate species could also be employed in the reaction (7), 
and heteroaromatic systems were readily accommodated as well. Despite a longer reaction time, 
the pyridyl moiety (26) afforded a reasonable yield. Notably, although both pyrrole (23) and thienyl 
(13) ring systems are known for radical polymerization reactivity,18 the desired products were 
successfully isolated. The functional group tolerance of this reaction also provides possibilities for 
sequential functionalization. For example, an aryl chloride (10) was accessed in good yield, 
providing a means for further elaboration via traditional cross-coupling. The (EtO)3Si group was 
also compatible, which led to installation of a hydroxy group (6) in 68% yield after a one-pot, 
Tamao-Fleming oxidation.19 Although alkenyl moieties are vulnerable to radical addition reactions, 




Figure 2.5. Scope of Silicates. a 2.0 equiv for alkyl isocyanates, 0.5 mmol, 1.0 equiv for aryl 
isocyanates. bHNMe3
+ was used as a counterion. c NMR yield. d 36 h is needed for complete 
conversion. 
Next, we sought to understand the intricacies of the reaction pathway. First, control 
experiments were performed. Unsurprisingly, in the absence of photocatalyst or light, no 
conversion was observed. By addition of TEMPO in the reaction (Figure 2.3, entry 14), no product 
was formed, which supported the radical pathway. The lack of product formation without a nickel 
catalyst (Figure 2.3, entry 10) ruled out the direct radical addition pathway, suggesting a necessary 
interaction between the isocyanate and the nickel complex. Alternative metal catalysts (e.g., Fe, 
Co) and aprotic silicate counterions only rendered trace amounts of product, thus highlighting both 
the need for a proton source for the reaction to turn over and the unique role of nickel.17 Based on 
these results and our previous understanding of photoredox/nickel dual catalysis,9 a plausible 
mechanism is proposed (Figure 2.6), where Ni(II) carbonyl-amido intermediate 4b20,21 is formed 
upon oxidative addition of Ni(0) to the isocyanate. Subsequently, intermediate 4c will be generated 
upon radical addition.9-10 The generated Ni(III) complex then undergoes reductive elimination to 
generate the new C-C bond, followed by protonation with the ammonium counterion. The resulting 
Ni(I) complex is then reduced by Ru(bpy)3





Figure 2.6. Plausible Mechanism of Nickel Catalyzed Photoredox Amidation. 
Attempts to synthesize complex 4b with bipyridine supporting ligands failed because of 
the instability of this complex. By mixing a stable Ni(0) source, Ni(COD)2, in the presence of 
phenanthroline and 2,6-diisopropylphenyl isocyanate, we were able to observe rapid changes by 
NMR and IR, corresponding to the disappearance of the isocyanate and formation of a new carbonyl 
peak. These signals are consistent with formation of an oxidative addition intermediate. Indeed, the 
corresponding product was observed by reaction of the in situ-generated 5a with cyclohexylsilicate 
under photoredox conditions (Figure 2.7a).20,22  
 
Figure 2.7. Mechanistic Investigation. 
The plausibility of this proposal is also in line with the work by Hillhouse on the synthesis 
of related stable (dtbpe)Ni(II)-DippNCO oxidative addition complexes.20,23 As noted in our 
optimization, similar, sterically bulky bisphosphino ligands were viable catalysts, affording a 
moderate 30% isolated yield of the desired coupled product (Figure 2.3, entry 16).24  
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Interestingly, during the reaction between the cyclohexylsilicate and diisopropylphenyl 
isocyanate, diisopropylphenyl urea, 6a, was isolated (Figure 2.7b). This off-cycle product suggests 
a reaction pathway where CO extrusion from 4b results in formation of a Ni-imido complex,20 
which can then react with another equivalent of isocyanate to generate the observed urea.20 
Additionally, detection of dicyclohexyl ketone 6b via GC-MS demonstrates the capture of CO by 
cyclohexyl radical generated during reaction. Notably, these CO extrusion-derived side products 
further support the viability of intermediates 4b and 4c as intermediates along the reaction cycle. 
Overall, the proposed mechanism and experiments are consistent with previous work by Martin, in 
which a reductive coupling strategy was used.13 In their cases, coupling was validated to occur via 
a radical pathway, using super-stoichiometric zinc to both generate the alkyl radical and reduce the 
nickel catalyst. 
2.3 Conclusion  
In conclusion, a nickel-catalyzed photoredox amidation of alkylsilicates and aryl/alkyl 
isocyanates has been developed. Under these mild conditions, this reaction utilizes a similar 
pathway to that previously used in reductive couplings, but eliminates the required stoichiometric 
reductant by using a photocatalyst for both radical generation and nickel cycle turnover.  With a 
series of electrophilic functional groups tolerated, this reaction is complementary to those afforded 
by conventional methods such as acylation of amines and isocyanate alkylation via organometallic 
reagents. Most excitingly, the recognition regarding the mechanistic similarities between 
Ni/photoredox dual cross-coupling and nickel reductive couplings can serve as a foundation for 
developing new chemistry in both fields. As such, a closer examination of the literature between 





Unless otherwise noted, all reactions were carried out under inert atmosphere of argon or 
nitrogen via standard Schlenk techniques or gloveboxes. Reactions were monitored by GC-MS, 
HPLC, 1H NMR, and/or by TLC on 254 nm silica gel plates. Thin layer chromatography was 
performed using hexanes/EtOAc as the eluant and visualized using KMnO4 stain and/or UV light. 
Reactions were purified by flash chromatography accompanied with an automated system 
(visualized at 254 nm, monitored with all-wavelength and ELS detector) with silica cartridges (60 
Å porosity, 20-40 µm). All isocyanates were purchased from commercial sources, stored under a 
nitrogen atmosphere, and used as received. Triethylammounium alkylbis(catecholato)silicates were 
synthesized according to the literature.10d {Ir[dF(CF3)ppy]2[dtbpy]}[PF6],
25 [Ru(bpy)3][PF6]2,
26 and 
4CzIPN27 were synthesized via reported procedures. DMF (extra dry, 99.8%) was purchased and 
used as received. Other solvents were purified either by distillation over sodium or CaH2 or by 
running through alumina cartridges through solvent purification system. Irradiation of reaction 
vessels was accomplished using blue LEDs (light-emitting diode) about 3 cm from the reaction 
vessel with a fan above to maintain rt. The photoredox reaction equipment was constructed 
according to a previous reported literature.12 Melting points (°C) are uncorrected. NMR Spectra 
(1H, 13C {1H}, 19F) were recorded on a 500 MHz spectrometer at 298 K. All 1H NMR spectra are 
reported in parts per million (ppm) downfield of TMS and were measured relative to the signals 
for CHCl3 (7.26 ppm). All 
13C NMR spectra were reported in ppm relative to residual CHCl3 (77.2 
ppm) and were obtained with 1H decoupling. Coupling constants (J) are reported in Hertz (Hz). 
HRMS was obtained by either ESI or EI with a TOF mass spectrometer in MeCN or CDCl3. IR 
spectra were obtained with neat samples. NMR yields were obtained via analysis of crude reaction 
mixture with addition of 10 mol % of 4,4’-di-tert-butyl-biphenyl as the internal standard. Cyclic 
voltammetry experiments were carried out on a CHI electrochemical workstation using glassy 
carbon working electrode, Ag/AgCl reference electrode and Pt wire counter electrode, in an 
undivided cell. The measurements were taken at rt in MeCN containing 0.1 M Bu4NPF6 as 
electrolyte. 0.0025 mmol of the designated substrate was dissolved in 10 mL of this soln, and 1.9 
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mg of ferrocene was added as a reference. A scan rate of 200mV/s was used for the reported 
voltammograms, 
General Procedure for Trimethylammonium Alkylbis(catecholato)silicates  
A slightly modified procedure from literature was applied.10d To a 25-mL microwave vial 
equipped with stir bar was added catechol (858 mg, 7.8 mmol, 1.95 equiv) under an inert 
atmosphere, which was dissolved in a THF soln of Me3N (2 M, 1.2 equiv, 2.4 mL). Additional 2.6 
mL of dry THF was added to aid in dissolving the readily formed ammonium catecholate salt. The 
soln was stirred for 15 min before corresponding alkyltrimethoxylsilane (4 mmol, 1.0 equiv) was 
added. After the addition, the reaction was heated at reflux (70 ˚C) overnight. The reaction was 
then cooled to rt, and the soln was diluted by adding 30 mL of Et2O, rendering a white precipitate. 
The mixture was sonicated for 15 min before filtration. The filter cake was washed 3 times with 5 
mL Et2O and dried under high vacuum. 
General Procedure for Photoredox/Nickel Dual-Catalyzed Amidation: 
To an 8-mL reaction vial equipped with a stir bar and septa screw cap were added 
organosilicates (0.5 mmol, 1.0 equiv), isocyanates (0.5 mmol, 1 equiv for aryl isocyanate, 1 mmol, 
2 equiv for alkyl isocyanate), (phen)NiCl2 (3.9 mg, 2.5 mol %) and [Ru(bpy)3][PF6]2 (6.4 mg, 1.5 
mmol %). The reaction was charged with argon under a Schlenk line, and 5 mL of dry DMF (0.1 
M) was added. After stirring under a blue LED for 16 h, the reaction was diluted by adding 40 mL 
of EtOAc and was washed three times with 30 mL satd Na2CO3 and subsequently three times with 
30 mL brine. The organic phase was dried (MgSO4), and the solvent was removed by rotovap. The 
final product was purified by flash column chromatography, using hexanes and EtOAc as eluent. 
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Gram-Scale Procedure: To a 100-mL round bottom 
flask equipped with a stir bar and septum were added 
triethylammonium cyclohexylbis(catecholato)silicates (3.21 g, 
7.5 mmol, 1.0 equiv), phenylisocyanate (893.4 mg, 7.5 mmol. 
1.0 equiv), [Ru(bpy)3][PF6]2 (96.7 mg, 0.1125 mmol, 1.5 mol 
%), and (phen)NiCl2 (58.1 mg, 0.1875 mmol, 2.5 mol %). The 
reaction was set up in a glovebox under a nitrogen atmosphere, 
and 75 mL of dry DMF (0.1 M) was added. After stirring under a blue LED for 16 h, the reaction 
was filtered, and most of the DMF was removed via rotovap. The residue was diluted by 150 mL 
of EtOAc, washed three times with 100 mL of satd Na2CO3, and subsequently three times with 100 
mL brine. The organic phase was dried (MgSO4), and the solvent was removed by rotovap. The 
final product (1.044 g, 69%) was purified by flash column chromatography, using hexanes/EtOAc, 
and the spectrum was identical to the corresponding 0.5mmol-scale example 2n.  
Reaction Discovery by High Throughput Experimentation 
To a 96-well reactor block with a hollow bottom were added the corresponding nickel 
sources and ligand for precomplexing. After removing the solvents, organosilicates, solvents, and 
photoredox catalysts were added. The block was then put on a photoreactor for 16 h. After 
completion, the mixture was diluted with THF and centrifuged, and the clear soln was further 
diluted before being analyzed by UPLC with 4,4’-di-tert-butyl-1,1’-biphenyl as the internal 
standard. The product/internal standard ratio of the screening is shown below: 
 MeCN DMF i-PrOAc acetone toluene dioxane DMA DMSO THF t-BuOH DCE DME 
dtbbpy 0.00 0.83 0.32 0.42 0.36 0.29 0.00 0.00 0.34 0.34 0.00 0.00 
Phen 0.00 1.15 0.66 0.55 0.64 0.66 0.00 0.13 0.73 0.47 0.00 0.00 
dMeObpy 0.00 0.91 0.58 0.55 0.62 0.00 0.30 0.00 0.61 0.43 0.00 0.00 
Me4Phen 0.00 1.03 0.49 0.00 0.54 0.74 0.00 0.00 0.41 0.26 0.11 0.11 





0.00 0.65 0.00 0.42 0.47 0.73 0.46 0.00 0.65 0.33 0.25 0.25 
 
0.00 1.08 0.45 0.56 0.47 0.58 0.47 0.00 0.45 0.41 0.09 0.00 
BnBox 0.00 0.55 0.14 0.00 0.23 0.17 0.00 0.00 0.18 0.10 0.00 0.00 
 
Figure 2.8. High Throughput Screening of Ligand and Solvent 
Benchtop Reaction Optimization 
 To a 4-mL reaction vial equipped with a septa screw cap and stir bar were added the 
corresponding metal sources, 4,4’-di-tert-butyl-2,2’-bipyridyl ligands, and 100 µL of THF under 
an inert atmosphere. After stirring for 5 min, the THF was removed, followed by addition of 
phenethyl isocyanate and triethylammonium cyclohexylbis(catecholato)silicate and DMF. The 
reaction was stirred under blue light for 16 h before being analyzed by HPLC with 0.1 equiv 4,4’-
















dtbbpy Phen dMeObpy Me4Phen dppf dppp bisamine BnBOx
 
 38 
Metal Catalyst Complex Attempted: Co(OAc)2, CuOAc, Cu(OAc)2, FeCl3, Fe(acac)3, 
Pd2(dba)3 and AuCl. Only Co(OAc)2 gave a trace amount of product. 
A combinatorial screening with Co(OAc)2, CuI and 11 different ligands was also 
attempted, and still only trace amount of product was observed (shown below are Product/IS 
value acquired in UPLC trace): 
Table 2.1 Metal Center and Ligand Screening Result 
CuI 
dtbpy bathophen bpy phen SPhos Box 
0 0 0 0 0.27 0 
dMeObpy dCF3bpy dppf dppp  no ligand 
0 0 0 0 0 0 
Co(OAc)2 
dtbpy bathophen bpy phen SPhos Box 
0 0 0 0 0.15 0 
dMeObpy dCF3bpy dppf dppp  no ligand 
0 0 0 0 0 0 
Substrate and Catalyst Loading 







X 1 1.5 2 2.5 3 3.5 
P/IS 1.71 1.89 2.1 2.12 2.14 2.17 
    (phen)NiCl2 
  2.50% 5% 10% 
[Ru(bpy)3][PF6]2 
1.5% 1.514 1.458 1.431 
3% 1.43 1.428 1.436 






entry photocatalyst ligand [M] yielda 
1 [Ru(bpy)3][PF6]2 Phen Ni(DME)Cl2 97% 
2 [Ru(bpy)3][PF6]2 Phen Co(OAc)2 trace 
3 [Ru(bpy)3][PF6]2 Phen CuOAc trace 
4 - Phen Ni(DME)Cl2 0 
5 [Ru(bpy)3][PF6]2 - - 0 
6b [Ru(bpy)3][PF6]2 Phen Ni(DME)Cl2 0 
Figure 2.9. Control Experiment. a HPLC yield b without light  
 Entries 1~6 indicated that both light and photocatalyst were needed for the reaction to 
transpire. Notably, other potentially Lewis acidic metal species were tested during reaction 
optimization, and none of them led to a reasonable yield, while no reaction took place without the 
nickel species. This indicated that nickel was not likely to act as a Lewis acid activator of isocyanate 
substrates in this reaction. 
CV Study of Phenethyl Isocyanate and Phenyl Isocyanate 
 
Figure 2.10. Cyclovoltammetry Data for Isocyanates 
-2.5-1.5-0.50.51.52.5
V (vs. SCE)
CV of phenethyl isocyanate
-2.5-0.51.53.5
V (vs. SCE)
CV of Phenyl Isocyanate
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No obvious peak was observed within the redox window of the photoredox catalyst, 
indicating that it was not likely for the isocyanate species to be reduced by the photocatalyst. 




+ and 18C6-K+) were tested in the 
reaction. When using ammonium counterions that could act as proton sources, products were 
observed. However, when the non-protic 18-C-6-K+ was applied, no reaction took place. When 
ammonium salts such as HNEt3Cl were applied as additives for reaction with 18C6-K
+ silicates, 
product could be observed again. This result indicated that the reaction needed a proton source.  
Plausible Key Intermediate in the Reaction 
 
Step 1: To a 4-mL vial was added 1,10-phenanthroline (0.5 mmol, 9 mg, 1.0 equiv), 
Ni(COD)2 (0.5 mmol, 13.8 mg, 1.0 equiv) and CD3CN (1 mL, 0.05 M) at rt, and a dark purple soln 
was generated. 2,6-Diisopropylphenyl isocyanate (DippNCO, 10.2 mg, 0.05 mmol, 1.0 equiv) was 
then added at -35 ℃. NMR and IR spectra were obtained immediately after the reaction reached rt. 
The IR spectra (Figure 2.11b) showed complete consumption of DippNCO, with appearance of a 
significant carbonyl peak. 1H NMR (Figure 2.11a) exhibited a significant shift, and 13C-NMR 
indicated full consumption of isocyanate with a new peak at 142.03 ppm (Figure 2.12), likely the 








Figure 2.12. 13C NMR of intermediate 5a 
Step 2: After removal of solvent, the purple solid together with triethylammonium 
cyclohexylbis(catecholato)silicate (0.05 mmol, 21.4 mg, 1.0 equiv), [Ru(bpy)3][PF6]2 (0.02 mmol, 
8.6 mg, 0.2 equiv) and 10 mol % of internal standard was dissolved in DMF-d7 (0.5 mL, 0.1 M), 
and the reaction was set up under blue LED lighting for 6 h. Alternatively, this experiment could 
also be carried out with both step 1 and 2 in DMF-d7, and a similar result was observed. 
1H NMR 
and GCMS spectra was obtained after filtration. A GCMS trace confirmed the formation of the 
desired product, together with other expected byproducts (Figure 2.13). 
(Note: Other single-electron oxidants with sufficient redox potential, such as TBPA+SbCl6
- 
and AgOTf, were also attempted to facilitate Step Two, but no reaction was observed. Although 
those oxidants should be capable of facilitating the reaction, one could expect many other side 
reactions to occur with them. This further supported that the photoredox approach is suitably mild 
for the reactions to be conducted.) 
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GCMS methods for data acquisition: 
Column: capillary column, 30 m, dominal diameter 250 μm, nominal film thickness 0.25 
μm. 
Carrier gas composition: helium. 
Flow rate: 29.2 mL/min. 
Inject temp: 250 ℃. 
Column temp: 50 – 160 ℃ at 60 ℃/min, then 160 – 270 ℃ at 30 ℃/min, then remain 270 
℃ 
Total run time: 9 min. 












Side Products Indicative of the Mechanism Pathway  
Two side products were detected during the substrate scope study. One was the 
dicyclohexyl ketone (6b), which indicated an intermediate that could possibly undergo CO 
extrusion and/or C-N cleavage during the reaction (Figure 2.14a off-cycle pathway i and ii). 
Another is the diisopropylphenyl urea (6a) when applying diisopropylphenyl isocyanate as the 
coupling partner, which indicated a possible pathway that could generate a nickel-imido complex 
(this complex was also supported by identification of DippNH2 in Figure 2.13), and that could result 
from CO-extrusion (Scheme S5a, off-cycle pathway i).  
Based on the observations above, it is most plausible that the reaction undergoes Ni(0)-
Ni(II)-Ni(III) pathway via oxidative addition of isocyanate (Figure 2.15a). Both intermediate 4b 
and 4c are proposed to be responsible for CO extrusion, which could lead to formation of 6b in 
pathway ii. The NiII-imido complex proposed to derive from 4b was responsible for the formation 
of 2,6-diisopropylaniline detected in the GCMS trace (Figure 2.13), as well as the urea byproduct 
6a via a possible [2+2] process (Figure 2.14a, off-cycle pathway i). Although it is still difficult to 
rule out the migratory-insertion pathway (Figure 2.14b), as further evidence, the related Ni-













Trimethylammonium 3-(N-pyrrole)propyl bis(catecholato)silicate 
(1.49 g, 4.1 mmol,82%). 1H NMR (500 MHz, CDCl3) δ 6.72 (dt, J = 7.6, 3.8 Hz, 4H), 6.67 (dd, J 
= 5.7, 3.4 Hz, 4H), 6.49 (d, J = 2.1 Hz, 2H), 6.01 (d, J = 2.1 Hz, 2H), 3.69 (t, J = 7.2 Hz, 2H), 2.85 
(s, 9H), 1.75 (tt, 2H, J = 8.3, 7.2 Hz, 2H), 0.65 (t, J = 8.3 Hz, 2H). 13C NMR (126 MHz, CDCl3) δ 
149.4, 120.8, 119.1, 111.0, 107.3, 52.4, 46.2, 26.8, 13.8. mp = 152-155 ˚C (decomp). No desired 
peak found in HRMS, probably because of its instability in ESI environment. IR (neat, cm-1): 3045, 
2750, 1484, 1355, 1279, 1263, 1241, 1190, 1103, 1088, 1066, 1015, 983, 887, 776, 727, 677, 618, 
586, 513, 480. 
 Trimethylammonium 2-Oxo-N-(4-Oxo-4-
(bis(catecholato)silicate)butyl)azepane-1-carboxamide (1.46 g, 3.65 mmol, 73%).10d 1H NMR (500 
MHz, CDCl3) δ 9.10 (d, J = 5.3 Hz, 1H), 6.69 (dd, J = 5.6, 3.4 Hz, 4H), 6.63 (dd, J = 5.7, 3.4 Hz, 
4H), 3.96 – 3.85 (m, 2H), 3.18 – 3.08 (m, 2H), 2.92 (s, 9H), 2.67 – 2.57 (m, 2H), 1.76 – 1.67 (m, 
4H), 1.64 (t, J = 5.3 Hz, 2H), 1.57 – 1.46 (m, 2H), 0.75 – 0.64 (m, 2H). 13C NMR (126 MHz, CDCl3) 
δ 179.2, 154.8, 149.5, 118.9, 110.9, 46.1, 43.8, 43.5, 39.9, 29.2, 28.4, 24.6, 23.5, 14.0. mp = 155-
160 ˚C(decomp).  
 Trimethylammonium acetoxymethyl bis(catecholato)silicate (905 mg, 
3.00 mmol, 60%).28 1H NMR (500 MHz, CDCl3) δ 9.55 (s, 1H), 6.71 (dd, J = 5.5, 3.4 Hz, 4H), 6.68 
– 6.63 (m, 4H), 3.98 (s, 2H), 3.04 (s, 9H), 1.80 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 172.9, 149.5, 
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119.1, 110.9, 58.3, 46.3, 21.1. mp = 150-155 ˚C(decomp).  HRMS calculated for [C15H13O6Si
-]: 
317.0487 found 317.0487 IR (neat, cm-1): 3050, 1720, 1484, 1355, 1295, 1236, 1217, 1149, 1098, 
1038, 1016, 982, 836, 776, 735, 676, 647, 604, 586, 522, 479. 
 Trimethylammonium 3-methoxypropyl bis(catecholato)silicate 
(1.48 g, 4.40 mmol, 88%).10d 1H NMR (500 MHz, CDCl3) δ 10.17 (s, 1H), 6.70 (dd, J = 5.6, 3.5 
Hz, 4H), 6.64 (dd, J = 5.7, 3.4 Hz, 4H), 3.19 (s, 3H), 3.17 (d, J = 7.1 Hz, 2H), 2.91 (s, 9H), 1.56 
(dq, J = 11.9, 7.2 Hz, 2H), 0.71 – 0.60 (m, 2H). 13C NMR (126 MHz, CDCl3) δ 149.5, 118.9, 110.9, 
75.9, 58.4, 46.2, 24.7, 12.6. mp = 145-150 ˚C (decomp).   
 Trimethylammonium 3-cyanopropyl bis(catecholato)silicate (1.34g, 
4.50 mmol, 90%).12 1H NMR (500 MHz, CDCl3) δ 8.94 (s, 2H), 6.71 (dd, J = 5.7, 3.5 Hz, 4H), 6.68 
– 6.63 (m, 4H), 2.84 (s, 10H), 2.17 (t, J = 7.1 Hz, 2H), 1.64 (ddt, J = 7.3, 7.3, 7.1 Hz, 2H), 0.84 – 
0.76 (m, 2H). 13C NMR (126 MHz, CDCl3) δ 149.2, 119.2, 115.7, 111.0, 46.2, 21.1, 20.1, 16.2. mp 
= 163-169 ˚C(decomp). 
 
 Trimethylammonium 3-(heptafluoroisopropoxy)propyl 
bis(catecholato)silicate (1.45 g, 3.40 mmol, 68%). 1H NMR (500 MHz, CDCl3) δ 9.89 (s, 1H), 6.72 
(dd, J = 5.6, 3.6 Hz, 4H), 6.66 (dd, J = 5.6, 3.6 Hz, 4H), 3.80 (t, J = 6.9 Hz, 2H), 2.92 (s, 9H), 1.68 
(tt, J = 12.5, 7.1 Hz, 2H), 0.75 – 0.64 (m, 2H). 13C NMR (126 MHz, CDCl3) δ 149.3, 119.1, 111.0, 
70.2, 46.2, 24.6, 12.0. 19F NMR (471 MHz, CDCl3) δ -78.90 (d, J = 2.8 Hz), -141.15 – -141.57 (m). 
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mp = 130-140 ˚C(decomp). No desired peak found in HRMS, probably because of its instability in 
ESI environment. IR (neat, cm-1): 3071,1486, 1435, 1347, 1329, 1243, 1222, 1180, 1152, 1096, 
1003, 985, 889, 860, 831, 764, 736, 671, 588, 517. Two carbons are missing possibly because of 
the fluorines. 
 Trimethylammonium 5-hexenyl bis(catecholato)silicate (1.40 g, 
4.50 mmol, 90%). 1H NMR (500 MHz, CDCl3) δ 9.67 (s, 1H), 6.67 (ddd, J = 23.2, 5.6, 3.5 Hz, 8H), 
5.70 (ddt, J = 17.0, 10.1, 6.7 Hz, 1H), 4.94 – 4.72 (m, 2H), 2.88 (s, 9H), 1.90 (q, J = 7.1 Hz, 2H), 
1.41 – 1.17 (m, 4H), 0.69 (dd, J = 9.3, 6.9 Hz, 2H). 13C NMR (126 MHz, CDCl3) δ 149.3, 139.5, 
118.7, 113.6, 110.7, 46.0, 33.5, 32.4, 23.9, 16.6. mp = 160-166 ˚C(decomp).  HRMS calculated for 
C18H19O4Si [M-HNMe3]
-: 327.1053; found: 327.1029. IR (neat, cm-1): 3045, 2923, 1639, 1599, 
1485, 1411, 1355, 1243, 1146, 1101, 1054, 1017, 983, 915, 897, 822, 731, 596, 525, 485. 
N-Phenethylcyclohexanecarboxamide (1).29 Prepared from 
triethylammonium cyclohexylbis(catecholato)silicate (214.5 mg) and phenethyl isocyanate (147.2 
mg). Product was purified by a gradient of 0 to 20% of EtOAc/hexanes mixture and was obtained 
as a white solid (85.6 mg, 0.37 mmol, 74%). mp = 90-92 ˚C 1H NMR (500 MHz, CDCl3) δ 7.34 – 
7.29 (m, 2H), 7.25 – 7.21 (m, 1H), 7.19 (d, J = 7.5 Hz, 2H), 5.39 (s, 1H), 3.55 – 3.47 (m, 2H), 2.81 
(t, J = 6.9 Hz, 2H), 2.00 (tt, J = 12.1, 3.5 Hz, 1H), 1.78 (dd, J = 19.4, 11.6 Hz, 4H), 1.65 (d, J = 9.8 
Hz, 1H), 1.38 (q, J = 11.6, 11.2 Hz, 2H), 1.22 (qd, J = 15.6, 14.3, 6.3 Hz, 3H).13C NMR (126 MHz, 
CDCl3) δ 176.14, 139.15, 128.93, 128.73, 126.59, 45.67, 40.48, 35.86, 29.80, 25.86. 
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 N-Cyclohexylcyclohexanecarboxamide (2).30 Prepared from 
triethylammonium cyclohexylbis(catecholato)silicate (214.5 mg) and cyclohexyl isocyanate (125.2 
mg). Product was purified by a gradient of 0 to 20% of EtOAc/hexanes mixture and was obtained 
as a white solid (80.6 mg, 0.39 mmol, 77%). mp = 162-164 ˚C. 1H-NMR(500 MHz, CDCl3) 
1H 
NMR (500 MHz, CDCl3) δ 5.24 (s, 1H), 3.81 – 3.72 (m, 1H), 2.02 (tt, J = 11.8, 3.5 Hz, 1H), 1.90 
(dd, J = 12.0, 3.5 Hz, 2H), 1.85 (d, J = 12.8 Hz, 2H), 1.79 (d, J = 11.4 Hz, 2H), 1.71 (d, J = 4.2 Hz, 
1H), 1.68 (s, 2H), 1.62 (d, J = 13.0 Hz, 1H), 1.40 (m, 4H), 1.26 (t, J = 11.8 Hz, 3H), 1.22 – 1.14 
(m, 1H), 1.14 – 1.06 (m, 2H). 13C NMR (126 MHz, CDCl3) δ 175.2, 77.4, 76.9, 47.8, 45.9, 33.4, 
29.9, 25.9, 25.7, 25.0. 
 N-(tert-Butyl)cyclohexanecarboxamide (3).5 Prepared from triethylammonium 
cyclohexylbis(catecholato)silicate (214.5 mg) and tert-butyl isocyanate (99.1 mg). Product was 
purified by a gradient of 0 to 20% of EtOAc/hexanes mixture and was obtained as a white solid 
(64.2 mg, 0.35 mmol, 70%). mp = 155-157 ˚C. 1H-NMR (500 MHz, CDCl3)
 δ 5.20 (s, 1H), 1.98 – 
1.89 (m, 1H), 1.80 (t, J = 16.2 Hz, 4H), 1.66 (s, 1H), 1.40 (m, 2H), 1.34 (s, 9H), 1.24 (m, 3H). 13C 
NMR (126 MHz, CDCl3) δ 175.7, 50.9, 46.5, 29.9, 29.7, 29.0, 25.9. 
 
  Ethyl (Cyclohexanecarbonyl)glycinate (4).31 Prepared from 
triethylammonium cyclohexylbis(catecholato)silicate (214.5 mg) and ethyl isocyanatoacetate 
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(129.1 mg). Product was purified by a gradient of 0 to 35% of EtOAc/hexanes mixture and was 
obtained as a white solid (56.5 mg, 0.27 mmol, 53%). mp = 81-83 ˚C. 1H NMR (500 MHz, CDCl3) 
δ 5.93 (s, 1H), 4.22 (q, J = 7.1 Hz, 2H), 4.03 (d, J = 5.1 Hz, 2H), 2.16 (tt, J = 11.7, 3.5 Hz, 1H), 
1.89 (d, J = 12.8 Hz, 2H), 1.83 – 1.75 (m, 2H), 1.68 (d, J = 10.7 Hz, 1H), 1.45 (m, 2H), 1.33 – 1.19 
(m, 6H). 13C NMR (126 MHz, CDCl3) δ 176.3, 170.4, 61.6, 45.3, 41.4, 29.7, 25.9, 25.8, 14.3. 
N-Allyl-3-phenylpropanamide (5).132 Prepared from triethylammonium 
phenethylbis(catecholato)silicate (225.8 mg) and allyl isocyanate (83.1 mg). Product was purified 
by a gradient of 0 to 20% of EtOAc/hexanes mixture and was obtained as a white solid (72.8 mg, 
0.39 mmol, 77%). mp = 38-40 ˚C. 1H-NMR (500 MHz, CDCl3): δ 7.40 – 7.27 (m, 2H), 7.24 – 7.15 
(m, 3H), 5.89 – 5.70 (m, 1H), 5.36 (s, 1H), 5.20 – 4.94 (m, 2H), 4.05 – 3.75 (m, 2H), 2.98 (t, J = 
7.7 Hz, 2H), 2.50 (d, J = 8.4 Hz, 2H). 13C NMR (126 MHz, CDCl3) δ 172.0, 141.0, 134.3, 128.6, 
128.5, 126.4, 116.4, 42.0, 38.6, 31.8. 
N-(3-Hydroxypropyl)3-phenylpropanamide(6). Prepared from 
triethylammonium phenethylbis(catecholato)silicate (225.8 mg) and 3-(Triethoxylsilyl)propyl 
isocyanate (83.1 mg) followed by Tamao-Fleming oxidation.19 Product was purified by a gradient 
of 0 to 100% of EtOAc/hexanes mixture and was obtained as a white solid (70.6 mg, 0.34 mmol, 
68%). mp = 46-49 ˚C. 1H NMR (500 MHz, CDCl3) δ 7.33 – 7.27 (m, 2H), 7.21 (q, J = 2.7 Hz, 2H), 
7.20 (t, J = 1.4 Hz, 1H), 3.52 (t, J = 5.6 Hz, 2H), 3.37 (q, J = 6.1 Hz, 2H), 2.97 (t, J = 7.6 Hz, 2H), 
2.50 (t, J = 7.6 Hz, 2H), 1.59 (m, 2H). 13C NMR (126 MHz, CDCl3) δ 173.4, 140.8, 128.7, 128.5, 
126.5, 59.4, 38.6, 36.4, 32.4, 31.9. HRMS calculated for [C12H17NO2]: 207.1259, found 207.1247. 
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IR (neat, cm-1): 3295, 2928, 2874, 1639, 1604, 1542, 1497, 1453, 1423, 1369, 1307, 1228, 1058, 
1034, 963, 748, 698, 592, 559, 497. 
N-Cyclohexyl-3-phenylpropanethioamide (7). Prepared from 
triethylammonium phenethylbis(catecholato)silicate (225.8 mg) and cyclohexyl isothiocyanate 
(141.23 mg). Product was purified by a gradient of 0 to 100% of EtOAc/hexanes mixture and was 
obtained as a white solid (64.3 mg, 0.26 mmol, 52%). mp = 81-86 ˚C.  1H NMR (500 MHz, CDCl3) 
δ 7.31 – 7.27 (m, 2H), 7.21 (dt, J = 5.1, 2.6 Hz, 3H), 6.65 (s, 1H), 4.27 (tt, J = 8.2, 4.1 Hz, 1H), 
3.10 (t, J = 7.2 Hz, 2H), 2.88 (t, J = 7.2 Hz, 2H), 1.95 – 1.86 (m, 2H), 1.67 – 1.56 (m, 3H), 1.41 – 
1.29 (m, 2H), 1.12 (q, J = 13.1, 10.9 Hz, 1H), 1.03 – 0.94 (m, 2H). 13C NMR (126 MHz, CDCl3) δ 
202.3, 140.3, 128.7, 128.7, 126.6, 54.2, 49.6, 35.6, 31.5, 25.5, 24.7. HRMS calculated for 
[C15H21NS]: 247.1395, found 247.1378. IR (neat, cm
-1): 3225, 2925, 2853, 1543, 1495, 1450, 1436, 
1422, 1364, 1343, 1116, 1108, 1089, 1073, 751, 726, 699, 638, 602, 561. 
 N-(2,6-Diisopropylphenyl)cyclohexanecarboxamide (8).33 Prepared from 
triethylammonium cyclohexylbis(catecholato)silicate (214.5 mg) and 2,6-diisopropylphenyl 
isocyanate (101.6 mg). Product was purified by a gradient of 0 to 20% of EtOAc/hexanes mixture 
and was obtained as a white solid (94.9 mg, 0.33 mmol, 66%). mp > 260 ˚C. 1H NMR (500 MHz, 
CDCl3) δ 7.29 (t, J = 7.8 Hz, 3H), 7.16 (d, J = 7.7 Hz, 2H), 6.60 (s, 1H), 3.04 (m, J = 6.9 Hz, 2H), 
2.36 (tt, J = 11.8, 7.1, 3.5 Hz, 1H), 2.06 (d, J = 12.9 Hz, 2H), 1.87 (dd, J = 13.5, 4.3 Hz, 2H), 1.74 
(d, J = 12.4 Hz, 1H), 1.59 (dt, J = 12.4, 3.3 Hz, 3H), 1.42 – 1.27 (m, 3H), 1.19 (d, J = 6.8 Hz, 12H). 
13C-NMR (126 MHz, CDCl3) δ 175.2, 146.4, 131.3, 128.4, 123.5, 46.1, 30.1, 28.9, 26.0, 25.9, 23.7. 
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 N-(4-Acetylphenyl)cyclohexanecarboxamide(9). Prepared from 
triethylammonium cyclohexylbis(catecholato)silicate (214.5 mg) and 4-acetylphenyl isocyanate 
(80.5 mg). Product was purified by a gradient of 0 to 20% of EtOAc/hexanes mixture and was 
obtained as a white solid (62.6 mg, 0.26 mmol, 51%). mp = 165-168 ˚C. 1H-NMR (500 MHz, 
CDCl3): 7.97 – 7.90 (m, 2H), 7.68 – 7.60 (m, 2H), 7.34 (s, 1H), 2.57 (s, 3H), 2.26 (tt, J = 11.8, 3.5 
Hz, 1H), 2.01 – 1.93 (m, 2H), 1.89 – 1.81 (m, 2H), 1.72 (d, J = 10.5 Hz, 1H), 1.55 (m, 2H), 1.38 – 
1.20 (m, 3H). 13C NMR (126 MHz, CDCl3) δ 197.16, 174.87, 142.71, 132.80, 129.88, 118.97, 
46.77, 29.72, 26.59, 25.73. HRMS calculated for [C15H19NO2]: 245.1416, found 245.1405. IR (neat, 
cm-1): 3500, 2930, 2751, 1674, 1659, 1605, 1586, 1515, 1403, 1365, 1334, 1319, 1297, 1270, 1255, 
1194, 1174, 954, 823, 694, 678, 593, 584. 
 N-(3-Chlorophenyl)cyclohexanecarboxamide (10).34 Prepared from 
triethylammonium cyclohexylbis(catecholato)silicate (214.5 mg) and 3-chlorophenyl isocyanate 
(76.8 mg). Product was purified by a gradient of 0 to 20% of EtOAc/hexanes mixture and was 
obtained as a white solid (71.3 mg, 0.30 mmol, 60%). mp = 113-116 ˚C. 1H-NMR (500 MHz, 
CDCl3): δ 7.67 (s, 1H), 7.35 (d, J = 8.2 Hz, 1H), 7.23 (t, J = 8.1 Hz, 1H), 7.07 (d, J = 8.4 Hz, 2H), 
2.26 – 2.17 (m, 1H), 1.95 (d, J = 13.1 Hz, 2H), 1.85 (d, J = 11.8 Hz, 2H), 1.71 (d, J = 10.8 Hz, 1H), 
1.54 (dt, J = 15.7, 10.1 Hz, 4H), 1.35 – 1.21 (m, 3H). 13C NMR (126 MHz, CDCl3) δ 174.7, 139.4, 
134.8, 130.1, 124.2, 120.0, 117.8, 46.7, 29.7, 25.8, 25.7. 
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 N-(4-Cyanophenyl)cyclohexanecarboxamide(11). Prepared from 
triethylammonium cyclohexylbis(catecholato)silicate (214.5 mg) and 4-cyanophenyl isocyanate 
(72.1 mg). Product was purified by a gradient of 0 to 20% of EtOAc/hexanes mixture and was 
obtained as a white solid (50.2 mg, 0.22 mmol, 44%). mp = 132-134 ˚C. 1H-NMR (500 MHz, 
CDCl3) δ 7.67 (d, J = 8.7 Hz, 2H), 7.60 (d, J = 8.7 Hz, 2H), 7.41 (s, 1H), 2.26 (tt, J = 11.7, 3.5 Hz, 
1H), 2.01 – 1.91 (m, 2H), 1.85 (m, 2H), 1.76 – 1.67 (m, 1H), 1.54 (m, 2H), 1.29 (m, 3H). 13C NMR 
(126 MHz, CDCl3) δ 174.9, 142.3, 133.4, 119.6, 119.0, 107.0, 46.8, 29.7, 25.7. HRMS calculated 
for [C14H16N2O]: 228.1263, found 228.1254. IR (neat, cm
-1): 3300, 2919, 2853, 1668, 1590, 1521, 
1509, 1449, 1407, 1381, 1338, 1320, 1303, 1253, 1193, 1172, 952, 836, 827, 714, 547. 
 Dimethyl 5-(Cyclohexanecarboxamido)isophthalate(12). Prepared 
from triethylammonium cyclohexylbis(catecholato)silicate (214.5 mg) and dimethyl 5-
isocyanatoisophthlate (117.6 mg). Product was purified by a gradient of 0 to 40% of 
EtOAc/hexanes mixture and was obtained as a white solid (79.8 mg, 0.25 mmol, 50%). mp = 152-
155 ˚C 1H-NMR (500 MHz, CDCl3) δ 8.41 (dd, J = 11.1, 1.6 Hz, 3H), 3.94 (s, 5H), 2.26 (tt, J = 
11.6, 3.5 Hz, 1H), 1.98 (d, J = 13.1 Hz, 2H), 1.86 (d, J = 12.3 Hz, 2H), 1.73 (d, J = 11.0 Hz, 1H), 
1.57 (m, 2H), 1.32 (m 3H). 13C NMR (126 MHz, CDCl3) δ 174.75, 166.10, 138.76, 131.48, 126.28, 
124.86, 52.60, 46.56, 29.72, 25.76, 25.73. HRMS calculated for [C17H21NO5]: 319.1420, found 
319.1420. IR (neat, cm-1): 3257, 2934, 1726, 1657, 1537, 1436, 1335, 1257, 1230, 1193, 1135, 
1121, 1001, 962, 902, 880, 749, 720, 669, 604. 
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 N-(Thiophen-2-yl)cyclohexanecarboxamide(13). Prepared from 
triethylammonium cyclohexylbis(catecholato)silicate (214.5 mg) and thienyl isocyanate (62.6 mg). 
Product was purified by a gradient of 0 to 20% of EtOAc/hexanes mixture and was obtained as a 
yellow solid (31.4 mg, 0.15 mmol, 30%). mp = 236-240˚C. (decomp).  1H-NMR (500 MHz, 
CDCl3): δ 7.88 (s, 1H), 6.86 (dd, J = 5.5, 1.4 Hz, 1H), 6.83 (dd, J = 5.5, 3.7 Hz, 1H), 6.62 (dd, J = 
3.7, 1.5 Hz, 1H), 2.27 (tt, J = 11.8, 3.6 Hz, 1H), 2.00 – 1.91 (m, 2H), 1.83 (dt, J = 12.2, 3.4 Hz, 
2H), 1.74 – 1.66 (m, 1H), 1.54 (m, 2H), 1.36 – 1.20 (m, 3H). 13C NMR (126 MHz, CDCl3) δ 172.7, 
139.2, 123.9, 118.0, 111.5, 45.5, 29.7, 25.8, 25.7. HRMS calculated for [C11H15NOS]: 209.0874, 
found 209.0883. IR (neat, cm-1): 3257, 2930, 2850, 1646, 1571, 1505, 1445, 1389, 1347, 1336, 
1316, 1272, 1230, 1174, 957, 894, 845, 805, 726, 680. 
 N-Phenylcyclohexanecarboxamide (14).35 Prepared from triethylammonium 
cyclohexylbis(catecholato)silicate (214.5 mg) and phenyl isocyanate (59.6 mg). Product was 
purified by a gradient of 0 to 20% of EtOAc/hexanes mixture and was obtained as a white solid 
(66.1 mg, 0.33 mmol, 65%). mp = 142-144 ˚C. 1H-NMR (500 MHz, CDCl3): δ 7.52 (d, J = 8.0 Hz, 
2H), 7.31 (t, J = 7.8 Hz, 2H), 7.14 (s, 1H), 7.09 (t, J = 7.4 Hz, 1H), 2.22 (tt, J = 11.9, 3.6 Hz, 1H), 
2.00 – 1.93 (m, 2H), 1.84 (dd, J = 12.3, 4.3 Hz, 2H), 1.71 (d, J = 10.6 Hz, 1H), 1.60 – 1.50 (m, 2H), 




 N-(4-Methoxyphenyl)cyclohexanecarboxamide (15).36 Prepared from 
triethylammonium cyclohexylbis(catecholato)silicate (214.5 mg) and 4-methoxyphenyl isocyanate 
(74.6 mg). Product was purified by a gradient of 0 to 30% of EtOAc/hexanes mixture and was 
obtained as a white solid (49.0 mg, 0.21 mmol, 42%). mp = 146-148 ˚C. 1H-NMR (500 MHz, 
CDCl3): 7.41 (d, J = 8.7 Hz, 2H), 7.00 (s, 1H), 6.85 (d, J = 8.6 Hz, 2H), 3.79 (s, 3H), 2.20 (t, J = 
11.9 Hz, 1H), 1.96 (d, J = 13.0 Hz, 2H), 1.84 (d, J = 12.1 Hz, 2H), 1.71 (d, J = 10.7 Hz, 1H), 1.56 
(d, J = 11.6 Hz, 1H), 1.35 – 1.23 (m, 3H). 13C NMR (126 MHz, CDCl3) δ 174.25, 156.4, 131.3, 
121.7, 114.2, 77.4, 77.4, 77.2, 76.9, 55.6, 46.6, 29.9, 25.9. 
4-Cyano-N-phenylbutanamide (16).37 Prepared from trimethylammonium 3-
cyanopropylbis(catecholato)silicate (186.1 mg) and phenyl isocyanate (59.6 mg). Product was 
purified by a gradient of 0 to 40% of EtOAc/hexanes mixture and was obtained as a white solid 
(45.2 mg, 0.24 mmol, 48%). mp = 57-60 ˚C. 1H-NMR (500 MHz, CDCl3) 7.58 (d, J = 8.7 Hz, 1H), 
7.51 (d, J = 8.0 Hz, 2H), 7.32 (t, J = 7.9 Hz, 2H), 7.12 (t, J = 7.4 Hz, 1H), 2.53 (dt, J = 14.2, 6.9 
Hz, 4H), 2.07 (ddt, J = 14.2, 7.4, 6.9 Hz, 2H). 13C NMR (126 MHz, CDCl3) δ 169.4, 137.8, 129.2, 
124.7, 120.1, 119.5, 35.1, 21.0, 16.8.  
 N-Cyclohexyl-3-phenylpropanamide (17).38 Prepared from 
triethylammonium phenethylbis(catecholato)silicate (225.8 mg) and cyclohexyl isocyanate (125.2 
mg). Product was purified by a gradient of 0 to 20% of EtOAc/hexanes mixture and was obtained 
as a white solid (97.2 mg, 0.42 mmol, 84%). mp = 92-95 ˚C.   1H NMR (500 MHz, CDCl3) δ 7.33 
– 7.25 (m, 2H), 7.20 (dd, J = 7.5, 5.3 Hz, 3H), 5.17 (s, 1H), 3.75 (tt, J = 10.8, 4.2 Hz, 1H), 2.96 (t, 
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J = 7.7 Hz, 2H), 2.44 (t, J = 7.6 Hz, 2H), 1.88 – 1.81 (m, 2H), 1.70 – 1.59 (m, 3H), 1.35 (tt, J = 
13.3, 3.7 Hz, 2H), 1.14 (td, J = 12.1, 10.4, 4.7 Hz, 1H), 1.02 (m, 2H). 13C NMR (126 MHz, CDCl3) 
δ 171.2, 141.1, 128.6, 128.5, 126.3, 48.2, 39.0, 33.3, 32.0, 25.7, 24.9. 
 4-((Perfluoropropan-2-yl)oxy)-N-phenylbutanamide(18). Prepared 
from trimethylammonium 3-(heptafluoroisopropoxy)propylbis(catecholato)silicate (375.1 mg) and 
phenyl isocyanate (59.6 mg). Product was purified by a gradient of 0 to 20% of EtOAc/hexanes 
mixture and was obtained as a light-yellow oil (83.3 mg, 0.24 mmol, 48%).  1H-NMR (500 MHz, 
CDCl3) δ 7.49 (d, J = 7.9 Hz, 2H), 7.33 (t, J = 7.9 Hz, 2H), 7.13 (d, J = 7.5 Hz, 2H), 7.11 (s, 1H), 
4.12 (t, J = 5.9 Hz, 2H), 2.50 (t, J = 7.2 Hz, 2H), 2.14 (tt, J = 7.1, 5.8 Hz, 2H). 13C NMR (126 MHz, 
CDCl3) δ 170.0, 137.8, 129.2, 124.6, 120.1, 66.6, 33.0, 25.0.
 19F NMR (471 MHz, CDCl3) δ -79.01 
(d, J = 2.0 Hz, 6F), -141.66 – -142.87 (m, 1F). HRMS calculated for [C13H12F7NO2+H
+]: 348.0835, 
found 348.0810. IR (neat, cm-1): 3275, 2970, 1631, 1594, 1525, 1501, 1474, 1446, 1421, 1374, 
1366, 1333, 1245, 1175, 1147, 1131, 1055, 745, 692, 603, 506, 497. Two carbons are missing 
possibly because of the fluorines. 
4-(Perfluorophenyl)-N-phenylbutanamide(19). Prepared from 
triethylammonium 3-(pentafluorophenyl)propylbis(catecholato)silicate (284.8 mg) and phenyl 
isocyanate (59.6 mg). Product was purified by a gradient of 0 to 20% of EtOAc/hexanes mixture 
and was obtained as a white solid (82.5 mg, 0.25 mmol, 50%). mp = 116-120 ˚C. 1H-NMR (500 
MHz, CDCl3) δ 7.49 (d, J = 8.0 Hz, 2H), 7.32 (t, J = 7.8 Hz, 2H), 7.15 (s, 1H), 7.11 (t, J = 7.4 Hz, 
1H), 2.81 (t, J = 7.5 Hz, 2H), 2.39 (t, J = 7.5 Hz, 2H), 2.05 (m, 2H). 13C NMR (126 MHz, CDCl3) 
δ 170.0, 145.0 (dt, J = 245.9, 15.7, 3.9 Hz), 139.5(ddd, J = 246.5, 7.4, 2.1 Hz), 137.6, 137.4 (ddd, 
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J = 250.7, 17.5, 3.1 Hz), 128.9, 124.3, 119.8, 114.2 (dt, J = 16.6, 5.1 Hz), 36.3, 24.6, 21.6. 19F NMR 
(471 MHz, CDCl3) δ -143.97 (dd, J = 22.3, 8.4 Hz), -157.31 (t, J = 20.8 Hz), -162.56 (td, J = 21.6, 
8.3 Hz). HRMS calculated for [C16H12F5NO]: 329.0839, found 329.0844. IR (neat, cm
-1): 3250, 
1657, 1598, 1551, 1521, 1498, 1445, 1432, 1370, 1313, 1299, 1261, 1203, 1121, 1069, 961, 929, 
906, 756, 698, 508. 
4-Methoxy-N-phenylbutanamide(20). Prepared from trimethylammonium 
3-methoxypropylbis(catecholato)silicate (188.6 mg) and phenyl isocyanate (59.6 mg). Product was 
purified by a gradient of 0 to 30% of EtOAc/hexanes mixture and was obtained as colorless oil 
(30.0 mg, 0.16 mmol, 31%). 1H NMR (500 MHz, CDCl3) δ 7.71 (s, 1H), 7.51 (d, J = 8.0 Hz, 2H), 
7.31 (t, J = 7.9 Hz, 2H), 7.09 (t, J = 7.3 Hz, 1H), 3.50 (t, J = 5.8 Hz, 2H), 3.39 (s, 3H), 2.48 (t, J = 
6.9 Hz, 2H), 2.00 (tt, J = 6.9, 5.8 Hz, 2H). 13C NMR (126 MHz, CDCl3) δ 171.3, 138.3, 129.1, 
124.2, 119.8, 72.0, 58.8, 34.9, 25.5. HRMS calculated for [C11H15NO2]: 193.1102, found 193.1082. 
IR (neat, cm-1): 3271, 3250, 2930, 2875, 1656, 1597, 1543, 1500, 1490, 1439, 1379, 1335, 1307, 
1296, 1255, 1244, 1205, 1117, 1071, 1025, 886, 756, 694, 508. 
2-Oxo-2-(phenylamino)ethyl acetate(21). Prepared from trimethylammonium 
acetoxymethyl bis(catecholato)silicate (158.5 mg) and phenyl isocyanate (59.6 mg). Product was 
purified by a gradient of 0 to 40% of EtOAc/hexanes mixture and was obtained as a white solid 
(70.1 mg, 0.36 mmol, 72%). mp = 78-81 ˚C. 1H-NMR (500 MHz, CDCl3): δ 7.77 (s, 1H), 7.54 (d, 
J = 8.0 Hz, 1H), 7.36 (t, J = 7.7 Hz, 1H), 7.16 (t, J = 7.4 Hz, 1H), 4.70 (s, 1H), 2.24 (s, 1H). 13C 
NMR (126 MHz, CDCl3) δ 169.4, 165.1, 136.8, 129.2, 125.1, 120.3, 63.4, 20.9. HRMS calculated 
for [C10H11NO3]: 193.0739, found 193.0728. IR (neat, cm
-1): 3334, 1726, 1689, 1605, 1551, 1502, 




carboxamide(22). Prepared from trimethylammonium 2-oxo-N-(4-oxo-4-
(bis(catecholato)silicate)butyl)azepane-1-carboxamide (250.6 mg) and phenyl isocyanate (59.6 
mg). Product was purified by a gradient of 0 to 40% of EtOAc/hexanes mixture and was obtained 
as an off-white solid (84.1 mg, 0.27 mmol, 53%). mp = 98-101˚C. 1H-NMR (500 MHz, CDCl3): δ 
9.48 (t, J = 6.3 Hz, 1H), 8.59 (s, 1H), 7.60 (d, J = 8.0 Hz, 2H), 7.30 (t, J = 7.8 Hz, 2H), 7.08 (t, J = 
7.4 Hz, 1H), 4.06 – 3.91 (m, 2H), 3.42 (dd, J = 6.2, 6.2 Hz, 2H), 2.75 – 2.64 (m, 2H), 2.38 (t, J = 
6.8 Hz, 2H), 1.95 (tt, J = 6.8, 6.2 Hz, 2H), 1.80 – 1.69 (m, 7H). 13C NMR (126 MHz, CDCl3) δ 
179.7, 171.1, 156.2, 138.5, 129.0, 124.0, 119.8, 44.1, 39.8, 39.4, 34.9, 29.2, 28.5, 26.9, 23.6. HRMS 
calculated for [C17H23N3O3+Na
+]:340.1637, found 340.1662. IR (neat, cm-1): 3348, 3250, 2928, 
2800, 1694, 1668, 1597, 1520, 1500, 1462, 1440, 1397, 1374, 1311, 1300, 1246, 1159, 1084, 969, 
847, 754, 689, 659, 585. 
N-Phenyl-4-(1H-pyrrol-1-yl)butanamide (23). Prepared from 
trimethylammonium 3-(N-pyrrole)propyl bis(catecholato)silicate (206.2 mg) and phenyl 
isocyanate (59.6 mg). Product was purified by a gradient of 0 to 40% of EtOAc/hexanes mixture 
and was obtained as a white solid (64.1 mg, 0.28 mmol, 56%). mp = 71-75 ˚C. 1H NMR (500 MHz, 
CDCl3) δ 7.48 (d, J = 7.8 Hz, 2H), 7.32 (t, J = 7.2 Hz, 2H), 7.11 (t, J = 7.5 Hz, 1H), 7.00 (s, 1H), 
6.71 – 6.61 (m, 2H), 6.17 (d, J = 2.2 Hz, 2H), 4.01 (t, J = 6.5 Hz, 2H), 2.26 (t, J = 7.1 Hz, 2H), 2.20 
(q, J = 6.6 Hz, 2H). 13C NMR (126 MHz, CDCl3) δ 170.6, 137.8, 129.1, 124.5, 120.7, 120.1, 108.4, 
48.5, 33.8, 27.0. HRMS calculated for [C14H16N2O+H
+]: 229.1341, found 229.1364. IR (neat, cm-
1): 3335, 1696, 1597, 1534, 1501, 1440, 1368, 1312, 1279, 1263, 1241, 1167, 1085, 754, 730, 712, 
694, 633, 619, 505. 
 
 61 
4-Oxo-4-(phenylamino)butyl Acetate (24). Prepared from 
triethylammonium 3-acetoxypropyl bis(catecholato)silicate (223.8 mg) and phenyl isocyanate 
(59.6 mg). Product was purified by a gradient of 0 to 40% of EtOAc/hexanes mixture and was 
obtained as a colorless oil (45.5 mg, 0.22 mmol, 41%). 1H NMR (500 MHz, CDCl3) δ 7.52 (d, J = 
7.9 Hz, 2H), 7.32 (t, J = 7.5 Hz, 3H), 7.11 (t, J = 7.4 Hz, 1H), 4.19 (t, J = 6.0 Hz, 2H), 2.43 (t, J = 
7.1 Hz, 2H), 2.09 (t, J = 7.0 Hz, 2H), 2.06 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 171.5, 170.5, 
138.0, 129.1, 124.4, 119.9, 63.7, 34.1, 24.8, 21.1. HRMS calculated for [C12H15NO3]: 221.1052, 
found 221.1059. IR (neat, cm-1): 3312, 3138, 3061, 2963, 1738, 1663, 1600, 1543, 1499, 1443, 
1388, 1366, 1310, 1241, 1178, 1042, 756, 694, 607, 507. 
N-Phenethyl-3-phenylpropanamide (25).39 Prepared from 
triethylammonium phenethylbis(catecholato)silicate (225.8 mg) and phenyl isocyanate (59.6 mg). 
Product was purified by a gradient of 0 to 20% of EtOAc/hexanes mixture and was obtained as a 
white solid (91.3 mg, 0.36 mmol, 72%). mp = 91-93 ˚C. 1H NMR (500 MHz, CDCl3) δ 7.28 (t, J = 
6.0 Hz, 4H), 7.21 (dt, J = 14.6, 7.2 Hz, 4H), 7.09 (d, J = 7.5 Hz, 2H), 5.36 (s, 1H), 3.48 (t, J = 6.6 
Hz, 2H), 2.94 (t, J = 7.7 Hz, 2H), 2.74 (t, J = 6.9 Hz, 2H), 2.42 (t, J = 7.6 Hz, 2H). 13C NMR (126 
MHz, CDCl3) δ 172.1, 141.0, 139.0, 129.0, 128.8, 128.7, 128.5, 126.6, 126.4, 40.7, 38.7, 35.8, 31.8. 
N-(2,6-Diisopropylphenyl)-3-(pyridin-2-yl)propenamide (26). 
Prepared from triethylammonium 2-pyridylethyl(catecholato)silicate (226.5 mg) and 2,6-
diisopropylphenyl isocyanate (101.6 mg). Product was purified by a gradient of 0 to 40% of 
EtOAc/hexanes mixture and was obtained as a white solid (68.3 mg, 0.22 mmol, 44%). mp = 115-
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118 ˚C. 1H-NMR (500 MHz, CDCl3 δ 8.52 (dd, J = 5.0, 1.8 Hz, 1H), 8.11 (d, J = 4.3 Hz, 1H), 7.64 
(td, J = 7.7, 1.9 Hz, 1H), 7.27 (d, J = 1.8 Hz, 1H), 7.17 (dd, J = 7.6, 4.4 Hz, 1H), 7.14 (d, J = 7.7 
Hz, 2H), 3.32 – 3.21 (m, 2H), 2.98 – 2.94 (m, 3H), 2.94 – 2.87 (m, 3H), 1.11 (d, J = 6.9 Hz, 12H). 
13C NMR (126 MHz, CDCl3) δ 172.3, 160.6, 149.1, 146.3, 137.0, 131.6, 128.2, 123.9, 123.5, 121.8, 
35.6, 33.5, 28.8, 23.8. HRMS (EI) calculated for [C20H26N2O]: 310.2123, found 310.2111. IR (neat, 
cm-1): 3251, 2959, 2922, 1648, 1592, 1518, 1474, 1441, 1383, 1362, 1329, 1305, 1262, 796, 765, 
746, 707, 667, 627, 516. 
N-(tert-Butyl)-3-phenylpropanamide40(27) Prepared from triethylammonium 
phenethylbis(catecholato)silicate (225.8 mg) and tert-butyl isocyanate (83.1 mg). Product was 
purified by a gradient of 0 to 20% of EtOAc/hexanes mixture and was obtained as a white solid (61 
mg, 0.30 mmol, 59%). mp= 71-76 ˚C. 1H NMR (500 MHz, CDCl3) δ 7.33 – 7.24 (m, 2H), 7.20 (d, 
J = 8.3 Hz, 3H), 5.10 (s, 1H), 2.93 (t, J = 7.6 Hz, 2H), 2.38 (t, J = 7.6 Hz, 2H), 1.28 (s, 9H). 13C 
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Figure A1.1. 1H NMR (500 MHz, CDCl3) of trimethylammonium 3-(N-pyrrole)propyl 
bis(catecholato)silicate  
 





Figure A1.3. 1H NMR (500 MHz, CDCl3) of Trimethylammonium 2-Oxo-N-(4-Oxo-4-
(bis(catecholato)silicate)butyl)azepane-1-carboxamide  
 





Figure A1.5. 1H NMR (500 MHz, CDCl3) of Trimethylammonium acetoxymethyl 
bis(catecholato)silicate  
 





Figure A1.7. 1H NMR (500 MHz, CDCl3) of Trimethylammonium 3-methoxypropyl 
bis(catecholato)silicate  
 





Figure A1.9. 1H NMR (500 MHz, CDCl3) of Trimethylammonium 3-cyanopropyl 
bis(catecholato)silicate  
 





Figure A1.11. 1H NMR (500 MHz, CDCl3) of Trimethylammonium 3-
(heptafluoroisopropoxy)propyl bis(catecholato)silicate  
 













Figure A1.14. 1H NMR (500 MHz, CDCl3) of Trimethylammonium 5-hexenyl 
bis(catecholato)silicate 
 





Figure A1.16. 1H NMR (500 MHz, CDCl3) of N-Phenethylcyclohexanecarboxamide (1) 
 




Figure A1.18. 1H NMR (500 MHz, CDCl3) of N-Cyclohexylcyclohexanecarboxamide(2) 
  
Figure A1.19. 13C-NMR (126 MHz, CDCl3) of N-Cyclohexylcyclohexanecarboxamide(2)  
 
 78 
Figure A1.20. 1H NMR (500 MHz, CDCl3) of N-(tert-Butyl)cyclohexanecarboxamide(3)  
 




Figure A1.22. 1H NMR (500 MHz, CDCl3) of Ethyl (Cyclohexanecarbonyl)glycinate(4)  
 




Figure A1.24. 1H NMR (500 MHz, CDCl3) of N-Allyl-3-phenylpropanamide(5)  





Figure A1.26. 1H NMR (500 MHz, CDCl3) of N-(3-hydroxypropyl)-3-phenylpropanamide(6) 
 




Figure A1.28. 1H NMR (500 MHz, CDCl3) of N-Cyclohexyl-3-phenylpropanethioamide(7) 
 




Figure A1.30. 1H NMR (500 MHz, CDCl3) of N-(2,6-
Diisopropylphenyl)cyclohexanecarboxamide(8)  
 





Figure A1.32. 1H NMR (500 MHz, CDCl3) of N-(4-Acetylphenyl)cyclohexanecarboxamide (9) 
 




Figure A1.34. 1H NMR (500 MHz, CDCl3) of N-(3-Chlorophenyl)cyclohexanecarboxamide(10)  
 




Figure A1.36. 1H NMR (500 MHz, CDCl3) of N-(4-Cyanophenyl)cyclohexanecarboxamide(11)  
 




Figure A1.38. 1H NMR (500 MHz, CDCl3) of Dimethyl 5-
(cyclohexanecarboxamido)isophthalate(12)  
 





Figure A1.40. 1H NMR (500 MHz, CDCl3) of N-(thiophen-2-yl)cyclohexanecarboxamide(13)  
  




Figure A1.42. 1H NMR (500 MHz, CDCl3) of N-phenylcyclohexanecarboxamide(14)  
  




Figure A1.44. 1H NMR (500 MHz, CDCl3) of N-(4-Methoxyphenyl)cyclohexanecarboxamide(15) 
 





Figure A1.46. 1H NMR (500 MHz, CDCl3) of 4-Cyano-N-phenylbutanamide(16) 
 




Figure A1.48. 1H NMR (500 MHz, CDCl3) of N-Cyclohexyl-3-phenylpropanamide(17)  
 




Figure A1.50. 1H NMR (500 MHz, CDCl3) of 4-((Perfluoropropan-2-yl)oxy)-N-
phenylbutanamide(18)  
 



































Figure A1.53. 1H NMR (500 MHz, CDCl3) of 4-(Perfluorophenyl)-N-phenylbutanamide(19)   
 












Figure A1.56. 1H NMR (500 MHz, CDCl3) of 4-Methoxy-N-phenylbutanamide(20)   
 




Figure A1.58. 1H NMR (500 MHz, CDCl3) of 2-oxo-2-(phenylamino)ethyl acetate(21)  
 




Figure A1.60. 1H NMR (500 MHz, CDCl3) of 2-Oxo-N-(4-Oxo-4-(phenylamino)butyl)azepane-1-
carboxamide(22) 
 





Figure A1.62. 1H NMR (500 MHz, CDCl3) of N-phenyl-4-(1H-pyrrol-1-yl)butanamide(23)  
 




Figure A1.64. 1H NMR (500 MHz, CDCl3) of 4-oxo-4-(phenylamino)butyl acetate(24)  
 




Figure A1.66. 1H NMR (500 MHz, CDCl3) of N-phenethyl-3-phenylpropanamide(25)  
 




Figure A1.68. 1H NMR (500 MHz, CDCl3) of N-(2,6-Diisopropylphenyl)-3-(pyridin-2-
yl)propenamide(26)  
 





Figure A1.70. 1H NMR (500 MHz, CDCl3) of N-(tert-Butyl)-3-phenylpropanamide(27) 
 




Chapter 3. Merging Photoredox PCET with Nickel-Catalyzed Cross-Coupling: Cascade 
Amidoarylation of Unactivated Olefins 
3.1 Introduction 
The disclosure of photoredox/nickel dual-catalyzed amidation with isocyanates provided a 
complementary mechanistic approach compared to the conventional reductive coupling and 
nucleophilic addition approaches.‡ Moving forward, we sought to explore a more general reaction 
design that would facilitate the difunctionalization of ubiquitous unactivated C=C bonds. Thus, 
although photoredox/Ni dual catalysis has facilitated the construction of numerous challenging 
Csp2-Csp3
1-7 and Csp3-Csp3
8 bonds that are crucial to the synthetic organic chemistry community,9 
most of the radical precursors contain a traceless redox handle previously introduced via multi-step 
synthesis1,2,6,7 that is homolytically cleaved, generating the desired radical species. Ideally, if 
radicals were generated from native functional groups benefiting from innate reactivity, excellent 
atom- and step-efficiencies could be achieved, on top of the many other existing advantages 
associated with Ni/photoredox dual catalysis (i.e., mild reaction conditions, good chemoselectivity, 
reduced risks of side reactions, etc.).  
In this vein, significant achievements have been reached by merging hydrogen atom 
transfer (HAT) of activated C-H bonds with Ni-catalyzed cross-coupling reactions.3,4 However, 
there has been a lack of reports in which heteroatom-centered radicals, derived from the homolytic 
cleavage of heteroatom-hydrogen bonds, are used as initial intermediates in a sequence of 
transformations, leading to subsequent Csp2-Csp3 bond construction.
10 In fact, if the generation of 
such radicals could be coupled with a cyclization onto naturally-abundant olefins, one could not 
only maintain excellent atom-economy while accessing privileged heterocyclic scaffolds, but also 
transform relatively unreactive olefins to reactive, nucleophilic C-centered radicals, thereby 
 
 
‡ Reproduced in part from Zheng, S.; Gutiérrez-Bonet, Á.; Molander, G. A. Chem 2019, 5, 339 
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providing new opportunities for rapidly increasing molecular complexity via novel radical 
cyclization/cross-coupling paradigms. 
Owing to the prevalence of nitrogen-containing heterocycles in FDA-approved small-
molecule drugs,10 an investigation was undertaken to explore the applicability of amidyl radicals, 
generated via homolytic N-H cleavage, to synthesize nitrogen-containing heterocycles via radical 
cyclization/cross-coupling paradigm. The generation of amidyl radicals from N-H bonds has 
previously posed significant challenges because of their high stability (BDFE ~100 kcal/mol).11-14 
As a result, through a stepwise electron transfer and proton transfer (ET/PT), or PT/ET mechanism, 
amidyl radical formation was only achieved using strong oxidants (e.g., DMP,15 IBX,16 di-tert-
butyl peroxide17) at high temperatures (Figure 3.1),15,16,18 seriously compromising the applicability 
of the developed methods. Alternatively, the use of prefunctionalized amides19-21 [e.g., LG = Cl,22 
SPh,23 PTOC (pyridine-2-thione-N-oxycarbonyl),24 OAr,26 or SO2Ar
25] made amidyl radicals more 
accessible under various conditions (i.e., UV light, radical initiators, reductants). However, this 
approach posed numerous disadvantages, such as the requirement for multistep syntheses of the 
amide derivatives, poor stability of the functionalized amides, and the use of hazardous reagents, 
among others.   
In a seminal publication, the Knowles group reported the generation of amidyl radicals by 
merging concerted Proton-Coupled Electron Transfer (PCET) with photoredox catalysis (Figure 
3.1).13,26-28 After adoption of the biologically ubiquitous PCET mechanism,14,29 this challenging 
bond disconnection was realized under very mild conditions by emphasizing a much lower-barrier 
concerted pathway, where charged intermediates are avoided.14-16 Mechanistic studies showed that 
upon hydrogen-bonding with a phosphate base, the amidyl radical was generated via SET oxidation 
by the excited photocatalyst. Subsequent addition of the amidyl radical across the pendant alkene 
resulted in a C-centered radical, which was quenched via hydrogen atom abstraction or Giese-type 
addition to a Michael acceptor.13,26    
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Being aware of the potential of alkene difunctionalization strategies for the rapid 
construction of molecular complexity,15,30-33 a means was sought to use PCET to expand the 
repertoire of current organic synthetic transformations in this realm. Indeed, this scenario to some 
extent mimics some stages of the dual-catalysis that we have been conducting with different radical 
precursors, where alkyl radicals generated via reductive quenching were merged with a nickel-
catalyzed cross-coupling cycle with different aryl electrophiles.1,2 Based on our previous 
experience, a process was envisioned that would benefit from the rapid 5-exo-trig cyclization of 
amidyl radicals (k~105 s-1 )34 generated via PCET to funnel the resulting alkyl radical into a nickel-
catalyzed cross-coupling cycle, resulting in the introduction of biologically relevant pyrrolidinone 
cores10 onto aromatic backbones.  
 
Figure 3.1. Generation of Amidyl Radicals from Functionalized and Non-Functionalized Amides 
This novel photoredox PCET/Ni dual catalytic strategy would be expected to expedite the 
synthesis of medicinally privileged N-containing heterocyclic scaffolds. Importantly, there are 
several notable examples of bioactive molecules with this structure, such as zolmitriptan and 
cytochalasin B (Figure 3.2). It is also worth noting that, whereas other aminoarylation strategies 
rely on harsh reaction conditions35,36 or very reactive arylating reagents,37,38 this new strategy would 
benefit from the mild reaction conditions associated with photoredox catalysis and PCET 
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mechanisms, providing ample opportunities for the high chemoselectivity profile required for the 
late-stage construction of densely functionalized molecules. Moreover, the proposed 
transformation would not necessarily be restricted to amides, so that carbamates and ureas could 
also be employed, expanding the array of heterocyclic cores within range. Carbamates are 
particularly interesting, considering the tremendous number of bioactive molecules containing 
allylic alcohols (Figure 3.2) that might be engaged in this transformation through conversion to the 
carbamate, as well as the ease of carbamate motif installation via quantitative alcoholysis of aryl 
isocyanates. Notably, thanks to the ease of oxazolidinone hydrolysis, ring-opened derivatives 
would be readily accessible,15,16 resulting in a formal three-component difunctionalization of 
unactivated olefins (Figure 3.2). Together with other derivatization possibilities such as 
reduction,39,40 a series of cyclic or acyclic aminoarylation backbones could be constructed.  
 
Figure 3.2. Biological Relevance, Diversification of “Lidinone” Derivatives, and Naturally 
Occurring Allylic Alcohols 
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3.2 Results and Discussion 
Reaction Optimization 
Prior to the search for suitable reaction conditions, an analysis was undertaken on the 
possible challenges in developing this demanding, yet appealing, transformation. Although 5-exo-
trig cyclization was expected to be fast, a low thermodynamic driving force (ΔG° ≈ -3 to -5 
kcal/mol in the transformation of amidyl- to 1º or 2º alkyl radicals) was anticipated to be non-
optimal for the reaction progress.11,41 Indeed, in a previous hydroamination study, a thiophenol 
HAT catalyst was required to drive the transformation to completion.26 Moreover, the coexistence 
of amidyl- and alkyl radical species in the reaction medium could lead to selectivity issues, 
depending on the affinity of the nickel complexes for these species and the energy barrier of the 
subsequent step.  These issues provided the potential for the generation of mixtures of N-arylated 
and olefin amidoarylated products.17  With these challenges in mind, an investigation was begun 
using pent-4-enylanilide S1 and 4-bromobenzonitrile as reaction partners. Initial screening using a 
mildly oxidizing Ir-photocatalyst [Ir-1] (E1/2
*
 = 1.32 V vs. SCE) and the weak base 
Bu4N[OP(O)(OBu)2] (pKa = 1.72)
42 led to a 29% yield of the expected product 1 (Figure 3.3, entry 
1). Ir-based photocatalysts with higher oxidizing power (entries 2-3) gave lower yields or no 
product at all, likely owing to a poorer rate match between the two catalytic cycles or relative 
instability of the photocatalyst.  Stronger bases favoring the formation of the corresponding 
amidate, such as KOt-Bu (entry 4), proved unsuccessful in this case. However, higher amounts of 
the phosphate base translated into higher yields (entry 6). The necessity for superstoichiometric 
amounts of Bu4N[OP(O)(OBu)2] was further validated after seeing failures at attempting to use it 
catalytically in combination with inorganic bases to regenerate the former over the course of 
reaction (entry 5). Supporting the initial mechanistic hypothesis, these conditions, along with the 
physical properties of the anilide [pKa of ~2112 and redox potential of 1.78 V (vs SCE)], suggest 
that the cleavage of the anilide N-H bond is most likely occurring via a concerted PCET pathway. 
Both Ni(II) and Ni(0) sources rendered similar yields (entries 6 and 9). Consequently, well-defined 
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Ni(dMeObpy)(H2O)2Br2 was used as the catalyst precursor based on its stability, ease of 
preparation, and more convenient reaction set up. Among the several bipyridyl-type ligands tested, 
dMeObpy clearly stood out (entries 6-8), likely owing to easier oxidative addition with aryl halides 
because of its more electron-rich nature.  
 
Figure 3.3. Optimization of Reaction Conditions. aReactions were performed on a 0.3 mmol scale. 
bYield of isolated product after column chromatography. 
Attempting to increase the reaction yield, we investigated the byproducts generated over 
the course of the reaction. Among the few identified, chlorobenzonitrile was, by far, predominant. 
We reasoned that the 1,2-dichloroethane (DCE) solvent was responsible for the formation of this 
byproduct, being the only chloride source present in the reaction medium.43 After confirming that 
aryl chlorides are inert under reaction conditions, we examined other non-chlorinated solvents to 
avoid the consumption of the aryl bromide and its deleterious effect on yield. Upon testing 
numerous options, t-BuOH proved to be an excellent replacement, affording considerably enhanced 
yields (entry 9). We suggest that this improvement is likely due to an acidity enhancement from 
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the H-bond acceptor property of t-BuOH. Finally, in an attempt to match the polarity of DCE, 
different binary solvent systems with t-BuOH were tested. In the event, a 78% yield was obtained 
using a 2:1 t-BuOH/PhCF3 mixture, which came as no surprise considering the beneficial effects 
of α,α,α-trifluorotoluene in radical reactions.44 As expected, control experiments showed the key 
role played by all of the reaction components.45 
Substrate Scope Study 
Subsequently, the limits of this reaction were explored via a substrate scope study. As 
shown in Figure 3, substitutions from the α- to the γ- positions on the amide are all accommodated, 
allowing the synthesis of a tetra-substituted carbon center (7). Notably, no significant Thorpe-
Ingold effect was observed when comparing differently α-substituted substrates (1-3). A series of 
bicyclic (8, 10, 11), tricyclic (9), and spirocyclic structures (4) were accessible from simple 
precursors. Remarkably, when an endocyclic double bond was involved, the reaction in all cases 
showed diastereoselectivities greater than 20:1 in favor of the trans product (8-11). Protic 
functional groups such as hydroxy (10) and carbamate (5) did not pose a problem, nor did activated 
α-protons. Excellent regioselectivity was achieved, with no 6-endo-trig cyclization observed in any 
of the substrates examined. A notable yield drop was observed using an α,α-difluorosubstituted 
amide (12), most likely because of the higher oxidation potential of this more electron-deficient 
amide (2.03 V vs 1.78 V for non-substituted pentenamide S1). In line with this observation, when 
a more electron-deficient anilide was involved, a significantly lower yield was observed (16, 17). 
The more oxidizing photocatalyst [Ir-2] had to be applied to form 16, because [Ir-1] failed to give 
any product. We reasoned that the former favored the amidyl radical formation, whereas the latter 
was not oxidizing enough to accomplish the formation of that intermediate. Electron-neutral and 
electron-rich anilines or heteroaryl amines (13-15, 18) delivered the corresponding products in 
moderate to good yields. Considering that N-aryl amides are required to facilitate the PCET step, 
PMP was incorporated as the aryl motif, which allowed the synthesis of unsubstituted 
pyrrolidinones upon removal of the PMP group with CAN (19).46 Moreover, a gram-scale reaction 
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was carried out without further optimization on the PMP-protected substrate (14) with no erosion 
in the yield, thus establishing the scalability of this reaction. 
 
Figure 3.4. Scope of N-Arylated Alkenyl Amides. Reaction conditions: amide S1-S18 (0.36 mmol, 
1.2 equiv), 4-bromobenzonitrile (0.3 mmol, 1.0 equiv), Bu4N[OP(O)(OBu)2] (0.75 mmol, 2.5 
equiv), Ni(dMeObpy)(H2O)2Br2 (0.018 mmol, 6 mol %), [Ir-1] (0.009 mmol, 3 mol %), blue LED, 
6 mL t-BuOH/PhCF3 (2:1).
 a Reaction run on 5 mmol scale. b [Ir-2] was used. 
Excellent functional group tolerance was observed when different aryl bromides were 
subjected to the reaction conditions, including electron-deficient and electron-neutral substrates 
(20, 22-35, 37), featuring functional units such as aldehydes, boronates, sulfones, amides, esters, 
trifluoromethoxy groups, and various halides. Electron-rich aryl bromides were challenging, 
probably because of the more demanding oxidative addition step, yet good yields could be achieved 
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using the corresponding aryl iodides (21, 36 and 49). Similarly, because of the more challenging 
oxidative addition, relatively electron-neutral (hetero)aryl bromides (e.g., 23, 32 and 39) and ortho-
substituted aryl bromides (33) exhibited diminished efficiency, with the remaining anilide starting 
material and (hetero)aryl bromides recovered after purification. Notably, aryl iodides only seemed 
to work with electron-rich systems, whereas electron-neutral or electron-poor substrates afforded 
compromised yields. Substructures with reduceable functional groups or activated hydrogens such 
as benzylic alcohols (40), saccharides (36) and aldehydes (29, 35) remained intact under the 
reaction conditions, demonstrating the highly chemoselective nature of this sequential 
transformation. In an effort to focus on more medicinally relevant scaffolds, several electron-
deficient (37-39) or electron-rich (49) heteroaryl bromides were tested, resulting in modest to high 
yields of the desired products. 
To broaden the utility of this transformation, β,γ-unsaturated aryl carbamates and ureas 
were attempted to provide an easy route toward oxazolidinone and imidazolidinone scaffolds. 
Unfortunately, initial attempts with an O-allyl aryl carbamate produced a mixture of N-arylation 
(41a) and amidoarylation (41) products (37% and 22% yield, respectively).45  To improve the 
reaction performance, an all-substituted carbon was placed at the β-position (42) to favor the 
cyclization rate by invoking the Thorpe-Ingold effect. In line with previous observations (1-3), the 
yield enhancement was poor. However, the N-arylated product was suppressed in this case. Indeed, 
although a highly reversible amidyl radical addition to nickel has been described,17 such 




Figure 3.5. Scope of (Hetero)Aryl Halides, Carbamates, and Ureas. Reaction conditions: amide, 
urea or carbamate S20-S52 (0.36 mmol, 1.2 equiv), (hetero)aryl halide (0.3 mmol, 1.0 equiv), 
Bu4N[OP(O)(OBu)2] (0.75 mmol, 2.5 equiv), Ni(dMeObpy)(H2O)2Br2 (0.018 mmol, 6 mol %), [Ir-
1] (0.009 mmol, 3 mol %), blue LED, 6 mL t-BuOH/PhCF3 (2:1).  
 a(Hetero)aryl iodide was used. 
b7.5 equiv of base were used. 
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As a more electron-rich motif compared to amides, nitrogen-based radicals derived from 
carbamates would be expected to exhibit a higher nucleophilicity, therefore favoring bonding with 
nickel. To minimize this putative reactivity, a design motif was sought to enhance the rate of 5-
exo-trig cyclization. Considering that the BDE of a carbamate N-H bond (~95 kcal/mol)12 is lower 
than that of amides (~100 kcal/mol),11,13 it becomes evident that, from a thermodynamic standpoint, 
generation of a primary alkyl radical via cyclization (BDE of primary C-H ~98 kcal/mol)41 is less 
favored for carbamates than for amides (ΔG° ≈ 3 kcal/mol vs -2 kcal/mol). Owing to the BDE 
difference between primary and secondary C-H bonds (~4 kcal/mol lower for secondary C-H),41 
we anticipated that internal alkenes would react more smoothly. To test this hypothesis, an indirect 
kinetic study was carried out using N-(phenylthiol)amides as the amidyl radical precursors to 
determine the relative rate of radical cyclization (Figure 3.6, Figure 3.11).23,34 As shown, the 
cyclization rate for O-crotyl phenylcarbamate (S55) was ~25 times faster than O-allyl 
phenylcarbamate (S56), thus supporting the notion that generation of a secondary alkyl radical 
leads to a more efficient cyclization step. Indeed, for both ureas and carbamates, satisfactory yields 
were obtained when internal alkenes were used (42-52, Figure 3.5). Along this line, amino aryl 
glycoside 50 derived from galactal was obtained in an 83% yield and excellent diastereoselectivity, 
suggesting a more efficient cyclization step that can most likely be attributed to stabilization of the 
generated α-oxy radical. The success of incorporating N-Boc-indole (49) provides an excellent 
starting point for the synthesis of zolmitriptan analogs in a straightforward manner, thus 
highlighting a direct application of this method. Interestingly, for the urea 52, one of the double 




Figure 3.6. Relative Cyclization Rate Studies and Radical Clock Experiment. a The values reported 
are relative to kT. See Figure 3.11 for further details. 
Mechanistic Insights 
Although preliminary results pointed toward a mechanistic pathway in line with our initial 
proposal (Figure 3.3), further experiments were conducted to substantiate the mechanism. As 
anticipated, control experiments excluding photocatalyst, nickel precatalyst, base, and light, gave 
no product (See Figure 3.9).45 A radical clock experiment (Figure 3.6, see also Experimental 
Section) led exclusively to rearranged product 53, indicating the unlikelihood of undergoing an 
energy transfer-mediated migratory insertion mechanism or alkene aminometalation.32 Still, the 
crucial role for 2.5 equiv of Bu4N[OP(O)(OBu)2] base remained unclear. Cyclic voltammetry 
measurements showed that after addition of 2.5 equiv of base, the redox potential of the amide 
dropped from 1.78 V to 1.27 V (vs SCE), which is within the [Ir-1] photocatalyst oxidative range, 
thus favoring a PCET mechanistic scenario.  However, this potential was also achieved with only 
1 equiv of base.45 Stern-Volmer studies were carried out (see Experimental Section) with a fixed 
ratio of 1:2.5 (substrate/base) to mimic the reaction medium. A linear relationship was observed. 
Although possessing a narrower linear range, the quenching efficiency of the carbamate-base 
mixture [KSV = (1.9 ± 0.2) x 10
4 M-1, Figure 3.18] was higher than that of amide-base [KSV = (8.2 
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± 0.7) x 103 M-1, Figure 3.17], consistent with the relative ease of oxidation of the carbamate 
compared to that of an amide (1.73 V vs SCE for allyl phenylcarbamate S41, 1.18V after addition 
of 2.5 equiv of base, see Figures 3.12-3.14). A linear correlation was found between variable base 
loadings and quenching as well [KSV = (5.7 ± 0.5) x 10
3 M-1 and (4.8 ± 0.3) x 103 M-1 for amides 
and carbamates, respectively. See Figures 3.15-3.21].45  
The differences in quenching efficiency in these two experiment sets (with amide 
quenching being higher in the latter case) indicated that the base might have different affinity for 
amides versus carbamates. Hydrogen-bonding affinity constants were obtained via NMR titration 
(Figures 3.7, 3.22-3.25), with an amide affinity almost 45-times higher than that of the carbamate 
(33 ± 4 M-1 for the amide and 0.74 ± 0.05 M-1 for the carbamate).47 Interestingly, NMR titration 
showed a behavior close to saturation for the amide at loadings higher than 2.5 equiv, whereas for 
the carbamate, even upon addition of 5 equiv of base, no signs of saturation were observed. 
Expecting that near-saturation conditions would be ideal for a PCET mechanistic scenario, a 
reaction of carbamate S43 with 7.5 equiv of Bu4N[OP(O)(OBu)2] was carried out,
45 achieving a 
14% yield increase within the same timeframe (Figure 3.5, 43). It is also noteworthy that, after 
adding t-BuOH to mimic the solvent system used in the reaction, a significant N-H chemical shift 
change from 7.19 to 9.14 ppm was observed, which suggested a beneficial N-H acidity 
enhancement in the presence of t-BuOH (see Figure 3.26).45 Under such reaction conditions, the 
substrate-base adduct would predominate and facilitate PCET, potentially via a proton wire-type 
mechanism.48 Finally, kinetic isotope effects were measured with an N-deuterated amide and 
carbamate. Although both the amide and the carbamate revealed a small secondary KIE, the value 
for carbamate (1.08 ± 0.04) was still more significant than that for amide (1.02 ± 0.02) (see Figure 
3.10, Tables 3.1 and 3.2). Although small KIEs are consistent with PCET processes,14 these data 
could indicate different rate-limiting steps between carbamates and amides. Further studies are 




Figure 3.7. Measuring the Hydrogen-Bonding Affinity of Amides and Carbamates 
Based on the previous empirical evidence gathered and precedented literature,13,16,18,49 we 
propose a mechanistic scenario (Figure 3.8) initiated by formation of an amidyl radical (II) via 
PCET as suggested by cyclic voltammetry, NMR experiments, and Stern-Volmer studies. Next, a 
fast 5-exo-trig cyclization follows, the rate of which is related to the nature of the newly-formed 
alkyl radical and N-H BDE, as evidenced by indirect kinetic studies. Once the alkyl radical I is 
formed, it enters the nickel catalytic cycle, forming Ni(I)-complex III, which undergoes oxidative 
addition with the aryl halide.50 Next, the resultant high-valent Ni(III) intermediate IV undergoes 
reductive elimination, delivering the final product 1 along with a Ni(I)-halide complex (V). Both 
catalytic cycles are simultaneously closed by reduction of the Ni(I)-halide with the reduced form 
of the photocatalyst. Even though the key organonickel intermediates in the proposed mechanism 
proved challenging to isolate because of their highly reactive nature, their existence is in line with 
preliminary mechanistic investigations as well as previous computational studies on 




Figure 3.8. Proposed Catalytic Cycle and PCET Mechanism 
3.3 Conclusion  
In conclusion, a photoredox PCET/Ni dual-catalyzed amidoarylation of unactivated olefins 
has been disclosed, forging highly functionalized 5-membered heterocyclic systems under mild 
reaction conditions from readily available precursors. This method merges the concept of concerted 
PCET with a nickel-catalyzed cross-coupling process for the first time, taking advantage of 
photocatalytic activation of strong N-H bonds assisted by a phosphate H-bond acceptor, followed 
by rapid 5-exo-trig cyclization and alkyl-aryl single-electron cross-coupling. Relative cyclization 
rates for amides and carbamates were studied, the latter being disclosed for the first time, which 
allowed the introduction of carbamates and ureas into the protocol. Stern-Volmer studies, NMR 
titration experiments, cyclic voltammetry, and control experiments point toward a concerted PCET 
mechanism. This transformation adds to the repertoire of alkene difunctionalization processes in a 
manner that is exceedingly functional group tolerant, using readily available alkenyl amides, 
carbamates and ureas, and takes advantage of the tens of thousands of commercially available 





Unless otherwise noted, all reactions were carried out under an inert atmosphere of argon 
or nitrogen via standard Schlenk techniques or in a glovebox. Reactions were monitored by HPLC, 
1H NMR, and/or by TLC on 254 nm silica gel plates. Thin layer chromatography was performed 
using hexanes/EtOAc as the eluents and visualized using KMnO4 stain and/or UV light. Reactions 
were purified by flash chromatography accompanied with an automated system (visualized at 254 
nm, monitored with all-wavelength and ELS detector) with silica cartridges (60 Å porosity, 20-40 
µm). Unless otherwise mentioned, all carboxylic acids, isocyanates, anlines and alcohols were 






26 were synthesized through literature procedures. t-BuOH and PhCF3 (extra 
dry, 99.8%) were purchased and used as received. Other solvents were purified either by distillation 
over Na or CaH2 or by passing through alumina cartridges in a solvent purification system. 
Irradiation of reaction vessels was accomplished using blue LEDs (light emitting diodes) about 3 
cm from the reaction vessel with a fan above to maintain room temperature. The photoredox 
reaction equipment was constructed according to a previous report.52 Reaction optimization was 
carried out via high throughput experimentation and verified on the benchtop. Factors affecting 
reaction performance, such as solvents, nickel sources, photoredox catalysts, bases, substrates 
loadings as well as temperature have been thoroughly examined. 
Melting points (°C) are uncorrected. NMR Spectra (1H, 13C {1H}, 19F) were recorded on a 
500 MHz spectrometer at 298 K. All 1H NMR spectra are reported in parts per million (ppm) 
downfield of TMS and were measured relative to the signal for CHCl3 (7.26 ppm). All 
13C NMR 
spectra were reported in ppm relative to residual CHCl3 (77.2 ppm) and were obtained with 
1H 
decoupling. Coupling constants (J) are reported in Hertz (Hz). HRMS was obtained by either ESI 
or EI with a TOF spectrometer in CH3CN or CHCl3. IR spectra were obtained with neat samples. 
Cyclic voltammetry experiments were carried out on a CHI electrochemical workstation using 
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glassy carbon working electrode, Ag/AgCl reference electrode and Pt wire counter electrode. The 
measurements were taken at rt in MeCN containing 0.1 M Bu4NPF6 as electrolyte. 0.0025 mmol of 
the designated substrate was dissolved in 10 mL of this soln, and 1.9 mg of ferrocene was added as 
a reference. A scan rate of 200mV/s was used for the reported voltammograms, although the 
measurements were taken at three different scan rates. 
General Procedure  
Procedures for Synthesis of Amide, Carbamate, and Urea Starting Materials 
 
General Procedure I (GPI): Under an inert atmosphere, CDI (1.0 equiv) was added to a 
soln of the corresponding carboxylic acid (1.0 equiv) in dry THF (1.0 M) (Caution! CO2 is released 
violently!). Upon stirring at rt for 1 h, the corresponding aniline derivative (1.0 equiv) was added. 
The reaction was stirred at rt overnight. Then, it was taken to dryness under reduced pressure and 
purified using an automated system (silica gel, hexanes/EtOAc gradient), obtaining the 
corresponding products. 
 
General Procedure II (GPII): To a soln of the corresponding carboxylic acid (1.0 equiv) 
in dry CH2Cl2 (0.3 M) were added oxalyl chloride (1.0 equiv) and a few drops of dry DMF at 0 ºC 
(gas evolution observed). The mixture was stirred at rt for 1 h. Next, a soln of the corresponding 
aniline (1.2 equiv) and DMAP (2.7 equiv) in dry CH2Cl2 was added, and the mixture was stirred at 
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rt for 16 h. Upon completion, the reaction was quenched by addition of satd NH4Cl (aq), followed 
by three extractions with EtOAc. The combined organic phases were washed with brine, dried 
(MgSO4) and concentrated. The crude mixture was purified using an automated system (silica gel, 
hexanes/EtOAc gradient), obtaining the corresponding products. 
 
General Procedure III (GPIII): Over a soln of aniline (1.1 equiv) in dry THF (1.0 M) under 
inert atmosphere at 0 ºC was slowly added n-BuLi (2.2 equiv, 2.5 M in hexanes). The reaction 
mixture was stirred for 1 h at 0 ºC. Then, it was cooled to -78 ºC. Over this mixture, a soln of the 
corresponding ester or lactone (1.0 equiv) in dry THF (0.2 M) was added dropwise. The reaction 
was stirred at -78 ºC for 2 h, until TLC showed completion. The reaction was quenched by slowly 
adding satd NH4Cl (aq), followed by three extractions with EtOAc. Upon washing with brine, the 
soln was dried (MgSO4) and then filtered. The corresponding soln was taken to dryness under 
reduced pressure and purified using an automated system (silica gel, hexanes/EtOAc gradient), 
obtaining the corresponding products. 
 
General Procedure IV (GPIV): Over a soln of the corresponding aryl isocyanate (1.0 equiv) 
in dry THF (0.5 M) under an inert atmosphere was added the corresponding allylic alcohol (1.0 
equiv), followed by addition of Et3N (1.0 equiv). The reaction was stirred at rt overnight. Next, the 
reaction was taken to dryness and purified using an automated system (silica gel, hexanes/EtOAc 
gradient) to obtain the corresponding products. Allyl phenylcarbamate (S41)53 and (4aR, 8R, 8aS)-
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2,2-dimethyl-4,4a,8,8a-tetrahydropyrano[3,2-d][1,3]dioxin-8-ylphenylcarbamate (S50)26 were 
synthesized according to General Procedure IV. All characterization data matched previous 
literature reports. 
 
General Procedure V (GPV): Over a soln of the corresponding aryl isocyanate (1.0 equiv) 
in dry THF (0.5 M) under an inert atmosphere was added the corresponding allylic amine (1.0 
equiv) followed by addition of Et3N (1.0 equiv). The reaction was stirred at rt overnight. Next, the 
reaction was taken to dryness and purified using an automated system (silica gel, hexanes/EtOAc 
gradient), obtaining the corresponding products. 
Procedure for Photoredox PCET/Nickel-Catalyzed Amidoarylation with Aryl Halides 
General Procedure VI (GPVI): An 8.0 mL screw-cap vial containing a stirring bar was 
charged with [Ni(dMeObpy)(H2O)2(Br)2] (8.5 mg, 0.018 mmol, 6 mol %), 
[[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 0.009 mmol, 3 mol %), amide (0.36 mmol, 1.2 equiv), aryl 
bromide (if solid) (0.3 mmol, 1.0 equiv), and Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 
equiv). Next, the vial was closed, and three vacuum/argon cycles were carried out. Under an inert 
atmosphere, a 2:1 mixture of dry t-BuOH/PhCF3 was added (6.0 mL, 0.05 M) followed by addition 
of the aryl bromide (if liquid). After further sealing with Parafilm®, the reaction was placed in the 
blue LED bay and stirred at rt until completion (a fan was added to disperse any heat coming from 
the blue LEDs). When completed, the reactions were taken to dryness and purified by column 
chromatography using an automated system (hexanes/EtOAc gradient), delivering the 
corresponding pure product. 




Synthesis of PhSCl: Over a 0 ºC suspension of NCS (1.18 g, 8.9 mmol, 2.5 equiv) in dry 
CH2Cl2 (36 mL) under an inert atmosphere was added thiophenol (788.9 mg, 7.16 mmol, 2.0 equiv) 
dropwise. After stirring at 0 ºC for 15 min, the reaction mixture was concentrated under vacuum. 
Next, dry hexanes were added, and the white solid formed during the reaction was filtered off. After 
rinsing three times with dry hexanes, the soln was taken to dryness. Under an inert atmosphere, 7.2 
mL of dry THF was added to make a 1.0 M soln of PhSCl. 
 General Procedure VII (S54-S56): Over a -78 ºC soln of the corresponding amide or 
carbamate (3.58 mmol, 1.0 equiv) in dry THF (12 mL) was added n-BuLi (2.5 M in hexanes, 1.43 
mL, 3.58 mmol, 1.0 equiv) dropwise. The reaction was stirred at the same temperature for 1 h. 
Next, a soln of PhSCl (1.0 M in THF, 3.6 mL, 3.6 mmol, 1.0 equiv) was added dropwise. After 
further stirring at -78 ºC for 15-30 min, the reaction was quenched by slow addition of H2O. The 
crude reaction mixture was extracted with EtOAc three times followed by a wash with brine. Upon 
drying (MgSO4) and filtration, the reaction mixture was taken to dryness and purified using an 
automated system (silica gel, hexanes/EtOAc, 0 to 20%), obtaining the corresponding products. 




Over a soln of NiBr2·3H2O (1.0 g, 3.67 mmol, 1.0 equiv) and 4,4'-dimethoxy-2,2'-
bipyridine (793.5 mg, 3.67 mmol, 1.0 equiv) in EtOH (20 mL, 0.18 M) was added deionized H2O 
(79.2 mg, 4.4 mmol, 1.2 equiv). The tube was sealed and heated at 80 ºC for 16 h. Next, the reaction 
was cooled to rt and concentrated under vacuum. The green solid obtained was rinsed several times 
with Et2O and dried overnight (1.5381 g, 3.27 mmol, 89% yield). mp > 240 ºC. IR (neat, cm
-1): 
3372, 1614, 1493, 1422, 1271, 1046. Upon recrystallization from boiling CH3CN, suitable crystals 
were obtained for X-ray diffraction analysis, showing the formation of the complex 
Ni(dMeObpy)(H2O)(CH3CN)Br2, where a molecule of H2O was replaced by a molecule of solvent. 
Gram-Scale Reaction 
 
To a 250 mL round bottom flask was added N-(4-methoxyphenyl)pent-4-enamide (1.23 g, 
6.0 mmol, 1.2 equiv), 4-bromobenzonitrile (910.1 mg, 5.0 mmol, 1.0 equiv), 
[Ni(dMeObpy)(H2O)2Br2] (140 mg, 0.3 mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (150 mg, 
0.15 mmol, 3 mol %), Bu4N[OP(O)(OBu)2] (5.65 g, 12.5 mmol, 2.5 equiv) and dry t-BuOH/PhCF3 
(2:1, 100 mL, 0.05 M) under an argon atmosphere. The reaction was set up as shown in the picture 
and stirred under blue LED irradiation at rt for 48 h using a fan on the top of it (not shown in the 
picture) to disperse the heat, keeping it at rt. Silica gel purification using an automated system 
(hexanes/EtOAc, 0 to 40%) gave the product as a colorless oil (898 mg, 3.48 mmol, 58% yield). 




PMP (p-methoxyphenyl) Removal 
 
4-((5-Oxopyrrolidin-2-yl)methyl)benzonitrile (19): Removal of the PMP protecting group 
was accomplished following a previous report.46 To a soln of 4-((5-oxo-1-(p-
methoxyphenyl)pyrrolidin-2-yl)methyl)benzonitrile (104.6 mg, 0.35 mmol, 1.0 equiv.) in 5:1 
MeCN/H2O (10.2 mL), Ce(NH4)2(NO3)6 (CAN) (823.6 mg, 1.5 mmol, 4.4 equiv) was added in one 
portion at 0 ℃. The mixture was stirred at 0 ℃ for 30 min and then rt for 12 h. The reaction mixture 
was then diluted with 30 mL of EtOAc and washed with NaHCO3 (2x50 mL) and brine (50 mL). 
The organic phase was separated and dried (Na2SO4), and then concentrated and purified by flash 
chromatography (hexanes/EtOAc, 0 to 100%). The product was obtained as a white solid (64.0 mg, 
0.32 mmol, 91% yield). mp = 142-145 ºC. 1H NMR (500 MHz, CDCl3) δ 7.68 – 7.56 (m, 2H), 7.30 
(d, J = 7.8 Hz, 2H), 6.25 (s, 1H), 3.91 (tt, J = 6.7, 6.6 Hz, 1H), 2.86 (ddd, J = 6.8, 6.6, 6.6 Hz, 2H), 
2.37 – 2.19 (m, 3H), 1.82 (tt, J = 9.6, 5.1 Hz, 1H) ppm. 13C NMR (126 MHz, CDCl3) δ 178.0, 143.1, 
132.7, 130.0, 118.7, 111.1, 55.2, 43.1, 30.0, 26.9 ppm. IR (neat, cm-1): 3182, 2227, 1688, 1607, 
1351, 1272, 822, 512. HRMS (ES+) calcd for (C12H13N2O) [M+H]
+ 201.1028, found 201.1028. 




Following modified General Procedure VI using (E)-but-2-en-1-yl phenylcarbamate (68.7 
mg, 0.36 mmol, 1.2 equiv), 4-bromobenzonitrile (54.6 mg, 0.3 mmol, 1.0 equiv), 
[Ni(dMeObpy)(H2O)2(Br)2] (8.5 mg, 0.0018 mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 
mg, 0.009 mmol, 3 mol %), Bu4N[OP(O)(OBu)2] (1016.4 mg, 2.25 mmol, 7.5 equiv) and dry t-
BuOH/PhCF3 (2:1, 6.0 mL, 0.05 M). The reaction was stirred under blue LED irradiation at rt for 
48 h. Silica gel purification using an automated system (hexanes/EtOAc, 0 to 40%) gave the product 




All reactions were done according to General Procedure VI on a 0.1 mmol scale and 
monitored by HPLC. As depicted in Figure 3.9, all components were required for reaction success. 
 
Figure 3.9. Control Reactions 




(E)-4-(4-(5-Oxo-1-phenylpyrrolidin-2-yl)but-3-en-1-yl)benzonitrile (53): Following 
General Procedure VI using (E)-5-cyclopropyl-N-phenylpent-4-enamide (77.5 mg, 0.36 mmol, 1.2 
equiv), 4-bromobenzonitrile (54.6 mg, 0.3 mmol, 1.0 equiv), [Ni(dMeObpy)(H2O)2(Br)2] (8.5 mg, 
0.0018 mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 0.009 mmol, 3 mol %), 
Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry t-BuOH/PhCF3 (2:1, 6.0 mL, 0.05 
M). The reaction was stirred under blue LED irradiation at rt for 96 h. Silica gel purification using 
an automated system (hexanes/EtOAc, 0 to 40%) gave the product as a yellowish oil (17.1 mg, 
0.054 mmol, 18% yield). 1H NMR (500 MHz, CDCl3) δ 7.49 (d, J = 8.2 Hz, 2H), 7.41 – 7.36 (m, 
2H), 7.34 (t, J = 7.9 Hz, 2H), 7.18 (t, J = 7.1 Hz, 1H), 7.10 (d, J = 7.9 Hz, 2H), 5.55 (dt, J = 14.2, 
6.7 Hz, 1H), 5.34 (dd, J = 15.3, 7.3 Hz, 1H), 4.60 (td, J = 7.4, 4.8 Hz, 1H), 2.64 (t, J = 7.3 Hz, 2H), 
2.63 – 2.55 (m, 1H), 2.55 – 2.48 (m, 1H), 2.37 – 2.27 (m, 3H), 1.88 – 1.76 (m, 1H) ppm. 13C NMR 
(126 MHz, CDCl3) δ 174.4, 146.9, 138.2, 132.3, 131.8, 131.0, 129.3, 128.8, 125.4, 123.1, 119.1, 
110.0, 61.9, 35.5, 33.2, 31.2, 26.4 ppm.  IR (neat, cm-1): 2927, 2225, 1693, 1497, 1379, 1217. 
HRMS (ES+) calcd for (C21H21N2O) [M+H]
+ 317.1654, found 317.1665. 
Kinetic Isotope Effect 
 
Synthesis of S1-d: A soln of N-phenylpent-4-enamide (123.5 mg, 0.7 mmol) in EtOD (2.0 
mL) was stirred at rt for 16 h. Then, the reaction was taken to dryness under vacuum, giving the 
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corresponding product as a white solid (124.3 mg, 0.7 mmol, 100% yield). mp = 85-87 ºC. 1H NMR 
(500 MHz, CDCl3) δ 7.51 (d, J = 7.9 Hz, 2H), 7.32 (t, J = 8.0 Hz, 2H), 7.10 (t, J = 7.4 Hz, 1H), 
5.98 – 5.83 (m, 1H), 5.14 (d, J = 17.2 Hz, 1H), 5.06 (d, J = 10.8 Hz, 1H), 2.62 – 2.26 (m, 4H) ppm. 
13C NMR (126 MHz, CDCl3) δ 170.8, 138.0, 137.0, 129.1, 124.4, 120.0, 116.0, 36.9, 29.6 ppm. IR 
(neat, cm-1): 3324, 1653, 1602, 1498, 1412. HRMS (ES+) calcd for (C11H13DNO) [M+H]
+ 
177.1138, found 177.1128. 
 
Synthesis of S43-d: A soln of (E)-but-2-en-1-yl phenylcarbamate (191 mg, 1 mmol) in 
EtOD (5 mL) was stirred at rt for 16 h. Then, the reaction was taken to dryness under vacuum giving 
the corresponding product as a white solid (124.3 mg, 1 mmol, 100% yield). mp = 72-75 ºC. 1H 
NMR (500 MHz, CDCl3) δ 7.37 (d, J = 7.9 Hz, 2H), 7.30 (t, J = 7.7 Hz, 2H), 7.06 (t, J = 7.3 Hz, 
1H), 5.85 (dq, J = 7.0, 6.5 Hz, 1H), 5.65 (ddd, J = 14.0, 7.0, 5.3 Hz, 1H), 4.60 (d, J = 6.5 Hz, 2H), 
1.75 (ddd, J = 6.5, 1.2, 1.2 Hz, 3H) ppm. 13C NMR (126 MHz, CDCl3) δ 153.5, 137.9, 131.7, 129.2, 
125.4, 123.5, 118.7, 77.2, 66.0, 17.9 ppm. IR (neat, cm-1): 3321, 2944, 1707, 1600, 1540, 1444, 
1314, 1220, 1049, 1028, 754. HRMS (EI) calcd for (C11H12DNO2) [M]
+ 192.1009, found 192.0994.  
Kinetic isotopic effect experiments were carried out in the high throughput experimentation facility. 
Two 24-well plates were divided into four different areas with different reaction conditions as 
shown in the scheme. The reactions were stopped and worked up after 6 h and analyzed by UPLC 




Figure 3.10. Kinetic Isotope Effect by High Throughput Experimentation 
1.622002 1.746714 1.764167 1.730504 1.762762 1.706898 
1.767397 1.73354 1.685087 1.658901 1.759688 1.757608 
1.777961 1.710306 1.662135 1.674445 1.701461 1.792385 
1.723048 1.690985 1.655725 1.667587 1.68661 1.726664 
Table 3.1. Product/Internal Standard Values of 4-Pentenoic Anilide Reaction 
2.295832 2.679649 2.668391 2.697098 2.652171 2.522082 
2.612468 2.579522 2.571539 2.576554 2.629425 2.600115 
2.184311 2.521864 2.543304 2.605048 1.793452 2.24123 
2.446269 2.479978 2.505344 2.50372 2.306706 2.605026 
Table 3.2. Product/Internal Standard Values of (E)-But-2-en-1-yl Phenylcarbamate Reaction 
In both cases, the solvent KIE is negligible. The KIE with non-deuterated solvent was 
calculated using data from the second and fourth quadrants. For 4-pentenoic anilide, kH/kD = 1.02 
± 0.02, for (E)-but-2-en-1-yl phenylcarbamate, kH/kD = 1.08 ± 0.04. 
Indirect Kinetic Experimentation on Amidyl Radical-Alkene 5-exo Cyclization Rate 
The relative rate constant for cyclization vs. radical trapping with Bu3SnH was measured 
from modified previous literature reports.23,34,54,55 Under an inert atmosphere, 
(phenylthiol)carbamate or amide (1.0 equiv) was dissolved in dry and degassed toluene, followed 
by addition of a toluene soln containing n-Bu3SnH (6.0 equiv) and AIBN (0.1 equiv). The reaction 
was then heated at 65 ℃ for 4 h until full consumption of (phenylthiol)carbamate/amide. The 
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reactions were run four times for each substrate with various concentrations. The ratio between 
cyclized product and reduced amide or carbamate was determined via 1H-NMR and plotted. 
 




Figure 3.11. Indirect Kinetic Study of Amidyl/Carbamate-N Radical 
Based on the plot, the relative rate constants of radical cyclization (rel kc) comparing with 
Bu3SnH N· radical trapping (kT) are (0.32 ± 0.01) M
 (S55), (0.014 ± 0.001) M (S56) and (0.29 ± 
0.02) M (S54), respectively. Therefore, kinetically, the cyclization of (E)-but-2-en-1-yl 
phenylcarbamate radical is ~24 times faster than that of O-allyl carbamate radical. Furthermore, if 
we venture a similar rate for the trapping of the N-radical with Bu3SnH for carbamates and amides, 
we could conclude that the radical cyclization rate between (E)-but-2-en-1-yl phenylcarbamate and 
pentenoic anilide are on the same order of magnitude. 
Cyclic Voltammogram Survey on Amides and Carbamates 
CVs of Pent-4-enoic Anilide (S1) with Different Loadings of Bu4N[OP(O)(OBu)2] 
y = 3.1142x + 0.015
R² = 0.9977
y = 73.797x + 0.0715
R² = 0.9824






































Figure 3.12. CV Diagrams of Pent-4-enoic Anilide S1. 
As shown above, after addition of 1 equiv of Bu4N[OP(O)(OBu)2], the redox potential of 
pent-4-enoic anilide shifted from 1.78 V to 1.27 V (vs. SCE). No significant potential shift was 
observed after addition of another 1.5 equiv of Bu4N[OP(O)(OBu)2]. 
CVs of Allyl and (E)-But-2-en-1-yl Phenylcarbamate (S43) with Different Base Loading 
 
-0.500.511.522.5
Potential vs. SCE (V)
Pent-4-enoic anilide (S1) +
Base (0 equiv)
-1-0.500.511.52
Potential vs. SCE (V)
Pent-4-enoic anilide (S1) +
Base (1.0 equiv)
-1-0.500.511.52
Potential vs. SCE (V)
Pent-4-enoic anilide (S1) +
base (2.5 equiv)
-10123
Potential vs. SCE (V)
Allyl phenylcarbamate (S41) +
base (0 equiv)
-0.500.511.522.5
Potential vs. SCE (V)





Figure 3.13. CV Diagrams of Carbamates and Variable Amounts of Base 
Surprisingly, in the absence of exogenous base, the redox potential of allyl 
phenylcarbamate (1.75 V vs. SCE) showed little difference from that of pent-4-enoic anilide. 
However, after addition of 2.5 equiv of base the potential dropped to 1.18 V (vs. SCE), a 
considerably bigger potential shift than that observed for amides. Methyl substitution at the 
terminal position does not affect the redox properties as shown for substrate S43. 
CV of 2,2-Difluoro-N-phenylpent-4-enamide (S12) 
 
Figure 3.14. CV Diagrams of 2,2-Difluoro-N-phenylpent-4-enamide(S12) 
After ,-difluoro substitution, a significantly higher redox potential has been observed 
on S12 (2.03 V, comparing to 1.78 V vs. SCE). Although after addition of base the redox potential 
fell within the range of [Ir-1]’s range, it is still considerably more difficult than others.  
Stern-Volmer Fluorescence Quenching Study 
-10123
Potential vs. SCE (V)
Allyl Phenylcarbamate (S41) +
base (2.5 equiv)
-0.500.511.52
Potential vs. SCE (V)
(E)-But-2-en-1-yl phenylcarbamate 
(S43) + base (1.0 equiv)
-0.500.511.522.53




Potential vs. SCE (V)
2,2-difluoro-N-phenylpent-4-enamide 




Stern-Volmer experiments were conducted on a Horiba Fluorolog® Spectrofluorometer. 
Stock solutions of substrates, photocatalyst, and base were prepared with dry 1,2-dichloroethane. 
The solutions were mixed and purged with argon for 30 sec right before measurement. The samples 
were excited at 370 nm, and emission data were recorded at 494 nm. I0/I values of each sample 
were calculated from the average of three scans per data point. Linear regression of I0/I against 
concentration was carried out to yield Ksv. 
Quenching with Variable Amounts of Amide or Base 
Species Concentration (10-6 M) 
[Ir-1] 1.0 
Pent-4-enoic anilide S1 50 to 250 
Phosphate Base 0 
 
Figure 3.15. Quenching with Variable Amounts of Amide S1 
The trendline is parallel to the X-axis, suggesting that photocatalyst is not quenched in the 
absence of base. 
Species Concentration (10-6 M) 
[Ir-1] 1.0 
Pent-4-enoic anilide S1 0 















Figure 3.16. Quenching with Variable Amounts of Base 
Because quenching is non-linear, electron transfer most likely did not take place between 
the base and the photocatalyst. Non-linear quenching has been observed by redox inactive anions 
via H-bonding interaction with the photocatalyst;27,56 such an interaction should have little 
influence on redox properties of the photocatalyst according to literature precedent.27,56 
Quenching with Amide/Carbamate and 2.5 equiv of Base 
Species Concentration (10-6 M) 
[Ir-1] 1.0 
Pent-4-enoic anilide S1 40n (n = 1 – 3) 
Phosphate Base 100n (n = 1 – 3) 
 














Various Amounts of Base (No amide)












Amide S1 + Base (2.5 equiv)
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Species Concentration (10-6 M) 
[Ir-1] 1.0 
(E)- But-2-en-1-yl phenylcarbamate S43 10n (n = 1 – 4) 
Phosphate Base 25n (n = 1 – 4) 
 
Figure 3.18. Quenching with Carbamate S43 and 2.5 equiv of Base 
Both the carbamate and the amide exhibited efficient quenching capability with 2.5 equiv 
of base, with KSV(amide) = (8.2 ± 0.7) x 10
3 M-1 and KSV(carbamate) = (1.9 ± 0.2) x 10
4 M-1. Likely because 
of a lower redox potential, the carbamate quenched photocatalyst more efficiently than the amide; 
however, it also has a narrower linear range: 
Species Concentration (10-6 M) 
[Ir-1] 1.0 
Carbamate S43 40n (n=1 – 5) 
Phosphate Base 100n (n = 1 – 5) 
 






















2.5 equiv base w/carbamate (continued)
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Figure 3.19. Quenching with Carbamate S43 and 2.5 equiv of Base 
At a similar concentration range as that of the amide, (E)-but-2-en-1-yl phenylcarbamate 
is already out of quenching linear range, because of quenching saturation of excess base. Indeed, 
as is indicated by an NMR H-bonding affinity experiment (Section 4.6), the H-bonding 
interaction between the base and the carbamate is significantly weaker than that between the base 
and the amide. 
Quenching with a Constant Amount of Carbamate/Amide and Various Amounts of Base 
Species Concentration (10-6 M) 
[Ir-1] 1.0 
Pent-4-enoic anilide S1 50 
Phosphate Base 50 to 200 
 
Figure 3.20. Quenching with amide S1 and various amount of base 
Species Concentration (10-6M) 
[Ir-1] 1.0 
(E)-But-2-en-1-yl phenylcarbamate S43 40 
Phosphate Base 50 to 200 



















Figure 3.21. Quenching with Carbamate S43 and Various Amounts of Base 
With various amounts of base, the KSV
 of the carbamate and the amide are (4.8 ± 0.3) x 103 
M-1 and (5.7 ± 0.5) x 103 M-1, respectively. Here, the quenching efficiency of carbamate is lower 
than that of amides, which indicated a noticeable difference in the base’s influence on the 
photocatalyst quenching. Nevertheless, in both cases, the linear relationship supported the fact that 
a superstoichiometric amount of base could lead to a higher conversion. 
NMR H-bond Binding Affinity Determination 
A series of 0.0378 M CDCl3 solutions of 4-pentenoic anilide S1 or (E)-but-2-en-1-yl 
phenylcarbamate S43 were prepared with 0, 0.25, 0.5, 1.0, 2.5 and 5.0 equiv of 
Bu4N[OP(O)(OBu)2] added. 
1H-NMR was taken for each sample, and the chemical shift was 
plotted against base concentration. A non-linear regression was carried out using an online fitting 
software according to a literature procedure47 to acquire the binding affinity constant. 















Figure 3.22. 1H-NMR  of 4-Pentenoic Anilide with Different Bu4N[OP(O)(OBu)2] Loadings, 
Related to Figure 3.7 
 
Figure 3.23. 1H-NMR of (E)-But-2-en-1-yl Phenylcarbamate S43 with Different 





Figure 3.24. Binding Curve of Pent-4-enoic Anilide, Kbinding = (32 ± 4) M
-1, Related to Figure 3.7 
 
Figure 3.25. Binding Curve of (E)-But-2-en-1-yl Phenylcarbamate, Kbinding = (0.74 ± 0.05) M
-1, 
Related to Figure 3.7 
NMR Investigation of Influence of t-BuOH on Amides’ N-H Bond Acidity 
A series of 0.0378 M solutions of 4-pentenoic anilide S1 were prepared with solvents 
combination of t-BuOH/CDCl3 in ratios of 1:2, 1:1, 2:1 and 3:1, respectively. A 













































Binding Curve of Carbamate S1
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for each sample - the spectra are displayed below. As indicated in Figure S9, a significant downfield 
shift was observed with higher t-BuOH ratios. As a potential H-bonding acceptor, this is likely an 
indication of an increase of the N-H bond’s acidity, which we believed is beneficial for the PCET 
step. It is also noteworthy that after the ratio between t-BuOH and CDCl3 reached 2:1, the chemical 
shift change is difficult to appreciate, with this ratio being close to the optimal reaction conditions. 
This suggests that under reaction conditions, both the amount of base and t-BuOH solvent are 
optimal for an easy PCET step. 
 
CDCl3 : t-BuOH 100:0 2:1 1:1 1:2 1:3 
δN-H (ppm) 7.19 8.67 8.87 9.11 9.14 
Figure 3.26. 1H-NMR of 4-Pentenoic Anilide with Different t-BuOH:CDCl3 Solvent Ratios 
Characterization Data 
N-Phenylpent-4-enamide (S1),49 2-methyl-N-phenylpent-4-enamide (S2),57 1-allyl-N-
phenylcyclohexane-1-carboxamide (S4),58 3-methyl-N-phenylpent-4-enamide (S6),57 4-methyl-N-
phenylpent-4-enamide (S7),58 and N-phenylcyclohex-3-ene-1-carboxamide (S8),59 N-(p-tolyl)pent-
4-enamide (S13),60 N-(4-(methoxy)phenyl)pent-4-enamide (S14),61 and N-(4-fluorophenyl)pent-4-
enamide (S15)58  were synthesized following General Procedure I. 2,2-Dimethyl-N-phenylpent-4-
enamide (S3)62, 2-endo-N-phenylbicyclo[2.2.1]hept-5-ene-2-carboxamide (S9),26 N-
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phenylcyclopent-3-ene-1-carboxamide (S11),63 N-(4-(trifluoromethyl)phenyl)pent-4-enamide 
(S16),58 and N-(4-cyanophenyl)pent-4-enamide (S17)58 were prepared via General Procedure II. 
Allyl phenylcarbamate (S41)53 and (4aR, 8R, 8aS)2,2-dimethyl-4,4a,8,8a-tetrahydropyrano[3,2-
d][1,3]dioxin-8-ylphenylcarbamate (S50)26 was synthesized according to General Procedure IV. 
All characterization data match previous literature reports. 
tert-Butyl (S)-(1-Oxo-1-(phenylamino)pent-4-en-2-yl)carbamate (S5): 
Prepared following General Procedure I, starting from N-Boc protected L-allylglycine (1.08 g, 5.00 
mmol).64 The corresponding product was obtained as a white solid (1.14 g, 3.93 mmol, 78% yield), 
upon purification using an automated system (silica gel, hexanes/EtOAc, 0 to 50%). mp = 103-105 
ºC.  1H NMR (500 MHz, CDCl3) δ 8.42 (s, 1H), 7.52 – 7.45 (m, 2H), 7.28 (t, J = 7.8 Hz, 2H), 7.08 
(t, J = 7.4 Hz, 1H), 5.83 (ddt, J = 17.1, 9.8, 7.1 Hz, 1H), 5.28 – 5.03 (m, 3H), 4.33 (s, 1H), 2.68 – 
2.47 (m, 2H), 1.46 (s, 9H) ppm. 13C NMR (126 MHz, CDCl3) δ 169.9, 156.3, 137.7, 133.2, 129.1, 
124.5, 120.1, 119.3, 80.8, 54.7, 36.4, 28.4 ppm. IR (neat, cm-1): 3300, 2980, 1666, 1602, 1530, 
1499, 1444, 1392, 1048, 753. HRMS (ES+) calcd for (C16H23N2O3) [M+H]
+ 291.1709, found 
291.1709. 
2-((1R,5S)-5-Hydroxycyclopent-2-en-1-yl)-N-phenylacetamide (S10): 
Prepared following General Procedure III, starting from commercially available (1S,5R)-2-
oxabicyclo[3.3.0]oct-6-en-3-one (500 mg, 4.03 mmol). The corresponding product was obtained 
as a tan solid (638.4 mg, 2.99 mmol, 74% yield), upon purification using an automated system 
(silica gel, hexanes/EtOAc, 0 to 50%). mp = 96-100 ºC.  1H NMR (500 MHz, CDCl3) δ 7.88 (s, 
 
 144 
1H), 7.50 (d, J = 7.8 Hz, 2H), 7.32 (t, J = 7.9 Hz, 2H), 7.11 (t, J = 7.5 Hz, 1H), 5.77 (dt, J = 4.9, 
2.5 Hz, 1H), 5.58 – 5.54 (m, 1H), 4.59 (td, J = 6.4, 2.7 Hz, 1H), 3.13 (dtt, J = 8.4, 4.2, 2.1 Hz, 2H), 
2.78 – 2.66 (m, 2H), 2.55 (dd, J = 14.1, 4.0 Hz, 1H), 2.40 (dt, J = 17.3, 2.4 Hz, 1H) ppm. 13C NMR 
(126 MHz, CDCl3) δ 172.4, 138.0, 131.8, 129.4, 129.1, 124.6, 120.4, 72.2, 47.7, 41.7, 36.8 ppm. 
IR (neat, cm-1): 3301, 1658, 1534, 1442, 1079, 709. HRMS (ES+) calcd for (C13H16NO2) [M+H]
+ 
218.1181, found 218.1178.  
2,2-Difluoro-N-phenylpent-4-enamide (S12): Prepared following General 
Procedure II, starting from commercially available 2,2-difluoropent-4-enoic acid (1.36 g, 10.00 
mmol). The corresponding product was obtained as a white solid (1.3874 g, 6.57 mmol, 65% yield), 
upon purification using an automated system (silica gel, hexanes/EtOAc, 0 to 30%). mp = 42-45 
ºC. 1H NMR (500 MHz, CDCl3) δ 7.91 (s, 1H), 7.56 (d, J = 7.4 Hz, 2H), 7.38 (t, J = 8.0 Hz, 2H), 
7.20 (t, J = 7.4 Hz, 1H), 5.79 (ddt, J = 17.3, 10.2, 7.2 Hz, 1H), 5.40 – 5.26 (m, 2H), 2.97 (td, J = 
16.8, 7.2 Hz, 2H) ppm. 13C NMR (126 MHz, CDCl3) δ 162.0 (t, J = 28.4 Hz), 136.1, 129.3, 127.2 
(t, J = 5.5 Hz), 125.8, 122.2, 120.6, 117.3 (t, J = 254.6 Hz), 38.6 (t, J = 24.0 Hz) ppm. 19F NMR 
(471 MHz, CDCl3) δ -105.3 ppm. IR (neat, cm
-1): 3371, 1685, 1599, 1538, 1447, 1178, 1021. 
HRMS (ES+) calcd for (C11H12F2NO) [M+H]
+ 212.0887, found 212.0891. 
N-(Thiophen-3-yl)pent-4-enamide (S18): Prepared following General Procedure 
I, starting from commercially available 3-aminothiophene hydrochloride (818.1 mg, 6.0 mmol) and 
1 equiv of Et3N (607.8 mg, 6.0 mmol). The corresponding product was obtained as a white solid 
(667.0 mg, 3.68 mmol, 61% yield), upon purification using an automated system (silica gel, 
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hexanes/EtOAc, 0 to 50%). mp = 107-110 ºC. 1H NMR (500 MHz, CDCl3) δ 7.67 – 7.59 (m, 1H), 
7.56 (dd, J = 3.2, 1.3 Hz, 1H), 7.21 (dd, J = 5.2, 3.2 Hz, 1H), 6.98 (dd, J = 5.2, 1.4 Hz, 1H), 5.87 
(ddt, J = 16.8, 10.3, 6.2 Hz, 1H), 5.11 (dd, J = 17.1, 1.6 Hz, 1H), 5.05 (dd, J = 10.3, 1.4 Hz, 1H), 
2.58 – 2.37 (m, 4H) ppm. 13C NMR (126 MHz, CDCl3) δ 169.9, 136.9, 135.6, 124.6, 121.1, 116.1, 
110.4, 36.4, 29.6 ppm. IR (neat, cm-1): 3287, 3105, 1657, 1641, 1577, 1536, 1427, 1362, 1212, 912, 
839, 776. HRMS(ES+) calcd for (C9H12NOS) [M+H]
+ 182.0639, found 182.0640. 
2-Methylbut-3-en-2-yl Phenylcarbamate (S42): Prepared following General 
Procedure IV, starting from commercially available 2-methyl-3-buten-2-ol (910.7 mg, 9.0 mmol) 
and phenyl isocyanate (1.072 g, 9.0 mmol). The corresponding product was obtained as a white 
solid (986.8 mg, 4.77 mmol, 53% yield), upon purification using an automated system (silica gel, 
hexanes/EtOAc, 0 to 20%). mp = 53-57 ºC.  1H NMR (500 MHz, CDCl3) δ 7.37 (d, J = 8.0 Hz, 
2H), 7.33 – 7.28 (m, 2H), 7.04 (t, J = 7.4 Hz, 1H), 6.51 (s, 1H), 6.19 (dd, J = 17.5, 10.9 Hz, 1H), 
5.23 (d, J = 17.5 Hz, 1H), 5.13 (d, J = 10.9 Hz, 1H), 1.60 (s, 6H) ppm. 13C NMR (126 MHz, CDCl3) 
δ 152.6, 142.9, 138.4, 129.1, 123.3, 118.8, 112.9, 81.0, 26.9 ppm. IR (neat, cm-1): 3281, 1692, 1544, 
1315, 1242, 1125. HRMS (ES+) calcd for (C12H16NO2) [M+H]
+ 206.1181, found 206.1186. 
(E)-But-2-en-1-yl Phenylcarbamate (S43): Prepared following General 
Procedure IV, starting from commercially available crotyl alcohol (360.6 mg, 5.0 mmol) and 
phenyl isocyanate (596 mg, 5.0 mmol).  The corresponding product was obtained as a white solid 
(852 mg, 4.45 mmol, 89% yield), upon purification using an automated system (silica gel, 
hexanes/EtOAc, 0 to 20%). mp = 72-75 ºC. 1H NMR (500 MHz, CDCl3) δ 7.37 (d, J = 8.0 Hz, 2H), 
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7.33 – 7.28 (m, 2H), 7.08 – 7.04 (m, 1H), 6.61 (s, 1H), 5.90 – 5.78 (m, 1H), 5.65 (m, 1H), 4.60 (dd, 
J = 6.6, 1.2 Hz, 2H), 1.74 (d, J = 6.6, 3H) ppm.13C NMR (126 MHz, CDCl3) δ 153.5, 138.0, 131.7, 
129.2, 125.4, 123.6, 118.8, 66.1, 17.9 ppm. IR (neat, cm-1): 3321, 2944, 1707, 1600, 1540, 1444, 
1314, 1220, 1049, 1028, 754. HRMS (ES+) calcd for (C11H14NO2) [M+H]
+ 192.1025, found 
192.1042. 
(E)-But-2-en-1-yl (4-Acetyl)carbamate (S44): Prepared following 
General Procedure IV, starting from commercially available crotyl alcohol (360.6 mg, 5.0 mmol) 
and 4-acetylphenyl isocyanate (806 mg, 5.0 mmol).  The corresponding product was obtained as a 
white solid (1.150 g, 4.90 mmol, 98% yield), upon purification using an automated system (silica 
gel, hexanes/EtOAc, 0 to 50%) obtaining the corresponding product. mp = 97-99 ºC. 1H NMR (500 
MHz, CDCl3) δ 7.92 (d, J = 8.2 Hz, 2H), 7.48 (d, J = 8.2 Hz, 2H), 6.96 (s, 1H), 5.91 – 5.79 (m, 
1H), 5.63 (dddt, J = 15.1, 6.6, 4.9, 1.7 Hz, 1H), 4.61 (dt, J = 6.6, 1.1 Hz, 2H), 2.56 (s, 3H), 1.74 (d, 
J = 6.5 Hz, 3H) ppm. 13C NMR (126 MHz, CDCl3) δ 153.3, 137.2, 132.1, 132.0, 125.2, 120.3, 
116.0, 66.3, 17.9 ppm. IR (neat, cm-1): 3300, 1695, 1594, 1522, 1214, 1073, 906, 820, 730, 502. 
HRMS (ES+) calcd for (C13H16NO3) [M+H]
+ 234.1130, found 234.1129. 
(E)-But-2-en-1-yl (4-Methoxyphenyl)carbamate (S45): Prepared 
following General Procedure IV, starting from commercially available crotyl alcohol (360.6 mg, 
5.0 mmol) and 4-methoxyphenyl isocyanate (745.7 mg, 5.0 mmol).  The corresponding product 
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was obtained as a white solid (1.302 g, 4.65 mmol, 93% yield), upon purification using an 
automated system (silica gel, hexanes/EtOAc, 0 to 40%). mp = 61-63 ºC. 1H NMR (500 MHz, 
CDCl3) δ 7.28 (s, 2H), 6.85 (d, J = 9.0 Hz, 2H), 6.45 (s, 1H), 5.89 – 5.79 (m, 1H), 5.69 – 5.58 (m, 
1H), 4.58 (d, J = 6.6 Hz, 2H), 3.78 (s, 3H), 1.74 (d, J = 6.2 Hz, 3H) ppm. 13C NMR (126 MHz, 
CDCl3) δ 197.0, 153.1, 142.6, 132.3, 132.2, 130.0, 125.1, 117.7, 66.4, 26.5, 17.9 ppm. IR (neat, 
cm-1): 3309, 1735, 1712, 1666, 1593, 1532, 1411, 1274, 1214, 1043, 840. HRMS (ES+) calcd for 
(C12H16NO3) [M+H]
+ 222.1130, found 222.1140. 
(E)-But-2-en-1-yl (4-Bromophenyl)carbamate (S46): Prepared following 
General Procedure IV, starting from commercially available crotyl alcohol (360.6 mg, 5.0 mmol) 
and 4-bromophenyl isocyanate (990 mg, 5.0 mmol).  The corresponding product was obtained as a 
white solid (1.211 g, 4.50 mmol, 90% yield), upon purification using an automated system (silica 
gel, hexanes/EtOAc, 0 to 20%). mp = 99-101 ºC. 1H NMR (500 MHz, CDCl3) δ 7.46 – 7.35 (m, 
2H), 7.31 – 7.22 (m, 2H), 6.65 (s, 1H), 5.90 – 5.80 (m, 1H), 5.63 (m, 1H), 4.59 (d, J = 6.5 Hz, 2H), 
1.74 (d, J = 6.2 Hz, 3H) ppm. 13C NMR (126 MHz, CDCl3) δ 153.3, 137.2, 132.1, 132.0, 125.2, 
120.3, 116.0, 66.3, 17.9 ppm. IR (neat, cm-1): 3300, 1695, 1594, 1522, 1214, 1073, 906, 820, 730, 
502. HRMS (ES+) calcd for (C11H13BrNO2) [M+H]
+ 270.0130, found 270.0150. 
(E)-But-2-en-1-yl (4-Cyanophenyl)carbamate (S47): Prepared following 
General Procedure IV, starting from commercially available crotyl alcohol (360.6 mg, 5.0 mmol) 
and 4-isocyanatobenzonitrile (720.6 mg, 5.0 mmol).  The corresponding product was obtained as a 
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white solid (822.5 mg, 3.8 mmol, 76% yield), upon purification using an automated system (silica 
gel, hexanes/EtOAc, 0 to 40%). mp = 132-138 ºC. 1H NMR (500 MHz, CDCl3) δ 7.59 (d, J = 8.8 
Hz, 2H), 7.50 (d, J = 8.8 Hz, 2H), 6.81 (s, 1H), 6.00 – 5.82 (m, 1H), 5.70 – 5.59 (m, 1H), 4.62 (d, 
J = 6.7 Hz, 2H), 1.75 (d, J = 6.5 Hz, 3H) ppm.  13C NMR (126 MHz, CDCl3) δ 152.9, 142.3, 133.5, 
132.4, 124.9, 119.1, 118.4, 106.3, 66.6, 17.9 ppm. IR (neat, cm-1): 3320, 2225, 1703, 1315, 1221. 
HRMS (EI+) calcd for (C12H12N2O2) [M]
+ 216.0899, found 216.0899. 
(E)-1-(But-2-en-1-yl)-1-butyl-3-phenylurea (S51): Prepared following 
General Procedure V, starting from (E)-N-butylbut-2-en-1-amine65 (159 mg, 1.25 mmol) and 
phenyl isocyanate (149 mg, 1.25 mmol). The corresponding product was obtained as a white solid 
(210 mg, 1.06 mmol, 85% yield), upon purification using an automated system (silica gel, 
hexanes/EtOAc, 0 to 40%). mp = 59-61 ºC. 1H NMR (500 MHz, CDCl3) δ 7.32 (d, J = 8.4 Hz, 2H), 
7.25 (t, J = 7.9 Hz, 2H), 6.98 (t, J = 7.3 Hz, 1H), 6.48 (s, 1H), 5.81 – 5.70 (m, 1H), 5.60 – 5.48 (m, 
1H), 3.92 – 3.79 (m, 2H), 3.40 – 3.27 (m, 2H), 1.81 – 1.73 (m, 3H), 1.64 – 1.52 (m, 2H), 1.35 (m, 
2H), 0.94 (t, J = 7.5, Hz, 3H) ppm. 13C NMR (126 MHz, CDCl3) δ 155.5, 139.5, 128.9, 128.6, 
127.5, 122.7, 119.6, 49.8, 47.7, 30.9, 20.3, 17.8, 14.0 ppm. IR (neat, cm-1): 3331, 2958, 2872, 1637, 
1595, 1499, 1377, 1309, 1221, 692. HRMS (ES+) calcd for (C15H23N2O) [M+H]
+ 247.1810, found 
247.1810. 
1,1-di((E)-But-2-en-1-yl)-3-phenylurea (S52): Prepared following 
General Procedure V, starting from a ~1:1 mixture of (E)-but-2-en-1-amine and di((E)-but-2-en-1-
yl)amine65 (294.5 mg, 3 mmol) and phenyl isocyanate (357.0 mg, 3 mmol). The corresponding 
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product was obtained as a white solid (142.0 mg, 0.57 mmol, 19% yield) upon purification using 
an automated system (silica gel, hexanes/EtOAc, 0 to 70%). mp = 55-57 ºC. 1H NMR (500 MHz, 
CDCl3) δ 7.32 (d, J = 7.4 Hz, 2H), 7.26 (t, J = 7.9 Hz, 2H), 7.00 (t, J = 7.3 Hz, 1H), 6.57 (s, 1H), 
5.78 – 5.66 (m, 2H), 5.58 – 5.46 (m, 2H), 3.87 (dd, J = 5.7, 0.7 Hz, 4H), 1.75 (dd, J = 6.4, 1.6 Hz, 
6H) ppm. 13C NMR (126 MHz, CDCl3) δ 155.7, 139.5, 129.0, 128.7, 127.3, 122.8, 119.5, 49.1, 
17.8 ppm. IR (neat, cm-1): 3333, 2917, 1640, 1596, 1531, 1500, 1476, 1443, 1310, 964, 751. HRMS 
(ES+) calcd for (C15H21N2O) [M+H]
+
 245.1654, found 245.1660. 
N-Phenyl-N-(Phenylthio)pent-4-enamide (S54):  Prepared following General 
Procedure VII using N-phenylpent-4-enamide (701.0 mg, 4.0 mmol). Silica gel purification using 
an automated system (hexanes/EtOAc, 0 to 20%) gave the product as a colorless oil (591.9 mg, 
2.08 mmol, 52% yield).  Rotamers were observed in 1H and 13C NMRs. 1H NMR (500 MHz, CDCl3) 
δ 7.37 – 7.31 (m, 6H), 7.29 – 7.24 (m, 2H), 7.17 (d, J = 7.7 Hz, 2H), 5.90 – 5.74 (m, 1H), 5.03 (d, 
J = 17.1 Hz, 1H), 4.98 (d, J = 10.2 Hz, 1H), 2.67 (s, 2H), 2.43 (dd, J = 7.2, 7.2 Hz, 2H) ppm. 13C 
NMR (126 MHz, CDCl3) δ 176.0 (br), 145.1, 137.2, 129.4, 129.4, 127.8, 127.8, 127.1, 126.7 (br), 
115.7, 33.9, 29.7 ppm. IR (neat, cm-1): 1686, 1489, 1259, 1152, 737. HRMS (ES+) calcd for 
(C17H18NOS) [M+H]
+ 284.1109, found 284.1112. 
(E)-But-2-en-1-yl phenyl(phenylthio)carbamate (S55): Prepared following General 
Procedure VII using but-2-en-1-yl phenylcarbamate (708.8 mg, 4.0 mmol). Silica gel purification 
using an automated system (hexanes/EtOAc, 0 to 20%) gave the product as a white solid (676.2 
mg, 2.24 mmol, 56% yield). mp = 43-45 ºC. 1H NMR (500 MHz, CDCl3) δ 7.40 – 7.34 (m, 4H), 
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7.33 – 7.27 (m, 3H), 7.24 – 7.20 (m, 3H), 5.82 – 5.70 (m, 1H), 5.67 – 5.53 (m, 1H), 4.63 (d, J = 6.4 
Hz, 2H), 1.70 (dd, J = 6.5, 1.5 Hz, 3H) ppm. 13C NMR (126 MHz, CDCl3) δ 157.1, 145.0, 138.2, 
131.7, 129.2, 129.0, 127.8, 127.1, 127.0, 126.6, 125.1, 68.3, 17.9 ppm. IR (neat, cm-1): 1706, 1490, 
1268, 1220, 1053, 969. HRMS (ES+) calcd for (C17H18NO2S) [M+H]
+ 300.1058, found 300.1066.  
Allyl phenyl(phenylthio)carbamate (S56): Prepared following General Procedure 
VII using allyl phenylcarbamate (634.3 mg, 3.58 mmol). Silica gel purification using an automated 
system (hexanes/EtOAc, 0 to 20%) gave the product as a colorless oil (492.3 mg, 1.72 mmol, 48% 
yield). 1H NMR (500 MHz, CDCl3) δ 7.48 – 7.15 (m, 10H), 5.92 (ddt, J = 16.2, 10.6, 5.4 Hz, 1H), 
5.27 (d, J = 17.4 Hz, 1H), 5.21 (d, J = 10.4 Hz, 1H), 4.72 (d, J = 5.5 Hz, 2H) ppm. 13C NMR (126 
MHz, CDCl3) δ 156.8, 144.8, 137.8, 131.9, 129.1, 128.9, 127.7, 127.1, 127.0, 126.5, 118.1, 67.9 
ppm. IR (neat, cm-1): 1715, 1267, 1226, 1212, 688. HRMS (ES+) calcd for (C16H16NO2S) [M+H]
+ 
286.0902, found 286.0898.  
4-((5-Oxo-1-Phenylpyrrolidin-2-yl)methyl)benzonitrile (1): Prepared 
following General Procedure VI using N-phenylpent-4-enamide (63.1 mg, 0.36 mmol, 1.2 equiv), 
4-bromobenzonitrile (54.6 mg, 0.3 mmol, 1.0 equiv), [Ni(dMeObpy)(H2O)2(Br)2] (8.5 mg, 0.0018 
mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 0.009 mmol, 3 mol %), 
Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry t-BuOH/PhCF3 (2:1, 6.0 mL, 0.05 
M). The reaction was stirred under blue LED irradiation at rt for 24 h. Silica gel purification using 
an automated system (hexanes/EtOAc, 0 to 40%) gave the product as a white solid (65.0 mg, 0.23 
mmol, 78% yield). mp = 108-111 ºC. 1H NMR (500 MHz, CDCl3) δ 7.57 (d, J = 7.9 Hz, 2H), 7.48 
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– 7.40 (m, 4H), 7.25 (t, J = 8.7 Hz, 1H), 7.21 (d, J = 7.9 Hz, 2H), 4.51 (tt, J = 8.3, 4.2 Hz, 1H), 3.04 
(dd, J = 13.7, 3.8 Hz, 1H), 2.74 (dd, J = 13.7, 8.4 Hz, 1H), 2.44 (m, 2H), 2.26 – 2.14 (m, 1H), 1.85 
(ddt, J = 13.6, 9.9, 5.3 Hz, 1H) ppm. 13C NMR (126 MHz, CDCl3) δ 174.1, 142.6, 137.4, 132.5, 
130.2, 129.4, 126.2, 123.9, 118.7, 111.0, 60.2, 39.8, 31.0, 23.4 ppm. IR (neat, cm-1): 2226, 1689, 




(2): Prepared following General Procedure VI using 2-methyl-N-phenylpent-4-enamide (68.1 mg, 
0.36 mmol, 1.2 equiv), 4-bromobenzonitrile (54.6 mg, 0.3 mmol, 1.0 equiv), 
[Ni(dMeObpy)(H2O)2(Br)2] (8.5 mg, 0.0018 mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 
mg, 0.009 mmol, 3 mol %), Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry t-
BuOH/PhCF3 (2:1, 6.0 mL, 0.05 M). The reaction was stirred under blue LED irradiation at rt for 
24 h. Silica gel purification using an automated system (hexanes/EtOAc, 0 to 40%) gave two 
diastereoisomers with a ratio of 2.4:1. Isomer 1 is a white solid, 49.6 mg, 0.17 mmol ; isomer 2 is 
colorless oil, 21.0 mg, 0.072 mmol. 81% yield in total. Isomer 1: mp = 119-122 ºC.  1H NMR (500 
MHz, CDCl3) δ 7.57 (m, 4H), 7.43 (t, J = 7.7 Hz, 2H), 7.24 (m, 3H), 4.50 (td, J = 8.3, 4.0 Hz, 1H), 
3.01 (dd, J = 13.7, 3.8 Hz, 1H), 2.80 (dd, J = 13.7, 8.3 Hz, 1H), 2.51 – 2.36 (m, 1H), 2.13 (ddd, J 
= 11.3, 8.7, 2.3 Hz, 1H), 1.85 (dt, J = 12.8, 9.0 Hz, 1H), 1.21 (d, J = 7.0 Hz, 3H) ppm. 13C NMR 
(126 MHz, CDCl3) δ 176.2, 142.7, 137.5, 132.3, 130.0, 129.2, 125.5, 122.8, 118.5, 110.8, 76.9, 
76.7, 57.8, 38.8, 36.0, 31.6, 16.1 ppm. IR (neat, cm-1): 2968, 2227, 1692, 1597, 1498, 1457, 1394, 
1226, 757, 693. HRMS (EI) calcd for (C19H18N2O) [M]
+ 290.1407, found 290.1419. Isomer 2: 1H 
NMR (500 MHz, CDCl3) δ 7.56 (d, J = 8.1 Hz, 2H), 7.42 (dd, J = 8.4, 7.3 Hz, 2H), 7.37 – 7.33 (m, 
2H), 7.27 – 7.23 (m, 1H), 7.18 (d, J = 7.9 Hz, 2H), 4.35 (tdd, J = 8.7, 6.6, 4.0 Hz, 1H), 3.15 (dd, J 
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= 13.6, 4.0 Hz, 1H), 2.63 – 2.52 (m, 2H), 2.33 (ddd, J = 12.8, 8.9, 6.7 Hz, 1H), 1.40 (ddd, J = 12.8, 
10.2, 8.3 Hz, 1H), 1.25 (d, J = 7.1 Hz, 3H) ppm. 13C NMR (126 MHz, CDCl3) δ 176.8, 142.6, 
137.4, 132.4, 130.1, 129.3, 126.4, 124.8, 118.8, 110.9, 58.0, 40.8, 36.9, 33.7, 16.7 ppm. IR (neat, 
cm-1): 2925, 2227, 1693, 1494, 1385, 1225, 910, 756, 693. HRMS (ES+) calcd for (C19H19N2O) 
[M+H]+ 291.1497, found 291.1489. 
4-((4,4-Dimethyl-5-oxo-1-phenylpyrrolidin-2-yl)methyl)benzonitrile 
(3): Prepared following General Procedure VI using 2-methyl-N-phenylpent-4-enamide (73.2 mg, 
0.36 mmol, 1.2 equiv), 4-bromobenzonitrile (54.6 mg, 0.3 mmol, 1.0 equiv), 
[Ni(dMeObpy)(H2O)2(Br)2] (8.5 mg, 0.0018 mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 
mg, 0.009 mmol, 3 mol %), Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry t-
BuOH/PhCF3 (2:1, 6.0 mL, 0.05 M). The reaction was stirred under blue LED irradiation at rt for 
24 h. Silica gel purification using an automated system (hexanes/EtOAc, 0 to 30%) gave the product 
as a white solid (66.6 mg, 0.22 mmol, 73% yield). mp = 139-141 ºC.  1H NMR (500 MHz, CDCl3) 
δ 7.57 (d, J = 7.8 Hz, 2H), 7.42 (t, J = 7.7 Hz, 2H), 7.38 (d, J = 7.9 Hz, 2H), 7.24 (t, J = 7.4 Hz, 
1H), 7.20 (d, J = 7.8 Hz, 2H), 4.37 (tt, J = 11.1, 6.7 Hz, 1H), 3.16 (dd, J = 13.6, 4.0 Hz, 1H), 2.59 
(dd, J = 13.5, 9.2 Hz, 1H), 1.98 (dd, J = 12.9, 7.0 Hz, 1H), 1.67 (dd, J = 12.8, 7.8 Hz, 1H), 1.25 (s, 
3H), 1.17 (s, 3H) ppm. 13C NMR (126 MHz, CDCl3) δ 179.1, 142.7, 137.6, 132.4, 130.1, 129.2, 
126.3, 124.5, 118.8, 110.9, 56.6, 40.9, 40.7, 40.0, 25.9, 25.2 ppm. IR (neat, cm-1): 2959, 2228, 1688, 
1596, 1493, 1394, 1363, 1234, 754, 553. HRMS (EI) calcd for (C20H20N2O) [M]





(4): Prepared following General Procedure VI using 1-allyl-N-phenylcyclohexane-1-carboxamide 
(146.0 mg, 0.6 mmol, 1.2 equiv), 4-bromobenzonitrile (91.0 mg, 0.5 mmol, 1.0 equiv), 
[Ni(dMeObpy)(H2O)2(Br)2] (14.1 mg, 0.03 mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (15.1 
mg, 0.015 mmol, 3 mol %), Bu4N[OP(O)(OBu)2]  (564.6 mg, 1.25 mmol, 2.5 equiv) and dry t-
BuOH/PhCF3 (2:1, 10.0 mL, 0.05 M). The reaction was stirred under blue LED irradiation at rt for 
16 h. Silica gel purification using an automated system (hexanes/EtOAc, 0 to 40%) gave the product 
as a white solid (109.3 mg, 0.19 mmol, 63% yield). mp = 112-119 ºC.  1H NMR (500 MHz, CDCl3) 
δ 7.59 (d, J = 7.8 Hz, 2H), 7.46 – 7.36 (m, 4H), 7.26 – 7.18 (m, 3H), 4.49 – 4.33 (m, 1H), 3.15 (dd, 
J = 13.6, 3.9 Hz, 1H), 2.61 (dd, J = 13.6, 9.1 Hz, 1H), 2.15 (dd, J = 13.1, 7.5 Hz, 1H), 1.87 (td, J = 
12.7, 3.8 Hz, 1H), 1.78 – 1.58 (m, 5H), 1.47 (d, J = 13.0 Hz, 1H), 1.39 (d, J = 12.9 Hz, 1H), 1.35 – 
1.23 (m, 3H) ppm. 13C NMR (126 MHz, CDCl3) δ 178.8, 142.9, 137.6, 132.4, 130.2, 129.3, 126.2, 
124.5, 118.9, 110.8, 56.9, 45.5, 40.8, 35.5, 34.7, 32.6, 25.5, 22.2 ppm. IR (neat, cm-1): 2927, 2852, 
2232, 1674, 1496, 1394. HRMS (ES+) calcd for (C23H25N2O) [M+H]
+ 345.1967, found 345.1982. 
tert-Butyl ((3S)-5-(4-Cyanobenzyl)-2-oxo-1-phenylpyrrolidin-3-
yl)carbamate (5): Prepared following General Procedure VI using tert-butyl (S)-(1-oxo-1-
(phenylamino)pent-4-en-2-yl)carbamate (104.5 mg, 0.36 mmol, 1.2 equiv), 4-bromobenzonitrile 
(54.6 mg, 0.3 mmol, 1.0 equiv), [Ni(dMeObpy)(H2O)2(Br)2] (8.5 mg, 0.0018 mmol, 6 mol %), 
[[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 0.009 mmol, 3 mol %), Bu4N[OP(O)(OBu)2] (338.8 mg, 
0.75 mmol, 2.5 equiv) and dry t-BuOH/PhCF3 (2:1, 6.0 mL, 0.05 M). The reaction was stirred under 
 
 154 
blue LED irradiation at rt for 36 h. Silica gel purification using an automated system 
(hexanes/EtOAc, 0 to 50%) gave two diastereoisomeric (5:1) products as off-white sticky oils (89.0 
mg, 0.23 mmol and 17.8 mg, 0.045 mmol, respectively; 91% yield in total). Isomer 1:  1H NMR 
(500 MHz, CDCl3) δ 7.58 (d, J = 8.1 Hz, 2H), 7.53 (d, J = 8.1 Hz, 2H), 7.44 (t, J = 7.9 Hz, 2H), 
7.26 – 7.20 (m, 3H), 5.09 (s, 1H), 4.52 (td, J = 8.8, 3.8 Hz, 1H), 4.15 (s, 1H), 3.02 (dd, J = 13.7, 
3.8 Hz, 1H), 2.83 (dd, J = 13.6, 8.6 Hz, 1H), 2.57 (d, J = 10.6 Hz, 1H), 2.08 (ddd, J = 15.2, 8.8, 6.5 
Hz, 1H), 1.44 (s, 9H) ppm. 13C NMR (126 MHz, CDCl3) δ 171.5, 155.9, 142.4, 137.1, 132.6, 130.2, 
129.6, 126.3, 122.7, 118.7, 111.2, 80.3, 60.5, 51.9, 38.7, 32.0, 28.4 ppm. IR (neat, cm-1): 3333, 
2975, 2227, 1692, 1495, 1365, 1245, 1162, 1048, 910, 754, 557. HRMS (ES+) calcd for 
(C23H26N3O3) [M+H]
+ 392.1974, found 392.1988. Isomer 2: 1H NMR (500 MHz, CDCl3) δ 7.58 – 
7.54 (m, 2H), 7.44 (dd, J = 8.4, 7.3 Hz, 2H), 7.36 – 7.33 (m, 2H), 7.32 – 7.27 (m, 1H), 7.17 – 7.13 
(m, 2H), 5.18 (s, 1H), 4.35 (tdd, J = 9.4, 6.0, 4.1 Hz, 1H), 4.23 (ddd, J = 9.7, 8.7, 4.7 Hz, 1H), 3.14 
(dd, J = 13.6, 4.1 Hz, 1H), 2.71 (s, 1H), 2.62 (dd, J = 13.6, 8.9 Hz, 1H), 1,57 (m, 1H), 1.44 (s, 9H) 
ppm. 13C NMR (126 MHz, CDCl3) δ 171.8, 155.9, 141.9, 136.6, 132.5, 130.1, 129.5, 127.1, 124.9, 
118.7, 111.1, 80.3, 56.7, 52.6, 40.2, 34.3, 28.5 ppm. IR (neat, cm-1): 3425, 2978, 2228, 1699, 1597, 
1495, 1455, 1366, 1165, 732. HRMS (ES+) calcd for (C23H26N3O3) [M+H]
+ 392.1974, found 
392.1999. 
4-((3-Methyl-5-oxo-1-phenylpyrrolidin-2-yl)methyl)benzonitrile (6): 
Prepared following General Procedure VI using 3-methyl-N-phenylpent-4-enamide (56.8 mg, 0.36 
mmol, 1.2 equiv), 4-bromobenzonitrile (54.6 mg, 0.3 mmol, 1.0 equiv), 
[Ni(dMeObpy)(H2O)2(Br)2] (8.5 mg, 0.0018 mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 
mg, 0.009 mmol, 3 mol %), Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry t-
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BuOH/PhCF3 (2:1, 6.0 mL, 0.05 M). The reaction was stirred under blue LED irradiation at rt for 
72 h. 1H NMR of the crude mixture showed a 3:2 dr. Silica gel purification using an automated 
system (hexanes/EtOAc, 0 to 40%) gave two different diastereomeric products (first eluting isomer 
(white solid): 35.6 mg, 0.12 mmol, 41% yield; second eluting isomer (white solid): 26.4 mg, 0.090 
mmol, 30% yield). mp (first isomer) = 75-80 ºC. mp (second isomer) = 128-130 ºC.  First eluting 
diastereomer: 1H NMR (500 MHz, CDCl3) δ 7.55 (d, J = 7.8 Hz, 2H), 7.47 – 7.37 (m, 4H), 7.23 (t, 
J = 7.0 Hz, 1H), 7.17 (d, J = 7.7 Hz, 2H), 4.07 (dt, J = 7.8, 3.9 Hz, 1H), 3.00 (dd, J = 13.9, 4.1 Hz, 
1H), 2.83 (dd, J = 13.9, 7.7 Hz, 1H), 2.60 (dd, J = 17.0, 8.4 Hz, 1H), 2.25 – 2.18 (m, 1H), 2.12 (dd, 
J = 17.1, 4.7 Hz, 1H), 1.07 (d, J = 6.8 Hz, 3H) ppm. 13C NMR (126 MHz, CDCl3) δ 173.4, 142.8, 
137.6, 132.4, 130.3, 129.4, 126.1, 123.9, 118.8, 110.9, 67.7, 39.3, 39.0, 30.5, 20.6 ppm. Second 
eluting diastereoisomer: 1H NMR (500 MHz, CDCl3) δ 7.45 (d, J = 8.3 Hz, 2H), 7.29 – 7.26 (m, 
4H), 7.17 (d, J = 8.2 Hz, 2H), 7.15 – 7.12 (m, 1H), 4.59 (q, J = 6.8 Hz, 1H), 2.97 – 2.86 (m, 2H), 
2.73 – 2.58 (m, 2H), 2.29 (dd, J = 16.2, 7.9 Hz, 1H), 1.12 (d, J = 6.8 Hz, 3H) ppm. 13C NMR (126 
MHz, CDCl3) δ 173.7, 143.6, 137.7, 132.2, 129.8, 129.1, 126.2, 124.5, 118.8, 110.4, 63.8, 39.5, 
35.4, 31.2, 15.3 ppm. IR (neat, cm-1): (first isomer) 2225, 1683, 1497, 1394, 1287, (second isomer) 
2225, 1674, 1407, 1359, 1221, 1115. HRMS (ES+) calcd for (C19H19N2O) [M+H]
+ 291.1497, found 
291.1505. 
4-((2-Methyl-5-oxo-1-phenylpyrrolidin-2-yl)methyl)benzonitrile (7): 
Prepared following General Procedure VI using 4-methyl-N-phenylpent-4-enamide (68.1 mg, 0.36 
mmol, 1.2 equiv), 4-bromobenzonitrile (54.6 mg, 0.3 mmol, 1.0 equiv), 
[Ni(dMeObpy)(H2O)2(Br)2] (8.5 mg, 0.0018 mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 
mg, 0.009 mmol, 3 mol %), Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry t-
 
 156 
BuOH/PhCF3 (2:1, 6.0 mL, 0.05 M). The reaction was stirred under blue LED irradiation at rt for 
72 h. Silica gel purification using an automated system (hexanes/EtOAc, 0 to 40%) gave the product 
as a colorless oil (52.9 mg, 0.18 mmol, 61% yield). 1H NMR (500 MHz, CDCl3) δ 7.60 (d, J = 7.8 
Hz, 2H), 7.48 (t, J = 7.6 Hz, 2H), 7.41 (t, J = 7.4 Hz, 1H), 7.28 (d, J = 7.9 Hz, 2H), 7.24 (d, J = 7.7 
Hz, 2H), 3.00 (d, J = 13.1 Hz, 1H), 2.83 (d, J = 13.1 Hz, 1H), 2.53 (ddd, J = 16.9, 9.4, 5.8 Hz, 1H), 
2.41 (ddd, J = 16.9, 9.1, 7.3 Hz, 1H), 2.25 (ddd, J = 12.8, 9.1, 5.8 Hz, 1H), 1.81 (ddd, J = 12.8, 9.3, 
7.3 Hz, 1H), 1.26 (s, 3H) ppm. 13C NMR (126 MHz, CDCl3) δ 174.9, 142.3, 136.1, 132.1, 131.1, 
129.5 (2C), 128.3, 118.6, 111.0, 65.3, 46.2, 31.7, 29.9, 25.9 ppm. IR (neat, cm-1): 2226, 1687, 1497, 
1375, 698. HRMS (ES+) calcd for (C19H19N2O) [M+H]
+ 291.1497, found 291.1508. 
cis-4-(cis-7-Oxo-6-phenyl-6-azabicyclo[3.2.1]octan-4-yl)benzonitrile 
(8): Prepared following General Procedure VI using N-phenylcyclohex-3-ene-1-carboxamide (72.5 
mg, 0.36 mmol, 1.2 equiv), 4-bromobenzonitrile (54.6 mg, 0.3 mmol, 1.0 equiv), 
[Ni(dMeObpy)(H2O)2(Br)2] (17.0 mg, 0.0036 mmol, 12 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 
mg, 0.009 mmol, 3 mol %), Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry t-
BuOH/PhCF3 (2:1, 6.0 mL, 0.05 M). The reaction was stirred under blue LED irradiation at rt for 
72 h. Silica gel purification using an automated system (hexanes/EtOAc, 0 to 40%) gave the product 
as a white solid (29.8 mg, 0. 099 mmol, 33% yield). mp = 179-185 ºC. 1H NMR (500 MHz, CDCl3) 
δ 7.75 (d, J = 7.8 Hz, 2H), 7.68 (d, J = 8.0 Hz, 2H), 7.50 – 7.38 (m, 4H), 7.20 (t, J = 7.4 Hz, 1H), 
4.57 – 4.41 (m, 1H), 3.47 (s, 1H), 2.86 – 2.60 (m, 1H), 2.28 – 1.95 (m, 5H), 1.68 (d, J = 11.6 Hz, 
1H) ppm. 13C NMR (126 MHz, CDCl3) δ 176.3, 148.1, 138.1, 132.6, 129.5, 128.6, 125.0, 120.5, 
118.7, 110.7, 62.9, 42.1, 38.7, 30.0, 24.3, 21.6 ppm. IR (neat, cm-1): 2214, 1686, 1597, 1394, 1217, 
1176. HRMS (ES+) calcd for (C20H19N2O) [M+H]




yl)benzonitrile (9): Prepared following General Procedure VI using (2-exo)-N-
phenylbicyclo[2.2.1]hept-5-ene-2-carboxamide (76.8 mg, 0.36 mmol, 1.2 equiv), 4-
bromobenzonitrile (54.6 mg, 0.3 mmol, 1.0 equiv), [Ni(dMeObpy)(H2O)2(Br)2] (17.0 mg, 0.0036 
mmol, 12 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 0.009 mmol, 3 mol %), 
Bu4N[OP(O)(OBu)2]  (338.8 mg, 0.75 mmol, 2.5 equiv) and dry t-BuOH/PhCF3 (2:1, 6.0 mL, 0.05 
M). The reaction was stirred under blue LED irradiation at rt for 48 h. Silica gel purification using 
an automated system (hexanes/EtOAc, 0 to 30%) gave the product as a white solid (67.8 mg, 0.22 
mmol, 72% yield). mp = 178-181 ºC.  1H NMR (500 MHz, CDCl3) δ 7.66 (d, J = 7.9 Hz, 2H), 7.36 
(d, J = 8.1 Hz, 2H), 7.33 – 7.27 (m, 4H), 7.09 (t, J = 7.4 Hz, 1H), 4.46 (d, J = 5.0 Hz, 1H), 3.25 (d, 
J = 5.2 Hz, 1H), 2.96 (s, 1H), 2.73 (dd, J = 11.4, 4.5 Hz, 1H), 2.59 – 2.49 (m, 1H), 2.20 – 2.08 (m, 
1H), 1.90 (t, J = 11.8 Hz, 2H), 1.55 (d, J = 11.4 Hz, 1H) ppm. 13C NMR (126 MHz, CDCl3) δ 177.7, 
147.9, 138.8, 132.7, 129.2, 128.4, 124.5, 119.8, 118.8, 110.9, 65.9, 54.4, 45.4, 44.3, 43.9, 35.8, 
34.1 ppm. IR (neat, cm-1): 2958, 2225, 1700, 1597, 1493, 1389, 1219, 1118, 1020, 824, 756, 557. 
HRMS (ES+) calcd for (C21H19N2O) [M+H]
+ 315.1497, found 315.1491. 
4-((3aR,4S,6R,6aR)-4-Hydroxy-2-oxo-1-
phenyloctahydrocyclopenta[b]pyrrol-6-yl)benzonitrile (10): Prepared following General 
Procedure VI using 2-((1R,5S)-5-hydroxycyclopent-2-en-1-yl)-N-phenylacetamide (78.2 mg, 0.36 
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mmol, 1.2 equiv), 4-bromobenzonitrile (54.6 mg, 0.3 mmol, 1.0 equiv), 
[Ni(dMeObpy)(H2O)2(Br)2] (8.5 mg, 0.0018 mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 
mg, 0.009 mmol, 3 mol %), Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry t-
BuOH/PhCF3 (2:1, 6.0 mL, 0.05 M). The reaction was stirred under blue LED irradiation at rt for 
16 h. Silica gel purification using an automated system (hexanes/EtOAc, 0 to 60%) gave the product 
as a brown solid (51.5 mg, 0.16 mmol, 54% yield). mp = 165-170 ºC.  1H NMR (500 MHz, CDCl3) 
δ 7.52 – 7.46 (m, 2H), 7.20 (t, J = 7.3 Hz, 2H), 7.16 – 7.09 (m, 3H), 6.99 (d, J = 7.8 Hz, 2H), 4.70 
(dd, J = 9.0, 5.0 Hz, 1H), 4.51 (s, 1H), 3.37 (dt, J = 11.7, 6.0 Hz, 1H), 3.14 – 3.04 (m, 1H), 2.93 
(dd, J = 17.7, 2.7 Hz, 1H), 2.72 (dd, J = 17.6, 10.3 Hz, 1H), 2.50 (s, 1H), 2.27 (dd, J = 13.6, 7.0 
Hz, 1H), 2.02 – 1.92 (m, 1H) ppm. 13C NMR (126 MHz, CDCl3) δ 173.9, 149.3, 137.2, 132.4, 
128.9, 128.3, 126.2, 124.6, 118.9, 110.4, 73.2, 71.9, 50.0, 44.2, 41.4, 31.9 ppm. IR (neat, cm-1): 




yl)benzonitrile (11): Prepared following General Procedure VI using N-phenylcyclopent-3-ene-1-
carboxamide (67.4 mg, 0.36 mmol, 1.2 equiv), 4-bromobenzonitrile (54.6 mg, 0.3 mmol, 1.0 
equiv), [Ni(dMeObpy)(H2O)2(Br)2] (8.5 mg, 0.0018 mmol, 6 mol %), 
[[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 0.009 mmol, 3 mol %), Bu4N[OP(O)(OBu)2] (338.8 mg, 
0.75 mmol, 2.5 equiv) and dry t-BuOH/PhCF3 (2:1, 6.0 mL, 0.05 M). The reaction was stirred under 
blue LED irradiation at rt for 36 h. Silica gel purification using an automated system 
(hexanes/EtOAc, 0 to 40%) gave the product as a white solid (59.7 mg, 0.21 mmol, 69% yield). mp 
= 162-164 ºC.  1H NMR (500 MHz, CDCl3) δ 7.70 – 7.65 (m, 2H), 7.57 – 7.52 (m, 2H), 7.42 (d, J 
= 8.2 Hz, 2H), 7.41 – 7.36 (m, 2H), 7.14 (t, J = 7.4 Hz, 1H), 4.48 (d, J = 2.0 Hz, 1H), 3.51 (dd, J = 
9.2, 5.3 Hz, 1H), 3.08 (dd, J = 4.0, 1.9 Hz, 1H), 2.38 (ddd, J = 13.2, 9.0, 2.3 Hz, 1H), 2.21 – 2.10 
 
 159 
(m, 2H), 1.85 (dt, J = 10.0, 1.6 Hz, 1H) ppm. 13C NMR (126 MHz, CDCl3) δ 175.9, 147.4, 137.8, 
132.8, 129.4, 128.2, 124.4, 119.2, 118.7, 111.0, 65.3, 47.2, 46.3, 36.8, 32.7 ppm. IR (neat, cm-1): 
2227, 1704, 1606, 1597, 1377, 1302, 1179, 1129, 911, 758, 558. HRMS (ES+) calcd for 
(C19H17N2O) [M+H]
+ 289.1349, found 289.1341. 
4-((4,4-Difluoro-5-oxo-1-phenylpyrrolidin-2-yl)methyl)benzonitrile 
(12):  Prepared following General Procedure VI using 2,2-difluoro-N-phenylpent-4-enamide (76.0 
mg, 0.36 mmol, 1.2 equiv), 4-bromobenzonitrile (54.6 mg, 0.3 mmol, 1.0 equiv), 
[Ni(dMeObpy)(H2O)2(Br)2] (8.5 mg, 0.0018 mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 
mg, 0.009 mmol, 3 mol %), Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry t-
BuOH/PhCF3 (2:1, 6.0 mL, 0.05 M). The reaction was stirred under blue LED irradiation at rt for 
96 h. Silica gel purification using an automated system (hexanes/EtOAc, 0 to 25%) gave the product 
as a colorless oil (45.8 mg, 0.15 mmol,  49% yield). 1H NMR (500 MHz, CDCl3) δ 7.60 (d, J = 7.8 
Hz, 2H), 7.48 (m, 4H), 7.35 (q, J = 4.3 Hz, 1H), 7.22 (d, J = 7.9 Hz, 2H), 4.51 (ddt, J = 11.7, 7.4, 
3.7 Hz, 1H), 3.18 (dd, J = 13.8, 4.1 Hz, 1H), 2.72 (dd, J = 13.8, 9.7 Hz, 1H), 2.61 (qd, J = 15.8, 7.9 
Hz, 1H), 2.35 (ddd, J = 26.7, 14.2, 3.5 Hz, 1H) ppm. 13C NMR (126 MHz, CDCl3) δ 162.6 (t, J = 
31.3 Hz), 141.2, 135.7, 132.8, 130.1, 129.8, 127.7, 123.9, 118.5, 117.3 (t, J = 249.8 Hz), 111.6, 
55.2 (m), 39.8, 34.0 (t, J = 22.2 Hz) ppm. 19F NMR (471 MHz, CDCl3) δ -100.3 (d, J = 271.8 Hz), 
-105.5 (d, J = 271.9 Hz) ppm. IR (neat, cm-1): 2230, 1723, 1495, 1328, 1315, 1135, 1090. HRMS 
(EI+) calcd for (C18H14F2N2O) [M]
+ 312.1074, found 312.1084. 
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4-((5-Oxo-1-(p-tolyl)pyrrolidin-2-yl)methyl)benzonitrile (13): Prepared 
following General Procedure VI using N-(p-tolyl)pent-4-enamide (68.1 mg, 0.36 mmol, 1.2 equiv), 
4-bromobenzonitrile (54.6 mg, 0.3 mmol, 1.0 equiv), [Ni(dMeObpy)(H2O)2(Br)2] (8.5 mg, 0.0018 
mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 0.009 mmol, 3 mol %), 
Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry t-BuOH/PhCF3 (2:1, 6.0 mL, 0.05 
M). The reaction was stirred under blue LED irradiation at rt for 24 h. Silica gel purification using 
an automated system (hexanes/EtOAc, 0 to 40%) gave the product as a colorless oil (42.5 mg, 0.15 
mmol, 49% yield). 1H NMR (500 MHz, CDCl3) δ 7.57 (d, J = 7.8 Hz, 2H), 7.37 – 7.29 (m, 2H), 
7.22 (m, 4H), 4.45 (tt, J = 8.0, 4.0 Hz, 1H), 3.03 (dd, J = 13.7, 3.8 Hz, 1H), 2.72 (dd, J = 13.7, 8.6 
Hz, 1H), 2.47 – 2.39 (m, 2H), 2.36 (s, 3H), 2.20 – 2.14 (m, 1H), 1.89 – 1.78 (m, 1H) ppm. 13C NMR 
(126 MHz, CDCl3) δ 174.1, 142.7, 136.1, 134.7, 132.4, 130.1, 130.0, 124.0, 118.7, 110.9, 60.3, 
39.7, 30.9, 23.4, 21.1 ppm. IR (neat, cm-1): 2974, 2228, 1692, 1388, 1295, 1115. HRMS (ES+) 
calcd for (C19H19N2O) [M+H]
+ 291.1497, found 291.1500. 
4-((5-Oxo-1-(p-methoxyphenyl)pyrrolidin-2-yl)methyl)benzonitrile 
(14):  Prepared following General Procedure VI using N-(4-methoxyphenyl)pent-4-enamide (73.9 
mg, 0.36 mmol, 1.2 equiv), 4-bromobenzonitrile (54.6 mg, 0.3 mmol, 1.0 equiv), 
[Ni(dMeObpy)(H2O)2(Br)2] (8.5 mg, 0.0018 mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 
mg, 0.009 mmol, 3 mol %), Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry t-
BuOH/PhCF3 (2:1, 6.0 mL, 0.05 M). The reaction was stirred under blue LED irradiation at rt for 
36 h. Silica gel purification using an automated system (hexanes/EtOAc, 0 to 40%) gave the product 
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as a colorless oil (51.5 mg, 0.17 mmol, 56% yield). 1H NMR (500 MHz, CDCl3) δ 7.55 (d, J = 8.1 
Hz, 2H), 7.30 (d, J = 9.0 Hz, 2H), 7.19 (d, J = 8.1 Hz, 2H), 6.94 (d, J = 8.9 Hz, 2H), 4.38 (tt, J = 
8.5, 4.4 Hz, 1H), 3.81 (s, 3H), 3.00 (dd, J = 13.6, 3.9 Hz, 1H), 2.68 (dd, J = 13.7, 8.7 Hz, 1H), 2.51 
– 2.33 (m, 2H), 2.16 (ddt, J = 13.0, 9.7, 7.4 Hz, 1H), 1.81 (dddd, J = 13.5, 9.2, 6.6, 4.8 Hz, 1H) 
ppm. 13C NMR (126 MHz, CDCl3) δ 174.2, 157.9, 142.7 (2C), 132.4, 130.1, 125.9, 118.7, 114.7, 
110.8, 60.8, 55.6, 39.9, 30.8, 23.5 ppm. IR (neat, cm-1): 2925, 2227, 1684, 1607, 1509, 1463, 1395, 
1245, 1178, 1031, 729, 556. HRMS (ES+) calcd for (C19H19N2O2) [M+H]
+ 307.1447, found 
307.1447. 
4-((5-Oxo-1-(p-fluorophenyl)pyrrolidin-2-yl)methyl)benzonitrile (15): 
Prepared following General Procedure VI using N-(4-fluorophenyl)pent-4-enamide (69.6 mg, 0.36 
mmol, 1.2 equiv), 4-bromobenzonitrile (54.6 mg, 0.3 mmol, 1.0 equiv), 
[Ni(dMeObpy)(H2O)2(Br)2] (8.5 mg, 0.0018 mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 
mg, 0.009 mmol, 3 mol %), Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry t-
BuOH/PhCF3 (2:1, 6.0 mL, 0.05 M). The reaction was stirred under blue LED irradiation at rt for 
24 h. Silica gel purification using an automated system (hexanes/EtOAc, 0 to 40%) gave the product 
as a white solid (64.5 mg, 0.17 mmol, 56% yield). mp = 139-141 ºC.  1H NMR (500 MHz, CDCl3) 
δ 7.62 – 7.55 (m, 2H), 7.48 – 7.37 (m, 2H), 7.25 – 7.16 (m, 2H), 7.12 (td, J = 8.7, 2.6 Hz, 2H), 4.44 
(tt, J = 8.4, 4.3 Hz, 1H), 3.02 (dd, J = 13.7, 4.0 Hz, 1H), 2.71 (dd, J = 13.6, 8.5 Hz, 1H), 2.55 – 
2.33 (m, 2H), 2.19 (ddt, J = 12.7, 9.4, 7.3 Hz, 1H), 1.85 (dddd, J = 13.2, 8.8, 6.3, 4.5 Hz, 1H) ppm. 
13C NMR (126 MHz, CDCl3) δ 174.2, 160.6 (d, J = 246.2 Hz), 142.4, 133.4, 132.5, 130.1, 125.9 
(d, J = 8.3 Hz), 118.7, 116.3 (d, J = 22.5 Hz), 111.1, 60.5, 39.8, 30.8, 23.5 ppm. 19F NMR (471 
MHz, CDCl3) δ -115.24 ppm. IR (neat, cm
-1): 2227, 1690, 1506, 1391, 1228, 1117, 833, 557. 
HRMS (EI) calcd for (C18H15FN2O) [M]




(16): Prepared following General Procedure VI using N-(4-trifluoromethylphenyl)pent-4-enamide 
(87.6 mg, 0.36 mmol, 1.2 equiv), 4-bromobenzonitrile (54.6 mg, 0.3 mmol, 1.0 equiv), 
[Ni(dMeObpy)(H2O)2(Br)2] (8.5 mg, 0.0018 mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(dFbpy)]PF6] 
(9.3 mg, 0.009 mmol, 3 mol %), Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry t-
BuOH/PhCF3 (2:1, 6.0 mL, 0.05 M). The reaction was stirred under blue LED irradiation at rt for 
24 h. Silica gel purification using an automated system (hexanes/EtOAc, 0 to 40%) gave the product 
as an off-white oil (30.1 mg, 0.09 mmol, 29% yield).   1H NMR (500 MHz, CDCl3) δ 7.76 – 7.64 
(m, 4H), 7.63 – 7.53 (m, 2H), 7.25 – 7.16 (m, 2H), 4.60 (tt, J = 8.0, 3.9 Hz, 1H), 3.05 (dd, J = 13.8, 
3.9 Hz, 1H), 2.78 (dd, J = 13.7, 8.3 Hz, 1H), 2.53 – 2.32 (m, 2H), 2.29 – 2.19 (m, 1H), 1.89 (dddd, 
J = 13.1, 9.4, 5.5, 4.0 Hz, 1H) ppm. 13C NMR (126 MHz, CDCl3) δ 174.3, 142.1, 140.7, 132.6, 
130.2, 127.5 (q, J = 32.9 Hz), 126.5 (q, J = 3.7 Hz), 124.0 (q, J = 271.9 Hz), 122.9, 118.6, 111.3, 
59.5, 39.4, 31.0, 23.1 ppm. 19F NMR (471 MHz, CDCl3) δ -62.37 ppm.  IR (neat, cm
-1): 2929, 2229, 
1701, 1612, 1519, 1323, 1164, 1119, 841. HRMS (ES+) calcd for (C19H16F3N2O) [M+H]
+ 
345.1215, found 345.1192. 
4-((5-Oxo-1-(p-cyanophenyl)pyrrolidin-2-yl)methyl)benzonitrile (17): 
Prepared following General Procedure VI using N-(4-cyanophenyl)pent-4-enamide (69.6 mg, 0.36 
mmol, 1.2 equiv), 4-bromobenzonitrile (54.6 mg, 0.3 mmol, 1.0 equiv), 
[Ni(dMeObpy)(H2O)2(Br)2] (8.5 mg, 0.0018 mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 
mg, 0.009 mmol, 3 mol %), Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry t-
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BuOH/PhCF3 (2:1, 6.0 mL, 0.05 M). The reaction was stirred under blue LED irradiation at rt for 
36 h. Silica gel purification using an automated system (hexanes/EtOAc, 0 to 40%) gave the product 
as a white solid (18.1 mg, 0.06 mmol, 20% yield). mp = 116-119 ºC.   1H NMR (500 MHz, CDCl3) 
δ 7.74 (m, 4H), 7.62 (d, J = 7.1 Hz, 2H), 7.23 (d, J = 7.8 Hz, 2H), 4.63 (tt, J = 7.9, 3.6 Hz, 1H), 
3.08 (dd, J = 13.9, 3.6 Hz, 1H), 2.82 (dd, J = 13.9, 8.3 Hz, 1H), 2.53 – 2.44 (m, 1H), 2.38 (dt, J = 
16.0, 8.8 Hz, 1H), 2.31 – 2.18 (m, 1H), 1.97 – 1.87 (m, 1H) ppm. 13C NMR (126 MHz, CDCl3) δ 
174.4, 141.8, 141.7, 133.4, 132.7, 130.2, 122.3, 118.6, 118.5, 111.5, 108.6, 59.1, 39.1, 31.1, 22.9 
ppm. IR (neat, cm-1): 2219, 1694, 1602, 1506, 1377, 1201, 1143, 803, 543. HRMS (ES+) calcd for 
(C19H16N3O) [M+H]
+ 302.1293, found 302.1299. 
4-((5-Oxo-1-(thiophen-3-yl)pyrrolidin-2-yl)methyl)benzonitrile (18): 
Prepared following General Procedure VI using N-(thiophen-3-yl)pent-4-enamide (65.2 mg, 0.36 
mmol, 1.2 equiv), 4-bromobenzonitrile (54.6 mg, 0.3 mmol, 1.0 equiv), 
[Ni(dMeObpy)(H2O)2(Br)2] (8.5 mg, 0.0018 mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 
mg, 0.009 mmol, 3 mol %), Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry t-
BuOH/PhCF3 (2:1, 6.0 mL, 0.05 M). The reaction was stirred under blue LED irradiation at rt for 
48 h. Silica gel purification using an automated system (hexanes/EtOAc, 0 to 40%) gave the product 
as a light-yellow oil (38.9 mg, 0.14 mmol, 46% yield).  1H NMR (500 MHz, CDCl3) δ 7.59 (d, J = 
7.9 Hz, 2H), 7.47 (dd, J = 3.1, 1.6 Hz, 1H), 7.36 (dd, J = 5.3, 2.3 Hz, 2H), 7.23 (d, J = 7.9 Hz, 2H), 
4.46 (ddd, J = 8.1, 4.9, 2.9 Hz, 1H), 3.06 (dd, J = 13.8, 3.6 Hz, 1H), 2.92 (dd, J = 13.8, 7.7 Hz, 1H), 
2.44 – 2.31 (m, 1H), 2.30 – 2.08 (m, 2H), 1.89 (tt, J = 9.0, 2.4 Hz, 1H) ppm. 13C NMR (126 MHz, 
CDCl3) δ 173.2, 142.4, 136.1, 132.5, 130.3, 125.4, 121.3, 118.7, 112.4, 111.1, 60.2, 38.9, 30.5, 23.0 
ppm. IR (neat, cm-1): 2927, 2227, 1688, 1536, 1421, 1383, 1277, 1173, 1100, 775, 557. HRMS 
(ES+) calcd for (C16H15N2OS) [M+H]
+ 283.0905, found 283.0907. 
 
 164 
5-(4-Acetylbenzyl)-1-phenylpyrrolidin-2-one (20): Prepared following 
General Procedure VI using N-phenylpent-4-enamide (63.1 mg, 0.36 mmol, 1.2 equiv), 4’-
bromoacetophenone (59.7 mg, 0.3 mmol, 1.0 equiv), [Ni(dMeObpy)(H2O)2(Br)2] (8.5 mg, 0.0018 
mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 0.009 mmol, 3 mol %), 
Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry t-BuOH/PhCF3 (2:1, 6.0 mL, 0.05 
M). The reaction was stirred under blue LED irradiation at rt for 24 h. Silica gel purification using 
an automated system (hexanes/EtOAc, 0 to 50%) gave the product as a colorless oil (59.9 mg, 0.20 
mmol, 68% yield).  1H NMR (500 MHz, CDCl3) δ 7.87 (d, J = 7.8 Hz, 2H), 7.50 (d, J = 8.0 Hz, 
2H), 7.43 (t, J = 7.8 Hz, 2H), 7.24 (d, J = 7.4 Hz, 1H), 7.20 (d, J = 7.9 Hz, 2H), 4.52 (tt, J = 8.2, 
3.9 Hz, 1H), 3.03 (dd, J = 13.7, 3.6 Hz, 1H), 2.72 (dd, J = 13.5, 8.5 Hz, 1H), 2.57 (s, 3H), 2.48 – 
2.35 (m, 2H), 2.22 – 2.10 (m, 1H), 1.93 – 1.81 (m, 1H) ppm. 13C NMR (126 MHz, CDCl3) δ 197.7, 
174.2, 142.6, 137.5, 135.9, 129.6, 129.3, 128.7, 126.0, 123.8, 60.3, 39.4, 31.1, 26.7, 23.3 ppm. IR 
(neat, cm-1):1678, 1606, 1597, 1498, 1389, 1266, 1183, 1027, 958, 755, 693. HRMS (ES+) calcd 
for (C19H20NO2) [M+H]
+ 294.1494, found 294.1517. 
5-(4-Methoxybenzyl)-1-phenylpyrrolidin-2-one (21): Prepared following 
General Procedure VI using N-phenylpent-4-enamide (63.1 mg, 0.36 mmol, 1.2 equiv), 4-
iodoanisole (70.2 mg, 0.3 mmol, 1.0 equiv), [Ni(dMeObpy)(H2O)2(Br)2] (8.5 mg, 0.0018 mmol, 6 
mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 0.009 mmol, 3 mol %), Bu4N[OP(O)(OBu)2] 
(338.8 mg, 0.75 mmol, 2.5 equiv) and dry t-BuOH/PhCF3 (2:1, 6.0 mL, 0.05 M). The reaction was 
stirred under blue LED irradiation at rt for 24 h. Silica gel purification using an automated system 
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(hexanes/EtOAc, 0 to 50%) gave the product as a colorless oil (43.1 mg, 0.15 mmol, 51% yield).  
1H NMR (500 MHz, CDCl3) δ 7.53 (d, J = 7.9 Hz, 2H), 7.43 (t, J = 7.7 Hz, 2H), 7.23 (t, J = 7.4 
Hz, 1H), 7.02 (d, J = 8.3 Hz, 2H), 6.83 (d, J = 8.2 Hz, 2H), 4.45 (tt, J = 8.0, 3.8 Hz, 1H), 3.78 (s, 
3H), 2.91 (dd, J = 13.8, 3.5 Hz, 1H), 2.60 (dd, J = 13.8, 8.5 Hz, 1H), 2.48 – 2.28 (m, 2H), 2.23 – 
2.05 (m, 1H), 1.97 – 1.85 (m, 1H) ppm. 13C NMR (126 MHz, CDCl3) δ 174.5, 158.6, 137.8, 130.4, 
129.2, 128.7, 125.7, 123.6, 114.1, 60.7, 55.3, 38.3, 31.2, 23.2 ppm. IR (neat, cm-1): 2930, 1688, 
1596, 1511, 1497, 1388, 1246, 1225, 1177, 1032, 908, 756, 727. HRMS (ES+) calcd for 
(C18H20NO2) [M+H]
+ 282.1494, found 282.1499. 
1-Phenyl-5-(4-(trifluoromethoxy)benzyl)pyrrolidin-2-one (22): Prepared 
following General Procedure VI using N-phenylpent-4-enamide (63.1 mg, 0.36 mmol, 1.2 equiv), 
1-bromo-4-(trifluoromethoxy)benzene (72.3 mg, 0.3 mmol, 1.0 equiv), 
[Ni(dMeObpy)(H2O)2(Br)2] (8.5 mg, 0.0018 mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 
mg, 0.009 mmol, 3 mol %), Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry t-
BuOH/PhCF3 (2:1, 6.0 mL, 0.05 M). The reaction was stirred under blue LED irradiation at rt for 
48 h. Silica gel purification using an automated system (hexanes/EtOAc, 0 to 30%) gave the product 
as a colorless oil (75.0 mg, 0.23 mmol, 75% yield). 1H NMR (500 MHz, CDCl3) δ 7.51 – 7.46 (m, 
2H), 7.43 (t, J = 8.0 Hz, 2H), 7.23 (t, J = 7.2 Hz, 1H), 7.12 (m, 4H), 4.49 (tt, J = 8.0, 3.9 Hz, 1H), 
2.98 (dd, J = 13.8, 3.7 Hz, 1H), 2.68 (dd, J = 13.7, 8.5 Hz, 1H), 2.43 (td, J = 9.6, 7.1 Hz, 2H), 2.24 
– 2.16 (m, 1H), 1.93 – 1.86 (m, 1H) ppm. 13C NMR (126 MHz, CDCl3) δ 174.3, 148.2, 137.6, 
135.7, 130.7, 129.3, 126.0, 123.8, 121.2, 120.6 (q, J = 257.6 Hz), 60.5, 38.8, 31.1, 23.4 ppm. 19F 
NMR (471 MHz, CDCl3) δ -57.9 ppm. IR (neat, cm
-1): 2976, 1697, 1499, 1384, 1221. HRMS (ES+) 
calcd for (C18H17F3NO2) [M+H]
+ 336.1211, found 336.1210. 
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5-([1,1'-Biphenyl]-4-ylmethyl)-1-phenylpyrrolidin-2-one (23): Prepared 
following General Procedure VI using N-phenylpent-4-enamide (63.1 mg, 0.36 mmol, 1.2 equiv), 
4-bromo-1,1’-biphenyl (69.9 mg, 0.3 mmol, 1.0 equiv), [Ni(dMeObpy)(H2O)2(Br)2] (8.5 mg, 
0.0018 mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 0.009 mmol, 3 mol %), 
Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry t-BuOH/PhCF3 (2:1, 6.0 mL, 0.05 
M). The reaction was stirred under blue LED irradiation at rt for 24 h. Silica gel purification using 
an automated system (hexanes/EtOAc, 0 to 50%) gave the product as a white solid (30.4 mg, 0.093 
mmol, 31% yield). mp = 85-87 ºC. 1H NMR (500 MHz, CDCl3) δ 7.60 – 7.54 (m, 2H), 7.53 (m, 
4H), 7.46 (d, J = 7.7 Hz, 2H), 7.43 (d, J = 7.1 Hz, 2H), 7.34 (t, J = 7.4 Hz, 1H), 7.24 (d, J = 7.3 Hz, 
1H), 7.19 (d, J = 7.9 Hz, 2H), 4.53 (tt, J = 8.0, 4.0 Hz, 1H), 3.04 (dd, J = 13.6, 3.6 Hz, 1H), 2.69 
(dd, J = 13.7, 8.9 Hz, 1H), 2.45 (dd, J = 9.0, 7.3 Hz, 2H), 2.27 – 2.14 (m, 1H), 2.01 – 1.90 (m, 1H) 
ppm. 13C NMR (126 MHz, CDCl3) δ 174.5, 140.8, 139.9, 137.8, 136.0, 129.9, 129.3, 129.1, 128.9, 
127.4, 127.1, 125.9, 123.9, 60.8, 39.1, 31.2, 23.4 ppm. IR (neat, cm-1):1683, 1596, 1487, 1397, 
1300, 1232, 1122, 831, 693. HRMS (ES+) calcd for (C23H22NO) [M+H]
+ 328.1701, found 
328.1711. 
N,N-Dimethyl-4-((5-oxo-1-phenylpyrrolidin-2-yl)methyl)benzamide 
(24): Prepared following General Procedure VI using N-phenylpent-4-enamide (63.1 mg, 0.36 
mmol, 1.2 equiv), 4-bromo-N,N-dimethylbenzamide (68.4 mg, 0.3 mmol, 1.0 equiv), 
[Ni(dMeObpy)(H2O)2(Br)2] (8.5 mg, 0.0018 mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 
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mg, 0.009 mmol, 3 mol %), Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry t-
BuOH/PhCF3 (2:1, 6.0 mL, 0.05 M). The reaction was stirred under blue LED irradiation at rt for 
24 h. Silica gel purification using an automated system (hexanes/EtOAc, 0 to 60%) gave the product 
as an off-white solid (69.7 mg, 0.22 mmol, 72% yield). mp = 116-120 ºC.  1H NMR (500 MHz, 
CDCl3) δ 7.49 (d, J = 7.9 Hz, 2H), 7.43 (t, J = 7.8 Hz, 2H), 7.35 (d, J = 7.8 Hz, 2H), 7.23 (t, J = 
7.3 Hz, 1H), 7.14 (d, J = 7.7 Hz, 2H), 4.49 (tt, J = 8.2, 4.0 Hz, 1H), 3.10 (s, 3H), 3.02 (dd, J = 13.6, 
3.7 Hz, 1H), 2.96 (s, 3H), 2.66 (dd, J = 13.6, 8.8 Hz, 1H), 2.47 – 2.40 (m, 2H), 2.16 (tt, J = 13.0, 
8.2 Hz, 1H), 1.95 – 1.84 (m, 1H) ppm. 13C NMR (126 MHz, CDCl3) δ 174.3, 171.4, 138.6, 137.7, 
135.0, 129.4, 129.3, 127.6, 126.0, 123.9, 60.6, 39.4, 35.5, 31.1, 23.4 ppm. IR (neat, cm-1): 3460, 
2929, 1688, 1623, 1596, 1496, 1390, 1223, 1080, 758, 694. HRMS (EI) calcd for (C20H22N2O2) 
[M]+ 322.1681, found 322.1676. 
5-(4-Bromobenzyl)-1-phenylpyrrolidin-2-one (25): Prepared following 
General Procedure VI using N-phenylpent-4-enamide (63.1 mg, 0.36 mmol, 1.2 equiv), 1,4-
dibromobenzene (70.8 mg, 0.3 mmol, 1.0 equiv), [Ni(dMeObpy)(H2O)2(Br)2] (8.5 mg, 0.0018 
mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 0.009 mmol, 3 mol %), 
Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry t-BuOH/PhCF3 (2:1, 6.0 mL, 0.05 
M). The reaction was stirred under blue LED irradiation at rt for 24 h. Silica gel purification using 
an automated system (hexanes/EtOAc, 0 to 40%) gave the product as a white solid (54.5 mg, 0.17 
mmol, 55% yield). mp = 101-103 ºC.  1H NMR (500 MHz, CDCl3) δ 7.51 – 7.47 (m, 2H), 7.46 – 
7.43 (m, 2H), 7.43 – 7.39 (m, 2H), 7.24 (tt, J = 7.3, 1.3 Hz, 1H), 6.98 (d, J = 8.3 Hz, 2H), 4.46 (tt, 
J = 8.2, 4.0 Hz, 1H), 2.93 (dd, J = 13.7, 3.6 Hz, 1H), 2.62 (dd, J = 13.7, 8.6 Hz, 1H), 2.50 – 2.32 
(m, 2H), 2.16 (ddt, J = 13.0, 9.8, 7.7 Hz, 1H), 1.87 (dddd, J = 13.3, 9.2, 6.1, 4.4 Hz, 1H) ppm. 13C 
NMR (126 MHz, CDCl3) δ 174.3, 137.6, 135.9, 131.8, 131.1, 129.4, 126.0, 123.8, 120.9, 60.4, 
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38.8, 31.1, 23.3 ppm. IR (neat, cm-1): 2927, 1693, 1596, 1497, 1388, 1293, 1071, 756, 693. HRMS 
(EI) calcd for (C17H16BrNO) [M]
+ 329.0415, found 329.0401. 
5-(4-(5,5-Dimethyl-1,3,2-dioxaborinan-2-yl)benzyl)-1-
phenylpyrrolidin-2-one (26): Prepared following General Procedure VI using N-phenylpent-4-
enamide (63.1 mg, 0.36 mmol, 1.2 equiv), 4-bromobenzeneboronic acid neopentyl glycol ester 
(80.7 mg, 0.3 mmol, 1.0 equiv), [Ni(dMeObpy)(H2O)2(Br)2] (8.5 mg, 0.0018 mmol, 6 mol %), 
[[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 0.009 mmol, 3 mol %), Bu4N[OP(O)(OBu)2] (338.8 mg, 
0.75 mmol, 2.5 equiv) and dry t-BuOH/PhCF3 (2:1, 6.0 mL, 0.05 M). The reaction was stirred under 
blue LED irradiation at rt for 24 h. Silica gel purification using an automated system 
(hexanes/EtOAc, 0 to 40%) gave the product as a white solid (60.1 mg, 0.17 mmol, 55% yield). mp 
= 146-152 ºC.  1H NMR (500 MHz, CDCl3) δ 7.73 (d, J = 7.9 Hz, 2H), 7.54 – 7.50 (m, 2H), 7.44 
(t, J = 7.9 Hz, 2H), 7.25 – 7.21 (m, 1H), 7.11 (d, J = 7.6 Hz, 2H), 4.48 (tt, J = 8.1, 3.9 Hz, 1H), 3.76 
(s, 4H), 3.02 (dd, J = 13.5, 3.5 Hz, 1H), 2.62 (dd, J = 13.5, 9.2 Hz, 1H), 2.41 (dd, J = 8.9, 7.4 Hz, 
2H), 2.12 (tt, J = 13.0, 8.4 Hz, 1H), 1.90 (dtd, J = 12.4, 7.6, 4.3 Hz, 1H), 1.02 (s, 6H) ppm. 13C 
NMR (126 MHz, CDCl3) δ 174.5, 139.6, 137.8, 134.3, 129.3, 128.7, 125.9, 123.9 (3C), 72.5, 60.8, 
39.6, 32.0, 31.2, 23.4, 22.1 ppm. IR (neat, cm-1): 2940, 1681, 1477, 1404, 1300, 1289, 1248, 1128, 
761, 649. HRMS (ES+) calcd for (C22H27BNO3) [M+H]
+ 364.2084, found 364.2066. 
Methyl 4-((5-oxo-1-phenylpyrrolidin-2-yl)methyl)benzoate (27): 
Prepared following General Procedure VI using N-phenylpent-4-enamide (63.1 mg, 0.36 mmol, 
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1.2 equiv), methyl 4-bromobenzoate (64.5 mg, 0.3 mmol, 1.0 equiv), [Ni(dMeObpy)(H2O)2(Br)2] 
(8.5 mg, 0.0018 mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 0.009 mmol, 3 mol %), 
Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry t-BuOH/PhCF3 (2:1, 6.0 mL, 0.05 
M). The reaction was stirred under blue LED irradiation at rt for 24 h. Silica gel purification using 
an automated system (hexanes/EtOAc, 0 to 60%) gave the product as a colorless oil (53.1 mg, 0.17 
mmol, 57% yield).  1H NMR (500 MHz, CDCl3) δ 7.96 (d, J = 7.6 Hz, 2H), 7.50 (d, J = 7.8 Hz, 
2H), 7.44 (t, J = 7.6 Hz, 2H), 7.24 (d, J = 7.6 Hz, 1H), 7.18 (d, J = 7.7 Hz, 2H), 4.52 (tt, J = 8.6, 
4.3 Hz, 1H), 3.91 (s, 3H), 3.05 (dd, J = 13.7, 3.7 Hz, 1H), 2.71 (dd, J = 13.7, 8.7 Hz, 1H), 2.51 – 
2.35 (m, 2H), 2.23 – 2.08 (m, 1H), 1.96 – 1.77 (m, 1H) ppm. 13C NMR (126 MHz, CDCl3) δ 174.3, 
167.0, 142.4, 137.6, 130.0, 129.5, 129.4, 129.0, 126.1, 123.9, 60.4, 52.3, 39.6, 31.1, 23.4 ppm. IR 
(neat, cm-1): 2951, 1716, 1694, 1497, 1389, 1279, 1180, 1110, 760, 694. HRMS (EI) calcd for 
(C19H19NO3) [M]
+ 309.1365, found 309.1373. 
5-(4-(Methylsulfonyl)benzyl)-1-phenylpyrrolidin-2-one (28): Prepared 
following General Procedure VI using N-phenylpent-4-enamide (63.1 mg, 0.36 mmol, 1.2 equiv), 
methyl 1-bromo-4-(methylsulfonyl)benzene (70.5 mg, 0.3 mmol, 1.0 equiv), 
[Ni(dMeObpy)(H2O)2(Br)2] (8.5 mg, 0.0018 mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 
mg, 0.009 mmol, 3 mol %), Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry t-
BuOH/PhCF3 (2:1, 6.0 mL, 0.05 M). The reaction was stirred under blue LED irradiation at rt for 
24 h. Silica gel purification using an automated system (hexanes/EtOAc, 0 to 60%) gave the product 
as an off-white solid (71.1 mg, 0.22 mmol, 72% yield). mp = 122-124 ºC. 1H NMR (500 MHz, 
CDCl3) δ 7.88 – 7.81 (m, 2H), 7.49 – 7.38 (m, 4H), 7.30 (d, J = 8.2 Hz, 2H), 7.26 – 7.20 (m, 1H), 
4.53 (tt, J = 8.3, 4.3 Hz, 1H), 3.08 (dd, J = 13.6, 3.9 Hz, 1H), 3.04 (s, 3H), 2.77 (dd, J = 13.6, 8.5 
Hz, 1H), 2.52 – 2.40 (m, 2H), 2.26 – 2.11 (m, 1H), 1.93 – 1.81 (m, 1H) ppm. 13C NMR (126 MHz, 
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CDCl3) δ 174.1, 143.6, 139.3, 137.5, 130.4, 129.4, 127.8, 126.2, 124.0, 60.3, 44.6, 39.6, 31.0, 23.5 
ppm. IR (neat, cm-1): 2926, 1691, 1596, 1497, 1392, 1297, 1147, 759, 526. HRMS (EI) calcd for 
(C18H19NO3S) [M]
+ 329.1086, found 329.1096. 
4-((5-Oxo-1-phenylpyrrolidin-2-yl)methyl)benzaldehyde (29): Prepared 
following General Procedure VI using N-phenylpent-4-enamide (63.1 mg, 0.36 mmol, 1.2 equiv), 
4-bromobenzaldehyde (55.5 mg, 0.3 mmol, 1.0 equiv), [Ni(dMeObpy)(H2O)2(Br)2] (8.5 mg, 
0.0018 mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 0.009 mmol, 3 mol %), 
Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry t-BuOH/PhCF3 (2:1, 6.0 mL, 0.05 
M). The reaction was stirred under blue LED irradiation at rt for 24 h. Silica gel purification using 
an automated system (hexanes/EtOAc, 0 to 60%) gave the product as an off-white solid (52.8 mg, 
0.22 mmol, 72% yield). mp = 122-124 ºC. 1H NMR (500 MHz, CDCl3) δ 9.97 (s, 1H), 7.79 (d, J = 
7.7 Hz, 2H), 7.48 (d, J = 8.7 Hz, 2H), 7.42 (t, J = 7.9 Hz, 2H), 7.27 (d, J = 6.1 Hz, 2H), 7.23 (t, J 
= 7.3 Hz, 1H), 4.53 (tt, J = 8.2, 4.2 Hz, 1H), 3.06 (dd, J = 13.6, 3.8 Hz, 1H), 2.74 (dd, J = 13.5, 8.6 
Hz, 1H), 2.49 – 2.34 (m, 2H), 2.17 (ddt, J = 12.8, 9.4, 7.6 Hz, 1H), 1.87 (dddd, J = 13.2, 9.0, 6.1, 
4.3 Hz, 1H) ppm. 13C NMR (126 MHz, CDCl3) δ 191.8, 174.2, 144.2, 137.5, 135.2, 130.1, 129.4, 
126.1, 123.9, 77.2, 60.3, 39.7, 31.0, 23.4. ppm. IR (neat, cm-1): 2926, 1691, 1596, 1497, 1392, 1297, 
1147, 759, 526. HRMS (ES+) calcd for (C18H18NO2) [M+H]
+ 280.1338, found 280.1344. 
5-(3-Methoxybenzyl)-1-phenylpyrrolidin-2-one (30): Prepared following 
General Procedure VI using N-phenylpent-4-enamide (63.1 mg, 0.36 mmol, 1.2 equiv), 1-bromo-
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3-methoxybenzene (56.1 mg, 0.3 mmol, 1.0 equiv), [Ni(dMeObpy)(H2O)2(Br)2] (17.0 mg, 0.0036 
mmol, 12 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 0.009 mmol, 3 mol %), 
Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry t-BuOH/PhCF3 (2:1, 6.0 mL, 0.05 
M). The reaction was stirred under blue LED irradiation at rt for 48 h. Silica gel purification using 
an automated system (hexanes/EtOAc, 0 to 30%) gave the product as a colorless oil (65.7 mg, 0.23 
mmol, 78% yield). 1H NMR (500 MHz, CDCl3) δ 7.52 (d, J = 7.9 Hz, 2H), 7.44 (t, J = 7.8 Hz, 2H), 
7.25 – 7.19 (m, 2H), 6.78 (dd, J = 8.3, 2.6 Hz, 1H), 6.72 (d, J = 7.6 Hz, 1H), 6.64 (s, 1H), 4.57 – 
4.44 (m, 1H), 3.78 (s, 3H), 2.97 (dd, J = 13.7, 3.4 Hz, 1H), 2.62 (dd, J = 13.6, 8.9 Hz, 1H), 2.42 (t, 
J = 7.8 Hz, 2H), 2.20 – 2.15 (m, 1H), 1.95 – 1.91 (m, 1H) ppm. 13C NMR (126 MHz, CDCl3) δ 
174.4, 159.8, 138.5, 137.8, 129.7, 129.3, 125.8, 123.7, 121.7, 115.4, 111.9, 60.6, 55.3, 39.3, 31.2, 
23.3 ppm. IR (neat, cm-1): 1689, 1596, 1584, 1497, 1286, 1259. HRMS (ES+) calcd for 
(C18H20NO2) [M+H]
+ 282.1494, found 282.1501. 
5-(3-Methylbenzyl)-1-phenylpyrrolidin-2-one (31): Prepared following 
General Procedure VI using N-phenylpent-4-enamide (63.1 mg, 0.36 mmol, 1.2 equiv), m-
bromotoluene (51.3 mg, 0.3 mmol, 1.0 equiv), [Ni(dMeObpy)(H2O)2(Br)2] (8.5 mg, 0.0018 mmol, 
6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 0.009 mmol, 3 mol %), Bu4N[OP(O)(OBu)2] 
(338.8 mg, 0.75 mmol, 2.5 equiv) and dry t-BuOH/PhCF3 (2:1, 6.0 mL, 0.05 M). The reaction was 
stirred under blue LED irradiation at rt for 24 h. Silica gel purification using an automated system 
(hexanes/EtOAc, 0 to 60%) gave the product as a colorless oil (37.6 mg, 0.14 mmol, 47% yield). 
1H NMR (500 MHz, CDCl3) δ 7.52 (d, J = 8.0 Hz, 2H), 7.44 (t, J = 7.7 Hz, 2H), 7.24 (t, J = 7.4 Hz, 
1H), 7.18 (t, J = 7.5 Hz, 1H), 7.05 (d, J = 7.6 Hz, 1H), 6.92 (d, J = 8.1 Hz, 2H), 4.47 (tt, J = 8.5, 
3.9 Hz, 1H), 2.97 (dd, J = 13.6, 3.5 Hz, 1H), 2.59 (dd, J = 13.6, 9.0 Hz, 1H), 2.43 (t, J = 8.2 Hz, 
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2H), 2.33 (s, 3H), 2.15 (m, 1H), 1.98 – 1.86 (m, 1H) ppm. 13C NMR (126 MHz, CDCl3) δ 174.5, 
138.3, 137.8, 136.9, 130.2, 129.3, 128.6, 127.6, 126.4, 125.8, 123.8, 60.8, 39.3, 31.2, 23.4, 21.5 
ppm. IR (neat, cm-1): 2923, 1692, 1596, 1497, 1386, 1221, 1113, 753, 693. HRMS (ES+) calcd for 
(C18H20NO) [M+H]
+ 266.1543, found 266.1538. 
5-(3-Fluorobenzyl)-1-phenylpyrrolidin-2-one (32): Prepared following General 
Procedure VI using N-phenylpent-4-enamide (63.1 mg, 0.36 mmol, 1.2 equiv), 1-bromo-3-
fluorobenzene (52.5 mg, 0.3 mmol, 1.0 equiv), [Ni(dMeObpy)(H2O)2(Br)2] (17.0 mg, 0.0036 
mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 0.009 mmol, 3 mol %), 
Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry t-BuOH/PhCF3 (2:1, 6.0 mL, 0.05 
M). The reaction was stirred under blue LED irradiation at rt for 48 h. Silica gel purification using 
an automated system (hexanes/EtOAc, 0 to 30%) gave the product as a yellowish oil (35.1 mg, 0.13 
mmol, 43% yield). 1H NMR (500 MHz, CDCl3) δ 7.50 (d, J = 8.0 Hz, 2H), 7.48 – 7.41 (m, 2H), 
7.25 (t, J = 8.1 Hz, 2H), 6.94 (t, J = 8.5 Hz, 1H), 6.90 (d, J = 7.7 Hz, 1H), 6.83 (d, J = 9.8 Hz, 1H), 
4.50 (dt, J = 8.3, 4.3 Hz, 1H), 3.00 (dd, J = 13.9, 3.6 Hz, 1H), 2.65 (dd, J = 13.7, 8.9 Hz, 1H), 2.45 
(t, J = 8.2 Hz, 2H), 2.24 – 2.15 (m, 1H), 1.96 – 1.85 (m, 1H) ppm. 13C NMR (126 MHz, CDCl3) δ 
174.3, 162.9 (d, J = 246.3 Hz), 139.4 (d, J = 7.2 Hz), 137.6, 130.2 (d, J = 8.4 Hz), 129.3, 126.0, 
125.1 (d, J = 2.8 Hz), 123.8, 116.2 (d, J = 21.0 Hz), 113.8 (d, J = 20.9 Hz), 60.4, 39.1 (d, J = 1.1 
Hz), 31.1, 23.3 ppm. 19F NMR (471 MHz, CDCl3) δ -113.0 ppm. IR (neat, cm
-1): 2974, 1694, 1588, 
1385, 1291. HRMS (ES+) calcd for (C17H17FNO) [M+H]
+ 270.1294, found 270.1309. 
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5-(2-Chlorobenzyl)-1-phenylpyrrolidin-2-one (33): Prepared following 
General Procedure VI using N-phenylpent-4-enamide (63.1 mg, 0.36 mmol, 1.2 equiv), 1-bromo-
2-chlorobenzene (57.4 mg, 0.3 mmol, 1.0 equiv), [Ni(dMeObpy)(H2O)2(Br)2] (8.5 mg, 0.0018 
mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 0.009 mmol, 3 mol %), 
Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry t-BuOH/PhCF3 (2:1, 6.0 mL, 0.05 
M). The reaction was stirred under blue LED irradiation at rt for 24 h. Silica gel purification using 
an automated system (hexanes/EtOAc, 0 to 60%) gave the product as a colorless oil (30.9 mg, 0.11 
mmol, 36% yield). 1H NMR (500 MHz, CDCl3) δ 7.52 (d, J = 7.9 Hz, 2H), 7.41 (t, J = 7.8 Hz, 2H), 
7.35 (dd, J = 5.6, 3.7 Hz, 1H), 7.22 (t, J = 7.4 Hz, 1H), 7.17 (dd, J = 5.8, 3.6 Hz, 2H), 7.15 – 7.11 
(m, 1H), 4.59 (tt, J = 12.3, 4.3 Hz, 1H), 3.26 (dd, J = 13.4, 4.1 Hz, 1H), 2.72 – 2.55 (m, 2H), 2.48 
(ddd, J = 16.7, 9.6, 6.0 Hz, 1H), 2.10 (ddd, J = 16.8, 13.6, 7.9 Hz, 1H), 1.92 (ddt, J = 13.8, 9.9, 5.3 
Hz, 1H) ppm. 13C NMR (126 MHz, CDCl3) δ 174.3, 137.6, 135.0, 134.4, 131.7, 129.9, 129.2, 128.4, 
127.0, 126.0, 124.0, 59.3, 37.4, 31.2, 23.5 ppm. IR (neat, cm-1): 2923, 1692, 1597, 1497, 1386, 
1223, 1112, 908, 728, 683. HRMS (ES+) calcd for (C17H17ClNO) [M+H]
+ 286.0999, found 
286.1015. 
5-((1-Oxo-2,3-dihydro-1H-inden-5-yl)methyl)-1-phenylpyrrolidin-2-one 
(34): Prepared following General Procedure VI using N-phenylpent-4-enamide (63.1 mg, 0.36 
mmol, 1.2 equiv), 5-bromo-2,3-dihydro-1H-inden-1-one (63.3 mg, 0.3 mmol, 1.0 equiv), 
[Ni(dMeObpy)(H2O)2(Br)2] (8.5 mg, 0.0018 mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 
 
 174 
mg, 0.009 mmol, 3 mol %), Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry t-
BuOH/PhCF3 (2:1, 6.0 mL, 0.05 M). The reaction was stirred under blue LED irradiation at rt for 
36 h. Silica gel purification using an automated system (hexanes/EtOAc, 0 to 60%) gave the product 
as a colorless oil (61.4 mg, 0.20 mmol, 67% yield). 1H NMR (500 MHz, CDCl3) δ 7.66 (d, J = 7.8 
Hz, 1H), 7.47 (d, J = 7.5 Hz, 2H), 7.41 (t, J = 7.8 Hz, 2H), 7.22 (t, J = 7.3 Hz, 1H), 7.18 (s, 1H), 
7.12 (d, J = 7.8 Hz, 1H), 4.51 (tt, J = 8.3, 4.1 Hz, 1H), 3.07 (m, 3H), 2.71 (dd, J = 13.5, 8.8 Hz, 
1H), 2.68 – 2.64 (m, 2H), 2.43 (dd, J = 9.1, 7.1 Hz, 2H), 2.23 – 2.10 (m, 1H), 1.96 – 1.81 (m, 1H) 
ppm. 13C NMR (126 MHz, CDCl3) δ 206.4, 174.2, 155.7, 144.4, 137.5, 136.0, 129.3, 128.7, 127.6, 
126.0, 123.9, 123.9, 60.5, 39.9, 36.4, 31.0, 25.7, 23.4 ppm. IR (neat, cm-1) 1694, 1610,1598, 1393, 
1284, 1105, 906, 759, 723, 646. HRMS (ES+) calcd for (C20H20NO2) [M+H]
+ 306.1494, found 
306.1489. 
3-Chloro-5-((5-oxo-1-phenylpyrrolidin-2-yl)methyl)benzaldehyde (35): 
Prepared following General Procedure VI using N-phenylpent-4-enamide (63.1 mg, 0.36 mmol, 
1.2 equiv), 3-bromo-5-chlorobenzaldehyde (65.8 mg, 0.3 mmol, 1.0 equiv), 
[Ni(dMeObpy)(H2O)2(Br)2] (8.5 mg, 0.0018 mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 
mg, 0.009 mmol, 3 mol %), Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry t-
BuOH/PhCF3 (2:1, 6.0 mL, 0.05 M). The reaction was stirred under blue LED irradiation at rt for 
48 h. Silica gel purification using an automated system (hexanes/EtOAc, 0 to 40%) gave the product 
as a yellow oil (52.7 mg, 0.17 mmol, 56% yield). 1H NMR (500 MHz, CDCl3) δ 9.92 (s, 1H), 7.70 
(s, 1H), 7.48 (s, 1H), 7.45 – 7.42 (m, 4H), 7.32 (s, 1H), 7.25 – 7.21 (m, 1H), 4.52 (tt, J = 8.5, 4.4 
Hz, 1H), 3.05 (dd, J = 13.8, 4.0 Hz, 1H), 2.74 (dd, J = 13.8, 8.5 Hz, 1H), 2.53 – 2.44 (m, 2H), 2.28 
– 2.17 (m, 1H), 1.92 – 1.82 (m, 1H) ppm. 13C NMR (126 MHz, CDCl3) δ 190.7, 174.2, 140.1, 
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138.0, 137.3, 135.6, 135.1, 129.4, 128.3, 128.3, 126.3, 124.1, 60.2, 39.2, 30.9, 23.5 ppm. IR (neat, 
cm-1): 2973, 1693, 1497, 1384, 1288, 1113. HRMS (ES+) calcd for (C18H17ClNO2) [M+H]
+ 
314.0948, found 314.0965. 
(2R,3R,4S,5R,6S)-2-(Acetoxymethyl)-6-(4-((5-oxo-1-
phenylpyrrolidin-2-yl)methyl)phenoxy)tetrahydro-2H-pyran-3,4,5-triyl Triacetate (36): 
Prepared following General Procedure VI using N-phenylpent-4-enamide (63.1 mg, 0.36 mmol, 
1.2 equiv), 4-iodophenyl β-D-glucopyranoside tetraacetate (165.1 mg, 0.3 mmol, 1.0 equiv), 
[Ni(dMeObpy)(H2O)2(Br)2] (8.5 mg, 0.0018 mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 
mg, 0.009 mmol, 3 mol %), Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry t-
BuOH/PhCF3 (2:1, 6.0 mL, 0.05 M). The reaction was stirred under blue LED irradiation at rt for 
48 h. Silica gel purification using an automated system (hexanes/EtOAc, 0 to 50%) gave the product 
as a yellow oil (104.4 mg, 0.17 mmol, 58% yield). 1H NMR (500 MHz, CDCl3) δ 7.50 (d, J = 8.0 
Hz, 2H), 7.43 (t, J = 7.0 Hz, 2H), 7.23 (t, J = 7.4 Hz, 1H), 7.02 (m, 4H), 5.69 (t, J = 9.8 Hz, 2H), 
5.16 (t, J = 9.7 Hz, 1H), 5.08 – 4.96 (m, 1H), 4.50 – 4.43 (m, 1H), 4.31 – 4.19 (m, 1H), 4.15 – 4.08 
(m, 1H), 4.09 – 4.04 (m, 1H), 3.01 – 2.86 (m, 1H), 2.69 – 2.59 (m, 1H), 2.45 – 2.37 (m, 2H), 2.21 
– 2.12 (m, 1H), 2.13 – 1.97 (m, 12H), 1.94 – 1.86 (m, 1H) ppm. 13C NMR (126 MHz, CDCl3) δ 
174.3, 170.6, 170.2, 169.6, 155.2, 137.7, 131.5, 130.6, 129.3, 125.8 (2C), 123.7, 116.9, 94.5, 70.6, 
70.1, 68.4, 68.1, 61.7, 60.6, 38.4, 31.1, 23.2, 20.8, 20.74 (2C), 20.7 ppm. The product was obtained 
as a 1:1 mixture of diastereoisomers according to 13C NMR. Only the peaks for one of the 
diastereoisomers are given for clarity. IR (neat, cm-1): 1747, 1697, 1509, 1383, 1367, 1214. HRMS 
(ES+) calcd for (C31H36NO11) [M+H]




(37): Prepared following General Procedure VI using N-phenylpent-4-enamide (63.1 mg, 0.36 
mmol, 1.2 equiv), 2-cyano-4-bromopyrimidine (55.2 mg, 0.3 mmol, 1.0 equiv), 
[Ni(dMeObpy)(H2O)2(Br)2] (8.5 mg, 0.0018 mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 
mg, 0.009 mmol, 3 mol %), Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry t-
BuOH/PhCF3 (2:1, 6.0 mL, 0.05 M). The reaction was stirred under blue LED irradiation at rt for 
24 h. Silica gel purification using an automated system (hexanes/EtOAc, 0 to 80%) gave the product 
as an off-white solid (60.1 mg, 0.22 mmol, 72% yield). mp = 155-158 ºC. 1H NMR (500 MHz, 
CDCl3) δ 8.52 (s, 2H), 7.45 – 7.40 (m, 2H), 7.38 – 7.34 (m, 2H), 7.28 – 7.23 (m, 1H), 4.58 (tt, J = 
7.5, 4.9 Hz, 1H), 3.01 (dd, J = 14.3, 4.6 Hz, 1H), 2.88 (dd, J = 14.3, 7.4 Hz, 1H), 2.62 – 2.44 (m, 
2H), 2.37 – 2.30 (m, 1H), 1.83 (dddd, J = 13.1, 9.5, 6.9, 5.2 Hz, 1H) ppm. 13C NMR (126 MHz, 
CDCl3) δ 173.7, 158.4, 143.8, 136.9, 133.6, 129.7, 126.8, 124.2, 115.6, 59.3, 35.0, 30.8, 23.7 ppm. 
IR (neat, cm-1) 1678, 1556, 1498, 1412, 1357, 1228, 850, 692, 551. HRMS (ES+) calcd for 
(C16H15N4O) [M+H]
+ 279.1246, found 279.1239. 
1-Phenyl-5-(pyridin-4-ylmethyl)pyrrolidin-2-one (38): Prepared following 
General Procedure VI using N-phenylpent-4-enamide (63.1 mg, 0.36 mmol, 1.2 equiv), 4-
bromopyridine hydrochloride (58.3 mg, 0.3 mmol, 1.0 equiv), [Ni(dMeObpy)(H2O)2(Br)2] (8.5 mg, 
0.0018 mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 0.009 mmol, 3 mol %), 
Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry t-BuOH/PhCF3 (2:1, 6.0 mL, 0.05 
M). The reaction was stirred under blue LED irradiation at rt for 36 h. Silica gel purification using 
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an automated system (hexanes/EtOAc, 0 to 100%) gave the product as a light-yellow oil (60.6 mg, 
0.24 mmol, 80% yield). 1H NMR (500 MHz, CDCl3) δ 8.59 – 8.40 (m, 2H), 7.47 – 7.38 (m, 4H), 
7.22 (tt, J = 7.1, 1.6 Hz, 1H), 7.11 – 6.96 (m, 2H), 4.50 (tt, J = 8.4, 4.2 Hz, 1H), 2.97 (dd, J = 13.6, 
3.7 Hz, 1H), 2.64 (dd, J = 13.6, 8.7 Hz, 1H), 2.51 – 2.38 (m, 2H), 2.18 (ddt, J = 12.9, 9.1, 7.7 Hz, 
1H), 1.92 – 1.69 (m, 1H) ppm. 13C NMR (126 MHz, CDCl3) δ 174.1, 149.9, 146.1, 137.3, 129.3, 
126.2, 124.7, 123.9, 59.8, 39.0, 30.9, 23.4 ppm. IR (neat, cm-1) 1689, 1598, 1497, 1294, 1223, 1115, 
757, 695. HRMS (ES+) calcd for (C16H17N2O) [M+H]
+ 253.1341, found 253.1348. 
1-Phenyl-5-(quinolin-5-ylmethyl)pyrrolidin-2-one (39): Prepared 
following General Procedure VI using N-phenylpent-4-enamide (63.1 mg, 0.36 mmol, 1.2 equiv), 
5-bromoquinoline (62.4 mg, 0.3 mmol, 1.0 equiv), [Ni(dMeObpy)(H2O)2(Br)2] (8.5 mg, 0.0018 
mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 0.009 mmol, 3 mol %), 
Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry t-BuOH/PhCF3 (2:1, 6.0 mL, 0.05 
M). The reaction was stirred under blue LED irradiation at rt for 36 h. Silica gel purification using 
an automated system (hexanes/EtOAc, 0 to 60%) gave the product as a light-yellow oil (40.2 mg, 
0.12 mmol, 40% yield). 1H NMR (500 MHz, CDCl3) δ 8.92 (dd, J = 4.2, 1.6 Hz, 1H), 8.12 (dt, J = 
8.5, 1.2 Hz, 1H), 8.02 (d, J = 8.5 Hz, 1H), 7.63 (dd, J = 8.5, 7.1 Hz, 1H), 7.51 – 7.44 (m, 4H), 7.40 
(dd, J = 8.6, 4.2 Hz, 1H), 7.36 (d, J = 7.0 Hz, 1H), 7.28 (tt, J = 6.7, 2.0 Hz, 1H), 4.57 (ddt, J = 9.8, 
8.0, 4.1 Hz, 1H), 3.53 (dd, J = 14.0, 3.8 Hz, 1H), 2.95 (dd, J = 14.0, 9.8 Hz, 1H), 2.59 (ddd, J = 
17.1, 9.4, 7.6 Hz, 1H), 2.48 (ddd, J = 17.2, 9.6, 5.8 Hz, 1H), 2.10 (ddt, J = 13.1, 9.6, 7.6 Hz, 1H), 
1.92 (dddd, J = 13.4, 9.7, 5.8, 4.3 Hz, 1H) ppm. 13C NMR (126 MHz, CDCl3) δ 174.2, 150.3, 148.8, 
137.6, 133.8, 131.7, 129.5, 129.2, 129.2, 128.0, 127.2, 126.6, 124.7, 121.2, 60.6, 36.1, 30.9, 24.0 
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ppm. IR (neat, cm-1) 2928, 1690, 1596, 1498, 1391, 1296, 1223, 1115, 804, 757, 695. HRMS (ES+) 
calcd for (C20H19N2O) [M+H]
+ 303.1497, found 303.1496. 
5-(3-Fluoro-4-(hydroxymethyl)benzyl)-1-phenylpyrrolidin-2-one (40): 
Prepared following General Procedure VI using N-phenylpent-4-enamide (63.1 mg, 0.36 mmol, 
1.2 equiv), (4-bromo-2-fluorophenyl)methanol (63.3 mg, 0.3 mmol, 1.0 equiv), 
[Ni(dMeObpy)(H2O)2(Br)2] (8.5 mg, 0.0018 mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 
mg, 0.009 mmol, 3 mol %), Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry t-
BuOH/PhCF3 (2:1, 6.0 mL, 0.05 M). The reaction was stirred under blue LED irradiation at rt for 
48 h. Silica gel purification using an automated system (hexanes/EtOAc, 0 to 60%) gave the product 
as a colorless oil (54.8 mg, 0.18 mmol, 61% yield). 1H NMR (500 MHz, CDCl3) δ 7.51 – 7.46 (m, 
2H), 7.46 – 7.41 (m, 2H), 7.34 (t, J = 7.7 Hz, 1H), 7.26 – 7.21 (m, 1H), 6.89 (dd, J = 7.7, 1.7 Hz, 
1H), 6.80 (dd, J = 10.8, 1.7 Hz, 1H), 4.71 (s, 2H), 4.47 (dt, J = 8.4, 4.2 Hz, 1H), 2.97 (dd, J = 13.7, 
3.6 Hz, 1H), 2.63 (dd, J = 13.7, 8.8 Hz, 1H), 2.43 (ddd, J = 9.6, 7.4, 2.8 Hz, 2H), 2.17 (ddt, J = 
12.9, 9.2, 7.8 Hz, 1H), 1.88 (dddd, J = 13.0, 8.6, 6.8, 4.5 Hz, 1H) ppm. 13C NMR (126 MHz, CDCl3) 
δ 174.4, 160.6 (d, J = 247.0 Hz), 138.8 (d, J = 7.6 Hz), 137.5, 129.6 (d, J = 5.0 Hz), 129.4, 126.5 
(d, J = 14.6 Hz), 126.1, 125.2 (d, J = 3.2 Hz), 123.9, 116.2 (d, J = 21.3 Hz), 60.5, 59.1 (d, J = 4.0 
Hz), 39.0, 31.1, 23.3 ppm. 19F NMR (471 MHz, CDCl3) δ -119.53 ppm. IR (neat, cm
-1) 3383, 1673, 
1628, 1596, 1498, 1424, 1289, 1113, 1023, 757, 694. HRMS (ES+) calcd for (C18H19FNO2) [M+H]
+ 
300.1400, found 300.1393. 
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4-((2-Oxo-3-phenyloxazolidin-4-yl)methyl)benzonitrile (41): Prepared 
following General Procedure VI using allyl phenylcarbamate (63.8 mg, 0.36 mmol, 1.2 equiv), 4-
bromobenzonitrile (54.6 mg, 0.3 mmol, 1.0 equiv), [Ni(dMeObpy)(H2O)2(Br)2] (8.5 mg, 0.0018 
mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 0.009 mmol, 3 mol %), 
Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry t-BuOH/PhCF3 (2:1, 6.0 mL, 0.05 
M). The reaction was stirred under blue LED irradiation at rt for 36 h. Silica gel purification using 
an automated system (hexanes/EtOAc, 0 to 40%) gave two products, 41 and 41a. Product 41 was 
isolated as a colorless oil (18.1 mg, 0.066 mmol, 22%). 1H NMR (500 MHz, CDCl3) δ 7.59 (d, J = 
8.2 Hz, 2H), 7.54 – 7.48 (m, 2H), 7.43 (dd, J = 8.6, 7.3 Hz, 2H), 7.25 – 7.20 (m, 3H), 4.71 (tt, J = 
8.4, 4.3 Hz, 1H), 4.41 (t, J = 8.6 Hz, 1H), 4.15 (dd, J = 8.9, 4.6 Hz, 1H), 3.13 (dd, J = 14.0, 3.8 Hz, 
1H), 2.92 (dd, J = 14.0, 8.4 Hz, 1H) ppm. 13C NMR (126 MHz, CDCl3) δ 155.4, 140.8, 136.4, 
132.8, 130.2, 129.6, 125.7, 121.9, 118.5, 111.6, 65.8, 56.8, 38.1 ppm. IR (neat, cm-1) 2228, 1746, 
1598, 1501, 1403, 1297, 1215, 1125, 1020, 757. HRMS (ES+) calcd for (C17H15N2O2) [M+H]
+ 
279.1134, found 279.1135. 
Allyl (4-Cyanophenyl)(phenyl)carbamate (41a): Colorless oil (31.0 mg, 
0.11 mmol, 37%). 1H NMR (500 MHz, CDCl3) δ 7.57 (d, J = 8.7 Hz, 2H), 7.41 (t, J = 7.7 Hz, 2H), 
7.36 (d, J = 8.6 Hz, 2H), 7.33 (t, J = 7.4 Hz, 1H), 7.21 (dd, J = 7.5, 1.7 Hz, 2H), 5.87 (ddt, J = 16.4, 
10.8, 5.4 Hz, 1H), 5.19 (d, J = 1.6 Hz, 1H), 5.16 (dd, J = 7.1, 1.6 Hz, 1H), 4.68 – 4.64 (m, 2H) ppm. 
13C NMR (126 MHz, CDCl3) δ 154.0, 146.8, 141.2, 132.8, 131.9, 129.6, 128.1, 127.7, 125.6, 118.7, 
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118.2, 108.5, 67.1 ppm. IR (neat, cm-1) 2227, 1719, 1594, 1503, 1304, 1215, 1056. HRMS (EI+) 
calcd for (C17H14N2O2) [M]
+ 278.1055, found 278.1042. 
4-((5,5-Dimethyl-2-oxo-3-phenyloxazolidin-4-yl)methyl)benzonitrile 
(42): Prepared following General Procedure VI using 2-methylbut-3-en-2-yl phenylcarbamate 
(73.9 mg, 0.36 mmol, 1.2 equiv), 4-bromobenzonitrile (54.6 mg, 0.3 mmol, 1.0 equiv), 
[Ni(dMeObpy)(H2O)2(Br)2] (14.2 mg, 0.03 mmol, 10 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 
mg, 0.009 mmol, 3 mol %), Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry t-
BuOH/PhCF3 (2:1, 6.0 mL, 0.05 M). The reaction was stirred under blue LED irradiation at rt for 
72 h. Silica gel purification using an automated system (hexanes/EtOAc, 0 to 40%) gave the product 
as a yellow oil (35.8 mg, 0.12 mmol, 39% yield). 1H NMR (500 MHz, CDCl3) δ 7.49 (d, J = 8.2 
Hz, 2H), 7.30 (m, 4H), 7.19 (d, J = 8.1 Hz, 2H), 7.18 – 7.15 (m, 1H), 4.39 (dd, J = 8.2, 5.7 Hz, 1H), 
3.07 (dd, J = 14.7, 5.7 Hz, 1H), 2.91 (dd, J = 14.7, 8.2 Hz, 1H), 1.45 (s, 3H), 1.42 (s, 3H) ppm. 13C 
NMR (126 MHz, CDCl3) δ 154.9, 142.6, 136.9, 132.4, 129.8, 129.3, 126.1, 123.6, 118.6, 110.9, 
80.6, 66.5, 35.9, 28.4, 22.6 ppm. IR (neat, cm-1): 2231, 1741, 1501, 1396, 1301, 1114. HRMS (ES+) 
calcd for (C19H19N2O2) [M+H]
+ 307.1447, found 301.1447. 
4-(1-(2-Oxo-3-phenyloxazolidin-4-yl)ethyl)benzonitrile (43): Prepared 
following General Procedure VI using (E)-but-2-en-1-yl phenylcarbamate (68.7 mg, 0.36 mmol, 
1.2 equiv), 4-bromobenzonitrile (54.6 mg, 0.3 mmol, 1.0 equiv), [Ni(dMeObpy)(H2O)2(Br)2] (8.5 
mg, 0.0018 mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 0.009 mmol, 3 mol %), 
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Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry t-BuOH/PhCF3 (2:1, 6.0 mL, 0.05 
M). The reaction was stirred under blue LED irradiation at rt for 48 h. Silica gel purification using 
an automated system (hexanes/EtOAc, 0 to 40%) gave the product as a white solid (56.2 mg, 0.19 
mmol, 64% yield). mp = 115-117 ºC.  1H NMR (500 MHz, CDCl3) δ 7.62 – 7.57 (m, 2H), 7.48 (d, 
J = 8.6 Hz, 2H), 7.40 (t, J = 8.0 Hz, 2H), 7.32 – 7.27 (m, 2H), 7.21 (t, J = 7.4 Hz, 1H), 4.69 (dt, J 
= 8.6, 4.6 Hz, 1H), 4.28 – 4.16 (m, 2H), 3.34 (qd, J = 7.0, 4.1 Hz, 1H), 1.27 (d, J = 7.1 Hz, 3H) 
ppm. 13C NMR (126 MHz, CDCl3) δ 155.8, 146.1, 136.3, 132.7, 129.5, 128.5, 125.8, 122.4, 118.5, 
111.3, 62.8, 60.5, 39.3, 11.6 ppm. IR (neat, cm-1) 2225, 1733, 1504, 1407, 1299, 1208, 1130, 1029, 
848, 758, 694. HRMS (ES+) calcd for (C18H17N2O2) [M+H]
+ 293.1290, found 293.1273. 
4-(1-(3-(4-Acetylphenyl)-2-oxooxazolidin-4-yl)ethyl)benzonitrile (44): 
Prepared following General Procedure VI using (E)-but-2-en-1-yl-(4-acetylphenyl)carbamate (84.0 
mg, 0.36 mmol, 1.2 equiv), 4-bromobenzonitrile (54.6 mg, 0.3 mmol, 1.0 equiv), 
[Ni(dMeObpy)(H2O)2(Br)2] (8.5 mg, 0.0018 mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 
mg, 0.009 mmol, 3 mol %), Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry t-
BuOH/PhCF3 (2:1, 6.0 mL, 0.05 M). The reaction was stirred under blue LED irradiation at rt for 
48 h. Silica gel purification using an automated system (hexanes/EtOAc, 0 to 60%) gave the product 
as a white solid (56.2 mg, 0.17 mmol, 56% yield). mp = 141-144 ºC.  1H NMR (500 MHz, CDCl3) 
δ 8.02 (d, J = 8.3 Hz, 2H), 7.66 (m, 4H), 7.35 (d, J = 7.9 Hz, 2H), 4.77 (dt, J = 8.5, 4.4 Hz, 1H), 
4.34 – 4.18 (m, 2H), 3.50 – 3.37 (m, 1H), 2.60 (s, 3H), 1.28 (d, J = 7.1 Hz, 3H) ppm. 13C NMR 
(126 MHz, CDCl3) δ 196.8, 155.1, 145.6, 140.7, 133.8, 132.9, 129.9, 128.5, 120.7, 118.4, 111.7, 
62.7, 59.9, 39.0, 26.6, 11.4 ppm. IR (neat, cm-1) 2228, 1752, 1678, 1601, 1400, 1270, 1202, 1135, 
1047, 841. HRMS (ES+) calcd for (C20H19N2O3) [M+H]




(45): Prepared following General Procedure VI using but-2-en-1-yl (4-methoxyphenyl)carbamate 
(79.6 mg, 0.36 mmol, 1.2 equiv), 4-bromobenzonitrile (54.6 mg, 0.3 mmol, 1.0 equiv), 
[Ni(dMeObpy)(H2O)2(Br)2] (8.5 mg, 0.0018 mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 
mg, 0.009 mmol, 3 mol %), Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry t-
BuOH/PhCF3 (2:1, 6.0 mL, 0.05 M). The reaction was stirred under blue LED irradiation at rt for 
72 h. Silica gel purification using an automated system (hexanes/EtOAc, 0 to 40%) gave the product 
as a white solid (46.6 mg, 0.14 mmol, 48% yield). mp = 128-130 ºC. 1H NMR (500 MHz, CDCl3) 
δ 7.64 – 7.55 (m, 2H), 7.33 (d, J = 9.0 Hz, 2H), 7.27 (d, J = 6.8 Hz, 2H), 6.92 (d, J = 9.1 Hz, 2H), 
4.58 (dt, J = 9.0, 4.6 Hz, 1H), 4.29 – 4.17 (m, 2H), 3.81 (s, 3H), 3.27 (dt, J = 11.0, 5.8 Hz, 1H), 
1.29 (d, J = 7.0 Hz, 3H) ppm. 13C NMR (126 MHz, CDCl3) δ 157.8, 156.2, 146.3, 132.7, 129.0, 
128.5, 124.8, 118.5, 114.8, 111.3, 62.9, 61.3, 55.6, 39.6, 11.8 ppm. IR (neat, cm-1): 2213, 1739, 
1514, 1408, 1221, 1030. HRMS (EI+) calcd for (C19H18N2O3) [M]
+ 322.1317, found 322.1307. 
4-(1-(3-(4-Bromophenyl)-2-oxooxazolidin-4-yl)ethyl)benzonitrile (46): 
Prepared following General Procedure VI using (E)-but-2-en-1-yl-(4-bromophenyl)carbamate 
(97.2 mg, 0.36 mmol, 1.2 equiv), 4-bromobenzonitrile (54.6 mg, 0.3 mmol, 1.0 equiv), 
[Ni(dMeObpy)(H2O)2(Br)2] (8.5 mg, 0.0018 mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 
mg, 0.009 mmol, 3 mol %), Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry t-
BuOH/PhCF3 (2:1, 6.0 mL, 0.05 M). The reaction was stirred under blue LED irradiation at rt for 
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24 h. Silica gel purification using an automated system (hexanes/EtOAc, 0 to 60%) gave the product 
as a colorless oil (65.9 mg,0.18 mmol, 59% yield). 1H NMR (500 MHz, CDCl3) δ 7.64 – 7.57 (m, 
2H), 7.50 (m, 2H), 7.46 – 7.35 (m, 2H), 7.35 – 7.27 (m, 2H), 4.66 (dt, J = 8.7, 4.5 Hz, 1H), 4.29 – 
4.15 (m, 2H), 3.33 (dt, J = 7.1, 3.5 Hz, 1H), 1.25 (d, J = 7.1 Hz, 3H) ppm. 13C NMR (126 MHz, 
CDCl3) δ 155.4, 145.7, 135.5, 132.7, 132.5, 128.5, 123.7, 118.8, 118.4, 111.5, 62.8, 60.3, 39.1, 11.5 
ppm. IR (neat, cm-1) 2228, 1746, 1608, 1490, 1399, 1211, 1132, 1074, 1008, 846, 730. HRMS 
(ES+) calcd for (C18H16BrN2O2) [M+H]
+ 371.0395, found 371.0418. 
4-(1-(3-(4-Cyanophenyl)-2-oxooxazolidin-4-yl)ethyl)benzonitrile (47): 
Prepared following General Procedure VI using but-2-en-1-yl (4-cyanophenyl)carbamate (77.8 mg, 
0.36 mmol, 1.2 equiv), 4-bromobenzonitrile (54.6 mg, 0.3 mmol, 1.0 equiv), 
[Ni(dMeObpy)(H2O)2(Br)2] (8.5 mg, 0.018 mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 
mg, 0.009 mmol, 3 mol %), Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry t-
BuOH/PhCF3 (2:1, 6.0 mL, 0.05 M). The reaction was stirred under blue LED irradiation at rt for 
72 h. Silica gel purification using an automated system (hexanes/EtOAc, 0 to 40%) gave the product 
as a white solid (47.5 mg, 0.15 mmol, 50% yield). mp = 174-176 ºC. 1H NMR (500 MHz, CDCl3) 
δ 7.73 (m, 4H), 7.67 (d, J = 8.1 Hz, 2H), 7.35 (d, J = 8.0 Hz, 2H), 4.87 – 4.63 (m, 1H), 4.31 – 4.08 
(m, 2H), 3.45 (dt, J = 11.0, 5.5 Hz, 1H), 1.29 (d, J = 7.0 Hz, 3H) ppm. 13C NMR (126 MHz, CDCl3) 
δ 154.9, 145.3, 140.6, 133.6, 132.9, 128.5, 121.0, 118.4, 118.3, 111.9, 108.5, 62.8, 59.7, 38.9, 11.4 
ppm. IR (neat, cm-1): 2225, 1738, 1398, 1205, 1141, 838. HRMS (EI+) calcd for (C19H15N3O2) [M]
+ 




(48): Prepared following General Procedure VI using cyclohex-2-en-1-yl phenylcarbamate (78.2 
mg, 0.36 mmol, 1.2 equiv), 4-bromobenzonitrile (54.6 mg, 0.3 mmol, 1.0 equiv), 
[Ni(dMeObpy)(H2O)2(Br)2] (14.2 mg, 0.03 mmol, 10 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 
mg, 0.009 mmol, 3 mol %), Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry t-
BuOH/PhCF3 (2:1, 6.0 mL, 0.05 M). The reaction was stirred under blue LED irradiation at rt for 
72 h. Silica gel purification using an automated system (hexanes/EtOAc, 0 to 40%) gave the product 
as a white solid (48.6 mg, 0.15 mmol, 51% yield). mp = 191-196 ºC. 1H NMR (500 MHz, CDCl3) 
δ 7.26 (m, 2H), 7.07 (d, J = 8.1 Hz, 2H), 7.01 – 6.95 (m, 4H), 6.90 (t, J = 7.3 Hz, 1H), 4.88 – 4.76 
(m, 1H), 4.41 (dd, J = 9.3, 6.1 Hz, 1H), 2.85 (ddd, J = 13.0, 9.4, 3.6 Hz, 1H), 2.43 (d, J = 15.3 Hz, 
1H), 1.89 – 1.68 (m, 4H), 1.48 (qd, J = 13.1, 3.6 Hz, 1H) ppm. 13C NMR (126 MHz, CDCl3) δ 
155.5, 148.8, 137.1, 132.0, 128.6, 128.4, 125.1, 122.5, 118.7, 110.2, 74.0, 62.6, 48.7, 30.9, 27.0, 
19.6 ppm. IR (neat, cm-1): 2215, 1739, 1502, 1391, 1135, 980. HRMS (EI+) calcd for (C20H18N2O2) 
[M]+ 318.1368, found 318.1359. 
tert-Butyl 5-(1-(2-Oxo-3-phenyloxazolidin-4-yl)ethyl)-1H-indole-1-
carboxylate (49): Prepared following General Procedure VI using (E)-but-2-en-1-yl 
phenylcarbamate (68.7 mg, 0.36 mmol, 1.2 equiv), N-Boc-5-iodoindole (102.9 mg, 0.3 mmol, 1.0 
equiv), [Ni(dMeObpy)(H2O)2(Br)2] (8.5 mg, 0.0018 mmol, 6 mol %), 
[[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 0.009 mmol, 3 mol %), Bu4N[OP(O)(OBu)2] (338.8 mg, 
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0.75 mmol, 2.5 equiv) and dry t-BuOH/PhCF3 (2:1, 6.0 mL, 0.05 M). The reaction was stirred under 
blue LED irradiation at rt for 48 h. Silica gel purification using an automated system 
(hexanes/EtOAc, 0 to 60%) gave the product as a light-yellow oil (66.9 mg, 0.17 mmol, 55% yield). 
1H NMR (500 MHz, CDCl3) δ 8.11 (d, J = 8.5 Hz, 1H), 7.64 – 7.58 (m, 3H), 7.49 – 7.43 (m, 2H), 
7.40 (d, J = 1.8 Hz, 1H), 7.23 (td, J = 7.4, 1.2 Hz, 1H), 7.15 (dd, J = 8.6, 1.8 Hz, 1H), 6.55 (d, J = 
3.7 Hz, 1H), 4.77 (dt, J = 8.7, 4.2 Hz, 1H), 4.32 (dd, J = 9.1, 4.5 Hz, 1H), 4.14 (td, J = 9.1, 1.0 Hz, 
1H), 3.47 (qd, J = 7.0, 3.6 Hz, 1H), 1.74 – 1.62 (m, 9H), 1.31 (d, J = 7.1 Hz, 3H) ppm. 13C NMR 
(126 MHz, CDCl3) δ 156.1, 149.7, 136.7, 134.7, 131.2, 129.5, 126.8, 125.5, 123.9, 122.1, 122.1, 
119.5, 115.7, 107.2, 84.0, 62.6, 61.1, 37.9, 28.3, 11.2 ppm. IR (neat, cm-1) 1731, 1501, 1470, 1400, 




phenyloctahydro-[1,3]dioxino[4',5':5,6]pyrano[3,4-d]oxazol-6-yl)benzonitrile (50): Prepared 
following General Procedure VI using (4aR,8R,8aS)-2,2-dimethyl-4,4a,8,8a-tetrahydropyrano[3,2-
d][1,3]dioxin-8-yl phenylcarbamate (109.9 mg, 0.36 mmol, 1.2 equiv), 4-bromobenzonitrile (54.6 
mg, 0.3 mmol, 1.0 equiv), [Ni(dMeObpy)(H2O)2(Br)2] (14.2 mg, 0.03 mmol, 10 mol %), 
[[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 0.009 mmol, 3 mol %), Bu4N[OP(O)(OBu)2] (338.8 mg, 
0.75 mmol, 2.5 equiv) and dry t-BuOH/PhCF3 (2:1, 6.0 mL, 0.05 M). The reaction was stirred under 
blue LED irradiation at rt for 72 h. Silica gel purification using an automated system 
(hexanes/EtOAc, 0 to 50%) gave the product as a white solid (98.1 mg, 0.24 mmol, 80% yield). mp 
> 220 ºC. 1H NMR (500 MHz, CDCl3) δ 7.46 (d, J = 8.3 Hz, 2H), 7.32 – 7.27 (m, 2H), 7.19 (t, J = 
7.7 Hz, 2H), 7.13 – 7.02 (m, 3H), 5.01 (d, J = 6.1 Hz, 1H), 4.92 (dd, J = 8.1, 6.2 Hz, 1H), 4.83 (t, 
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J = 7.8 Hz, 1H), 4.38 (dd, J = 10.8, 7.5 Hz, 1H), 3.91 (dd, J = 11.2, 5.5 Hz, 1H), 3.80 (t, J = 10.5 
Hz, 1H), 3.59 (dd, J = 10.4, 5.6 Hz, 1H), 1.58 (s, 3H), 1.45 (s, 3H) ppm. 13C NMR (126 MHz, 
CDCl3) δ 155.4, 142.6, 135.8, 132.4, 129.2, 128.3, 126.5, 123.7, 118.2, 112.7, 100.3, 74.3, 73.9, 
71.4, 64.9, 62.6, 59.5, 29.0, 19.2 ppm. IR (neat, cm-1): 2248, 1764, 1381, 1233, 1082, 997. HRMS 
(EI+) calcd for (C23H22N2O5) [M]
+ 406.1529, found 406.1552. 
4-(1-(1-Butyl-2-oxo-3-phenylimidazolidin-4-yl)ethyl)benzonitrile 
(51): Prepared following General Procedure VI using (E)-1-(but-2-en-1-yl)-1-butyl-3-phenylurea 
(88.6 mg, 0.36 mmol, 1.2 equiv), 4-bromobenzonitrile (54.6 mg, 0.3 mmol, 1.0 equiv), 
[Ni(dMeObpy)(H2O)2(Br)2] (8.5 mg, 0.0018 mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 
mg, 0.009 mmol, 3 mol %), Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry t-
BuOH/PhCF3 (2:1, 6.0 mL, 0.05 M). The reaction was stirred under blue LED irradiation at rt for 
48 h. Silica gel purification using an automated system (hexanes/EtOAc, 0 to 40%) gave the product 
as a sticky oil (56.2 mg, 0.17 mmol, 58% yield). 1H NMR (500 MHz, CDCl3) δ 7.61 (d, J = 8.0 Hz, 
2H), 7.49 (d, J = 8.2 Hz, 2H), 7.39 – 7.31 (m, 4H), 7.10 (t, J = 7.3 Hz, 1H), 4.56 (dt, J = 9.4, 4.7 
Hz, 1H), 3.39 (dq, J = 7.3, 3.2 Hz, 1H), 3.31 – 3.14 (m, 4H), 1.53 – 1.42 (m, 2H), 1.36 – 1.27 (m, 
2H), 1.20 (d, J = 7.1 Hz, 3H), 0.92 (t, J = 7.4 Hz, 3H) ppm. 13C NMR (126 MHz, CDCl3) δ 158.0, 
147.2, 138.5, 132.5, 129.1, 128.5, 124.1, 121.8, 118.7, 111.0, 57.4, 43.6, 43.0, 39.2, 29.6, 20.1, 
13.9, 11.4 ppm. IR (neat, cm-1) 2930, 2228, 1694, 1607, 1500, 1427, 1267, 908, 728, 646. HRMS 
(ES+) calcd for (C22H26N3O) [M+H]




yl)ethyl)benzonitrile (52): Prepared following General Procedure VI using 1,1-di((E)-but-2-en-1-
yl)-3-phenylurea (88.0 mg, 0.36 mmol, 1.2 equiv), 4-bromobenzonitrile (54.6 mg, 0.3 mmol, 1.0 
equiv), [Ni(dMeObpy)(H2O)2(Br)2] (8.5 mg, 0.0018 mmol, 6 mol %), 
[[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 0.009 mmol, 3 mol %), Bu4N[OP(O)(OBu)2] (338.8 mg, 
0.75 mmol, 2.5 equiv) and dry t-BuOH/PhCF3 (2:1, 6.0 mL, 0.05 M). The reaction was stirred under 
blue LED irradiation at rt for 48 h. Silica gel purification using an automated system 
(hexanes/EtOAc, 0 to 40%) gave the product as a sticky oil (54.9 mg, 0.16 mmol, 53% yield). 1H 
NMR (500 MHz, CDCl3) δ 7.60 (dd, J = 8.4, 2.1 Hz, 2H), 7.48 (dd, J = 7.4, 1.5 Hz, 2H), 7.36 (dd, 
J = 8.5, 7.3 Hz, 2H), 7.33 – 7.29 (m, 2H), 7.11 (m, 1H), 5.67 – 5.58 (m, 1H), 5.36 (dtt, J = 15.1, 
6.6, 1.6 Hz, 1H), 4.54 (dt, J = 9.3, 4.7 Hz, 1H), 3.81 – 3.72 (m, 2H), 3.38 (td, J = 7.0, 4.0 Hz, 1H), 
3.24 – 3.09 (m, 2H), 1.69 (dd, J = 6.6, 1.6 Hz, 3H), 1.19 (d, J = 7.1 Hz, 3H) ppm. 13C NMR (126 
MHz, CDCl3) δ 157.7, 147.2, 138.4, 132.5, 129.9, 129.1, 128.5, 125.5, 124.2, 121.9, 118.7, 110.9, 
57.4, 45.9, 42.5, 39.3, 17.8, 11.5 ppm. IR (neat, cm-1) 2970, 2228, 1698, 1599, 1500, 1436, 1379, 
1255, 1148, 755. HRMS (ES+) calcd for (C22H24N3O) [M+H]
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Figure A2.6. 13C-NMR (CDCl3, 126 MHz) spectrum of 2,2-difluoro-N-phenylpent-4-enamide (S12) 
 


































































































Figure A2.27. 13C-NMR (CDCl3, 126 MHz) spectrum of 4-((5-oxo-1-phenylpyrrolidin-2-




First eluted diasteromer: 
 























Second eluted diastereomer: 
 
Figure A2.30. 1H-NMR (CDCl3, 500 MHz) spectrum of second diastereomer of 4-((4-methyl-5-oxo-1-
phenylpyrrolidin-2-yl)methyl)benzonitrile (2) 
 
Figure A2.31. 13C-NMR (CDCl3, 126 MHz) spectrum of second diastereomer of 4-((4-methyl-5-oxo-1-





















Figure A2.35. 13C-NMR (CDCl3, 126 MHz) spectrum of 4-((1-oxo-2-phenyl-2-azaspiro[4.5]decan-3-




First eluted diasteroisomer: 
 























Second eluted isomer: 
 
Figure A2.38. 1H-NMR (CDCl3, 500 MHz) spectrum of second diastereomer of tert-butyl ((3S)-5-(4-
cyanobenzyl)-2-oxo-1-phenylpyrrolidin-3-yl)carbamate (5) 
 





First eluted diastereoisomer: 
 























Second eluted diastereoisomer: 
 
Figure A2.42. 1H-NMR (CDCl3, 500 MHz) spectrum of second diastereomer of 4-((3-methyl-5-oxo-1-
phenylpyrrolidin-2-yl)methyl)benzonitrile (6) 
 
Figure A2.43. 13C-NMR (CDCl3, 126 MHz) spectrum of second diastereomer of 4-((3-methyl-5-oxo-1-






















Figure A2.47. 13C-NMR (CDCl3, 126 MHz) spectrum of cis-4-(cis-7-oxo-6-phenyl-6-










Figure A2.49. 13C-NMR (CDCl3, 126 MHz) spectrum of 4-((6-exo)-2-oxo-1-Phenyloctahydro-3,5-










Figure A2.51. 13C-NMR (CDCl3, 126 MHz) spectrum of 4-((3aR,4S,6R,6aR)-4-hydroxy-2-oxo-1-










Figure A2.53. 13C-NMR (CDCl3, 126 MHz) spectrum of 4-(6-exo-3-oxo-2-phenyl-2-





Figure A2.54. 1H-NMR (CDCl3, 500 MHz) spectrum of 4-((4,4-difluoro-5-oxo-1-phenylpyrrolidin-2-




Figure A2.55. 13C-NMR (CDCl3, 126 MHz) spectrum of 4-((4,4-difluoro-5-oxo-1-phenylpyrrolidin-2-
yl)methyl)benzonitrile (12) 
 
Figure A2.56. 19F-NMR (CDCl3, 471 MHz) spectrum of 4-((4,4-difluoro-5-oxo-1-phenylpyrrolidin-2-























Figure A2.60. 13C-NMR (CDCl3, 126 MHz) spectrum of 4-((5-oxo-1-(p-methoxyphenyl)pyrrolidin-2-










Figure A2.62. 13C-NMR (CDCl3, 126 MHz) spectrum of 4-((5-oxo-1-(p-fluorophenyl)pyrrolidin-2-
yl)methyl)benzonitrile (15) 
 
Figure A2.63. 19F-NMR (CDCl3, 471 MHz) spectrum of 4-((5-oxo-1-(p-fluorophenyl)pyrrolidin-2-











Figure A2.65. 13C-NMR (CDCl3, 126 MHz) spectrum of 4-((5-oxo-1-(p-trifluomethylphenyl)pyrrolidin-2-
yl)methyl)benzonitrile (16) 
 























Figure A2.70. 13C-NMR (CDCl3, 126 MHz) spectrum of 4-((5-oxo-1-(thiophen-3-yl)pyrrolidin-2-








































Figure A2.78. 13C-NMR (CDCl3, 126 MHz) spectrum of 1-phenyl-5-(4-
(trifluoromethoxy)benzyl)pyrrolidin-2-one (22) 
 











Figure A2.81. 13C-NMR (CDCl3, 126 MHz) spectrum of 5-([1,1'-biphenyl]-4-ylmethyl)-1-phenylpyrrolidin-































Figure A2.87. 13C-NMR (CDCl3, 126 MHz) spectrum of 5-(4-(5,5-dimethyl-1,3,2-dioxaborinan-2-










Figure A2.89. 13C-NMR (CDCl3, 126 MHz) spectrum of methyl 4-((5-oxo-1-phenylpyrrolidin-2-










Figure A 2.91. 13C-NMR (CDCl3, 126 MHz) spectrum of 5-(4-(methylsulfonyl)benzyl)-1-










Figure A 2.93. 13C-NMR (CDCl3, 126 MHz) spectrum of 4-((5-oxo-1-Phenylpyrrolidin-2-






























Figure A 2.99. 13C-NMR (CDCl3, 126 MHz) spectrum of 5-(3-fluorobenzyl)-1-phenylpyrrolidin-2-one (32) 
 
































Figure A2.106. 13C-NMR (CDCl3, 126 MHz) spectrum of 3-chloro-5-((5-oxo-1-phenylpyrrolidin-2-





Figure A2.107. 1H-NMR (CDCl3, 500 MHz) spectrum of (2R,3R,4S,5R,6S)-2-(ccetoxymethyl)-6-(4-((5-




Figure A2.108. 13C-NMR (CDCl3, 126 MHz) spectrum of (2R,3R,4S,5R,6S)-2-(ccetoxymethyl)-6-(4-((5-










Figure A2.110. 13C-NMR (CDCl3, 126 MHz) spectrum of 5-((5-oxo-1-phenylpyrrolidin-2-










Figure A2.112. 13C-NMR (CDCl3, 126 MHz) spectrum of 1-phenyl-5-(pyridin-4-ylmethyl)pyrrolidin-2-























Figure A2.116. 13C-NMR (CDCl3, 126 MHz) spectrum of 5-(3-fluoro-4-(hydroxymethyl)benzyl)-1-
phenylpyrrolidin-2-one (40) 
 





















Figure A2.121. 13C-NMR (CDCl3, 126 MHz) spectrum of 4-((2-oxo-3-phenyloxazolidin-4-










Figure A2.123. 13C-NMR (CDCl3, 126 MHz) spectrum of 4-((5,5-Dimethyl-2-oxo-3-phenyloxazolidin-4-


































Figure A2.129. 13C-NMR (CDCl3, 126 MHz) spectrum of 4-(1-(3-(4-methoxyphenyl)-2-oxooxazolidin-4-






















Figure A2.133. 13C-NMR (CDCl3, 126 MHz) spectrum of 4-(1-(3-(4-cyanophenyl)-2-oxooxazolidin-4-










Figure A2.135. 13C-NMR (CDCl3, 126 MHz) spectrum of 4-cis-(2-Oxo-3-phenyloctahydrobenzo[d]oxazol-





Figure A2.136. 1H-NMR (CDCl3, 500 MHz) spectrum of tert-butyl 5-(1-(2-oxo-3-phenyloxazolidin-4-




Figure A2.137. 13C-NMR (CDCl3, 126 MHz) spectrum of tert-butyl 5-(1-(2-oxo-3-phenyloxazolidin-4-

















Figure A2.140. 1H-NMR (CDCl3, 500 MHz) spectrum of 4-(1-(1-butyl-2-oxo-3-phenylimidazolidin-4-




Figure A2.141. 13C-NMR (CDCl3, 126 MHz) spectrum of 4-(1-(1-butyl-2-oxo-3-phenylimidazolidin-4-





Figure A2.142. 1H-NMR (CDCl3, 500 MHz) spectrum of 52 (E)-4-(1-(1-(but-2-en-1-yl)-2-oxo-3-




Figure A2.143. 13C-NMR (CDCl3, 126 MHz) spectrum of (E)-4-(1-(1-(but-2-en-1-yl)-2-oxo-3-























Figure A2.145. 13C-NMR (CDCl3, 126 MHz) spectrum of (E)-4-(4-(5-Oxo-1-phenylpyrrolidin-2-yl)but-3-


































































Chapter 4. Diastereoselective Olefin Amidoacylation via Photoredox PCET/Nickel-Dual 
Catalysis: Reaction Scope and Mechanistic Insights 
4.1 Introduction 
Transition metal-catalyzed 1,2-difunctionalizations of unactivated olefins have emerged as 
powerful methods for the elaboration of commodity chemicals over the past decades,§ with great 
capabilities of rapidly building molecular complexity.1 Multiple strategies have been employed to 
achieve selectivity for heterodifunctionalization, such as directed migratory insertion,2 
nucleometalation,3 radical-polar crossover of activated olefins,4 utilization of bulky coupling 
partners and/or polarity reversal,5 as well as kinetically favorable radical cyclization approaches.6  
Among these transformations, carboamination has received significant attention because of the vast 
prevalence of nitrogen-containing small molecules and heterocycles in bio-active and drug-like 
molecules.7 Progress has been achieved using amines as nucleophilic species for directed 
aminopalladation2,8 or trapping cationic species after C-C bond formation.4,9 Great efforts have 
been made to utilize prefunctionalized, reductively generated amidyl and iminyl radicals10 to 
improve efficiency and selectivity, while the oxidative proton-coupled electron transfer (PCET) 
approach has been utilized to generate N-centered radicals directly from N-H functional units.6,11  
Although β-amino ketone structures are reasonably prevalent among bioactive molecules 
(Figure 4.1a), aminoacylation reactions and aminocarbonylative transformations of olefins appear 
relatively rare (Figure 4.1b). Early efforts were focused on net-oxidative transformation using 
alcohols as the terminal reagents, rendering β-amino esters as the final product.12 The Lambert 
group employed an oxidative strategy to access an amidoacylation product by tethering a Pd-
catalyzed carbonylation process with a Lewis acid-catalyzed Friedel-Crafts acylation of electron-
rich (hetero)aromatic systems.13 Later, Bower et al. utilized an umpolung approach using tethered 
 
 
§ Reproduced in part from Zheng, S.; Zhang, S.-Q.; Hong, X.; Saeednia, B.; Molander, G. A.; 
Chem. Sci., submitted for publication. 
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oxime ester as an electrophilic nitrogen source and disclosed an iminoacylation using tetraaryl 
borates.14 A similar transformation has also been achieved by using organozinc reagents.15 In a 
more recent report,16 such a transformation was achieved with aryl iodides using an 8-
aminoquinoline directing group. 
 
Figure 4.1. Amidoacylation of Olefin Species 
Together, these methods provide powerful tools for the synthesis of N-heterocycles as well 
as β-amino ketones, yet many challenges remain to be addressed. One common feature of these 
transformations is the need for CO gas. Although it is an inexpensive and abundant C-1 building 
block, its toxic and flammable nature have made its utilization undesirable. Additionally, the 
majority of present transformations require aryl electrophiles or nucleophiles, while alkyl 
electrophiles remain challenging to incorporate. Because of their reasonable commercial 
availability and convenient preparation, acyl (pseudo)halides would be ideal surrogates leading to 
such transformations. However, to the best of our knowledge, only one such reaction has been 
reported, utilizing a reductive coupling strategy.17 Inspired by our recent effort in merging 
photoredox PCET with nickel catalysis for amidoarylation of olefins as demonstrated in Chapter 
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3,6b we sought to address the challenges of amidoacylation by utilizing acyl electrophiles in 
photoredox PCET/Ni dual-catalyzed olefin difunctionalization (Figure 4.1c). 
4.2 Results and Discussion 
To test this strategy, an investigation was initiated using N-phenyl hex-4-enamide and 
benzoyl chloride as cross-coupling partners (Figure 4.2). Previous reports indicated 1,2-
dichloroethane (DCE) as a potential solvent for photoredox PCET/Ni dual catalysis,6b which indeed 
rendered a 46% yield in the initial attempt (Figure 4.2, entry 1). Although it is noteworthy that the 
less expensive organic photocatalyst 4CzIPN gave a comparable yield (entry 3), neither this nor a 
more oxidizing Ir photocatalyst ([Ir-2], entry 2) significantly improved the yield. Several ligands 
facilitate the reaction reasonably well, with the electron-rich dMeObpy being optimal (entries 1, 4, 
5). A careful examination of the reaction profile indicated a significant amount of hydroamidation 
byproduct, likely caused by hydrogen atom abstraction from the solvent,11b which prompted to a 
further solvent optimization. MeCN was eventually identified as the most suitable solvent, 
providing a 75% yield of 1 (entry 7). Owing to the availability of a large number of carboxylic acid 
functional groups in a variety of commodity chemicals, we also examined the possibility of using 
carboxylate as the acyl source via in situ activation.18 After several attempts (entries 8-11), oxalyl 
chloride was identified as a suitable activator through an in situ acyl chloride generation process, 




Figure 4.2.  Reaction Optimization. a Performed on 0.1 mmol scale. b Isolated yield. 
With suitable conditions in hand, an exploration of the scope of the reaction was initiated. 
The developed reaction conditions exhibited excellent functional group tolerance. For substituted 
benzoyl chlorides, electron-rich (Figure 4.3, 3-4), electron-neutral (1, 5-7), and electron-poor (2) 
substrates all gave reasonably good yields, with electron-deficient systems usually performing 
better. Interestingly, even though the terminal methyl group seemed rather sterically undemanding, 
exceptional diastereoselectivities were observed in all these examples. Other types of electrophiles, 
such as acyl anhydrides (8) and alkyl acyl halides (9-11), are also compatible, despite a lower 
diastereoselectivity in some cases. In situ activation of carboxylic acids did not lead to a 
compromise in either the yield or dr of the reactions (12,13), and interesting substructures, such as 
substituted cyclopropyl (14) and difluorobenzodioxolyl (15), were installed with reasonable yields. 
Various anilide and alkenyl backbones were next examined, and their influence in this 
reaction was tested both to expand the scope and to shed light on the diastereoselectivity. For 
anilines bearing different substituents (16-22), although the yields varied, with more electron-
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deficient systems giving lower yields, the diastereoselectivities remained consistent. Substrates 
leading to primary alkyl radicals were generally compatible in the reaction (23-30), and while both 
methyl and a bulky Boc-protected amino group at the α-carbonyl position induced 
diastereoselectivity to some extent (29, 30), the β-carbonyl substitution seemed to have minimal 
influence (28). Not surprisingly, polycyclic structures retain the highly diastereoselective nature of 
the reaction (37-39). Therefore, it seems that substitution at the δ-carbonyl position, where the alkyl 
radical would be generated after cyclization, is crucial for the high diastereoselectivity observed. 
Several additional functional groups were tested following this substitution pattern, such as 
thioether (32), ether (33), pendant olefin (34), and protected primary- (35) and secondary (36) 
amine, all showing excellent dr and good to excellent yields. The applicability of the protocol for 
amidoacylation of alkenyl carbamates was also examined, which initially led to a diminished yield 
of 40 (20%) along with 35% of N-phenyl benzamide byproduct. This byproduct is likely due to an 
SN2’-type oxidative addition by the Ni(0) catalyst to the ene carbamate,
19 and indeed after lowering 
the loading of Ni precatalyst to 2%, the yield of 40 was improved to 42%. Interestingly, possibly 
because of a more sterically demanding environment, under standard reaction conditions, such a 
side reaction was not observed in monosaccharide-derived substrates (41, 42), rendering C-acyl 




Figure 4.3. Reaction Scope. aReaction conditions: amide S1-S42 (0.36 mmol, 1.2 equiv), acyl 
(pseudo)halides (0.3 mmol, 1.0 equiv), Bu4N[OP(O)(OBu)2] (0.75 mmol, 2.5 equiv), 
Ni(dMeObpy)Cl2 (0.018 mmol, 6 mol %), [Ir-1] (0.009 mmol, 3 mol %), blue LED, 6 mL MeCN.
 
b A 1:1 mixture of two diastereoisomers originating from the acyl coupling partner. c 0.006 mmol, 
2 mol % of Ni precatalyst was used. 
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Several experiments were performed to aid in deciphering the mechanism of the reaction, 
and especially the origin of diastereoselectivity. First, control experiments (See Experimental 
Section for further details) as well as the radical probe substrate (23) supported the proposed 
reaction pathway and indicated that the reaction indeed underwent a single electron transfer 
process. Considering the versatility of different electrophilic species, the nature of the actual 
electrophile in the reaction was sought. After stirring a 1:1 mixture of benzoyl chloride and 
Bu4N[OP(O)(OBu)2] in dichloromethane for 20 min, the mixed benzoic-phosphonic anhydride was 
isolated and subjected to the reaction conditions, providing a 73% yield and a comparable 
diastereoselectivity to that observed under the normal reaction conditions (Figure 4.4a). 
Interestingly, a diminished yield was observed when an alkyl acyl chloride was used under such a 
protocol, which suggested a different active species during the reaction.  
 
Figure 4.4. Experimental Mechanistic Insights 
The origin of the high regioselectivity of this reaction was next explored. To investigate 
the stability of both stereoisomers, synthesis of the opposite diastereoisomer was attempted. 
Interestingly, by applying the hydroamination reaction developed by Knowles et al., the designed 
substrate S1’ led to a completely opposite diastereoisomer 1’. This isomer was subsequently 
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subjected to the standard reaction condition, and no isomerization toward 2a was observed (Figure 
4.4b). This result suggested that the high dr must originate from the catalytic process and not 
epimerization after product formation.20  
To gain further information on the diastereo-determining step, we continued our investigation 
using computational tools. First, the free energy calculation of 1 and 1’ indicated that 1’ is 
thermodynamically favorable (Figure 2a). Therefore, the diastereoselective formation of 1 is a 
kinetically controlled process. Our previous studies indicated that the Ni(0)-Ni(I)-Ni(III) 
mechanism,21 where radical addition takes place before oxidative addition of acyl halide, might be 
operative. However, because Bz–Cl is in much higher concentration than the photogenerated 
radicals A and B, it is proposed that the oxidative addition of Bz–X to a catalytically active nickel 
species initiates the reaction. Thus, Ni(0) catalyst C first undergoes oxidative addition to Bz–X, 
forming Ni(II) species D, which subsequently binds the radical B, which was generated through a 
kinetically favorable 5-exo-trig cyclization.21 The formed Ni(III) species E then undergoes 
reductive elimination, releasing product 1 and generating Ni(I) species F. Further SET between F 
and reduced photocatalyst [PC]
∙−
 regenerates active Ni(0) catalyst C.  
Based on the proposed reaction mechanism in Figure 4.5b, the most favorable computed 
free energy diagram of the thermochemical part (from A to D) of the catalytic cycle calculated by 
density functional theory (DFT) is shown in Figure 4.5c. The active triplet Ni(0) catalyst int1 is 
oxidized by BzCl (1b) via TS2, which is quite facile, with a free energy barrier of only 7.8 kcal/mol, 
generating closed-shell Ni(II) species int3. This step is vastly exothermic and thus irreversible as 
proposed. The following radical binding step between int3 and int4 via TS5 is also very fast, with 
a free energy barrier of only 4.6 kcal/mol, generating doublet Ni(III) species int6. Further 
irreversible and highly exothermic reductive elimination via TS7 requires a free energy barrier of 




Figure 4.5. (a) Free energy difference between 1 and 1’. (b) Proposed reaction mechanism of the 
acylation between 1a and 1b. (c) DFT computed free energy diagram between 1a and 1b of the 
thermochemical part (from C to F) of the catalytic cycle calculated at B3LYP-D3(BJ)/def2-
TZVPP-SMD(MeCN)//B3LYP-D3(BJ)/def2-SVP.  
Surprisingly, because TS5 is higher than TS7 in free energy, and conversion through TS7 
is fast and irreversible, it is the radical binding step via TS5 that determines the observed 
diastereoselectivity. As shown in Figure 4.6, TS9, which leads to the diastereomeric product 2a’, 
is 1.0 kcal/mol higher in energy than TS5, which is in good accordance with the observed 
diastereoselectivity of 9:1 using bpy as ligand. The highlighted steric issues between the Me and 




Figure 4.6. 3D diagrams of diastereoselectivity determining radical bound transition states TS5 
and TS9 calculated at B3LYP-D3(BJ)/def2-TZVPP-SMD(MeCN)//B3LYP-D3(BJ)/def2-SVP. 
Trivial H atoms are omitted for clarity. 
4.3 Conclusion  
In conclusion, we have disclosed a photoredox PCET/Ni dual-catalyzed diastereoselective 
amidoacylation of unfunctionalized olefins. Various acyl electrophiles, including alkyl and aryl 
acyl chlorides, anhydrides, as well as carboxylic acids, are incorporated and retain excellent dr 
value in most of the examples. Thanks to the mild conditions, various functional groups, such as 
thioethers, protected amines, and saccharide derivatives are compatible. Mechanistic experiments 
indicate that the diastereoselectivity originates in the Ni-catalytic cycle, while a detailed 
computational study provides good insights into the diastereo-determining step toward the kinetic 
product. We believe that this study not only provides a powerful tool toward olefin 
heterodifunctionalization, but also sheds light on future reaction development. 
4.4 Experimental 
General Consideration 
Unless otherwise noted, all reactions were carried out under an inert atmosphere of argon 
or nitrogen via standard Schlenk techniques or in a glovebox. Reactions were monitored by HPLC, 
1H NMR, and/or by TLC on silica gel plates (F254, 60 Å). Thin layer chromatography was performed 
using hexanes/EtOAc as the eluents and visualized using KMnO4 stain and/or UV light. Reactions 
were purified by flash chromatography accompanied with an automated system (visualized at 254 
nm, monitored with all-wavelength and ELS detector) with silica cartridges (60 Å porosity, 20-40 
µm). Unless otherwise mentioned, all acyl chlorides, anhydrides, carboxylic acids, isocyanates, 










were synthesized using literature procedures. Unless otherwise noted, all amides were synthesized 
according to a previous report.6b MeCN and 1,2-dichloroethane (DCE, extra dry, 99.8%) were 
purchased and used as received. Other solvents were purified either by distillation over Na or CaH2 
or by passing through alumina cartridges in a solvent purification system. Irradiation of reaction 
vessels was accomplished using a 5 W 455 nm blue LED (light emitting diodes) strip about 3 cm 
from the reaction vessel with a fan above to maintain room temperature. The photoredox reaction 
equipment was constructed according to a previous report.23 Reaction optimization was carried out 
via high throughput experimentation and verified on the benchtop. Factors affecting reaction 
performance, such as solvents, nickel sources, photoredox catalysts, bases, substrate loadings, as 
well as temperature have been thoroughly examined. Melting points (°C) are uncorrected. NMR 
spectra (1H, 13C {1H}, 19F) were recorded on a 500 MHz spectrometer at 298 K. All 1H NMR spectra 
are reported in parts per million (ppm) downfield of TMS and were measured relative to the signal 
for CHCl3 (7.26 ppm). All 
13C NMR spectra were reported in ppm relative to residual CHCl3 (77.2 
ppm) and were obtained with 1H decoupling. All 19F and 31P NMR spectra were obtained in CDCl3 
solution and are reported unreferenced. Coupling constants (J) are reported in Hertz (Hz). HRMS 
was obtained by either ESI or EI with a TOF spectrometer in CH3CN or CHCl3. The data were 
calibrated and reported by neutral atom masses, and the electron mass is not included. IR spectra 
were obtained with neat samples.  
General Procedure  




General Procedure I: Under an intert atmosphere, (3-
carboxypropyl)triphenylphosphonium bromide (1.288 g, 3 mmol, 1.0 equiv, purchased or prepared 
according to the literature24) was charged in a round-bottom flask and suspended in dry THF (1.0 
M). The mixture was cooled to 0 ℃ followed by slow addition of NaHMDS (6.0 mmol, 3 mL, 2.0 
M soln in THF). The reaction was then stirred at 0 ℃ for another 30 min, and the corresponding 
aldehyde (3.6 mmol, 1.2 equiv, neat if liquid; 1.0 M in THF if solid) was subsequently added 
dropwise into the reaction. The reaction was left to warm slowly to rt overnight before being 
quenched by satd aq NH4Cl. The pH was adjusted to 2 by addition of 2 M HCl, and the reaction 
was extracted with 50 mL of EtOAc. After concentrating the organic phase, the residue was directly 
used in the next step without purification. 
Under an inert atmosphere, CDI (3 mmol, 1.0 equiv) was added to a soln of the 
corresponding carboxylic acid (1.0 equiv) in dry THF (1.0 M) (Caution! CO2 is released violently!). 
Upon stirring at rt for 1 h, the corresponding aniline derivative (1.0 equiv) was added. The reaction 
was stirred at rt overnight. The reaction was subsequently taken to dryness under reduced pressure, 
and the resulting product was purified using an automated system (silica gel, hexanes/EtOAc 
gradient). 
Procedures for Photoredox PCET/Nickel-Catalyzed Amidoacylation Reaction 
General Procedure II: An 8.0 mL screw-cap vial containing a stirring bar was charged with 
[Ni(dMeObpy)Cl2] (6.3 mg, 0.018 mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 0.009 
mmol, 3 mol %), amide (0.36 mmol, 1.2 equiv), acyl (pseudo)halide (if solid) (0.3 mmol, 1.0 equiv) 
and Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv). Next, the vial was closed, and three 
vacuum/argon cycles were carried out. Under an inert atmosphere, MeCN was added (6.0 mL, 0.05 
M), followed by addition of the acyl (pseudo)halide (if liquid). After further sealing with 
Parafilm®, the reaction was placed in the blue LED bay and stirred at rt until completion (a fan 
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was added to disperse any heat coming from the blue LEDs). When completed, the reactions were 
taken to dryness and purified by column chromatography using an automated system 
(hexanes/EtOAc gradient), delivering the corresponding pure product. 
General Procedure III: Under an inert atmosphere, an 8.0 mL screw-cap vial containing a 
stirring bar was charged with carboxylic acid (0.3 mmol, 1.0 equiv), (COCl)2 (0.33 mmol, 1.1 
equiv) and CH2Cl2 (2 mL). The reaction was cooled to 0 ℃, followed by addition of DMF (10 µL). 
The mixture was stirred for 30 min before removal of the solvent under vacuum. It was 
subsequently charged with [Ni(dMeObpy)(H2O)2(Br)2] (8.5 mg, 0.018 mmol, 6 mol %), 
[[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 0.009 mmol, 3 mol %), amide (0.36 mmol, 1.2 equiv), and 
Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv). Next, the vial was closed, and three 
vacuum/argon cycles were carried out. Under inert atmosphere, MeCN was added (6.0 mL, 0.05 
M). After further sealing with Parafilm®, the reaction was placed in the blue LED bay and stirred 
at rt until completion (a fan was added to disperse any heat coming from the blue LEDs). When 
completed, the reactions were taken to dryness and purified by column chromatography using an 
automated system (hexanes/EtOAc gradient), delivering the corresponding pure product. 
Mechanistic Investigation 
Control Experiments 
All reactions were carried out according to General Procedure II on a 0.1 mmol scale and 




Figure 4.7. Control Reactions 
Radical Probe Experiment 
 
General Procedure II was followed using (E)-5-cyclopropyl-N-phenylpent-4-enamide 
(77.5 mg, 0.36 mmol, 1.2 equiv, synthesized according to literature6b), 4-bromobenzonitrile (54.6 
mg, 0.3 mmol, 1.0 equiv), [Ni(dMeObpy)Cl2] (6.3 mg, 0.0018 mmol, 6 mol %), 
[[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 0.009 mmol, 3 mol %), Bu4N[OP(O)(OBu)2] (338.8 mg, 
0.75 mmol, 2.5 equiv) and dry t-BuOH/PhCF3 (2:1, 6.0 mL, 0.05 M). The reaction was stirred under 
blue LED irradiation at rt for 96 h. Silica gel purification using an automated system 
(hexanes/EtOAc, 0 to 40%) gave product 23 exclusively as a yellowish oil (64.2 mg, 0.20 mmol, 
67% yield). The full characterization data is listed below in the Characterization Data section. 




Benzoic (dibutyl phosphoric) anhydride was prepared by charging benzoyl chloride (140.6 mg, 1.0 
mmol, 1.0 equiv) in a CH2Cl2 solution of Bu4N[OP(O)(OBu)2] (451.7 mg, 1.0 mmol, 1.0 equiv) 
and stirred for 15 min. Silica gel purification using an automated system (hexanes/EtOAc, 0 to 
20%) gave the product as a colorless oil (299.0 mg, 95% yield). 1H NMR (500 MHz, CDCl3) δ 
1H 
NMR (500 MHz, C6D6) δ 8.09 – 8.00 (m, 2H), 7.66 – 7.62 (m, 1H), 7.48 (t, J = 7.7 Hz, 2H), 4.29 
(td, J = 6.6, 4.0 Hz, 4H), 1.73 (tt, J = 7.0 Hz, 4H), 1.45 (q, J = 7.5 Hz, 4H), 0.95 (t, J = 7.4 Hz, 6H) 
ppm. 13C NMR (126 MHz, CDCl3) δ 161.2 (d, J = 8.3 Hz), 134.6, 130.8, 128.9, 128.4 (d, J = 8.4 
Hz), 69.1 (d, J = 6.2 Hz), 32.4 (d, J = 6.9 Hz), 18.7, 13.7 ppm. IR (neat, cm-1): 2961, 1693, 1465, 
1220, 1023, 1003, 713, 526. 31P NMR (203 MHz, CDCl3) δ -7.4 ppm. HRMS (ES+) calcd for 
(C15H24O5P) [M+H]
+ 315.1356, found 315.1367. 
 
General Procedure II was followed using N-phenylhex-4-enamide (68.1 mg, 0.36 mmol, 1.2 equiv), 
benzoic (dibutyl phosphoric) anhydride (94.3 mg, 0.3 mmol, 1.0 equiv), 
[Ni(dMeObpy)(H2O)2(Br)2] (8.5 mg, 0.0018 mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 
mg, 0.009 mmol, 3 mol %), Bu4N[OP(O)(OBu)2] (203.3 mg, 0.45 mmol, 1.5 equiv) and dry MeCN 
(6.0 mL, 0.05 M). The reaction was stirred under blue LED irradiation at rt for 36 h. Silica gel 
purification using an automated system (hexanes/EtOAc, 0 to 40%) gave product with 75% yield 
and > 20:1 diastereoselectivity. 1H and 13C NMR spectra match with those of substrate 1. 
Experiments Providing Insights on Diastereoselectivity 
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Synthesis of Opposite Diastereoisomer and Epimerization Study 
 
The synthesis of substrate S1’ was carried out according to modified procedures from the 
literature.25 To a solution of aniline (306.9 mg, 3.3 mmol, 1.1 equiv) in THF (15 mL), n-BuLi (2.5 
M in hexanes, 2.65 mL, 6.6 mmol, 2.2 equiv) was added at 0 °C and stirred 1 h, which was 
subsequently cooled −78 °C. γ-Butyrolactone (258.3 mg, 3 mmol, 1 equiv) was added dropwise, 
and the reaction mixture was stirred for 1 h at −78 °C. The reaction was quenched with satd NH4Cl 
(5 mL) and extracted with EtOAc (20 mL x 3). The organic extracts were combined, dried 
(Na2SO4), and concentrated in vacuo. Silica gel purification using an automated system 
(CH2Cl2/MeOH, 0 to 10%) gave the product 4-hydroxy-N-phenylbutanamide as a white solid (925 
mg, 2.94 mmol, 98%). Characterization data matched the literature report.25 
A microwave tube was charged with 4-hydroxy-N-phenylbutanamide (358.4 mg, 2.0 
mmol, 1.0 equiv) and 2-iodoxybenzoic acid (840 mg, 3.0 mmol, 1.5 equiv) under argon. The tube 
was sealed under argon and the solid was suspended in EtOAc (0.2 M, 10 mL). The reaction was 
heated under reflux for 12 h before cooling and filtration, and the resulting soln was concentrated 
in vacuo. Silica gel purification using an automated system (hexane/EtOAc, 0 to 100%) gave the 
product 4-oxo-N-phenylbutanamide as a colorless oil (336.68 mg, 1.90 mmol, 95%). 
Under an argon atmosphere, the Wittig reagent S1b (394.5 mg, 1.0 mmol, synthesized 
according to the literature26) was suspended in THF (0.2 M, 5 mL) and cooled to 0 ℃.  4-Oxo-N-
phenylbutanamide (177 mg, 1.0 mmol, dissolved in 5 mL THF) was added dropwise to the mixture 
via syringe. The reaction mixture was then allowed to warm to rt overnight, followed by 
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concentration in vacuo. Silica gel purification using an automated system (hexane/EtOAc, 0 to 
100%) gave the product S1’ as a yellow oil (242 mg, 0.83 mmol, 83%). 1H NMR (500 MHz, CDCl3) 
δ 7.66 – 7.59 (m, 2H), 7.52 – 7.41 (m, 4H), 7.39 – 7.27 (m, 4H), 7.10 (t, J = 7.5 Hz, 1H), 6.33 – 
6.19 (m, 1H), 2.69 (dt, J = 7.2, 7.3 Hz, 2H), 2.46 (t, J = 7.3 Hz, 2H), 1.99 (s, 3H) ppm. 13C NMR 
(126 MHz, CDCl3) δ 199.1, 170.2, 143.7, 138.3, 137.9, 137.7, 131.8, 129.5, 129.1, 128.2, 124.5, 
120.0, 36.1, 25.0, 12.8 ppm.  IR (neat, cm-1): 3321, 1638, 1598, 1540, 1498, 1442, 1309, 1280, 
1176, 1017, 907, 755, 728, 692, 632. HRMS (ES+) calcd for (C19H20NO2) [M+H]
+ 294.1494, found 
294.1500. 
 
The reaction was carried out following the literature,11b using S1’ (29.3 mg, 0.1 mmol, 1.0 
equiv), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (3.0 mg, 0.003 mmol, 3 mol %), Bu4N[OP(O)(OBu)2] (9.0 
mg, 0.45 mmol, 20 mol %), PhSH (1 μL, 0.01 mmol, 10 mol%) and dry CH2Cl2 (1.0 mL, 0.1 M). 
The reaction was stirred under blue LED irradiation at rt for 24 h. Silica gel purification using an 
automated system (hexanes/EtOAc, 0 to 30%) gave the product as a yellow oil (29.0 mg, 0.99 
mmol, 99% yield). 1H NMR (500 MHz, CDCl3) δ 7.58 (dt, J = 8.4, 1.6 Hz, 2H), 7.51 (tt, J = 7.3, 
1.4 Hz, 1H), 7.37 – 7.32 (m, 2H), 7.32 – 7.28 (m, 2H), 7.25 – 7.21 (m, 2H), 7.17 (tt, J = 7.1, 1.3 
Hz, 1H), 4.63 (ddd, J = 8.7, 5.2, 3.9 Hz, 1H), 3.88 (qd, J = 7.1, 5.0 Hz, 1H), 2.66 (dt, J = 17.2, 9.3 
Hz, 1H), 2.46 (ddd, J = 17.3, 9.8, 4.6 Hz, 1H), 2.39 – 2.23 (m, 2H), 1.17 (d, J = 7.1 Hz, 3H) ppm. 
13C NMR (126 MHz, CDCl3) δ 202.8, 174.5, 137.9, 136.9, 133.4, 129.1, 128.8, 128.2, 126.0, 124.1, 
62.7, 42.1, 31.2, 20.8, 15.0 ppm.  IR (neat, cm-1): 2926, 1678, 1597, 1498, 1447, 1387, 1294, 1220, 
973, 758, 694. HRMS (ES+) calcd for (C19H20NO2) [M+H]
+ 294.1494, found 294.1498. Overlay 
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of NMR suggested that the opposite (thermodynamically favorable) diastereoisomer was generated 
highly selectively, likely via a facile Hydrogen Atom Transfer (HAT) event:  
 
Figure 4.8. Mechanistic Proposal for Complementary Diastereoselectivity  
Subsequently, we subjected substrate 1’ to the standard reaction conditions for 
amidoacylation, and unsurprisingly, after 36 h, the same diastereoisomer was fully recovered, with 
no observation of epimerization. 
 




Figure 4.9. Ligand’s Influence on Diastereoselectivity 
Reactions were set up following General Procedure II using the corresponding Ni(II) 
precatalysts. Because the crude 1H-NMR was often inconclusive and the corresponding 
diastereoisomers were inseparable in either automated chromatography or HPLC analysis, the dr 
was analyzed by 1H NMR after purification. As is indicated in the charts, although 1,10-
phenanthroline gave a comparable yield, the diastereoselectivity was significantly compromised. 
Other bpy-type ligands that gave reasonable yields, such as dtbpy and bpy, led to an 8:1 to 9:1 ratio 
of diastereoisomers. Together with the observation in 4.4.1, these results strongly supported the 
hypothesis that the diastereoselectivities were established during the Ni-catalyzed cross-coupling 
cycle.  
Challenging Substrates 
The following contain inseparable decarbonylative byproducts: 
 





All DFT calculations were performed with the Gaussian 09 software package27. Geometry 
optimizations of all the minima and transition states were carried out at the B3LYP28 level of theory 
with additional Grimme’s D3 dispersion correction (Becke-Johnson damping)29 using the def2-SVP 
basis set30. Vibrational frequencies were computed at the same level to evaluate its zero-point 
vibrational energy (ZPVE) and thermal corrections at 298 K, as well as to check whether each 
optimized structure is a transition state or not. The single-point energies were computed at the same 
level of theory, combined with def2-TZVPP29 basis set and SMD solvation model31 for acetonitrile 
using the optimized structures. The 3D diagrams of molecules were generated using CYLView.32 
In addition, to correct the Gibbs free energies under pressure of 1 atm to the standard state in 
solution (1 mol/L), a correction of RTln(cs/cg) (about 1.89 kcal/mol) is added to the Gibbs energies 
of all the calculated species except acetonitrile. cs is the standard molar concentration in solution 
(1 mol/L), cg is the standard molar concentration in gas phase (0.0446 mol/L), and R is the gas 
constant. For acetonitrile, the actual molar concentration of 19.1 mol/L was used to correct the 
Gibbs free energy, and thus a correction of about 3.64 kcal/mol is added to the Gibbs energy of 
acetonitrile. The stability of “wavefunction” was checked for each calculated species. The 
conformation of each calculated species was carefully searched and only the most stable ones were 




Figure 4.10. DFT computed free energy diagram of generation of int4 from the open-chain radical 
intS1 at B3LYP-D3(BJ)/def2-TZVPP-SMD(MeCN)//B3LYP-D3(BJ)/def2-SVP. 
 





Figure 4.12. DFT computed free energy diagram between 1a and 1d of the thermochemical part (from 
C to F) of the catalytic cycle at B3LYP-D3(BJ)/def2-TZVPP-SMD(MeCN)//B3LYP-D3(BJ)/def2-
SVP. 
We have also investigated several potential ionic or radical dissociation pathways, for 
possibilities of an outer-sphere reductive-elimination mechanism. As is indicated in Figures 4.13 




Figure 4.13. DFT computed relative thermodynamics of the dissociation of ligands from int6 at 
B3LYP-D3(BJ)/def2-TZVPP-SMD(MeCN)//B3LYP-D3(BJ)/def2-SVP. (int6 is set to be the new 
relative zero and thus ΔΔG is used.) These dissociation processes are all unfavorable as TS7 only 






Figure 4.14. DFT computed relative thermodynamics of the dissociation of ligands from intS8 at 
B3LYP-D3(BJ)/def2-TZVPP-SMD(MeCN)//B3LYP-D3(BJ)/def2-SVP. (intS8 is set to be the new 
relative zero and thus ΔΔG is used.) These dissociation processes are all unfavorable as TS-S9 only 





An alternative reaction pathway featuring the oxidation states sequence of Ni as Ni(0), Ni(I) 
and Ni(III) could also be operative. However, considering the relative low concentration of int4, this 
pathway might not be diffusion controlled. Both TS-S15 and TS2 require 7.8 kcal/mol at standard states, 
but int4 will be present in much lower concentration than 1b. Moreover, in this scenario, the dr outcome 
of the reaction is controlled by TS-S15 and TS-S18, which has a difference of 6.0 kcal/mol. This is not 
in good accordance with the experimental observation. 
 
Figure 4.15. DFT computed free energy diagram of the alternative reaction pathway between 1a and 





N-Phenylhex-4-enamide (S1)33 was prepared via General Procedure I. Other starting 
materials were synthesized according to the literature.6b,11b All characterization data match previous 
literature reports. 
7-Methyl-N-phenyloct-4-enamide (S31): Prepared following General Procedure 
I, starting from commercially available isovaleraldehyde (310 mg, 3.6 mmol, 1.2 equiv). The 
corresponding product was obtained as a yellow oil (488.2 mg, 2.6 mmol, 86% yield), upon 
purification using an automated system (silica gel, hexanes/EtOAc, 0 to 20%).  1H NMR (500 MHz, 
CDCl3) of major stereoisomer δ 7.52 (d, J = 7.9 Hz, 2H), 7.43 – 7.29 (m, 3H), 7.10 (t, J = 7.4 Hz, 
1H), 5.62 – 5.36 (m, 2H), 2.52 – 2.36 (m, 4H), 1.97 (t, J = 7.0 Hz, 2H), 1.61 (qt, J = 12.9, 6.6 Hz, 
1H), 0.90 (d, J = 6.6 Hz, 6H) ppm. 13C NMR (126 MHz, CDCl3) δ 171.1, 138.0, 130.8, 129.1, 
128.2, 124.3, 120.0, 42.0, 37.7, 36.4, 28.7, 22.5 ppm. IR (neat, cm-1): 3300, 2955, 2926, 1659, 1619, 
1599, 1543, 1498, 1465, 1442, 1383, 1309, 1253, 753, 691. HRMS (ES+) calcd for (C15H22NO) 
[M+H]+ 232.1701, found 232.1703.  
7-(Methylthio)-N-phenylhept-4-enamide (S32): Prepared following General 
Procedure I, starting from commercially available 3-(methylthio)propanal (375 mg, 3.6 mmol, 1.2 
equiv). The corresponding product was obtained as a light brown oil (638.4 mg, 2.2 mmol, 74% 
yield), upon purification using an automated system (silica gel, hexanes/EtOAc, 0 to 20%).  1H 
NMR (500 MHz, CDCl3) δ 7.51 (d, J = 7.9 Hz, 2H), 7.44 – 7.36 (m, 1H), 7.32 (d, J = 7.8 Hz, 2H), 
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7.10 (t, J = 7.4 Hz, 1H), 5.61 – 5.43 (m, 2H), 2.52 (dt, J = 17.0, 7.4 Hz, 4H), 2.47 – 2.36 (m, 4H), 
2.10 (s, 3H) ppm. 13C NMR (126 MHz, CDCl3) δ 170.8, 138.0, 130.0, 129.3, 129.1, 124.4, 120.0, 
76.9, 37.6, 34.2, 27.1, 23.5, 15.7 ppm. IR (neat, cm-1): 3300, 2914, 1660, 1599, 1543, 1499, 1442, 
1309, 1255, 1078, 967, 755. HRMS (ES+) calcd for (C14H20NOS) [M+H]
+ 250.1266, found 
250.1272.  
6-(Benzyloxy)-N-phenylhex-4-enamide (S33): Prepared following General 
Procedure I, starting from commercially available 2-(benzyloxy)acetaldehyde (541 mg, 3.6 mmol, 
1.2 equiv). The corresponding product was obtained as a yellow oil (752.6 mg, 2.6 mmol, 85% 
yield), upon purification using an automated system (silica gel, hexanes/EtOAc, 0 to 50%).  1H 
NMR (500 MHz, CDCl3) δ 7.63 – 7.46 (m, 3H), 7.35 (d, J = 4.4 Hz, 4H), 7.32 – 7.28 (m, 3H), 7.10 
(t, J = 7.5 Hz, 1H), 5.72 (dt, J = 12.6, 6.5 Hz, 1H), 5.68 – 5.60 (m, 1H), 4.52 (s, 2H), 4.13 (d, J = 
6.4 Hz, 2H), 2.50 (d, J = 7.4 Hz, 2H), 2.48 – 2.36 (m, 2H) ppm. 13C NMR (126 MHz, CDCl3) δ 
170.6, 138.2, 131.8, 129.0, 128.5, 128.5, 128.0, 127.9, 127.8, 124.4, 120.0, 72.6, 65.8, 37.3, 23.7 
ppm. IR (neat, cm-1): 3301, 1660, 1600, 1540, 1498, 1441, 1387, 1363, 1309, 1248, 1167, 1070, 
971, 752, 693. HRMS (ES+) calcd for (C19H22NO2) [M+H]
+ 296.1652, found 296.1656.  
(8Z)-N-Phenylundeca-4,8-dienamide (S34): Prepared following General 
Procedure I, starting from commercially available (Z)-hept-4-enal (404 mg, 3.6 mmol, 1.2 equiv). 
The corresponding product was obtained as a light yellow oil (695.4 mg, 2.7 mmol, 90% yield), 
upon purification using an automated system (silica gel, hexanes/EtOAc, 0 to 20%). 1H NMR (500 
MHz, CDCl3) δ 7.51 (d, J = 7.9 Hz, 2H), 7.41 – 7.29 (m, 3H), 7.10 (t, J = 7.4 Hz, 1H), 5.59 – 5.26 
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(m, 4H), 2.48 (d, J = 7.3 Hz, 1H), 2.47 – 2.38 (m, 3H), 2.18 – 2.06 (m, 4H), 2.06 – 2.00 (m, 2H), 
0.95 (td, J = 7.5, 1.9 Hz, 3H) ppm. 13C NMR (126 MHz, CDCl3) δ 171.0, 138.0, 132.4, 131.5, 
129.1, 128.4, 128.0, 124.4, 120.0, 37.7, 32.8, 27.2, 23.5, 20.7, 14.5 ppm. IR (neat, cm-1): 3300, 
2914, 1660, 1599, 1543, 1499, 1442, 1309, 1255, 1078, 967, 755. HRMS (ES+) calcd for 
(C17H24NO) [M+H]
+ 258.1858, found 258.1848.  
 Benzyl (7-Oxo-7-(phenylamino)hept-3-en-1-yl)carbamateenamide 
(S35): Prepared following General Procedure I, starting from commercially available benzyl (3-
oxopropyl)carbamate (746.0 mg, 3.6 mmol). The corresponding product was obtained as a light 
brown oil (655.0 mg, 1.9 mmol, 62% yield), upon purification using an automated system (silica 
gel, hexanes/EtOAc, 0 to 20%). mp = 127 – 130 ℃. 1H NMR (500 MHz, CDCl3) δ 7.64 (s, 1H), 
7.56 – 7.49 (m, 3H), 7.36 – 7.29 (m, 6H), 7.14 – 7.04 (m, 2H), 5.63 – 5.50 (m, 1H), 5.50 – 5.38 (m, 
1H), 5.11 (s, 2H), 3.28 – 3.17 (m, 2H), 2.47 (dd, J = 7.3, 6.4 Hz, 1H), 2.40 (t, J = 8.2 Hz, 2H), 2.33 
(dd, J = 7.2, 7.1 Hz, 2H), 2.18 (s, 2H) ppm. 13C NMR (126 MHz, CDCl3) δ 170.8, 156.8, 138.2, 
136.8, 130.8, 129.1, 129.1, 128.7, 128.3, 128.2, 128.1, 127.8, 124.4, 124.3, 120.0, 119.9, 66.8, 41.0, 
37.7, 27.9, 23.6 ppm. IR (neat, cm-1):3309, 3064, 1696, 1667, 1599, 1540, 1499, 1442, 1314, 1255, 
1137, 1028, 754, 694. HRMS (ES+) calcd for (C21H25N2O3) [M+H]
+ 353.1865, found 353.1849.  
 tert-Butyl 4-(6-Oxo-6-(phenylamino)hex-2-en-1-yl)piperidine-1-
carboxylate (S36): Prepared following General Procedure I, starting from commercially available 
N-Boc-4-piperidineacetaldehyde (818 mg, 3.60 mmol). The corresponding product was obtained 
as a sticky yellow oil (1.018 g, 2.7 mmol, 91% yield), upon purification using an automated system 
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(silica gel, hexanes/EtOAc, 0 to 40%).  1H NMR (500 MHz, CDCl3) δ 7.75 (s, 1H), 7.52 (t, J = 6.5 
Hz, 2H), 7.29 (t, J = 7.7 Hz, 2H), 7.08 (t, J = 7.4 Hz, 1H), 5.50 – 5.39 (m, 2H), 4.19 – 3.89 (m, 
2H), 2.62 (s, 2H), 2.50 – 2.30 (m, 4H), 2.00 (t, J = 6.5 Hz, 2H), 1.60 (t, J = 13.7 Hz, 2H), 1.45 (s, 
9H), 1.38 (dtt, J = 14.7, 7.6, 3.9 Hz, 1H), 1.12 – 0.97 (m, 2H) ppm. 13C NMR (126 MHz, CDCl3) 
δ 171.0, 155.0, 138.2, 130.1, 129.1, 129.0, 124.2, 119.9, 79.4, 39.7, 37.5, 36.5, 34.1, 32.0, 28.6, 
23.5 ppm. IR (neat, cm-1): 3310, 2925, 1660, 1600, 1543, 1499, 1441, 1425, 1392, 1365, 1278, 
1244, 1158, 1125, 909, 755, 730, 693. HRMS (ES+) calcd for (C22H33N2O3) [M+H]
+ 373.2491, 
found 373.2482.  
(R*)-5-((R*)-1-Oxo-1-phenylpropan-2-yl)-1-phenylpyrrolidin-2-one (1): 
General Procedure II was followed using N-phenylhex-4-enamide (68.1 mg, 0.36 mmol, 1.2 equiv), 
benzoyl chloride (42.2 mg, 0.3 mmol, 1.0 equiv), [Ni(dMeObpy)Cl2] (6.3 mg, 0.018 mmol, 6 mol 
%), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 0.009 mmol, 3 mol %), Bu4N[OP(O)(OBu)2] (338.8 
mg, 0.75 mmol, 2.5 equiv) and dry MeCN (6.0 mL, 0.05 M). The reaction was stirred under blue 
LED irradiation at rt for 24 h. Silica gel purification using an automated system (hexanes/EtOAc, 
0 to 40%) gave the product as a white solid (66.1 mg, 0.23 mmol, 75% yield). mp = 93 – 95 ºC. 1H 
NMR (500 MHz, CDCl3) δ 7.79 – 7.71 (m, 2H), 7.56 (ddt, J = 8.8, 7.2, 1.7 Hz, 1H), 7.43 (dd, J = 
8.7, 7.2 Hz, 4H), 7.38 (dd, J = 8.6, 1.5 Hz, 2H), 7.26 (tt, J = 7.2, 1.4 Hz, 1H), 4.71 (dt, J = 8.5, 4.2 
Hz, 1H), 3.78 (qd, J = 6.8, 3.8 Hz, 1H), 2.61 (ddd, J = 17.5, 10.3, 7.2 Hz, 1H), 2.53 (ddd, J = 17.5, 
10.3, 6.1 Hz, 1H), 2.20 – 2.12 (m, 1H), 2.12 – 2.03 (m, 1H), 1.12 (d, J = 6.8 Hz, 3H) ppm. 13C 
NMR (126 MHz, CDCl3) δ 201.2, 174.4, 137.0, 136.1, 133.4, 129.4, 128.9, 128.0, 126.6, 124.9, 
60.3, 42.3, 31.5, 18.9, 9.6 ppm. IR (neat, cm-1): 2975, 1679, 1596, 1498, 1448, 1395, 1365, 1295, 
1211, 1158, 908. HRMS (ES+) calcd for (C19H20NO2) [M+H]




phenylpyrrolidin-2-one (2): General Procedure II was followed using N-phenylhex-4-enamide 
(68.1 mg, 0.36 mmol, 1.2 equiv), 4-(trifluoromethyl)benzoyl chloride (75.1 mg, 0.3 mmol, 1.0 
equiv), [Ni(dMeObpy)Cl2] (6.3 mg, 0.018 mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 
0.009 mmol, 3 mol %), Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry MeCN (6.0 
mL, 0.05 M). The reaction was stirred under blue LED irradiation at rt for 24 h. Silica gel 
purification using an automated system (hexanes/EtOAc, 0 to 40%) gave the product as a colorless 
oil (62.6 mg, 0.21 mmol, 69% yield). 1H NMR (500 MHz, CDCl3) δ 7.83 (d, J = 8.1 Hz, 2H), 7.71 
(d, J = 8.2 Hz, 2H), 7.46 – 7.40 (m, 2H), 7.38 – 7.33 (m, 2H), 7.29 – 7.24 (m, 1H), 4.71 (dt, J = 
8.6, 4.4 Hz, 1H), 3.76 (qd, J = 6.9, 4.0 Hz, 1H), 2.71 – 2.49 (m, 2H), 2.21 (dddd, J = 13.6, 10.2, 
8.6, 7.2 Hz, 1H), 2.07 (dddd, J = 13.8, 10.7, 6.3, 4.8 Hz, 1H), 1.16 (d, J = 6.9 Hz, 3H) ppm. 13C 
NMR (126 MHz, CDCl3) δ 200.6, 174.5, 138.9, 136.9, 134.7 (q, J = 33.6 Hz), 129.5, 128.5, 127.0, 
126.0 (q, J = 3.8 Hz), 123.6 (q, J = 272.4 Hz), 60.4, 43.0, 31.4, 19.3, 9.9 ppm. 19F NMR (471 MHz, 
CDCl3) δ -63.2 ppm. IR (neat, cm
-1): 1685, 1498, 1408, 1392, 1321, 1296, 1210, 1166, 1125, 1112, 
1065, 972, 759, 694. HRMS (ES+) calcd for (C20H19F3NO2) [M+H]
+ 362.1368, found 362.1364. 
(R*)-5-((R*)-1-(4-Methoxyphenyl)-1-oxopropan-2-yl)-1-
phenylpyrrolidin-2-one (3): General Procedure II was followed using N-phenylhex-4-enamide 
(68.1 mg, 0.36 mmol, 1.2 equiv), 4-(methoxy)benzoyl chloride (51.2 mg, 0.3 mmol, 1.0 equiv), 
[Ni(dMeObpy)Cl2] (6.3 mg, 0.018 mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 0.009 
mmol, 3 mol %), Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry MeCN (6.0 mL, 
0.05 M). The reaction was stirred under blue LED irradiation at rt for 24 h. Silica gel purification 
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using an automated system (hexanes/EtOAc, 0 to 40%) gave the product as a white solid (50.5 mg, 
0.16 mmol, 52% yield). mp = 109 – 112 ºC. 1H NMR (500 MHz, CDCl3) δ 7.78 – 7.73 (m, 2H), 
7.45 (dd, J = 8.5, 7.2 Hz, 2H), 7.42 – 7.38 (m, 2H), 7.30 – 7.25 (m, 1H), 6.94 – 6.89 (m, 2H), 4.70 
(ddd, J = 8.4, 4.8, 3.7 Hz, 1H), 3.87 (s, 3H), 3.74 (qd, J = 6.9, 3.7 Hz, 1H), 2.63 (ddd, J = 17.6, 
10.1, 7.5 Hz, 1H), 2.54 (ddd, J = 17.4, 10.0, 6.3 Hz, 1H), 2.21 – 2.07 (m, 2H), 1.12 (d, J = 6.9 Hz, 
3H) ppm. 13C NMR (126 MHz, CDCl3) δ 199.7, 174.6, 163.9, 137.1, 130.5, 129.4, 129.1, 126.7, 
125.1, 114.1, 60.7, 55.6, 41.9, 31.6, 19.0, 9.8 ppm. IR (neat, cm-1): 2930, 1693, 1670, 1595, 1572, 
1498, 1378, 1365, 1317, 1288, 1250, 1219, 1184, 1151, 1029, 862, 786, 756, 695. HRMS (ES+) 
calcd for (C20H22NO3) [M+H]
+ 324.1600, found 324.1606.  
(R*)-5-((R*)-1-Oxo-1-(p-tolyl)propan-2-yl)-1-phenylpyrrolidin-2-
one (4&13): General Procedure II was followed using N-phenylhex-4-enamide (68.1 mg, 0.36 
mmol, 1.2 equiv), p-toluoyl chloride (46.3 mg, 0.3 mmol, 1.0 equiv), [Ni(dMeObpy)Cl2] (6.3 mg, 
0.0018 mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 0.009 mmol, 3 mol %), 
Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry MeCN (6.0 mL, 0.05 M). The 
reaction was stirred under blue LED irradiation at rt for 24 h. Silica gel purification using an 
automated system (hexanes/EtOAc, 0 to 40%) gave the product as a colorless oil (52.6 mg, 0.17 
mmol, 57% yield for entry 4; 60.9 mg, 0.20 mmol, 66% yield for entry 13, following General 
Procedure III). 1H NMR (500 MHz, CDCl3) δ 7.66 (d, J = 8.1 Hz, 2H), 7.45 (dd, J = 8.4, 7.2 Hz, 
2H), 7.42 – 7.37 (m, 2H), 7.29 – 7.22 (m, 3H), 4.70 (dt, J = 8.4, 4.2 Hz, 1H), 3.77 (qd, J = 6.8, 3.7 
Hz, 1H), 2.62 (ddd, J = 17.5, 10.2, 7.4 Hz, 1H), 2.53 (ddd, J = 17.3, 10.2, 6.1 Hz, 1H), 2.41 (s, 3H), 
2.20 – 2.05 (m, 2H), 1.11 (d, J = 6.8 Hz, 3H) ppm. 13C NMR (126 MHz, CDCl3) δ 200.8, 174.5, 
144.4, 137.1, 133.6, 129.6, 129.4, 128.2, 126.6, 125.0, 60.5, 42.2, 31.5, 21.7, 18.8, 9.5 ppm. IR 
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(neat, cm-1): 2975, 1694, 1674, 1605, 1598, 1497, 1364, 1336, 1293, 1218, 1206, 1184, 968, 758, 
729, 694. HRMS (ES+) calcd for (C20H22NO2) [M+H]
+ 308.1651, found 308.1678. 
(R*)-5-((R*)-1-(4-Chlorophenyl)-1-oxopropan-2-yl)-1-
phenylpyrrolidin-2-one (5): General Procedure II was followed using N-phenylhex-4-enamide 
(68.1 mg, 0.36 mmol, 1.2 equiv), 4-chlorobenzoyl chloride (52.5 mg, 0.3 mmol, 1.0 equiv), 
[Ni(dMeObpy)Cl2] (6.3 mg, 0.0018 mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 0.009 
mmol, 3 mol %), Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry MeCN (6.0 mL, 
0.05 M). The reaction was stirred under blue LED irradiation at rt for 24 h. Silica gel purification 
using an automated system (hexanes/EtOAc, 0 to 40%) gave the product as a white solid (58.9 mg, 
0.18 mmol, 60% yield). mp = 99 – 103 ℃. 1H NMR (500 MHz, CDCl3) δ 7.68 (dt, J = 8.5, 1.9 Hz, 
2H), 7.46 – 7.40 (m, 4H), 7.39 – 7.34 (m, 2H), 7.30 – 7.25 (m, 1H), 4.70 (dt, J = 8.6, 4.3 Hz, 1H), 
3.72 (qd, J = 6.8, 3.8 Hz, 1H), 2.70 – 2.51 (m, 2H), 2.20 (dddd, J = 14.1, 10.4, 8.5, 7.1 Hz, 1H), 
2.14 – 2.03 (m, 1H), 1.14 (dd, J = 6.9, 1.3 Hz, 3H) ppm. 13C NMR (126 MHz, CDCl3) δ 200.2, 
174.5, 140.0, 137.0, 134.5, 129.6, 129.5, 129.3, 126.9, 125.2, 60.5, 42.6, 31.5, 19.2, 9.9 ppm. IR 
(neat, cm-1): 2975, 1680, 1589, 1498, 1456, 1397, 1333, 1295, 1210, 1091, 1012, 971, 846, 760, 
695. HRMS (ES+) calcd for (C19H19ClNO2) [M+H]
+ 328.1104, found 328.1107. 
(R*)-5-((R*)-1-(3-Methoxyphenyl)-1-oxopropan-2-yl)-1-
phenylpyrrolidin-2-one (6):  General Procedure II was followed using N-phenylhex-4-enamide 
(68.1 mg, 0.36 mmol, 1.2 equiv), 3-methoxybenzoyl chloride (51.2 mg, 0.3 mmol, 1.0 equiv), 
[Ni(dMeObpy)Cl2] (6.3 mg, 0.0018 mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 0.009 
mmol, 3 mol %), Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry MeCN (6.0 mL, 
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0.05 M). The reaction was stirred under blue LED irradiation at rt for 24 h. Silica gel purification 
using an automated system (hexanes/EtOAc, 0 to 40%) gave the product as a white solid (65.0 mg, 
0.23 mmol, 78% yield). mp = 92 – 95 ºC. 1H NMR (500 MHz, CDCl3) δ 7.78 – 7.73 (m, 2H), 7.45 
(dd, J = 8.5, 7.2 Hz, 2H), 7.42 – 7.38 (m, 2H), 7.30 – 7.25 (m, 1H), 6.94 – 6.89 (m, 2H), 4.70 (ddd, 
J = 8.4, 4.8, 3.7 Hz, 1H), 3.87 (s, 3H), 3.74 (qd, J = 6.9, 3.7 Hz, 1H), 2.63 (ddd, J = 17.6, 10.1, 7.5 
Hz, 1H), 2.54 (ddd, J = 17.4, 10.0, 6.3 Hz, 1H), 2.21 – 2.07 (m, 2H), 1.12 (d, J = 6.9 Hz, 3H) ppm. 
13C NMR (126 MHz, CDCl3) δ 201.2, 174.6, 160.2, 137.6, 137.1, 129.9, 129.5, 126.8, 125.1, 120.6, 
120.0, 112.6, 60.6, 55.6, 42.6, 31.6, 18.9, 9.6 ppm. IR (neat, cm-1): 1693, 1670, 1595, 1572, 1498, 
1378, 1365, 1317, 1288, 1250, 1219, 1184, 1151, 1029, 862, 786, 756, 695. HRMS (ES+) calcd for 
(C20H22NO3) [M+H]
+ 324.1600, found 324.1606. 
(R*)-5-((R*)-1-(3-Chlorophenyl)-1-oxopropan-2-yl)-1-
phenylpyrrolidin-2-one (7&12): General Procedure II was followed using N-phenylhex-4-
enamide (68.1 mg, 0.36 mmol, 1.2 equiv), 4-chlorobenzoyl chloride (52.5 mg, 0.3 mmol, 1.0 
equiv), [Ni(dMeObpy)Cl2] (6.3 mg, 0.0018 mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 
mg, 0.009 mmol, 3 mol %), Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry MeCN 
(6.0 mL, 0.05 M). The reaction was stirred under blue LED irradiation at rt for 24 h. Silica gel 
purification using an automated system (hexanes/EtOAc, 0 to 40%) gave the product as a white 
solid (56.8 mg, 0.17 mmol, 58% yield for entry 7; 55.7 mg, 0.17 mmol, 57% yield for entry 12, 
General Procedure III was followed). mp = 99 – 103 ℃. NMR spectra represent the major 
diastereoisomer. 1H NMR (500 MHz, CDCl3) δ 7.68 (dt, J = 8.5, 1.9 Hz, 2H), 7.46 – 7.40 (m, 4H), 
7.39 – 7.34 (m, 2H), 7.30 – 7.25 (m, 1H), 4.70 (dt, J = 8.6, 4.3 Hz, 1H), 3.72 (qd, J = 6.8, 3.8 Hz, 
1H), 2.70 – 2.51 (m, 2H), 2.20 (dddd, J = 14.1, 10.4, 8.5, 7.1 Hz, 1H), 2.14 – 2.03 (m, 1H), 1.14 
(dd, J = 6.9, 1.3 Hz, 3H) ppm. 13C NMR (126 MHz, CDCl3) δ 200.2, 174.5, 140.0, 137.0, 134.5, 
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129.6, 129.5, 129.3, 126.9, 125.2, 60.5, 42.6, 31.5, 19.2, 9.9 ppm. IR (neat, cm-1): 2975, 1680, 1589, 
1498, 1456, 1397, 1333, 1295, 1210, 1091, 1012, 971, 846, 760, 695. HRMS (ES+) calcd for 
(C19H19ClNO2) [M+H]
+ 328.1104, found 328.1107. 
(R*)-5-((R*)-3-Oxooctan-2-yl)-1-phenylpyrrolidin-2-one (8): General 
Procedure II was followed using N-phenylhex-4-enamide (68.1 mg, 0.36 mmol, 1.2 equiv), 
hexanoic anhydride (64.3 mg, 0.3 mmol, 1.0 equiv), [Ni(dMeObpy)Cl2] (6.3 mg, 0.0018 mmol, 6 
mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 0.009 mmol, 3 mol %), Bu4N[OP(O)(OBu)2] 
(338.8 mg, 0.75 mmol, 2.5 equiv) and dry MeCN (6.0 mL, 0.05 M). The reaction was stirred under 
blue LED irradiation at rt for 24 h. Silica gel purification using an automated system 
(hexanes/EtOAc, 0 to 40%) gave the product as a colorless oil (37.2 mg, 0.13 mmol, 43% yield). 
NMR data represent the major diastereoisomer. 1H NMR (500 MHz, CDCl3) δ 7.44 – 7.39 (m, 2H), 
7.39 – 7.35 (m, 2H), 7.27 – 7.23 (m, 1H), 4.75 (dt, J = 8.7, 4.5 Hz, 1H), 2.83 (qd, J = 7.1, 4.0 Hz, 
1H), 2.58 (ddd, J = 9.5, 7.2, 3.8 Hz, 2H), 2.37 (ddd, J = 17.2, 8.4, 6.3 Hz, 1H), 2.32 – 2.21 (m, 2H), 
1.91 (dddd, J = 14.0, 9.3, 6.9, 4.9 Hz, 1H), 1.55 – 1.42 (m, 2H), 1.32 – 1.24 (m, 2H), 1.24 – 1.16 
(m, 2H), 1.03 (d, J = 7.1 Hz, 3H), 0.88 (t, J = 7.2 Hz, 3H) ppm. 13C NMR (126 MHz, CDCl3) δ 
211.8, 174.6, 137.0, 129.4, 126.5, 124.8, 59.8, 47.4, 41.7, 31.6, 31.4, 23.3, 22.6, 19.5, 14.0, 9.3 
ppm. IR (neat, cm-1): 2931, 1700, 1598, 1458, 1392, 1296, 1224, 1045, 760, 695, 555. HRMS (ES+) 
calcd for (C18H26NO2) [M+H]
+ 288.1964, found 288.1989. 
(R*)-5-((R*)-3-Oxohexan-2-yl)-1-phenylpyrrolidin-2-one (9): General 
Procedure II was followed using N-phenylhex-4-enamide (68.1 mg, 0.36 mmol, 1.2 equiv), butyryl 
chloride (32.0 mg, 0.3 mmol, 1.0 equiv), [Ni(dMeObpy)Cl2] (6.3 mg, 0.0018 mmol, 6 mol %),  
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[[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 0.009 mmol, 3 mol %), Bu4N[OP(O)(OBu)2] (338.8 mg, 
0.75 mmol, 2.5 equiv) and dry MeCN (6.0 mL, 0.05 M). The reaction was stirred under blue LED 
irradiation at rt for 24 h. Silica gel purification using an automated system (hexanes/EtOAc, 0 to 
40%) gave the product as a colorless oil (38.1 mg, 0.15 mmol, 49% yield). NMR data represent the 
major diastereoisomer. 1H NMR (500 MHz, CDCl3) δ 7.41 (t, J = 7.8 Hz, 2H), 7.38 – 7.34 (m, 2H), 
7.26 – 7.20 (m, 1H), 4.74 (dt, J = 8.7, 4.4 Hz, 1H), 2.81 (qd, J = 7.1, 4.0 Hz, 1H), 2.56 (ddd, J = 
9.4, 7.3, 4.1 Hz, 2H), 2.35 (ddd, J = 17.2, 8.1, 6.4 Hz, 1H), 2.30 – 2.19 (m, 2H), 1.90 (dddd, J = 
13.9, 9.2, 6.9, 4.9 Hz, 1H), 1.50 (tq, J = 14.2, 7.1 Hz, 2H), 1.02 (d, J = 7.1 Hz, 3H), 0.85 (t, J = 7.4 
Hz, 3H) ppm. 13C NMR (126 MHz, CDCl3) δ 211.6, 174.6, 137.0, 129.4, 126.5, 124.8, 59.7, 47.5, 
43.6, 31.6, 19.5, 17.0, 13.8, 9.2 ppm. IR (neat, cm-1): 2963, 2934, 1693, 1597, 1498, 1388, 1295, 




(10): General Procedure II was followed using N-phenylhex-4-enamide (68.1 mg, 0.36 mmol, 1.2 
equiv), cyclohexanecarbonyl chloride (44.0 mg, 0.3 mmol, 1.0 equiv), [Ni(dMeObpy)Cl2] (6.3 mg, 
0.0018 mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 0.009 mmol, 3 mol %), 
Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry MeCN (6.0 mL, 0.05 M). The 
reaction was stirred under blue LED irradiation at rt for 24 h. Silica gel purification using an 
automated system (hexanes/EtOAc, 0 to 40%) gave the product as a colorless oil (39.7 mg, 0.13 
mmol, 44% yield). NMR data represent the major diastereoisomer. 1H NMR (500 MHz, CDCl3) δ 
7.42 (t, J = 7.8 Hz, 2H), 7.36 (d, J = 8.0 Hz, 2H), 7.28 – 7.23 (m, 1H), 4.68 (dt, J = 8.5, 4.3 Hz, 
1H), 2.98 (qd, J = 6.9, 3.6 Hz, 1H), 2.66 – 2.49 (m, 2H), 2.32 (ddt, J = 11.3, 7.1, 3.9 Hz, 1H), 2.28 
– 2.17 (m, 1H), 1.98 (tt, J = 14.2, 6.2 Hz, 1H), 1.81 – 1.69 (m, 3H), 1.65 (d, J = 9.5 Hz, 1H), 1.56 
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(d, J = 12.6 Hz, 1H), 1.31 – 1.14 (m, 5H), 1.01 (d, J = 7.0 Hz, 3H) ppm. 13C NMR (126 MHz, 
CDCl3) δ 214.7, 174.6, 137.0, 129.4, 126.5, 124.6, 59.7, 49.8, 45.5, 31.6, 28.7, 28.5, 25.8, 25.7, 
25.6, 19.5, 9.5 ppm. IR (neat, cm-1): 2929, 2854, 1695, 1597, 1498, 1389, 1295, 1251, 1222, 1143, 
1055, 988, 759, 695. HRMS (ES+) calcd for (C19H26NO2) [M+H]
+ 300.1964, found 300.1960. 
(R*)-5-((R*)-1-Cyclopropyl-1-oxopropan-2-yl)-1-phenylpyrrolidin-2-one 
(11): General Procedure II was followed using N-phenylhex-4-enamide (68.1 mg, 0.36 mmol, 1.2 
equiv), cyclopropanecarbonyl chloride (31.4 mg, 0.3 mmol, 1.0 equiv), [Ni(dMeObpy)Cl2] (6.3 
mg, 0.0018 mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 0.009 mmol, 3 mol %), 
Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry MeCN (6.0 mL, 0.05 M). The 
reaction was stirred under blue LED irradiation at rt for 24 h. Silica gel purification using an 
automated system (hexanes/EtOAc, 0 to 40%) gave the product as a colorless oil (40.2 mg, 0.16 
mmol, 52% yield). NMR data represent the major diastereoisomer. 1H NMR (500 MHz, CDCl3) δ 
7.46 – 7.38 (m, 4H), 7.27 – 7.23 (m, 1H), 4.83 (dt, J = 8.6, 4.3 Hz, 1H), 3.05 (qd, J = 7.0, 3.8 Hz, 
1H), 2.66 – 2.45 (m, 2H), 2.31 – 2.18 (m, 1H), 1.97 – 1.86 (m, 2H), 1.07 (d, J = 7.0 Hz, 3H), 1.03 
– 0.97 (m, 1H), 0.94 (dt, J = 9.3, 4.3 Hz, 1H), 0.90 – 0.81 (m, 2H) ppm. 13C NMR (126 MHz, 
CDCl3) δ 211.1, 174.6, 137.1, 129.4, 126.5, 124.7, 59.8, 48.2, 31.6, 19.8, 19.2, 11.4, 11.4, 8.8 ppm. 
IR (neat, cm-1): 2964, 1689, 1597, 1498, 1456, 1381, 1294, 1247, 1223, 1196, 1101, 1045, 1013, 
998, 694, 554. HRMS (ES+) calcd for (C16H20NO2) [M+H]
+ 258.1494, found 258.1505. 
(5R*)-5-((2R*)-1-Oxo-1-(2-phenylcyclopropyl)propan-2-yl)-1-
phenylpyrrolidin-2-one (14): General Procedure III was followed using 2-phenylcyclopropane-1-
carboxylic acid (48.7 mg, 0.3 mmol, 1.0 equiv), (COCl)2 (41.9 mg, 0.33 mmol, 1.1 equiv), DMF 
 
 375 
(10 µL), CH2Cl2 (2 mL), N-phenylhex-4-enamide (68.1 mg, 0.36 mmol, 1.2 equiv), 
[Ni(dMeObpy)Cl2] (6.3 mg, 0.0018 mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 0.009 
mmol, 3 mol %), Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry MeCN (6.0 mL, 
0.05 M). The reaction was stirred under blue LED irradiation at rt for 24 h. Silica gel purification 
using an automated system (hexanes/EtOAc, 0 to 40%) gave the product as a colorless oil (54.0 
mg, 0.16 mmol, 54% yield). NMR spectra represent a 1:1 mixture of two diastereoisomers 
originating from the acid coupling partner. 1H NMR (500 MHz, CDCl3) δ 7.41 (ddd, J = 13.7, 8.6, 
6.9 Hz, 4H), 7.37 – 7.32 (m, 1H), 7.32 – 7.28 (m, 1H), 7.24 (tt, J = 7.4, 4.5 Hz, 2H), 7.07 (dd, J = 
7.5, 2.0 Hz, 2H), 4.83 (ddt, J = 15.6, 8.6, 4.3 Hz, 1H), 3.07 (qd, J = 7.1, 3.7 Hz, 1H), 2.67 – 2.54 
(m, 2H), 2.53 – 2.39 (m, 1H), 2.33 – 2.20 (m, 1H), 2.13 (dddd, J = 16.5, 8.0, 5.2, 4.0 Hz, 1H), 1.98 
– 1.87 (m, 1H), [diastereoisomer 1: 1.67 (dt, J = 9.2, 4.7 Hz, 1H), diasteroisomer 2: 1.59 (dt, J = 
9.3, 4.6 Hz, 1H)], 1.38 (dddd, J = 17.4, 8.1, 6.6, 4.2 Hz, 1H), 1.09 (dd, J = 7.5 Hz, 3H) ppm. 13C 
NMR (126 MHz, CDCl3) δ 209.2, 208.9, 174.5, 174.4, 140.0, 139.9, 137.0, 137.0, 129.4, 128.8, 
128.7, 126.9, 126.8, 126.5, 126.5, 126.2, 126.0, 124.8, 124.6, 59.7, 59.5, 48.3, 31.7, 31.5, 29.6, 
29.6, 19.4, 19.2, 19.2, 8.9, 8.7 ppm. IR (neat, cm-1): 2975, 1688, 1497, 1456, 1392, 1342, 1294, 
1246, 1223, 1120, 1055, 994, 756, 695. HRMS (ES+) calcd for (C22H24NO2) [M+H]
+ 334.1807, 
found 334.1815.  
(R*)-5-((R*)-1-(2,2-Difluorobenzo[d][1,3]dioxol-5-yl)-1-
oxopropan-2-yl)-1-phenylpyrrolidin-2-one (15): General Procedure III was followed using 2,2-
difluorobenzo[d][1,3]dioxole-5-carboxylic acid (60.6 mg, 0.3 mmol, 1.0 equiv), (COCl)2 (41.9 mg, 
0.33 mmol, 1.1 equiv), DMF (10 µL), CH2Cl2 (2 mL), N-phenylhex-4-enamide (68.1 mg, 0.36 
mmol, 1.2 equiv), [Ni(dMeObpy)Cl2] (6.3 mg, 0.0018 mmol, 6 mol %), 
[[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 0.009 mmol, 3 mol %), Bu4N[OP(O)(OBu)2] (338.8 mg, 
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0.75 mmol, 2.5 equiv) and dry MeCN (6.0 mL, 0.05 M). The reaction was stirred under blue LED 
irradiation at rt for 24 h. Silica gel purification using an automated system (hexanes/EtOAc, 0 to 
40%) gave the product as a colorless oil (66.0 mg, 0.18 mmol, 59% yield). 1H NMR (500 MHz, 
CDCl3) δ 7.53 (dd, J = 8.3, 1.7 Hz, 1H), 7.47 (d, J = 1.7 Hz, 1H), 7.42 (t, J = 7.7 Hz, 2H), 7.37 – 
7.32 (m, 2H), 7.29 – 7.24 (m, 1H), 7.10 (d, J = 8.3 Hz, 1H), 4.69 (dt, J = 8.6, 4.3 Hz, 1H), 3.68 (qd, 
J = 6.8, 3.9 Hz, 1H), 2.70 – 2.48 (m, 2H), 2.21 (ddt, J = 13.2, 9.9, 7.7 Hz, 1H), 2.15 – 2.02 (m, 1H), 
1.14 (d, J = 6.8 Hz, 3H) ppm. 13C NMR (126 MHz, CDCl3) δ 199.0, 174.4, 147.3, 144.4, 137.0, 
132.7, 131.8, 129.5, 126.9, 125.2, 125.1, 109.4, 60.6, 42.6, 31.4, 19.3, 10.2 ppm. 19F NMR (471 
MHz, CDCl3) δ -115.5 ppm. IR (neat, cm
-1): 1708, 1686, 1493, 1440, 1379, 1292, 1242, 1215, 
1177, 1149, 1091, 1035, 908, 883, 789, 698. HRMS (ES+) calcd for (C20H18F2NO4) [M+H]
+ 
374.1204, found 374.1203. One carbon missing in 13C-NMR due to fluorine substitution. 
(R*)-1-(4-Chlorophenyl)-5-((R*)-1-oxo-1-phenylpropan-2-yl)pyrrolidin-2-
one (16): General Procedure II was followed using N-(4-chlorophenyl)hex-4-enamide (80.5 mg, 
0.36 mmol, 1.2 equiv), benzoyl chloride (42.2 mg, 0.3 mmol, 1.0 equiv), [Ni(dMeObpy)Cl2] (6.3 
mg, 0.0018 mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 0.009 mmol, 3 mol %), 
Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry MeCN (6.0 mL, 0.05 M). The 
reaction was stirred under blue LED irradiation at rt for 24 h. Silica gel purification using an 
automated system (hexanes/EtOAc, 0 to 40%) gave the product as a colorless oil (50.0 mg, 0.15 
mmol, 51% yield). 1H NMR (500 MHz, CDCl3) δ 7.74 (dd, J = 8.3, 1.4 Hz, 2H), 7.59 (td, J = 7.3, 
1.4 Hz, 1H), 7.46 (t, J = 7.8 Hz, 2H), 7.41 – 7.36 (m, 2H), 7.34 – 7.30 (m, 2H), 4.69 (dt, J = 8.7, 
4.4 Hz, 1H), 3.76 (qd, J = 6.9, 4.0 Hz, 1H), 2.69 – 2.49 (m, 2H), 2.21 (dddd, J = 13.6, 10.1, 8.5, 
7.2 Hz, 1H), 2.10 (dddd, J = 13.6, 10.5, 6.2, 4.6 Hz, 1H), 1.13 (d, J = 6.9 Hz, 3H) ppm. 13C NMR 
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(126 MHz, CDCl3) δ 201.3, 174.6, 136.2, 135.6, 133.6, 132.1, 129.6, 129.0, 128.1, 126.3, 60.4, 
42.5, 31.4, 19.3, 10.1 ppm. IR (neat, cm-1): 2975, 1695, 1679, 1595, 1492, 1448, 1415, 1382, 1364, 
1293, 1211, 1091, 1013, 1002, 969, 830, 726, 700, 649. HRMS (ES+) calcd for (C19H19ClNO2) 
[M+H]+ 328.1104, found 328.1116. 
(R*)-1-(4-Methoxyphenyl)-5-((R*)-1-oxo-1-phenylpropan-2-yl)pyrrolidin-
2-one (17): General Procedure II was followed using N-(4-methoxyphenyl)hex-4-enamide (78.9 
mg, 0.36 mmol, 1.2 equiv), benzoyl chloride (42.2 mg, 0.3 mmol, 1.0 equiv), [Ni(dMeObpy)Cl2] 
(6.3 mg, 0.0018 mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 0.009 mmol, 3 mol %), 
Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry MeCN (6.0 mL, 0.05 M). The 
reaction was stirred under blue LED irradiation at rt for 24 h. Silica gel purification using an 
automated system (hexanes/EtOAc, 0 to 40%) gave the product as a colorless oil (40.0 mg, 0.12 
mmol, 41% yield). 1H NMR (500 MHz, CDCl3) δ 7.78 – 7.70 (m, 2H), 7.60 – 7.52 (m, 1H), 7.44 
(t, J = 7.6 Hz, 2H), 7.25 (d, J = 8.4 Hz, 2H), 6.94 (d, J = 8.4 Hz, 2H), 4.63 (dt, J = 8.7, 4.5 Hz, 1H), 
3.82 (s, 3H), 3.75 (qd, J = 6.7, 4.0 Hz, 1H), 2.67 – 2.47 (m, 2H), 2.22 – 2.12 (m, 1H), 2.11 – 2.01 
(m, 1H), 1.14 (d, J = 6.9 Hz, 3H) ppm. 13C NMR (126 MHz, CDCl3) δ 201.4, 174.7, 158.3, 136.2, 
133.4, 129.7, 128.9, 128.1, 126.9, 114.8, 61.1, 55.6, 42.6, 31.4, 19.3, 9.9 ppm. IR (neat, cm-1): 2976, 
1682, 1610, 1596, 1511, 1447, 1424, 1397, 1365, 1336, 1291, 1247, 1212, 1181, 1106, 1032, 832, 
700, 650. HRMS (ES+) calcd for (C20H22NO3) [M+H]




yl)pyrrolidin-2-one (18): General Procedure II was followed using N-(4-(tert-butyl)phenyl)hex-
4-enamide (88.3 mg, 0.36 mmol, 1.2 equiv), benzoyl chloride (42.2 mg, 0.3 mmol, 1.0 equiv), 
[Ni(dMeObpy)Cl2] (6.3 mg, 0.0018 mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 0.009 
mmol, 3 mol %), Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry MeCN (6.0 mL, 
0.05 M). The reaction was stirred under blue LED irradiation at rt for 24 h. Silica gel purification 
using an automated system (hexanes/EtOAc, 0 to 40%) gave the product as a colorless oil (61.8 
mg, 0.18 mmol, 59% yield). 1H NMR (500 MHz, CDCl3) δ 7.75 (d, J = 7.7 Hz, 2H), 7.56 (t, J = 
7.4 Hz, 1H), 7.48 – 7.38 (m, 4H), 7.32 – 7.24 (m, 2H), 4.71 (dt, J = 8.8, 4.5 Hz, 1H), 3.79 (qd, J = 
6.9, 3.9 Hz, 1H), 2.69 – 2.47 (m, 2H), 2.21 – 2.11 (m, 1H), 2.06 (ddt, J = 14.1, 10.5, 5.5 Hz, 1H), 
1.32 (s, 9H), 1.14 (d, J = 6.8 Hz, 3H) ppm. 13C NMR (126 MHz, CDCl3) δ 201.4, 174.7, 149.7, 
136.2, 134.1, 133.4, 128.9, 128.2, 126.3, 124.8, 60.6, 42.7, 31.4, 19.3, 18.7, 13.7, 9.9 ppm. IR (neat, 
cm-1): 2961, 1680, 1515, 1448, 1393, 1297, 1212, 1159, 1028, 972, 835, 730, 647. HRMS (ES+) 
calcd for (C23H28NO2) [M+H]
+ 350.2120, found 350.2135. 
(R*)-5-((R*)-1-Oxo-1-phenylpropan-2-yl)-1-(4-phenoxyphenyl)pyrrolidin-
2-one (19): General Procedure II was followed using N-(4-phenoxyphenyl)hex-4-enamide (101.3 
mg, 0.36 mmol, 1.2 equiv), benzoyl chloride (42.2 mg, 0.3 mmol, 1.0 equiv), [Ni(dMeObpy)Cl2] 
(6.3 mg, 0.0018 mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 0.009 mmol, 3 mol %), 
Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry MeCN (6.0 mL, 0.05 M). The 
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reaction was stirred under blue LED irradiation at rt for 24 h. Silica gel purification using an 
automated system (hexanes/EtOAc, 0 to 40%) gave the product as a colorless oil (55.6 mg, 0.14 
mmol, 48% yield). 1H NMR (500 MHz, CDCl3) δ 7.79 – 7.73 (m, 2H), 7.58 (t, J = 7.4 Hz, 1H), 
7.46 (t, J = 7.6 Hz, 2H), 7.36 (t, J = 7.9 Hz, 2H), 7.33 – 7.28 (m, 2H), 7.14 (t, J = 7.4 Hz, 1H), 7.06 
– 7.00 (m, 4H), 4.68 (dt, J = 8.7, 4.5 Hz, 1H), 3.78 (qd, J = 6.8, 4.1 Hz, 1H), 2.68 – 2.50 (m, 2H), 
2.19 (dddd, J = 15.5, 10.1, 8.5, 7.0 Hz, 1H), 2.13 – 2.03 (m, 1H), 1.15 (d, J = 6.8 Hz, 3H) ppm. 13C 
NMR (126 MHz, CDCl3) δ 201.1, 174.4, 156.5, 155.7, 135.9, 133.3, 131.6, 129.7, 128.7, 127.9, 
126.6, 123.6, 119.1, 119.0, 60.6, 42.4, 31.1, 19.2, 9.9 ppm. IR (neat, cm-1): 3050, 2976, 1681, 1589, 
1505, 1488, 1422, 1393, 1334, 1291, 1233, 1163, 972, 842, 754, 731, 693. HRMS (ES+) calcd for 
(C25H24NO3) [M+H]
+ 386.1756, found 386.1748. 
Ethyl 4-((R*)-2-Oxo-5-((R*)-1-oxo-1-phenylpropan-2-yl)pyrrolidin-1-
yl)benzoate (20): General Procedure II was followed using ethyl (Z)-4-(hex-4-enamido)benzoate 
(94.1 mg, 0.36 mmol, 1.2 equiv), benzoyl chloride (42.2 mg, 0.3 mmol, 1.0 equiv), 
[Ni(dMeObpy)Cl2] (6.3 mg, 0.0018 mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 0.009 
mmol, 3 mol %), Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry MeCN (6.0 mL, 
0.05 M). The reaction was stirred under blue LED irradiation at rt for 24 h. Silica gel purification 
using an automated system (hexanes/EtOAc, 0 to 40%) gave the product as a colorless oil (30.7 
mg, 0.084 mmol, 28% yield). 1H NMR (500 MHz, CDCl3) δ 8.11 (d, J = 8.6 Hz, 2H), 7.79 – 7.73 
(m, 2H), 7.59 (t, J = 7.5 Hz, 1H), 7.54 – 7.51 (m, 2H), 7.47 (t, J = 7.6 Hz, 2H), 4.79 (dt, J = 8.5, 
4.1 Hz, 1H), 4.40 (q, J = 7.2 Hz, 2H), 3.81 (qd, J = 6.8, 3.7 Hz, 1H), 2.66 (ddd, J = 17.8, 10.3, 7.6 
Hz, 1H), 2.56 (ddd, J = 17.4, 10.3, 5.8 Hz, 1H), 2.25 – 2.18 (m, 1H), 2.13 (ddt, J = 14.4, 9.1, 3.7 
Hz, 1H), 1.41 (t, J = 7.2 Hz, 3H), 1.11 (d, J = 6.9 Hz, 3H) ppm. 13C NMR (126 MHz, CDCl3) δ 
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201.3, 174.7, 166.0, 141.3, 136.3, 133.7, 130.9, 129.1, 128.1, 128.1, 123.7, 61.2, 59.9, 42.3, 31.7, 
18.9, 14.5, 9.8 ppm. IR (neat, cm-1): 2980, 1706, 1682, 1605, 1511, 1448, 1421, 1383, 1367, 1274, 




General Procedure II was followed using N-(4-fluorophenyl)pent-4-enamide (69.5 mg, 0.36 mmol, 
1.2 equiv), benzoyl chloride (42.2 mg, 0.3 mmol, 1.0 equiv), [Ni(dMeObpy)Cl2] (6.3 mg, 0.0018 
mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 0.009 mmol, 3 mol %), 
Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry MeCN (6.0 mL, 0.05 M). The 
reaction was stirred under blue LED irradiation at rt for 24 h. Silica gel purification using an 
automated system (hexanes/EtOAc, 0 to 40%) gave the product as a colorless oil (51.7 mg, 0.17 
mmol, 58% yield). 1H NMR (500 MHz, CDCl3) δ 7.85 (d, J = 7.6 Hz, 2H), 7.61 – 7.55 (m, 1H), 
7.45 (t, J = 7.7 Hz, 2H), 7.39 (dd, J = 8.8, 4.7 Hz, 2H), 7.08 (t, J = 8.5 Hz, 2H), 4.85 (ddt, J = 10.0, 
7.8, 3.9 Hz, 1H), 3.30 (dd, J = 17.3, 3.2 Hz, 1H), 3.10 (dd, J = 17.3, 9.6 Hz, 1H), 2.72 – 2.64 (m, 
1H), 2.64 – 2.57 (m, 2H), 1.86 (tdd, J = 10.8, 5.5, 2.9 Hz, 1H) ppm. 13C NMR (126 MHz, CDCl3) 
δ 197.5, 174.4, 161.6, 160.7 (d, J = 246.3 Hz), 159.7, 136.6, 133.8, 133.3, 128.9, 128.1, 125.9 (d, 
J = 8.3 Hz), 116.2 (d, J = 22.5 Hz), 56.6, 42.4, 31.0, 25.2 ppm. 19F NMR (471 MHz, CDCl3) δ -
115.5 ppm. IR (neat, cm-1): 2925, 1681, 1598, 1507, 1449, 1421, 1385, 1331, 1292, 1216, 1203, 






yl)pyrrolidin-2-one (22): General Procedure II was followed using N-(3,5-dimethoxyphenyl)hex-
4-enamide (89.8 mg, 0.36 mmol, 1.2 equiv), benzoyl chloride (42.2 mg, 0.3 mmol, 1.0 equiv), 
[Ni(dMeObpy)Cl2] (6.3 mg, 0.0018 mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 0.009 
mmol, 3 mol %), Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry MeCN (6.0 mL, 
0.05 M). The reaction was stirred under blue LED irradiation at rt for 24 h. Silica gel purification 
using an automated system (hexanes/EtOAc, 0 to 40%) gave the product as a colorless oil (56.2 
mg, 0.16 mmol, 53% yield). 1H NMR (500 MHz, CDCl3) δ 7.83 – 7.76 (m, 2H), 7.58 (t, J = 7.4 
Hz, 1H), 7.45 (t, J = 7.6 Hz, 2H), 6.56 (d, J = 2.2 Hz, 2H), 6.36 (t, J = 2.3 Hz, 1H), 4.66 (dt, J = 
8.5, 4.2 Hz, 1H), 3.86 (qd, J = 6.7, 3.8 Hz, 1H), 3.79 (s, 6H), 2.68 – 2.49 (m, 2H), 2.19 – 2.11 (m, 
1H), 2.07 (ddt, J = 14.2, 10.3, 4.9 Hz, 1H), 1.14 (d, J = 6.8 Hz, 3H) ppm. 13C NMR (126 MHz, 
CDCl3) δ 201.4, 174.5, 161.4, 138.7, 136.2, 133.5, 128.9, 128.2, 103.5, 99.0, 60.7, 55.6, 42.5, 31.7, 
19.0, 9.8 ppm. IR (neat, cm-1): 2940, 1697, 1595, 1448, 1429, 1391, 1341, 1270, 1262, 1206, 1155, 
1064, 968, 838, 690. HRMS (ES+) calcd for (C21H24NO4) [M+H]
+ 354.1705, found 354.1721. 
(E)-4-(4-(5-Oxo-1-phenylpyrrolidin-2-yl)but-3-en-1-yl)benzonitrile (23): 
General Procedure II was followed using (E)-5-cyclopropyl-N-phenylpent-4-enamide (77.5 mg, 
0.36 mmol, 1.2 equiv, synthesized according to literature3), 4-bromobenzonitrile (54.6 mg, 0.3 
mmol, 1.0 equiv), [Ni(dMeObpy)Cl2] (6.3 mg, 0.0018 mmol, 6 mol %), 
[[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 0.009 mmol, 3 mol %), Bu4N[OP(O)(OBu)2] (338.8 mg, 
0.75 mmol, 2.5 equiv) and dry t-BuOH/PhCF3 (2:1, 6.0 mL, 0.05 M). The reaction was stirred under 
 
 382 
blue LED irradiation at rt for 96 h. Silica gel purification using an automated system 
(hexanes/EtOAc, 0 to 40%) gave the product as a yellowish oil (64.2 mg, 0.20 mmol, 67% yield). 
1H NMR (500 MHz, CDCl3) δ 7.87 (dd, J = 8.1, 1.4 Hz, 2H), 7.58 – 7.52 (m, 1H), 7.44 (t, J = 7.7 
Hz, 2H), 7.41 – 7.36 (m, 2H), 7.31 – 7.25 (m, 2H), 7.09 (t, J = 7.6 Hz, 1H), 5.68 (dt, J = 15.4, 6.8 
Hz, 1H), 5.41 (ddd, J = 15.4, 7.6, 1.5 Hz, 1H), 4.59 (td, J = 7.6, 5.2 Hz, 1H), 2.91 (t, J = 7.2 Hz, 
2H), 2.60 (ddd, J = 16.5, 9.3, 6.7 Hz, 1H), 2.49 (ddd, J = 16.8, 9.1, 6.6 Hz, 1H), 2.44 – 2.37 (m, 
2H), 2.37 – 2.31 (m, 1H), 1.86 (dddd, J = 12.3, 9.2, 6.7, 5.3 Hz, 1H) ppm. 13C NMR (126 MHz, 
CDCl3) δ 199.0, 174.3, 138.0, 136.8, 133.1, 132.5, 130.5, 128.7, 128.6, 128.0, 125.2, 123.3, 62.1, 
37.8, 31.2, 26.5, 26.4 ppm.  IR (neat, cm-1): 2927, 2225, 1693, 1497, 1379, 1217. HRMS (ES+) 
calcd for (C21H22N2O) [M+H]
+ 320.1651, found 320.1662.  
5-(2-Oxo-2-phenylethyl)-1-phenylpyrrolidin-2-one (24): General Procedure II 
was followed using N-phenylpent-4-enamide (63.1 mg, 0.36 mmol, 1.2 equiv), benzoyl chloride 
(42.2 mg, 0.3 mmol, 1.0 equiv), [Ni(dMeObpy)Cl2] (6.3 mg, 0.0018 mmol, 6 mol %), 
[[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 0.009 mmol, 3 mol %), Bu4N[OP(O)(OBu)2] (338.8 mg, 
0.75 mmol, 2.5 equiv) and dry MeCN (6.0 mL, 0.05 M). The reaction was stirred under blue LED 
irradiation at rt for 24 h. Silica gel purification using an automated system (hexanes/EtOAc, 0 to 
40%) gave the product as a white solid (47.2 mg, 0.17 mmol, 56% yield). mp = 104 – 106 ºC. 1H 
NMR (500 MHz, CDCl3) δ 7.89 – 7.81 (m, 2H), 7.57 (t, J = 7.7 Hz, 1H), 7.48 – 7.42 (m, 4H), 7.40 
(t, J = 8.0 Hz, 2H), 7.21 (t, J = 7.4 Hz, 1H), 4.91 (dddd, J = 10.0, 4.5, 3.1, 2.5 Hz, 1H), 3.34 (dd, J 
= 17.4, 3.0 Hz, 1H), 3.11 (dd, J = 17.4, 9.8 Hz, 1H), 2.73 – 2.63 (m, 1H), 2.60 (ddd, J = 13.0, 7.1, 
4.4 Hz, 2H), 1.86 (ddt, J = 11.5, 9.8, 4.8 Hz, 1H) ppm. 13C NMR (126 MHz, CDCl3) δ 197.7, 174.3, 
137.4, 136.6, 133.7, 129.4, 128.8, 128.1, 126.1, 123.8, 56.3, 42.4, 31.2, 25.1 ppm. IR (neat, cm-1): 
3051, 1679, 1596, 1581, 1497, 1449, 1381, 1289, 1181, 1003, 982, 756, 690, 639. HRMS (ES+) 
calcd for (C18H18NO2) [M+H]




General Procedure II was followed using 1-allyl-N-phenylcyclohexane-1-carboxamide (87.6 mg, 
0.36 mmol, 1.2 equiv), benzoyl chloride (42.2 mg, 0.3 mmol, 1.0 equiv), [Ni(dMeObpy)Cl2] (6.3 
mg, 0.0018 mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 0.009 mmol, 3 mol %), 
Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry MeCN (6.0 mL, 0.05 M). The 
reaction was stirred under blue LED irradiation at rt for 24 h. Silica gel purification using an 
automated system (hexanes/EtOAc, 0 to 40%) gave the product as a colorless oil (66.8 mg, 0.19 
mmol, 64% yield). 1H NMR (500 MHz, CDCl3) δ 7.89 – 7.82 (m, 2H), 7.57 (t, J = 7.4 Hz, 1H), 
7.45 (t, J = 7.7 Hz, 2H), 7.42 – 7.36 (m, 4H), 7.21 (tt, J = 6.4, 2.4 Hz, 1H), 4.87 – 4.74 (m, 1H), 
3.44 (dd, J = 17.3, 3.2 Hz, 1H), 2.99 (dd, J = 17.3, 9.9 Hz, 1H), 2.69 (dd, J = 13.2, 7.5 Hz, 1H), 
1.94 (td, J = 12.8, 3.9 Hz, 1H), 1.80 – 1.71 (m, 2H), 1.71 – 1.57 (m, 4H), 1.56 – 1.51 (m, 1H), 1.50 
– 1.40 (m, 1H), 1.32 (td, J = 12.4, 9.2 Hz, 2H) ppm. 13C NMR (126 MHz, CDCl3) δ 197.9, 178.9, 
137.6, 136.7, 133.7, 129.2, 128.8, 128.1, 126.1, 124.3, 52.8, 45.7, 44.0, 37.4, 35.0, 32.7, 25.5, 22.3 
ppm. IR (neat, cm-1): 2928, 2855, 1681, 1596, 1581, 1495, 1448, 1373, 1307, 1274, 1205, 1001, 
917, 757, 722, 690. HRMS (EI+) calcd for (C23H25NO2) [M]
+ 347.1885, found 347.1879. 
3,3-Dimethyl-5-(2-oxo-2-phenylethyl)-1-phenylpyrrolidin-2-one (26): 
General Procedure II was followed using 2,2-dimethyl-N-phenylpent-4-enamide (73.2 mg, 0.36 
mmol, 1.2 equiv), benzoyl chloride (42.2 mg, 0.3 mmol, 1.0 equiv), [Ni(dMeObpy)Cl2] (6.3 mg, 
0.0018 mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 0.009 mmol, 3 mol %), 
Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry MeCN (6.0 mL, 0.05 M). The 
reaction was stirred under blue LED irradiation at rt for 24 h. Silica gel purification using an 
automated system (hexanes/EtOAc, 0 to 40%) gave the product as a white solid (78.4 mg, 0.26 
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mmol, 85% yield). mp = 98 – 101 ºC. 1H NMR (500 MHz, CDCl3) δ 7.87 – 7.82 (m, 2H), 7.59 – 
7.55 (m, 1H), 7.44 (t, J = 7.8 Hz, 2H), 7.42 – 7.38 (m, 4H), 7.24 – 7.19 (m, 1H), 4.88 – 4.75 (m, 
1H), 3.44 (dd, J = 17.3, 3.2 Hz, 1H), 3.00 (dd, J = 17.3, 9.8 Hz, 1H), 2.53 (dd, J = 13.0, 7.1 Hz, 
1H), 1.67 (dd, J = 13.0, 7.3 Hz, 1H), 1.33 (s, 3H), 1.27 (s, 3H) ppm. 13C NMR (126 MHz, CDCl3) 
δ 197.8, 179.2, 137.6, 136.7, 133.7, 129.3, 128.8, 128.1, 126.1, 124.3, 52.5, 43.6, 41.6, 41.1, 26.2, 
25.4 ppm. IR (neat, cm-1): 2964, 2929, 1684, 1597, 1496, 1449, 1390, 1372, 1207, 1180, 1118, 
1001, 762, 692, 628. HRMS (EI+) calcd for (C20H21NO2) [M]
+ 307.1572, found 307.1596. 
5-Methyl-5-(2-oxo-2-phenylethyl)-1-phenylpyrrolidin-2-one (27): General 
Procedure II was followed using 4-methyl-N-phenylpent-4-enamide (68.1 mg, 0.36 mmol, 1.2 
equiv), benzoyl chloride (42.2 mg, 0.3 mmol, 1.0 equiv), [Ni(dMeObpy)Cl2] (6.3 mg, 0.0018 
mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 0.009 mmol, 3 mol %), 
Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry MeCN (6.0 mL, 0.05 M). The 
reaction was stirred under blue LED irradiation at rt for 24 h. Silica gel purification using an 
automated system (hexanes/EtOAc, 0 to 40%) gave the product as a white solid (36.2 mg, 0.12 
mmol, 41% yield). mp = 104 – 106 ºC. 1H NMR (500 MHz, CDCl3) δ 7.90 – 7.80 (m, 2H), 7.61 – 
7.53 (m, 1H), 7.48 – 7.41 (m, 4H), 7.40 – 7.35 (m, 1H), 7.19 (dd, J = 7.6, 1.7 Hz, 2H), 3.27 – 3.10 
(m, 2H), 2.76 – 2.55 (m, 2H), 2.45 (ddd, J = 13.2, 9.9, 6.5 Hz, 1H), 2.24 (ddd, J = 13.2, 9.6, 6.5 
Hz, 1H), 1.47 (s, 3H) ppm. 13C NMR (126 MHz, CDCl3) δ 197.2, 175.5, 137.4, 136.3, 133.5, 129.8, 
129.5, 128.8, 128.4, 127.9, 63.8, 46.8, 32.1, 30.2, 27.3 ppm. IR (neat, cm-1): 2965, 1681, 1596, 
1580, 1496, 1448, 1374, 1349, 1219, 1126, 1005, 756, 699, 691, 575. HRMS (ES+) calcd for 
(C19H20NO2) [M+H]
+ 294.1494, found 294.1483. 
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4-Methyl-5-(2-oxo-2-phenylethyl)-1-phenylpyrrolidin-2-one (28): General 
Procedure II was followed using 3-methyl-N-phenylpent-4-enamide (68.1 mg, 0.36 mmol, 1.2 
equiv), benzoyl chloride (42.2 mg, 0.3 mmol, 1.0 equiv), [Ni(dMeObpy)Cl2] (6.3 mg, 0.0018 
mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 0.009 mmol, 3 mol %), 
Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry MeCN (6.0 mL, 0.05 M). The 
reaction was stirred under blue LED irradiation at rt for 24 h. Silica gel purification using an 
automated system (hexanes/EtOAc, 0 to 40%) gave the product as a white solid (61.6 mg, 0.21 
mmol, 70% yield). mp = 130 – 132, 134 – 138 ºC. The two distinguishable melting ranges are likely 
because that the sample consists of two diastereoisomers. 1H NMR for major diastereoisomer (500 
MHz, CDCl3) δ 7.86 (t, J = 8.7 Hz, 2H), 7.57 (t, J = 7.4 Hz, 1H), 7.46 (dt, J = 15.7, 8.1 Hz, 4H), 
7.37 (td, J = 8.1, 2.4 Hz, 2H), 7.18 (t, J = 7.4 Hz, 1H), 4.51 (dt, J = 9.3, 2.8 Hz, 1H), 3.28 (dd, J = 
17.2, 3.0 Hz, 1H), 3.16 (dd, J = 17.5, 9.4 Hz, 1H), 2.94 – 2.85 (m, 1H), 2.71 (dd, J = 16.8, 8.2 Hz, 
1H), 2.29 – 2.19 (m, 1H), 1.31 (d, J = 6.9 Hz, 3H) ppm. 1H NMR for minor isomer (500 MHz, 
CDCl3) δ 7.86 (t, J = 8.7 Hz, 2H), 7.57 (t, J = 7.4 Hz, 1H), 7.46 (dt, J = 15.7, 8.1 Hz, 4H), 7.37 (td, 
J = 8.1, 2.4 Hz, 2H), 7.18 (t, J = 7.4 Hz, 1H), 5.06 (ddd, J = 10.0, 7.1, 3.0 Hz, 1H), 3.37 – 3.31 (m, 
1H), 3.03 (dd, J = 17.8, 3.1 Hz, 1H), 2.94 – 2.85 (m, 1H), 2.35 (dd, J = 16.8, 8.3 Hz, 1H), 2.29 – 
2.20 (m, 1H), 1.01 (d, J = 7.0 Hz, 3H) ppm. 13C NMR of mixture of two isomers (126 MHz, CDCl3) 
δ 197.9, 197.7, 173.8, 173.4, 137.6, 137.5, 136.6, 136.5, 133.7, 133.6, 129.3, 129.3, 128.8, 128.0, 
128.0, 125.9, 123.6, 123.5, 63.7, 59.2, 41.5, 39.5, 39.2, 36.8, 32.4, 30.1, 20.7, 15.2 ppm. IR (neat, 
cm-1): 3061, 2960, 1679, 1596, 1581, 1497, 1449, 1387, 1374, 1353, 1289, 1204, 1181, 1119, 1071, 
1000, 990, 756, 690, 642. HRMS (ES+) calcd for (C19H19NaNO2) [M+Na]





General Procedure II was followed using 2-methyl-N-phenylpent-4-enamide (68.1 mg, 0.36 mmol, 
1.2 equiv), benzoyl chloride (42.2 mg, 0.3 mmol, 1.0 equiv), [Ni(dMeObpy)Cl2] (6.3 mg, 0.0018 
mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 0.009 mmol, 3 mol %), 
Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry MeCN (6.0 mL, 0.05 M). The 
reaction was stirred under blue LED irradiation at rt for 24 h. Silica gel purification using an 
automated system (hexanes/EtOAc, 0 to 40%) gave the product as a white solid (42.3 mg, 0.14 
mmol for major isomer; 14.1 mg, 0.048 mmol for minor isomer. 64% yield in total). mp (major 
isomer) = 140 – 142 ºC. 1H NMR for first eluting (major) diastereoisomer (500 MHz, CDCl3) δ 
7.91 – 7.83 (m, 2H), 7.60 – 7.53 (m, 3H), 7.45 (t, J = 7.8 Hz, 2H), 7.39 (ddd, J = 8.6, 5.7, 1.9 Hz, 
2H), 7.21 – 7.17 (m, 1H), 4.89 (dtd, J = 10.3, 5.2, 2.9 Hz, 1H), 3.30 (dd, J = 17.4, 2.9 Hz, 1H), 3.16 
(dd, J = 17.3, 10.1 Hz, 1H), 2.78 (tq, J = 9.0, 7.1 Hz, 1H), 2.15 (dd, J = 9.1, 5.2 Hz, 2H), 1.30 (d, J 
= 7.1 Hz, 3H) ppm. 13C NMR (126 MHz, CDCl3) δ 197.9, 176.6, 137.7, 136.6, 133.7, 129.3, 128.9, 
128.1, 125.6, 122.8, 54.0, 41.4, 36.3, 33.5, 16.3 ppm. IR (neat, cm-1): 3061, 2960, 1679, 1596, 1581, 
1497, 1449, 1387, 1374, 1353, 1289, 1204, 1181, 1119, 1071, 1000, 990, 756, 690, 642. HRMS 
(ES+) calcd for (C19H20NO2) [M+H]
+ 294.1494, found 294.1500. mp (minor isomer) = 136 – 139 
ºC. 1H NMR for second eluting (minor) isomer (500 MHz, CDCl3) δ7.84 (dd, J = 8.2, 1.4 Hz, 2H), 
7.59 – 7.55 (m, 1H), 7.44 (t, J = 7.7 Hz, 2H), 7.41 – 7.38 (m, 2H), 7.37 – 7.33 (m, 2H), 7.22 (tt, J 
= 7.5, 1.2 Hz, 1H), 4.83 – 4.74 (m, 1H), 3.44 (dd, J = 17.3, 3.2 Hz, 1H), 2.96 (dd, J = 17.3, 9.7 Hz, 
1H), 2.89 (ddd, J = 12.9, 9.1, 6.8 Hz, 1H), 2.70 (td, J = 9.5, 7.0 Hz, 1H), 1.48 – 1.37 (m, 1H), 1.34 
(d, J = 7.1 Hz, 3H) ppm. 13C NMR (126 MHz, CDCl3) δ 197.7, 176.9, 137.4, 136.7, 133.7, 129.3, 
128.8, 128.1, 126.3, 124.6, 54.0, 43.9, 37.2, 35.2, 17.0 ppm. IR (neat, cm-1): 3062, 2928, 1697, 
1597, 1497, 1449, 1372, 1310, 1204, 1115, 1001, 760, 719, 692, 629. HRMS (ES+) calcd for 
(C19H20NO2) [M+H]




yl)carbamate (30): General Procedure II was followed using tert-butyl (R)-(1-oxo-1-
(phenylamino)pent-4-en-2-yl)carbamate (104.5 mg, 0.36 mmol, 1.2 equiv), benzoyl chloride (42.2 
mg, 0.3 mmol, 1.0 equiv), [Ni(dMeObpy)Cl2] (6.3 mg, 0.0018 mmol, 6 mol %), 
[[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 0.009 mmol, 3 mol %), Bu4N[OP(O)(OBu)2] (338.8 mg, 
0.75 mmol, 2.5 equiv) and dry MeCN (6.0 mL, 0.05 M). The reaction was stirred under blue LED 
irradiation at rt for 24 h. Silica gel purification using an automated system (hexanes/EtOAc, 0 to 
40%) gave the product as a colorless oil. First eluted isomer (60.4 mg, 0.15 mmol, 51% yield): 1H 
NMR (500 MHz, CDCl3) δ 7.90 – 7.81 (m, 2H), 7.60 – 7.53 (m, 3H), 7.45 (t, J = 7.7 Hz, 2H), 7.42 
– 7.37 (m, 2H), 7.23 – 7.19 (m, 1H), 5.15 (s, 1H), 5.02 – 4.91 (m, 1H), 4.56 (s, 1H), 3.35 – 3.20 
(m, 2H), 2.65 – 2.57 (m, 1H), 2.30 (d, J = 11.1 Hz, 1H), 1.46 (s, 9H) ppm. 13C NMR (126 MHz, 
CDCl3) δ 197.3, 171.7, 156.1, 137.1, 136.5, 133.8, 129.5, 128.9, 128.1, 126.1, 122.3, 53.1, 52.1, 
40.7, 33.7, 28.5 ppm. IR (neat, cm-1): 3347, 2978, 1685, 1597, 1497, 1392, 1367, 1328, 1294, 1248, 
1207, 1168, 1053, 1001, 756, 735, 691. HRMS (ES+) calcd for (C23H27N2O4) [M+H]
+ 395.1971, 
found 395.1943. Second eluted isomer (12.1 mg, 0.03 mmol, 10% yield): 1H NMR (500 MHz, 
CDCl3) δ 7.83 – 7.78 (m, 2H), 7.55 (t, J = 7.4 Hz, 1H), 7.46 – 7.38 (m, 4H), 7.38 – 7.33 (m, 2H), 
7.25 (dd, J = 8.2, 6.6 Hz, 1H), 5.29 (d, J = 13.5 Hz, 1H), 4.79 (tdd, J = 9.0, 6.4, 3.4 Hz, 1H), 4.33 
(td, J = 9.6, 5.3 Hz, 1H), 3.38 (dd, J = 17.4, 3.4 Hz, 1H), 3.28 – 3.15 (m, 1H), 3.06 (dd, J = 17.2, 
9.1 Hz, 1H), 1.75 (dt, J = 13.0, 9.7 Hz, 1H), 1.47 (s, 9H) ppm. 13C NMR (126 MHz, CDCl3) δ 
197.2, 171.7, 155.8, 136.6, 133.7, 129.4, 128.8, 128.1, 126.9, 124.8, 80.2, 61.0, 53.0, 43.1, 35.0, 
29.8, 28.5 ppm. IR (neat, cm-1): 3396, 1717, 1690, 1596, 1519, 1496, 1450, 1405, 1377, 1327, 1290, 






one (31): General Procedure II was followed using 7-methyl-N-phenyloct-4-enamide (83.3 mg, 
0.36 mmol, 1.2 equiv), benzoyl chloride (42.2 mg, 0.3 mmol, 1.0 equiv), [Ni(dMeObpy)Cl2] (6.3 
mg, 0.0018 mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 0.009 mmol, 3 mol %), 
Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry MeCN (6.0 mL, 0.05 M). The 
reaction was stirred under blue LED irradiation at rt for 24 h. Silica gel purification using an 
automated system (hexanes/EtOAc, 0 to 40%) gave the product as a colorless oil (60.4 mg, 0.18 
mmol, 60% yield). 1H NMR (500 MHz, CDCl3) δ 7.83 – 7.79 (m, 2H), 7.60 (t, J = 7.4 Hz, 1H), 
7.51 – 7.44 (m, 4H), 7.42 – 7.37 (m, 2H), 7.31 (t, J = 7.4 Hz, 1H), 4.55 (dt, J = 8.4, 4.0 Hz, 1H), 
3.83 (ddd, J = 11.0, 3.5, 2.1 Hz, 1H), 2.64 (ddd, J = 17.4, 10.3, 7.1 Hz, 1H), 2.51 (ddd, J = 17.2, 
10.5, 5.9 Hz, 1H), 2.21 – 2.11 (m, 1H), 2.11 – 1.94 (m, 2H), 1.26 (tq, J = 8.9, 3.3, 2.0 Hz, 1H), 1.15 
(ddd, J = 13.0, 9.0, 2.0 Hz, 1H), 0.78 (d, J = 6.6 Hz, 3H), 0.56 (d, J = 6.5 Hz, 3H) ppm. 13C NMR 
(126 MHz, CDCl3) δ 200.5, 174.5, 136.9, 136.8, 133.7, 129.4, 129.1, 128.1, 126.8, 125.2, 60.4, 
45.5, 32.5, 31.5, 26.5, 23.8, 21.8, 18.8 ppm. IR (neat, cm-1): 2955, 1697, 1679, 1596, 1498, 1447, 
1385, 1292, 1238, 1225, 1206, 1156, 992, 909, 762, 733, 692, 649. HRMS (ES+) calcd for 
(C22H26NO2) [M+H]
+ 358.1783, found 358.1798. 
(R*)-5-((R*)-4-(Methylthio)-1-oxo-1-phenylbutan-2-yl)-1-phenylpyrrolidin-
2-one (32): General Procedure II was followed using 7-(methylthio)-N-phenylhept-4-enamide 
(89.8  mg, 0.36 mmol, 1.2 equiv), benzoyl chloride (42.2 mg, 0.3 mmol, 1.0 equiv), 
[Ni(dMeObpy)Cl2] (6.3 mg, 0.0018 mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 0.009 
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mmol, 3 mol %), Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry MeCN (6.0 mL, 
0.05 M). The reaction was stirred under blue LED irradiation at rt for 24 h. Silica gel purification 
using an automated system (hexanes/EtOAc, 0 to 40%) gave the product as a colorless oil (52.0 
mg, 0.15 mmol, 49% yield). 1H NMR (500 MHz, CDCl3) δ 7.83 (d, J = 7.7 Hz, 2H), 7.61 (t, J = 
7.4 Hz, 1H), 7.48 (td, J = 7.8, 1.7 Hz, 4H), 7.40 (d, J = 7.9 Hz, 2H), 7.30 (t, J = 7.3 Hz, 1H), 4.60 
(dt, J = 8.6, 4.3 Hz, 1H), 4.03 (dt, J = 10.0, 2.9 Hz, 1H), 2.63 (ddd, J = 17.2, 10.1, 6.9 Hz, 1H), 
2.51 (ddd, J = 17.2, 10.3, 6.0 Hz, 1H), 2.35 (dddd, J = 16.1, 11.6, 5.5, 4.8 Hz, 2H), 2.21 (dt, J = 
15.8, 7.9 Hz, 1H), 2.18 – 2.09 (m, 1H), 2.03 – 1.97 (m, 1H), 1.86 (s, 3H), 1.72 – 1.62 (m, 1H) ppm. 
13C NMR (126 MHz, CDCl3) δ 200.0, 174.4, 136.8, 136.8, 133.7, 129.5, 129.1, 128.2, 126.9, 124.9, 
60.1, 46.6, 32.2, 31.3, 22.7, 19.1, 15.0 ppm. IR (neat, cm-1): 3062, 2918, 1698, 1596, 1498, 1447, 
1386, 1295, 1254, 1221, 1118, 1073, 1001, 935, 762, 694. HRMS (ES+) calcd for (C21H24NO2S) 
[M+H]+ 354.1528, found 354.1529. 
(R*)-5-((S*)-3-(benzyloxy)-1-oxo-1-phenylpropan-2-yl)-1-
phenylpyrrolidin-2-one (33): General Procedure II was followed using 6-(benzyloxy)-N-
phenylhex-4-enamide (106.3 mg, 0.36 mmol, 1.2 equiv), benzoyl chloride (42.2 mg, 0.3 mmol, 1.0 
equiv), [Ni(dMeObpy)Cl2] (6.3 mg, 0.0018 mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 
mg, 0.009 mmol, 3 mol %), Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry MeCN 
(6.0 mL, 0.05 M). The reaction was stirred under blue LED irradiation at rt for 24 h. Silica gel 
purification using an automated system (hexanes/EtOAc, 0 to 40%) gave the product as a colorless 
oil (61.2 mg, 0.15 mmol, 51% yield). 1H NMR (500 MHz, CDCl3) δ 7.75 (d, J = 7.7 Hz, 2H), 7.57 
(t, J = 7.5 Hz, 1H), 7.46 – 7.36 (m, 4H), 7.33 – 7.22 (m, 6H), 7.14 (dd, J = 7.3, 2.0 Hz, 2H), 4.70 
(ddd, J = 7.4, 5.5, 3.8 Hz, 1H), 4.43 (d, J = 12.1 Hz, 1H), 4.35 (d, J = 12.1 Hz, 1H), 4.07 – 4.00 (m, 
1H), 3.91 (dd, J = 9.2, 7.0 Hz, 1H), 3.69 (dd, J = 9.2, 4.7 Hz, 1H), 2.61 – 2.46 (m, 2H), 2.28 – 2.19 
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(m, 2H) ppm. 13C NMR (126 MHz, CDCl3) δ 199.5, 174.5, 137.6, 137.0, 136.6, 133.5, 129.4, 128.8, 
128.5, 128.3, 127.8, 127.7, 126.8, 125.4, 73.7, 66.7, 59.6, 48.6, 31.3, 20.5 ppm. IR (neat, cm-1): 
3062, 2864, 1698, 1596, 1498, 1448, 1392, 1294, 1209, 1182, 1100, 1028, 954, 758, 695, 552. 
HRMS (ES+) calcd for (C26H26NO3) [M+H]
+ 400.1913, found 400.1927. 
(R*)-5-((R*,E)-1-Oxo-1-phenyloct-5-en-2-yl)-1-phenylpyrrolidin-2-one 
(34): General Procedure II was followed using (8Z)-N-phenylundeca-4,8-dienamide (92.7 mg, 0.36 
mmol, 1.2 equiv), benzoyl chloride (42.2 mg, 0.3 mmol, 1.0 equiv), [Ni(dMeObpy)Cl2] (6.3 mg, 
0.0018 mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 0.009 mmol, 3 mol %), 
Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry MeCN (6.0 mL, 0.05 M). The 
reaction was stirred under blue LED irradiation at rt for 24 h. Silica gel purification using an 
automated system (hexanes/EtOAc, 0 to 40%) gave the product as a colorless oil (95.4 mg, 0.26 
mmol, 88% yield). E/Z = 3:1 likely due to photoisomerization. 1H NMR (500 MHz, CDCl3) δ 7.77 
(dd, J = 6.8, 6.8 Hz, 2H), 7.59 (dd, J = 8.4, 6.4 Hz, 1H), 7.47 (q, J = 7.7 Hz, 4H), 7.37 (d, J = 7.8 
Hz, 2H), 7.31 (t, J = 7.4 Hz, 1H), 5.27 – 5.11 (m, 1H), 5.06 – 4.95 (m, 1H), 4.55 (ddt, J = 12.7, 8.4, 
4.1 Hz, 1H), 3.77 (ddt, J = 19.4, 10.9, 2.8 Hz, 1H), 2.63 (ddd, J = 13.5, 9.9, 5.1 Hz, 1H), 2.57 – 
2.46 (m, 1H), 2.19 – 2.08 (m, 2H), 2.02 (ddt, J = 18.6, 9.5, 7.2 Hz, 1H), 1.95 – 1.84 (m, 1H), 1.82 
– 1.61 (m, 3H), 1.48 – 1.35 (m, 1H), 0.77 (td, J = 7.5, 2.2 Hz, 3H) ppm. 13C NMR (126 MHz, 
CDCl3) δ 199.5, 174.5, 137.6, 137.0, 136.6, 133.5, 129.4, 128.8, 128.5, 128.3, 127.8, 127.7, 126.8, 
125.4, 73.7, 66.7, 59.6, 48.6, 31.3, 20.5 ppm. IR (neat, cm-1): 3062, 2864, 1698, 1596, 1498, 1448, 
1392, 1294, 1209, 1182, 1100, 1028, 954, 758, 695, 552. HRMS (ES+) calcd for (C24H28NO2) 




phenylbutyl)carbamate (35): General Procedure II was followed using benzyl [7-oxo-7-
(phenylamino)hept-3-en-1-yl]carbamate (126.9 mg, 0.36 mmol, 1.2 equiv), benzoyl chloride (42.2 
mg, 0.3 mmol, 1.0 equiv), [Ni(dMeObpy)Cl2] (6.3 mg, 0.0018 mmol, 6 mol %), 
[[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 0.009 mmol, 3 mol %), Bu4N[OP(O)(OBu)2] (338.8 mg, 
0.75 mmol, 2.5 equiv) and dry MeCN (6.0 mL, 0.05 M). The reaction was stirred under blue LED 
irradiation at rt for 24 h. Silica gel purification using an automated system (hexanes/EtOAc, 0 to 
40%) gave the product as a colorless oil (67.1 mg, 49% yield). 1H NMR (500 MHz, CDCl3) δ 7.77 
(d, J = 7.7 Hz, 2H), 7.59 (t, J = 7.4 Hz, 1H), 7.49 – 7.41 (m, 4H), 7.35 (d, J = 8.1 Hz, 2H), 7.34 – 
7.30 (m, 3H), 7.30 – 7.25 (m, 1H), 7.23 (d, J = 6.9 Hz, 2H), 4.93 (d, J = 12.2 Hz, 1H), 4.85 (d, J = 
12.3 Hz, 1H), 4.56 (dt, J = 9.3, 4.7 Hz, 2H), 3.81 (d, J = 10.8 Hz, 1H), 3.08 – 2.93 (m, 2H), 2.59 
(ddd, J = 17.3, 9.9, 7.1 Hz, 1H), 2.49 (ddd, J = 17.3, 10.2, 6.3 Hz, 1H), 2.25 (dq, J = 12.2, 6.3 Hz, 
1H), 2.05 – 1.99 (m, 2H), 1.62 (dt, J = 13.9, 7.1 Hz, 1H) ppm. 13C NMR (126 MHz, CDCl3) δ 
199.9, 174.2, 156.1, 136.5, 136.4, 136.3, 133.6, 129.4, 128.9, 128.4, 128.0, 128.0, 127.9, 126.9, 
125.0, 66.4, 60.1, 45.5, 39.2, 31.0, 24.2, 18.8 ppm. IR (neat, cm-1): 1681, 1597, 1516, 1498, 1448, 
1402, 1294, 1233, 1138, 1002, 983, 906, 759, 725, 693, 647, 552. HRMS (ES+) calcd for 
(C28H29N2O4) [M+H]
+ 457.2127, found 457.2139. 
tert-Butyl 4-((R*)-3-Oxo-2-((R*)-5-oxo-1-phenylpyrrolidin-2-yl)-3-
phenylpropyl)piperidine-1-carboxylate (36): General Procedure II was followed using tert-butyl 
4-(6-oxo-6-(phenylamino)hex-2-en-1-yl)piperidine-1-carboxylate (134.1 mg, 0.36 mmol, 1.2 
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equiv), benzoyl chloride (42.2 mg, 0.3 mmol, 1.0 equiv), [Ni(dMeObpy)Cl2] (6.3 mg, 0.0018 
mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 0.009 mmol, 3 mol %), 
Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry MeCN (6.0 mL, 0.05 M). The 
reaction was stirred under blue LED irradiation at rt for 24 h. Silica gel purification using an 
automated system (hexanes/EtOAc, 0 to 40%) gave the product as a colorless oil (95.4 mg, 0.17 
mmol, 55% yield). 1H NMR (500 MHz, CDCl3) δ 7.79 (d, J = 7.6 Hz, 2H), 7.60 (t, J = 7.4 Hz, 1H), 
7.48 (q, J = 6.9 Hz, 4H), 7.37 (d, J = 7.9 Hz, 2H), 7.31 (t, J = 7.4 Hz, 1H), 4.57 (dt, J = 8.2, 4.0 Hz, 
1H), 3.92 (d, J = 16.4 Hz, 2H), 3.88 – 3.78 (m, 1H), 2.60 (ddd, J = 17.4, 10.1, 6.9 Hz, 1H), 2.49 
(ddd, J = 17.1, 10.4, 6.0 Hz, 2H), 2.41 – 2.30 (m, 1H), 2.08 (ddt, J = 14.1, 10.3, 4.5 Hz, 2H), 1.97 
(ddd, J = 12.1, 7.3, 6.2 Hz, 1H), 1.40 (s, 9H), 1.19 (t, J = 10.5 Hz, 2H), 1.10 – 0.97 (m, 2H), 0.90 
(t, J = 7.4 Hz, 1H), 0.76 – 0.64 (m, 1H) ppm. 13C NMR (126 MHz, CDCl3) δ 200.0, 174.4, 154.8, 
136.7, 136.4, 133.8, 129.5, 129.2, 128.0, 126.9, 125.0, 79.3, 60.1, 44.7, 34.2, 31.4, 31.3, 29.9, 28.5, 
28.5, 18.6 ppm. IR (neat, cm-1): 2974, 2923, 1679, 1597, 1498, 1447, 1423, 1392, 1366, 1289, 1277, 
1244, 1165, 1131, 1071, 910, 762, 727, 693. HRMS (ES+) calcd for (C29H36N2O4Na) [M+Na]
+ 
499.2573, found 499.2580. 
(6S*,6aR*)-6-Benzoyl-1-phenylhexahydro-3,5-methanocyclopenta[b]pyrrol-
2(1H)-one (37): General Procedure II was followed using endo-N-phenylbicyclo[2.2.1]hept-5-ene-
2-carboxamide (92.7 mg, 0.36 mmol, 1.2 equiv), benzoyl chloride (42.2 mg, 0.3 mmol, 1.0 equiv), 
[Ni(dMeObpy)Cl2] (6.3 mg, 0.0018 mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 0.009 
mmol, 3 mol %), Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry MeCN (6.0 mL, 
0.05 M). The reaction was stirred under blue LED irradiation at rt for 24 h. Silica gel purification 
using an automated system (hexanes/EtOAc, 0 to 40%) gave the product as a colorless oil (58.1 
mg, 0.18 mmol, 61% yield). 1H NMR (500 MHz, CDCl3) δ 7.96 (d, J = 7.8 Hz, 2H), 7.67 – 7.55 
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(m, 1H), 7.55 – 7.41 (m, 4H), 7.39 – 7.22 (m, 2H), 7.08 (t, J = 7.4 Hz, 1H), 4.94 (d, J = 5.0 Hz, 
1H), 3.36 (s, 1H), 3.18 (d, J = 5.2 Hz, 1H), 2.76 (d, J = 3.5 Hz, 1H), 2.75 – 2.71 (m, 1H), 2.12 (ddt, 
J = 12.8, 10.9, 2.8 Hz, 1H), 1.98 (d, J = 13.1 Hz, 1H), 1.79 (dt, J = 11.1, 2.0 Hz, 1H), 1.49 (d, J = 
11.1 Hz, 1H) ppm. 13C NMR (126 MHz, CDCl3) δ 199.3, 178.2, 139.0, 135.3, 133.7, 129.2, 129.0, 
128.8, 124.1, 118.8, 61.5, 56.0, 44.2, 43.7, 43.2, 35.4, 34.2 ppm. IR (neat, cm-1): 2979, 1701, 1671, 
1596, 1581, 1495, 1448, 1385, 1350, 1315, 1278, 1209, 1158, 1013, 1005, 912, 754, 691. HRMS 
(ES+) calcd for (C21H20NO2) [M+H]
+ 318.1494, found 318.1484. 
(1S*,4R*,5S*)-4-Benzoyl-6-phenyl-6-azabicyclo[3.2.1]octan-7-one (38): 
General Procedure II was followed using N-phenylcyclohex-3-ene-1-carboxamide (72.5 mg, 0.36 
mmol, 1.2 equiv), benzoyl chloride (42.2 mg, 0.3 mmol, 1.0 equiv), [Ni(dMeObpy)Cl2] (6.3 mg, 
0.0018 mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 0.009 mmol, 3 mol %), 
Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry MeCN (6.0 mL, 0.05 M). The 
reaction was stirred under blue LED irradiation at rt for 24 h. Silica gel purification using an 
automated system (hexanes/EtOAc, 0 to 40%) gave the product as a colorless oil (52.2 mg, 0.17 
mmol, 57% yield). 1H NMR (500 MHz, CDCl3) δ 7.88 – 7.83 (m, 2H), 7.72 (d, J = 8.0 Hz, 2H), 
7.61 (t, J = 7.5 Hz, 1H), 7.51 (t, J = 7.7 Hz, 2H), 7.46 (t, J = 7.9 Hz, 2H), 7.22 (t, J = 7.4 Hz, 1H), 
4.65 (dd, J = 5.6, 3.5 Hz, 1H), 3.90 (dd, J = 7.1, 3.4 Hz, 1H), 2.71 – 2.62 (m, 1H), 2.24 (dd, J = 
14.4, 5.9 Hz, 1H), 2.15 (dt, J = 11.4, 5.6 Hz, 1H), 2.10 – 1.97 (m, 2H), 1.93 (d, J = 11.4 Hz, 1H), 
1.91 – 1.82 (m, 1H) ppm. 13C NMR (126 MHz, CDCl3) δ 201.6, 176.9, 138.0, 136.4, 133.5, 129.6, 
129.1, 128.2, 125.1, 120.9, 59.5, 42.3, 42.1, 31.2, 23.9, 20.5 ppm. IR (neat, cm-1): 2950, 1701, 1678, 
1596, 1493, 1448, 1382, 1303, 1291, 1254, 1204, 1181, 978, 899, 765, 731, 690. HRMS (ES+) 
calcd for (C20H20NO2) [M+H]








(39): General Procedure II was followed using 2-(cyclopent-2-en-1-yl)-N-phenylacetamide (72.5 
mg, 0.36 mmol, 1.2 equiv), benzoyl chloride (42.2 mg, 0.3 mmol, 1.0 equiv), [Ni(dMeObpy)Cl2] 
(6.3 mg, 0.0018 mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 0.009 mmol, 3 mol %), 
Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry MeCN (6.0 mL, 0.05 M). The 
reaction was stirred under blue LED irradiation at rt for 24 h. Silica gel purification using an 
automated system (hexanes/EtOAc, 0 to 40%) gave the product as a white solid (55.9 mg, 0.18 
mmol, 61% yield). mp = 110 – 113 ℃. 1H NMR (500 MHz, CDCl3) δ 7.74 (d, J = 7.7 Hz, 2H), 
7.52 (t, J = 7.4 Hz, 1H), 7.43 (d, J = 7.9 Hz, 2H), 7.38 (t, J = 7.6 Hz, 2H), 7.28 (t, J = 7.8 Hz, 2H), 
7.10 (t, J = 7.4 Hz, 1H), 5.20 (dd, J = 7.9, 2.6 Hz, 1H), 3.76 – 3.67 (m, 1H), 3.11 – 3.00 (m, 1H), 
2.92 (dd, J = 17.7, 10.0 Hz, 1H), 2.45 (dd, J = 17.7, 3.4 Hz, 1H), 2.23 (ddd, J = 14.1, 7.3, 7.2 Hz, 
1H), 2.12 (ddd, J = 14.3, 7.3, 7.2 Hz, 1H), 1.83 (ddd, J = 12.7, 6.4, 6.4 Hz, 1H), 1.66 (ddd, J = 13.0, 
6.4, 6.4 Hz, 1H) ppm. 13C NMR (126 MHz, CDCl3) δ 201.2, 173.6, 137.9, 135.7, 133.4, 129.2, 
128.7, 128.5, 125.5, 122.7, 66.8, 52.3, 38.6, 35.2, 33.4, 31.3 ppm. IR (neat, cm-1): 2951, 1693, 1673, 
1596, 1498, 1448, 1386, 1354, 1310, 1285, 1206, 1180, 1125, 1005, 979, 907, 758, 729, 692. 
HRMS (ES+) calcd for (C20H20NO2) [M+H]
+ 306.1494, found 306.1512. 
(3aS,4R*)-4-Benzoyl-3-phenylhexahydrobenzo[d]oxazol-2(3H)-one (40): A 
modified General Procedure II was followed using cyclohex-2-en-1-yl phenylcarbamate (78.2 mg, 
0.36 mmol, 1.2 equiv), benzoyl chloride (42.2 mg, 0.3 mmol, 1.0 equiv), Ni(dMeObpy)Cl2 (2.1 
mg, 0.006 mmol, 2 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 0.009 mmol, 3 mol %), 
Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry MeCN (6.0 mL, 0.05 M). The 
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reaction was stirred under blue LED irradiation at rt for 24 h. Silica gel purification using an 
automated system (hexanes/EtOAc, 0 to 40%) gave the product as a white solid (47.2 mg, 0.17 
mmol, 56% yield). mp = 145 – 150 ºC. 1H NMR (500 MHz, CDCl3) δ 7.57 (d, J = 7.6 Hz, 2H), 
7.47 (t, J = 7.4 Hz, 1H), 7.31 (t, J = 7.7 Hz, 2H), 7.28 (d, J = 1.3 Hz, 2H), 7.10 (t, J = 7.7 Hz, 2H), 
6.95 (t, J = 7.4 Hz, 1H), 4.97 – 4.93 (m, 1H), 4.91 (dd, J = 6.9 Hz, 1H), 3.65 – 3.59 (m, 1H), 2.35 
– 2.26 (m, 1H), 1.95 – 1.82 (m, 2H), 1.73 – 1.63 (m, 2H), 1.44 – 1.34 (m, 1H) ppm. 13C NMR (126 
MHz, CDCl3) δ 201.4, 156.1, 136.2, 135.7, 133.4, 129.0, 128.6, 128.0, 126.0, 124.1, 73.4, 58.3, 
47.2, 27.3, 26.9, 18.6 ppm. IR (neat, cm-1): 2942, 1750, 1674, 1598, 1501, 1448, 1392, 1350, 1337, 
1292, 1274, 1226, 1196, 1135, 1087, 1015, 1001, 979, 953, 759, 693. HRMS (ES+) calcd for 
(C20H20NO3) [M+H]
+ 321.1365, found 321.1357. 
(4aR,8R,8aS)-6-Benzoyl-2,2-di-tert-butylhexahydropyrano[3,2-
d][1,3,2]dioxasilin-8-yl phenylcarbamate (41): General Procedure II was followed using 
(4aR,8R,8aR)-2,2-di-tert-butyl-4,4a,8,8a-tetrahydropyrano[3,2-d][1,3,2]dioxasilin-8-yl 
phenylcarbamate (145.9 mg, 0.36 mmol, 1.2 equiv), benzoyl chloride (42.2 mg, 0.3 mmol, 1.0 
equiv), Ni(dMeObpy)Cl2 (6.3 mg, 0.018 mmol, 6 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 
0.009 mmol, 3 mol %), Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry MeCN (6.0 
mL, 0.05 M). The reaction was stirred under blue LED irradiation at rt for 24 h. Silica gel 
purification using an automated system (hexanes/EtOAc, 0 to 40%) gave the product as a white 
solid (104.8 mg, 0.21 mmol, 69% yield). mp = 78 – 82 ºC. 1H NMR (500 MHz, CDCl3) δ 7.97 (d, 
J = 7.7 Hz, 2H), 7.62 (q, J = 7.7 Hz, 1H), 7.46 (dt, J = 16.0, 7.6 Hz, 4H), 7.29 (dd, J = 12.4, 4.6 
Hz, 3H), 5.26 (s, 1H), 5.13 (d, J = 7.6 Hz, 1H), 4.80 (t, J = 7.4 Hz, 1H), 4.22 – 4.04 (m, 1H), 3.82 
(d, J = 7.5 Hz, 2H), 3.23 (dt, J = 10.1, 7.5 Hz, 1H), 1.07 (s, 9H), 0.93 (s, 9H). 13C NMR (126 MHz, 
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CDCl3) δ 196.8, 156.6, 136.1, 134.6, 134.0, 129.8, 129.6, 129.0, 127.2, 124.6, 76.7, 75.8, 73.8, 
69.2, 66.2, 56.5, 27.5, 27.0, 22.8, 20.0. IR (neat, cm-1): 2933, 2859, 1767, 1682, 1501, 1472, 1387, 
1106, 1021, 1009, 967, 837, 824, 764, 692, 634. HRMS (ES+) calcd for (C28H36NO6Si) [M+H]
+ 
510.2320, found 510.2312. 
(4aR,8R,8aR)-6-Benzoyl-2,2-di-tert-butylhexahydropyrano[3,2-
d][1,3,2]dioxasilin-8-yl phenylcarbamate (42): General Procedure II was followed using 
(4aR,8R,8aS)-2,2-di-tert-butyl-4,4a,8,8a-tetrahydropyrano[3,2-d][1,3,2]dioxasilin-8-yl 
phenylcarbamate (145.9 mg, 0.36 mmol, 1.2 equiv), benzoyl chloride (42.2 mg, 0.3 mmol, 1.0 
equiv), Ni(dMeObpy)Cl2 (6.3 mg, 0.018 mmol, 2 mol %), [[Ir{dF(CF3)2ppy}2(bpy)]PF6] (9.0 mg, 
0.009 mmol, 3 mol %), Bu4N[OP(O)(OBu)2] (338.8 mg, 0.75 mmol, 2.5 equiv) and dry MeCN (6.0 
mL, 0.05 M). The reaction was stirred under blue LED irradiation at rt for 24 h. Silica gel 
purification using an automated system (hexanes/EtOAc, 0 to 40%) gave the product as an off-
white solid (63.4 mg, 0.13 mmol, 42% yield). mp = 89 – 92 ºC. 1H NMR (500 MHz, CDCl3) δ 8.09 
– 7.98 (m, 2H), 7.64 (t, J = 7.4 Hz, 1H), 7.49 (t, J = 7.7 Hz, 2H), 7.40 (t, J = 7.7 Hz, 2H), 7.32 (d, 
J = 8.0 Hz, 2H), 7.21 (t, J = 7.3 Hz, 1H), 5.41 (s, 1H), 5.10 (d, J = 7.9 Hz, 1H), 4.98 (dd, J = 7.9, 
4.6 Hz, 1H), 4.53 (dd, J = 4.8, 2.2 Hz, 1H), 4.05 (dd, J = 5.3, 3.1 Hz, 2H), 3.40 (q, J = 2.9 Hz, 1H), 
1.10 (s, 9H), 1.04 (s, 9H). 13C NMR (126 MHz, CDCl3) δ 197.5, 156.5, 136.7, 134.6, 134.2, 129.7, 
129.5, 129.0, 125.5, 121.9, 73.0, 70.8, 69.5, 67.2, 66.7, 52.2, 27.7, 27.2, 23.1, 21.2. IR (neat, cm-
1): 2925, 2850, 1761, 1680, 1386, 1197, 1197, 1127, 1068, 914, 796, 752, 693, 639. HRMS (ES+) 
calcd for (C28H36NO6Si) [M+H]
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Figure A3.1. 1H NMR (CDCl3, 500 MHz) of Benzoic (dibutyl phosphoric) anhydride(S1a) 
 
































Figure A3.4. 1H NMR (CDCl3, 500 MHz) of 5-methyl-6-oxo-N,6-diphenylhex-4-enamide(S1b) 
 





Figure A3.6. 1H NMR (CDCl3, 500 MHz) of 7-Methyl-N-phenyloct-4-enamide (S31) 
 





Figure A3.8. 1H NMR (CDCl3, 500 MHz) of 7-(methylthio)-N-Phenylhept-4-enamide (S32)  
 





Figure A3.10. 1H NMR (CDCl3, 500 MHz) of 6-(Benzyloxy)-N-phenylhex-4-enamide (S33) 
 





Figure A3.12. 1H NMR (CDCl3, 500 MHz) of (8Z)-N-Phenylundeca-4,8-dienamide (S34) 
 





Figure A3.14. 1H NMR (CDCl3, 500 MHz)of Benzyl (7-oxo-7-(phenylamino)hept-3-en-1-
yl)carbamateenamide (S35)  
 
Figure A3.15. 13C NMR (CDCl3, 126 MHz) of Benzyl (7-oxo-7-(phenylamino)hept-3-en-1-





Figure A3.16. 1H NMR (CDCl3, 500 MHz) of tert-Butyl 4-(6-oxo-6-(phenylamino)hex-2-en-1-
yl)piperidine-1-carboxylate (S36) 
 






Figure A3.18. 1H NMR (CDCl3, 500 MHz) of (R*)-5-((R*)-1-oxo-1-phenylpropan-2-yl)-1-
phenylpyrrolidin-2-one (1) 
 






Figure A3.20. 1H NMR (CDCl3, 500 MHz) of (R*)-5-((R*)-1-oxo-1-(4-(trifluoromethyl)phenyl)propan-2-
yl)-1-phenylpyrrolidin-2-one (2)  
 
Figure A3.21. 13C NMR (CDCl3, 126 MHz) of (R*)-5-((R*)-1-oxo-1-(4-(trifluoromethyl)phenyl)propan-2-





Figure A3.22. 19F NMR (CDCl3, 471 MHz) of (R*)-5-((R*)-1-oxo-1-(4-(trifluoromethyl)phenyl)propan-2-
























Figure A3.23. 1H NMR (CDCl3, 500 MHz) of (R*)-5-((R*)-1-(4-methoxyphenyl)-1-oxopropan-2-yl)-1-
phenylpyrrolidin-2-one (3)  
 
Figure A3.24. 13C NMR (CDCl3, 126 MHz) of (R*)-5-((R*)-1-(4-methoxyphenyl)-1-oxopropan-2-yl)-1-





Figure A3.25. 1H NMR (CDCl3, 500 MHz) of (R*)-5-((R*)-1-oxo-1-(p-tolyl)propan-2-yl)-1-
phenylpyrrolidin-2-one (4&13) 
 






Figure A3.27. 13C NMR (CDCl3, 126 MHz) of (R*)-5-((R*)-1-(4-chlorophenyl)-1-oxopropan-2-yl)-1-
phenylpyrrolidin-2-one (5) 
 






Figure A3.29. 1H NMR (CDCl3, 500 MHz) of (R*)-5-((R*)-1-(3-methoxyphenyl)-1-oxopropan-2-yl)-1-
phenylpyrrolidin-2-one (6) 
 






Figure A3.31. 1H NMR (CDCl3, 500 MHz) of (R*)-5-((R*)-1-(3-chlorophenyl)-1-oxopropan-2-yl)-1-
phenylpyrrolidin-2-one (7&12):  
 
Figure A3.32. 13C NMR (CDCl3, 126 MHz) of (R*)-5-((R*)-1-(3-chlorophenyl)-1-oxopropan-2-yl)-1-





Figure A3.33. 1H NMR (CDCl3, 500 MHz) of (R*)-5-((R*)-3-oxooctan-2-yl)-1-phenylpyrrolidin-2-one (8) 
 





Figure A3.35. 1H NMR (CDCl3, 500 MHz) of (R*)-5-((R*)-1-oxo-1-(p-tolyl)propan-2-yl)-1-
phenylpyrrolidin-2-one (9) 
 






Figure A3.37. 1H NMR (CDCl3, 500 MHz) of (R*)-5-((R*)-1-cyclohexyl-1-oxopropan-2-yl)-1-
phenylpyrrolidin-2-one (10) 
 






Figure A3.39. 1H NMR (CDCl3, 500 MHz) of (R*)-5-((R*)-1-cyclopropyl-1-oxopropan-2-yl)-1-
phenylpyrrolidin-2-one (11)  
 
Figure A3.39. 13C NMR (CDCl3, 126 MHz) of (R*)-5-((R*)-1-cyclopropyl-1-oxopropan-2-yl)-1-





Figure A3.40. 1H NMR (CDCl3, 500 MHz) of (5R*)-5-((2R*)-1-oxo-1-(2-phenylcyclopropyl)propan-2-yl)-
1-phenylpyrrolidin-2-one (14) 
 






Figure A3.42. 1H NMR (CDCl3, 500 MHz) of (R*)-5-((R*)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-1-
oxopropan-2-yl)-1-phenylpyrrolidin-2-one (15) 
 






























Figure A3.45. 1H NMR (CDCl3, 500 MHz) of (R*)-1-(4-Chlorophenyl)-5-((R*)-1-oxo-1-phenylpropan-2-
yl)pyrrolidin-2-one (16) 
 






Figure A3.47. 1H NMR (CDCl3, 500 MHz) of (R*)-1-(4-Methoxyphenyl)-5-((R*)-1-oxo-1-phenylpropan-2-
yl)pyrrolidin-2-one (17) 
 






Figure A3.49. 1H NMR (CDCl3, 500 MHz) of (R*)-1-(4-(tert-Butyl)phenyl)-5-((R*)-1-oxo-1-phenylpropan-
2-yl)pyrrolidin-2-one (18) 
 






Figure A3.51. 1H NMR (CDCl3, 500 MHz) of (R*)-5-((R*)-1-Oxo-1-phenylpropan-2-yl)-1-(4-
phenoxyphenyl)pyrrolidin-2-one (19) 
 






Figure A3.53. 1H NMR (CDCl3, 500 MHz) of Ethyl 4-((R*)-2-oxo-5-((R*)-1-oxo-1-phenylpropan-2-
yl)pyrrolidin-1-yl)benzoate (20) 
 






Figure A3.55. 1H NMR (CDCl3, 500 MHz) of (R*)-1-(4-fluorophenyl)-5-(2-oxo-2-phenylethyl)pyrrolidin-
2-one (21) 
 















































Figure A3.62. 1H NMR (CDCl3, 500 MHz) of 5-(2-Oxo-2-phenylethyl)-1-phenylpyrrolidin-2-one (24) 
 





Figure A3.64. 1H NMR (CDCl3, 500 MHz) of 3-(2-Oxo-2-phenylethyl)-2-phenyl-2-azaspiro[4.5]decan-1-
one (25) 
 






Figure A3.66. 1H NMR (CDCl3, 500 MHz) of 3,3-Dimethyl-5-(2-oxo-2-phenylethyl)-1-phenylpyrrolidin-2-
one (26) 
 






Figure A3.68. 1H NMR (CDCl3, 500 MHz) of 5-Methyl-5-(2-oxo-2-phenylethyl)-1-phenylpyrrolidin-2-one 
(27) 
 






Figure A3.70. 1H NMR (CDCl3, 500 MHz) of 4-Methyl-5-(2-oxo-2-phenylethyl)-1-phenylpyrrolidin-2-one 
(28) 
 






Figure A3.72. 1H NMR (CDCl3, 500 MHz) of firstly eluted diastereomer of 3-Methyl-5-(2-oxo-2-
phenylethyl)-1-phenylpyrrolidin-2-one (29) 
 





Figure A3.74. 1H NMR (CDCl3, 500 MHz) of secondly eluted diastereomer of 3-Methyl-5-(2-oxo-2-
phenylethyl)-1-phenylpyrrolidin-2-one (29) 
 






Figure A3.76. 1H NMR (CDCl3, 500 MHz) of firstly eluted diastereomer of tert-Butyl (2-oxo-5-(2-oxo-2-
phenylethyl)-1-phenylpyrrolidin-3-yl)carbamate (30) 
 





Figure A3.78. 1H NMR (CDCl3, 500 MHz) of secondly eluted diastereomer of tert-Butyl (2-oxo-5-(2-oxo-
2-phenylethyl)-1-phenylpyrrolidin-3-yl)carbamate (30) 
 






Figure A3.80. 1H NMR (CDCl3, 500 MHz) of (R*)-5-((R*)-4-methyl-1-oxo-1-phenylpentan-2-yl)-1-
phenylpyrrolidin-2-one (31) 
 






Figure A3.82. 1H NMR (CDCl3, 500 MHz) of (R*)-5-((R*)-4-(Methylthio)-1-oxo-1-phenylbutan-2-yl)-1-
phenylpyrrolidin-2-one (32) 
 






Figure A3.84. 1H NMR (CDCl3, 500 MHz) of (R*)-5-((S*)-3-(benzyloxy)-1-oxo-1-phenylpropan-2-yl)-1-
phenylpyrrolidin-2-one (33) 
 






Figure A3.86. 1H NMR (CDCl3, 500 MHz) of (R*)-5-((R*,Z)-1-Oxo-1-phenyloct-5-en-2-yl)-1-
phenylpyrrolidin-2-one (34) 
 






Figure A3.88. 1H NMR (CDCl3, 500 MHz) of Benzyl ((R*)-4-oxo-3-((R*)-5-oxo-1-phenylpyrrolidin-2-yl)-
4-phenylbutyl)carbamate (35) 
 






Figure A3.90. 1H NMR (CDCl3, 500 MHz) of tert-Butyl 4-((R*)-3-oxo-2-((R*)-5-oxo-1-phenylpyrrolidin-
2-yl)-3-phenylpropyl)piperidine-1-carboxylate (36) 
 






Figure A3.92. 1H NMR (CDCl3, 500 MHz) of (6S*,6aR*)-6-Benzoyl-1-phenylhexahydro-3,5-
methanocyclopenta[b]pyrrol-2(1H)-one (37) 
 






Figure A3.94. 1H NMR (CDCl3, 500 MHz) of (1S*,4R*,5S*)-4-Benzoyl-6-phenyl-6-azabicyclo[3.2.1]octan-
7-one (38) 
 






Figure A3.96. 1H NMR (CDCl3, 500 MHz) of (6R*,6aR*)-6-Benzoyl-1-
phenylhexahydrocyclopenta[b]pyrrol-2(1H)-one (39) 
 






Figure A3.98. 1H NMR (CDCl3, 500 MHz) of (3aS,4R*)-4-benzoyl-3-phenylhexahydrobenzo[d]oxazol-
2(3H)-one (40) 
 






Figure A3.100. 1H NMR (CDCl3, 500 MHz) of (4aR,8R,8aS)-6-benzoyl-2,2-di-tert-
butylhexahydropyrano[3,2-d][1,3,2]dioxasilin-8-yl phenylcarbamate (41) 
 
Figure A3.101. 13C NMR (CDCl3, 126 MHz) of (4aR,8R,8aS)-6-benzoyl-2,2-di-tert-






Figure A3.102. 1H NMR (CDCl3, 500 MHz) of (4aR,8R,8aR)-6-benzoyl-2,2-di-tert-
butylhexahydropyrano[3,2-d][1,3,2]dioxasilin-8-yl phenylcarbamate (42)  
 
Figure A3.102. 13C NMR (CDCl3, 126 MHz) of (4aR,8R,8aR)-6-benzoyl-2,2-di-tert-
butylhexahydropyrano[3,2-d][1,3,2]dioxasilin-8-yl phenylcarbamate (42)  
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Chapter 5. Regioselective Single-Electron Tsuji-Trost Reaction of Allylic Alcohols: A 
Photoredox/Nickel Dual Catalytic Approach 
5.1 Introduction 
Historically, palladium catalysis has proven to be a powerful means by which C–C bonds 
can be forged in a regioselective manner.1** To date, there have been numerous reports utilizing 
palladium catalysis for coupling allyl alcohol substrates with “soft” (pKa < 25) enolate nucleophiles 
(Scheme 1).2 Other “soft” nucleophiles (e.g., nitrogen- and oxygen-based nucleophiles) have also 
been employed,3 and significant advances have been accomplished in the field with the 
development of stereoselective transformations. By comparison, although known, transformations 
using “hard” nucleophiles, which coordinate to metal catalysts before reductive elimination, are 
less studied and often require harsh conditions and/or functional group intolerant reagents.4 In an 
effort to expand the nucleophile scope of the Tsuji-Trost reaction, reductive allylation strategies 
have been explored by numerous groups, enabling the employment of “hard” nucleophiles.5 
Notably, Tunge and coworkers pioneered the concept of a radical-based approach.5a In this 
paradigm, utilizing photoredox catalysis, the excited state photocatalyst undergoes a single-electron 
oxidation of a carboxylate anion substrate. Upon decarboxylation, a carbon-centered alkyl radical 
is generated and captured by a Pd(II) π-allyl complex, forming a Pd(III) intermediate that 
reductively eliminates to afford the cross-coupling product. 
Although numerous coupling methods using various palladium catalysts have been 
reported during the past decades, significantly fewer methods have been disclosed utilizing the 
group 10 base metal, nickel.6 In addition to the advantage of cost-effectiveness, recent studies have 
shed light on the complementary reactivity that can arise between nickel and palladium. For 
example, Fu et al. successfully carried out nickel-catalyzed, enantioselective cross-coupling 
 
 
** Reproduced in part from Wang, Z. -J.; Zheng, S.; Romero, E.; Matsui, J. K.; Molander, G. A. 
Org. Lett. 2019, 21, 6543 
 
 456 
between allyl chlorides and alkylzinc reagents.7  Nickel/photoredox dual-catalyzed alkylation of 
vinyl epoxides have also been developed, with strong evidence of an inner-sphere mechanism.8  
 
Figure 5.1. Radical-Based Addition to Ni-π Allyl Intermediate 
Inspired by previous work, a Ni-based radical approach to functionalize allylic 
electrophiles was sought. Herein, alkylation of allyl alcohol-derived motifs has been demonstrated 
by using alkyl 1,4-dihydropyridines (DHPs)9 as latent radical precursors. Both allyl carbonates and 
in situ activated allyl alcohols have proven effective in the reaction. To highlight the new chemical 
space, the disclosed reaction was employed for the synthesis of allylated monosaccharides. 
Heteroatomic radical sources, such as aryl sulfinates, were also used as partners in this reaction. 
Finally, from a mechanistic standpoint, various factors influencing regioselectivity (e.g., the ligand 
on the nickel center) were demonstrated, in addition to kinetic isotope effect studies that support 
oxidative addition as the turnover-limiting step. 
5.2 Results and Discussion 
At the outset of the synthetic studies, optimization was conducted using isopropyl DHP as 
the radical precursor, and the best results were observed with allyl methyl carbonate as the 
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electrophile. This result provided an opportunity to use dimethyl dicarbonate (DMDC) as an 
activator, which had proven to be compatible in previous studies (Figure 5.2, entry 2).10 To confirm 
the necessity of photocatalyst 4CzIPN [2,4,5,6-tetrakis(carbazol-9-yl)-4,6-dicyanobenzene], nickel 
catalyst, and light, control experiments were performed (Figure 5.2, entries 3–5). For each control 
experiment, no desired product was observed. Using high-throughput experimentation, further 
optimizations were carried out to identify a set of ideal reaction conditions (e.g., photocatalyst, Ni 
source, solvent and ligand, see Experimental Section for further details). To investigate the 
regioselectivity (linear/branched) and stereoselectivity (E/Z) of the reaction further, a series of 
bipyridine ligands was screened (entries 6–12). Most of the ligands led to highly selective linear 
product formation, although further investigations showed a substrate dependence on the 
linear/branched selectivity (see Experimental Section for further details). 1,10-Phenanthroline was 
identified to be a suitable ligand, rendering almost exclusively E-selective product with a high yield 
(entry 6). Further reactions were therefore carried out using the preformed complex, Ni(phen)Cl2, 




Figure 5.2. Control Studies and Ligand Optimization 
With suitable conditions in hand, an investigation of the stereoelectronic effects of the aryl 
moiety on the reaction was begun. Similar to reactivity trends reported for Tsuji-Trost reactions,11 
electron-withdrawing groups (4) did not significantly decrease overall reaction efficiency. 
Conversely, electron-donating moieties (5) led to slightly diminished yields (63%). Furthermore, 
exploration of alkyl-substituted electrophilic partners was of interest. Notably, 6 was successfully 
isolated from the corresponding isoprene dodecane derivative, albeit in lower yield. As a general 
note, alkyl-substituted allyl carbonates suffered from diminished reactivity and, in some cases, no 
reactivity. This occurrence may result from a decrease in electrophilicity, hampering π-allyl nickel 




Figure 5.3 Exploring Alkylation Scope with Carbonates. Reaction conditions: Allyl methyl 
carbonate (1.0 equiv, 0.30 mmol), DHP (1.5 equiv, 0.45 mmol), 4CzIPN (3 mol %), Ni(phen)Cl2 
(5 mol %), and DMF (3 mL, 0.1 M) thoroughly degassed followed by stirring near blue LEDs for 
16 h. E/Z ratios were determined by 1H-NMR of the isolated product. a1 mmol scale. bdr > 20:1. 
Next, attention was focused on incorporating a wider range of DHPs, beginning with cyclic 
carbon-centered radicals (1, 8 and 10). Functional groups such as alkenes (7) and activated 
hydrogens (2i) are also compatible, providing good yields of the desired products. A 1 mmol scale 




Figure 5.4. Coupling Allyl Alcohols with DHPs. Reaction conditions: Allyl alcohol (1.0 equiv, 
0.30 mmol), DHP (1.5 equiv, 0.45 mmol), 4CzIPN (3 mol %), Ni(phen)Cl2 (5 mol %), DMDC (3.0 
equiv, 0.90 mmol), and DMF (3 mL, 0.1 M) thoroughly degassed followed by stirring near blue 
LEDs for 16 h. E/Z ratios were determined by 1H-NMR of the isolated product. 
Although allyl carbonates are both commercially available and easily accessed, conditions 
were sought to improve step-economy by alkylating allylic alcohols in a single-step, one-pot 
reaction. With DMDC identified as the most efficient activator, the scope of this approach was 
examined with various cinnamyl alcohol derivatives and functionally diverse DHPs (Figure 5.3). 
Comparing previous yields with allyl carbonates and the newly developed allyl alcohol conditions, 
comparable results were achieved (1 and 2 versus 11 and 12). Therefore, investigation of the scope 
of the functional group breadth for the allyl alcohol and DHP pieces was continued. Similar 
compatibility for substitutions about the aryl motif was observed (13–17). Nitrogen- (21) and 
oxygen-containing (22) heterocyclic DHPs were successfully incorporated into the reaction 
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manifold, with moderate to good yield. Notably, a hydroxymethyl radical was successfully applied 
in this transformation, with a 57% yield of β-hydroxyl product 22 isolated. 
 
Figure 5.5. Direct Allylation of Monosaccharides. Reaction conditions: Allyl alcohol (1.0 equiv, 
0.30 mmol), DHP (1.5 equiv, 0.45 mmol), 4CzIPN (3 mol %), Ni(phen)Cl2 (5 mol %), DMDC (3.0 
equiv, 0.90 mmol), and DMF (3 mL, 0.1 M) thoroughly degassed, followed by stirring near blue 
LEDs for 16 h. E/Z ratios were determined by 1H-NMR of the isolated product. 
To broaden the scope and demonstrate the utility of this alkylation of allyl alcohol pro-
electrophiles, attention was turned toward more challenging scaffolds, specifically 
monosaccharides.12 Functionalization of carbohydrates has proven to be pivotal in many fields, 
including labelling technologies,13 cyclodextrin-mediated catalysis,14 and carbohydrate drug 
development.15 Notably, few C-allyl glycoside syntheses have been reported, most of which are 
restricted to C-1 alkylation of the carbohydrate and further limited to unsubstituted propenyl 
electrophiles.16 Upon treating both furanose (23) and pyranose (24) DHPs under the standard 
reaction conditions, the non-traditional C-allyl glycosides were isolated in acceptable yields and 
excellent regio- and diastereoselectivities. Notably, structurally similar organometallic saccharide 
partners cannot be accessed owing to rapid α-alkoxy elimination. During the course of these studies, 
Mazet and coworkers published a complementary approach, using a one-pot isolation/C-O 
arylation strategy with a glycoside-derived allyl electrophile and Grignard reagents, rendering 




Figure 5.6. Demonstrating Latent Radical Breadth. Reaction conditions: Allyl methyl carbonate 
(1.0 equiv, 0.30 mmol), DHP (1.5 equiv, 0.45 mmol), 4CzIPN (3 mol %), Ni(phen)Cl2 (5 mol %), 
and DMF (3 mL, 0.1 M) thoroughly degassed followed by stirring near blue LEDs for 16 h. E/Z 
ratios were determined by 1H-NMR of the isolated product. 
To extend the functional group repertoire of allyl alcohol-derived electrophiles further, 
other carbon- or heteroatom-centered radical sources were tested. Although toolboxes such as 
alkyltrifluoroborates,18 alkylsilicates,19 and N-centered radicals20 were incompatible, aryl sulfinate 
salts were coupled with allyl carbonates to generate allyl aryl sulfones (Figure 5.6).21 Both electron-
rich (29) and electron-deficient (27) allyl carbonates performed well, and an aliphatic allyl 
carbonate was applicable with good regioselectivity (30), providing the desired product in 56% 




Figure 5.7. Putative Radical-Based Mechanism 
Finally, to shed some light on the mechanism, several preliminary experiments were 
carried out, including Stern-Volmer quenching experiments. Although significant fluorescent 
quenching with alkyl DHPs has been previously reported,22 neither Ni(phen)Cl2 nor allyl methyl 
carbonate quenched the fluorescence of 4CzIPN. This finding suggests that the reductive generation 
of allylic radical either by photocatalysts or low-valent Ni species is not occurring. To determine 
the turnover-limiting step, we investigated the kinetic isotope effect by comparing reaction rates of 
α-deuterated cinnamyl methyl carbonate vs. its non-deuterated form. A significant secondary 
isotope effect (kH/kD = 1.15 ± 0.07) was observed, indicating a change in hybridization of the allyl 
carbonate substrate in the turnover-determining step, suggesting oxidative addition of allyl 
carbonate to the nickel complex as the turnover-limiting step. The regioselectivity would then most 
likely be dictated by energy differences between the corresponding transition structures involved 
in the reductive elimination step, which is consistent with previous computational studies.8,23 Based 
on these results and previous mechanistic studies, a plausible mechanism is proposed (Figure 5.7): 
upon excitation, the photocatalyst oxidizes the radical precursors to generate alkyl- or sulfonyl 
radicals, which are subsequently captured by Ni(0). Allyl methyl carbonate then oxidatively adds 
to the Ni(I) intermediate to generate the active Ni(III) species, followed by reductive elimination 
to form Csp3-Csp3 or Csp3-S bonds. The resulting Ni(I) species is reduced by the radical anion of 
4CzIPN, closing both catalytic cycles. 
5.3 Conclusion  
In conclusion, the in-situ activation and radical-mediated alkylation of cinnamyl alcohol 
scaffolds in a photoredox/nickel-mediated transformation has been disclosed. During the course of 
these studies, reaction conditions (e.g., ligand, solvent) to favor the regioselective linear product 
and E-isomer have been pinpointed. Furthermore, the range of “nucleophilic” partners has been 
expanded. By either prefunctionalization or in situ activation with DMDC, radical precursors such 
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as alkyl DHPs and aryl sulfinates can be engaged in the reaction, rendering alkylated or sulfonylated 
species in a highly stereoselective and regioselective manner. Notably, monosaccharide-derived 
DHPs have been coupled in the reaction to prepare non-traditional C-allylated glycosides. As a 
complementary approach for allyl-alkyl/sulfone coupling, the disclosed transformation extends the 
scope of allylic functionalization, while at the same time extending the range of Ni-catalyzed 
photoredox transformations, providing a useful synthetic tool for elaboration of readily available 




Unless otherwise noted, all reactions were carried out under an inert atmosphere of argon 
or nitrogen via standard Schlenk techniques or in a glovebox. Reactions were monitored by GC-
MS, 1H NMR, and/or by TLC on silica gel plates (F254, 60 Å). Thin layer chromatography was 
performed using hexanes/EtOAc as the eluents and visualized using KMnO4 or p-anisaldehyde 
stain and/or UV light. Reactions were purified by flash chromatography accompanied with an 
automated system (visualized at 254 nm, monitored with all-wavelength and ELS detector) with 
silica cartridges (60 Å porosity, 20-40 µm). Unless otherwise mentioned, all allylic alcohols were 
purchased from commercial sources and used as received. [Ir{dF(CF3)2ppy}2(bpy)][PF6]
24 and 
4CzIPN25 were synthesized according to literature procedures. DMF, MeCN, and acetone (extra 
dry, 99.8%) were purchased and used as received. Alkyl 1,4-dihydropyridines9 were synthesized 
according to the literature. Allylic alcohols and carbonates were either purchased or synthesized 
according to literature procedures26 and matched with reported data. Other solvents were purified 
either by distillation over Na or CaH2 or by passing through alumina cartridges in a solvent 
purification system. Irradiation of reaction vessels was accomplished using a 5 W blue (455 nm) 
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LED (light emitting diodes) strip about 3 cm from the reaction vessel with a fan above to maintain 
room temperature. The photoredox reaction equipment was constructed according to a previous 
report.27 Reaction optimization was carried out via high throughput experimentation and verified 
on the benchtop. Factors affecting reaction performance, such as solvents, photoredox catalysts, 
additives (e.g., transition metal, ligand, etc.), substrate loadings, as well as temperature have been 
thoroughly examined. NMR Spectra (1H, 13C, 19F) were recorded on a 500 MHz spectrometer at 
298 K. All 1H NMR spectra are reported in parts per million (ppm) downfield of TMS and were 
measured relative to the signal for CHCl3 (7.26 ppm). All 
13C NMR spectra are reported in ppm 
relative to residual CHCl3 (77.2 ppm) and were obtained with 
1H decoupling. All 19F NMR spectra 
were obtained in CDCl3 solution and are reported unreferenced.  Coupling constants (J) are reported 
in Hertz (Hz). HRMS was obtained by either ESI or EI with a TOF spectrometer in CH3CN or 
CHCl3. The data were calibrated and reported by neutral atom masses, and the mass of electron is 
not included. IR spectra were obtained with neat samples. 
General Procedures 
Using Allylic Carbonates (GP1): To an 8-mL reaction vial equipped with a stir bar and 
septa screw cap were added alkyl 1,4-dihydropyridines (0.45 mmol, 1.5 equiv), allylic carbonates 
(0.3 mmol, 1.0 equiv), (phen)NiCl2 (4.7 mg, 5 mol %), and 4CzIPN (7.1 mg, 3 mol %). The reaction 
vial was subsequently closed, and three vacuum/argon cycles were performed, followed by addition 
of 3 mL of dry DMF (0.1 M). After stirring under blue LEDs for 16 h, the reaction was diluted with 
30 mL of EtOAc and washed three times with 10 mL of satd Na2CO3 and subsequently three times 
with 10 mL of brine. The organic phase was dried (MgSO4), and the solvent was removed by 
rotoevaporation. The final product was purified by flash column chromatography, using hexanes 
and EtOAc as eluent. 
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Using Allylic Alcohols (GP2): To an 8-mL reaction vial equipped with a stir bar and septa 
screw cap were added alkyl 1,4-dihydropyridines (0.45 mmol, 1.5 equiv), allylic alcohols (0.3 
mmol, 1.0 equiv), DMDC (120.7 mg, 0.9 mmol. 3.0 equiv), (phen)NiCl2 (4.7 mg, 5 mol %), and 
4CzIPN (7.1 mg, 3 mol %). The reaction vial was subsequently closed, and three vacuum/argon 
cycles were performed, followed by addition of 3 mL of dry DMF (0.1 M). After stirring under 
blue LEDs for 16 h, the reaction was diluted with 30 mL of EtOAc and washed three times with 10 
mL of satd Na2CO3 and subsequently three times with 10 mL of brine. The organic phase was dried 
(MgSO4), and the solvent was removed by rotoevaporation. The final product was purified by flash 
column chromatography, using hexanes and EtOAc as eluent. 
Coupling with Sulfonyl Radicals (GP3): To an 8-mL reaction vial equipped with a stir bar 
and septa screw cap were added sodium benzenesulfinates (0.6 mmol, 2.0 equiv), allylic carbonates 
(0.3 mmol, 1.0 equiv), (phen)NiCl2 (4.7 mg, 5 mol %), and 4CzIPN (7.1 mg, 3 mol %). The reaction 
vial was subsequently closed, and three vacuum/argon cycles were performed, followed by addition 
of 3 mL of dry DMF (0.1 M). After stirring under blue LEDs for 16 h, the reaction was diluted with 
30 mL of EtOAc and washed three times with 10 mL of satd Na2CO3 and subsequently three times 
with 10 mL of brine. The organic phase was dried (MgSO4), and the solvent was removed by 
rotoevaporation. The final product was purified by flash column chromatography, using hexanes 
and EtOAc as eluent. 
Reaction Optimization 
High-Throughput Experimentation Screening 
To a 96-well block with hollow bottom were added nickel sources (5 mol %) and ligand (5 
mol %) for precomplexing. After removing the solvents, p-methoxy cinnamyl alcohol (1.0 equiv), 
dimethyl dicarbonate (DMDC, 3.0 equiv), solvents (0.1 M), isopropyl dihydropyridine (i-PrDHP, 
1.5 equiv), and photoredox catalysts (3 mol %) were added to set up 96 parallel reactions on a 10 
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µmol scale. The block was then put on a photoreactor for 16 h. After completion, the mixture was 
diluted with 500 µL of MeCN containing 0.002 M 4,4’-di-tert-butyl-1,1’-biphenyl as an internal 
standard, and centrifuged, and 25 µL of the clear solution was further diluted with 700 µL MeCN 




Figure 5.8. High Throughput Screening Results 
From the screening result it is evident that DMF is the best solvent, and 4CzIPN rendered 
comparable yields to that of the more expensive Ir photocatalyst. Both Ni(COD)2 and Ni(dme)Cl2 
gave good conversion, thus the air-stable Ni(II) salt is the more convenient choice. Several ligands 
led to good conversion into product, yet the E/Z selectivity still needs to be validated on the 
benchtop. 
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Figure 5.9. Benchtop Ligand Optimization 
Ligands of different classes have been extensively investigated. Although the increase of 
steric bulk should favor the E-product formation, it is interesting that when using box-type ligands, 
the Z-product became predominant. Unfortunately, the overall yield could not be further optimized. 
Additionally, ligand-free conditions and phosphine ligands were also tested, neither of which gave 
good results.   
Substrate Dependence on Alkylation of Allyl Alcohols 
During the substrate scope investigation of DMDC activation of allyl alcohols, several 
substrates exhibited diminished yield because of the formation of branched products and significant 
amounts of proto-dehydroxylation byproducts. Although the reason remains unclear, some 
examples still provided high regioselectivity using the prefunctionalized allyl carbonates as 
electrophiles (e.g., example 3). Alkyl-substituted allyl carbonates and alcohols generally suffered 




Figure 5.10. Challenging Substrates 
Mechanistic Investigation 
Stern-Volmer Fluorescence Quenching 
Stern-Volmer experiments were conducted on a Horiba Fluorolog® Spectrofluorometer. 
Stock solutions of substrates, photocatalyst, and base were prepared with dry acetone. The solutions 
were mixed and purged with argon for 30 sec immediately prior to measurement. The samples were 
excited at 435 nm, and emission data were recorded at 531 nm. I0/I value of each sample were 









Figure 5.11. Fluorescence Quenching Studies with Allyl Carbonate 
As indicated in the graph above, no significant quenching is observed with cinnamyl 
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A recent report showed that Ir photocatalyst can be quenched by (bpy)NiCl2,28 which indicated an 
alternative pathways of activation of Ni precatalyst and oxidative addition of allyl carbonates. To test this 
possibility, we performed Stern-Volmer studies of (phen)NiCl2 on 4CzIPN, mimicking the reaction 
conditions, but no significant quenching was observed. Therefore, it is unlikely that the Ni precatalyst is 
directly activated by excited photocatalyst 4CzIPN. 
Kinetic Isotope Experiments 
 
The α-deuterated allyl methyl carbonate was synthesized via reducing cinnamyl aldehyde 
with NaBD4, following previous reports.
26,29 
Kinetic isotopic effect experiments were carried out in the high throughput experimentation 
facility. Two 24-well plates were used to set up 24 reactions in parallel, each with α-deuterated and 
non-deuterated allyl carbonates. The reactions were stopped and worked up after 2 h and analyzed 
by UPLC using 10 mol % 4,4’-di-tert-butyl-1,1’-biphenyl as internal standard, and the data were 
analyzed using Excel. 
 
Regular Deuterated 
0.6588 0.7012 0.7066 0.7092 0.7361 0.7083 0.6712 0.6149 0.6455 0.5357 0.5854 0.5873 
0.6312 0.6831 0.6655 0.6678 0.6430 0.6813 0.6474 0.5531 0.5740 0.6634 0.5826 0.5362 
0.7258 0.7269 0.7313 0.6717 0.6549 0.6408 0.6671 0.5044 0.5564 0.6082 0.5504 0.5220 
0.7200 0.7737 0.7154 0.6724 0.6936 0.6749 0.6046 0.5768 0.5399 0.6479 0.5675 0.5819 
Figure 5.13. Kinetic Isotope Effect on Alkylation of Allylic Carbonate 
A secondary KIE is observed in this experiment, which indicated that oxidative addition 




(E)-(3-Cyclohexylprop-1-en-1-yl)benzene (1 & 11): Prepared following 
General Procedure GP1 using cinnamyl methyl carbonate (57.7 mg, 0.3 mmol, 1.0 equiv), diethyl 
4-cyclohexyl-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate (150.9 mg, 0.45 mmol, 1.5 
equiv), (phen)NiCl2 (4.7 mg, 5 mol %), and 4CzIPN (7.1 mg, 3 mol %) in DMF (3 mL, 0.1 M). 
The reaction was stirred under blue LEDs at rt for 16 h. Silica gel purification using an automated 
system (hexanes/EtOAc, 0 to 10%) gave the product as a colorless oil (52.3 mg, 0.26 mmol, 87%). 
1H NMR (500 MHz, CDCl3) δ 7.35 (d, J = 7.6 Hz, 2H), 7.29 (dd, J = 7.6, 7.4 Hz, 2H), 7.19 (t, J = 
7.4 Hz, 1H), 6.36 (d, J = 15.8 Hz, 1H), 6.23 (dt, J = 15.3, 7.2 Hz, 1H), 2.11 (t, J = 7.1 Hz, 2H), 
1.78-1.71 (m, 4H), 1.66 (d, J = 12.5 Hz, 1H), 1.45-1.37 (m, 1H), 1.29-1.13 (m, 3H), 1.01-0.93 (m, 
2H). 13C NMR (126 MHz, CDCl3) δ
 
138.1, 130.8, 129.9, 128.6, 126.9, 126.0, 41.2, 38.4, 33.4, 26.7, 
26.5. IR (neat, cm-1): 3059, 3025, 2919, 2850, 1599, 1496, 1447, 1349, 1262, 1071, 1028, 963, 940, 
909, 890, 846, 775, 739, 691, 513. HRMS (EI) calcd for C15H20 [M]
+ 200.1565, found 200.1557. A 
1-mmol scale reaction was carried out using cinnamyl methyl carbonate (192.3 mg, 1.0 mmol, 1.0 
equiv), diethyl 4-cyclohexyl-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate (503.1 mg, 1.5 
mmol, 1.5 equiv), (phen)NiCl2 (15.5 mg, 5 mol %), and 4CzIPN (23.7 mg, 3 mol %) in DMF (10 
mL, 0.1 M). The reaction was stirred under blue LEDs at rt for 16 h. Silica gel purification using 
an automated system (hexanes/EtOAc, 0 to 10%) gave the product as a colorless oil (170.2 mg, 
85%). 1H and 13C NMR spectra match with the reported data above. 
(E)-(4-Methylpent-1-en-1-yl)benzene (2 & 12): Prepared following General 
Procedure GP1 using cinnamyl methyl carbonate (57.7 mg, 0.3 mmol, 1.0 equiv), diethyl 4-
isopropyl-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate (146.3 mg, 0.45 mmol, 1.5 equiv), 
(phen)NiCl2 (4.7 mg, 5 mol %), and 4CzIPN (7.1 mg, 3 mol %) in DMF (3 mL, 0.1 M). The reaction 
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was stirred under blue LEDs at rt for 16 h. Silica gel purification using an automated system 
(hexanes/EtOAc, 0 to 10%) gave the product as a colorless oil (35.1 mg, 0.22 mmol, 73%). 1H 
NMR (500 MHz, CDCl3) δ 7.40 – 7.36 (m, 2H), 7.32 (dd, J = 7.7, 7.7 Hz, 2H), 7.24 – 7.19 (m, 
1H), 6.41 (d, J = 15.5 Hz, 1H), 6.25 (dt, J = 15.6, 7.2 Hz, 1H), 2.13 (ddd, J = 7.0, 7.0, 1.4 Hz, 2H), 
1.80 – 1.74 (m, 1H), 0.98 (d, J = 6.5 Hz, 6H). 13C NMR (126 MHz, CDCl3) δ
 
138.1, 131.0, 130.0, 
128.6, 126.9, 126.1, 42.6, 28.8, 22.5. IR (neat, cm-1): 3028, 2962, 2933, 2875, 1749, 1712, 1496, 
1406, 1368, 1267, 1124, 1071, 1019, 965, 908, 731, 693, 648, 498. HRMS (EI) calcd for C12H16 
[M]+ 160.1252, found 160.1247. 
(E)-2-(4-Methylpent-1-en-1-yl)naphthalene (3): Prepared following 
General Procedure GP1 using (E)-methyl (3-(naphthalen-2-yl)allyl) carbonate (72.7 mg, 0.3 mmol, 
1.0 equiv), diethyl 4-isopropyl-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate (146.3 mg, 
0.45 mmol, 1.5 equiv), (phen)NiCl2 (4.7 mg, 5 mol %), and 4CzIPN (7.1 mg, 3 mol %) in DMF (3 
mL, 0.1 M). The reaction was stirred under blue LEDs at rt for 16 h. Silica gel purification using 
an automated system (hexanes/EtOAc, 0 to 10%) gave the product as a colorless oil (46.7 mg, 0.22 
mmol, 74%). 1H NMR (500 MHz, CDCl3) δ 7.81-7.76 (m, 3H), 7.69 (s, 1H), 7.60 (dd, J = 8.5, 1.5 
Hz, 1H), 7.48-7.40 (m, 2H), 6.55 (d, J = 15.5 Hz, 1H), 6.40-6.33 (m, 1H), 2.17 (dt, J = 7.2, 1.0 Hz, 
2H), 1.81-1.75 (m, 1H), 0.99 (d, J = 6.5 Hz, 6H). 13C NMR (126 MHz, CDCl3) δ
 
135.3, 133.6, 
130.8, 130.3, 128.7, 127.9, 127.7, 127.5, 126.0, 125.3, 125.2, 123.5, 42.5, 28.6, 22.3. IR (neat, cm-
1): 3056, 3019, 2953, 2925, 2868, 1598, 1508, 1464, 1435, 1383, 1366, 1271, 1167, 965, 892, 857, 
815, 785, 741, 475. HRMS (EI) calcd for C16H18 [M]
+ 210.1409, found 210.1405. 
(E)-1-Fluoro-4-(4-methylpent-1-en-1-yl)benzene (4): Prepared 
following General Procedure GP1 using (E)-3-(4-fluorophenyl)allyl methyl carbonate (63.1 mg, 
0.3 mmol, 1.0 equiv), diethyl 4-isopropyl-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate 
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(146.3 mg, 0.45 mmol, 1.5 equiv), (phen)NiCl2 (4.7 mg, 5 mol %),  and 4CzIPN (7.1 mg, 3 mol %) 
in DMF (3 mL, 0.1 M). The reaction was stirred under blue LEDs at rt for 16 h. Silica gel 
purification using an automated system (hexanes/EtOAc, 0 to 10%) gave the product as a colorless 
oil (40.5 mg, 0.23 mmol, 76%). 1H NMR (500 MHz, CDCl3) δ 7.35 – 7.29 (m, 2H), 6.99 (dd, J = 
8.7, 8.7 Hz, 2H), 6.34 (d, J = 15.5 Hz, 1H), 6.14 (dt, J = 15.5, 7.3 Hz, 1H), 2.10 (t, J = 7.0 Hz, 2H), 
1.80-1.70 (m, 1H), 0.96 (d, J = 6.7 Hz, 6H). 13C NMR (126 MHz, CDCl3) δ
 
162.7, 160.8, 134.0, 
129.5, 127.2 (d, J = 7.8 Hz), 115.2 (d, J = 21.5 Hz), 42.2, 28.5, 22.3. 19F NMR (471MHz, CDCl3) 
δ 115.94. IR (neat, cm-1): 2956, 2927, 2870, 1602, 1508, 1465, 1436, 1384, 1367, 1227, 1157, 1093, 
966, 859, 841, 829, 780, 766, 573, 519. HRMS (EI) calcd for C12H15F [M]
+ 178.1158, found 
178.1157. 
(E)-1,2,3-Trimethoxy-5-(4-methylpent-1-en-1-yl)benzene (5): 
Prepared following General Procedure GP1 using (E)-methyl (3-(3,4,5-trimethoxyphenyl)allyl) 
carbonate (84.7 mg, 0.3 mmol, 1.0 equiv), diethyl 4-isopropyl-2,6-dimethyl-1,4-dihydropyridine-
3,5-dicarboxylate (146.3 mg, 0.45 mmol, 1.5 equiv), (phen)NiCl2 (4.7 mg, 5 mol %), and 4CzIPN 
(7.1 mg, 3 mol %) in DMF (3 mL, 0.1 M). The reaction was stirred under blue LEDs at rt for 16 h. 
Silica gel purification using an automated system (hexanes/EtOAc, 0 to 10%) gave the product as 
a colorless oil (47.3 mg, 0.19 mmol, 63%). 1H NMR (500 MHz, CDCl3) δ 6.59 (s, 2H), 6.30 (d, J 
= 15.7 Hz, 1H), 6.14 (dt, J = 15.3, 7.2 Hz, 1H), 3.89 (s, 6H), 3.85 (s, 3H), 2.15 – 2.05 (m, 2H), 1.74 
(m, 1H), 0.96 (d, J = 6.6 Hz, 6H). 13C NMR (126 MHz, CDCl3) δ
 
153.2, 133.6, 130.6, 129.3, 125.2, 
102.9, 60.8, 56.0, 42.3, 28.5, 22.3. IR (neat, cm-1): 2957, 2837, 2253, 1726, 1583, 1507, 1464, 1417, 
1384 1333, 1239, 1185, 1128, 1005, 965, 905, 828, 779, 726, 649. HRMS (EI) calcd for C15H22O3 




Prepared following General Procedure GP1 using (E)-4,8-dimethylnona-2,7-dien-1-yl methyl 
carbonate (67.9 mg, 0.3 mmol, 1.0 equiv), diethyl 2,6-dimethyl-4-(1-phenylethyl)-1,4-
dihydropyridine-3,5-dicarboxylate (160.8 mg, 0.45 mmol, 1.5 equiv), (phen)NiCl2 (4.7 mg, 5 mol 
%), and 4CzIPN (7.1 mg, 3 mol %) in DMF (3 mL, 0.1 M). The reaction was stirred under blue 
LEDs at rt for 16 h. Silica gel purification using an automated system (hexanes/EtOAc, 0 to 10%) 
gave the product as a colorless oil (42.3 mg, 0.17 mmol, 55%). 1H NMR (500 MHz, CDCl3) δ 7.31-
7.28 (m, 2H), 7.22-7.13 (m, 3H), 5.42-5.28 (m, 2H), 5.11-5.07 (m, 1H), 2.77-2.72 (m, 1H), 2.36-
2.30 (m, 1H), 2.26-2.18 (m, 1H), 1.99-1.93 (m, 3H), 1.82-1.78 (m, 1H), 1.70 (m, 3H), 1.61 (s, 3H), 
1.44-1.40 (m, 1H), 1.28-1.25 (m, 3H), 0.89-0.79 (m, 3H). 13C NMR (126 MHz, CDCl3) δ 130.7, 
129.8, 129.8, 128.4, 128.3, 127.9, 127.8, 127.2, 125.9, 125.1, 40.4, 40.1, 36.7, 32.9, 25.9, 25.7, 
21.6, 19.5, 17.8. IR (neat, cm-1): 3028, 2962, 2913, 2252, 1603, 1494, 1452, 1376, 1093, 969, 905, 
729, 699, 650, 545. HRMS (EI) calcd for C19H28 [M]
+ 256.2191, found 256.2189. 
 (E)-(4,9-Dimethyldeca-1,8-dien-1-yl)benzene (7): Prepared 
following General Procedure GP1 using cinnamyl methyl carbonate (57.7 mg, 0.3 mmol, 1.0 
equiv), diethyl 2,6-dimethyl-4-(6-methylhept-5-en-2-yl)-1,4-dihydropyridine-3,5-dicarboxylate 
(163.6 mg, 0.45 mmol, 1.5 equiv), (phen)NiCl2 (4.7 mg, 5 mol %), and 4CzIPN (7.1 mg, 3 mol %) 
in DMF (3 mL, 0.1 M). The reaction was stirred under blue LEDs at rt for 16 h. Silica gel 
purification using an automated system (hexanes/EtOAc, 0 to 10%) gave the product as a colorless 
oil (48.6 mg, 0.20 mmol, 67%). 1H NMR (500 MHz, CDCl3) δ 7.36 (d, J = 7.4 Hz, 2H), 7.31 (dd, 
J = 7.6, 7.6 Hz, 2H), 7.20 (t, J = 7.3 Hz, 1H), 6.39 (d, J = 15.8 Hz, 1H), 6.23 (dt, J = 15.8, 7.2 Hz, 
1H), 5.13 (t, J = 7.1 Hz, 1H), 2.28 – 2.21 (m, 1H), 2.10-1.96 (m, 3H), 1.71 (s, 3H), 1.63 (s, 3H), 
1.62 – 1.57 (m, 1H), 1.46 – 1.37 (m, 1H), 1.25 – 1.18 (m, 1H), 0.95 (d, J = 6.5 Hz, 3H). 13C NMR 
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(126 MHz, CDCl3) δ 137.8, 131.1, 130.8, 129.6, 128.4, 126.7, 125.8, 124.7, 40.4, 36.6, 32.8, 25.6, 
25.5, 19.4, 17.6. IR (neat, cm-1): 3026, 2963, 2911, 1652, 1599, 1494, 1377, 1115, 1071, 1028, 964, 
909, 829, 738, 691, 617, 524, 494. HRMS (EI) calcd for C17H24 [M]
+ 228.1878, found 228.1832. 
 Cinnamylcycloheptane (8): Prepared following General Procedure GP1 
using cinnamyl methyl carbonate (57.7 mg, 0.3 mmol, 1.0 equiv), diethyl 4-cycloheptyl-2,6-
dimethyl-1,4-dihydropyridine-3,5-dicarboxylate (170.8 mg, 0.45 mmol, 1.5 equiv), (phen)NiCl2 
(4.7 mg, 5 mol %), and 4CzIPN (7.1 mg, 3 mol %) in DMF (3 mL, 0.1 M). The reaction was stirred 
under blue LEDs at rt for 16 h. Silica gel purification using an automated system (hexanes/EtOAc, 
0 to 10%) gave the product as a colorless oil (46.2 mg, 0.22 mmol, 72%). 1H NMR (500 MHz, 
CDCl3) δ 7.35 (d, J = 7.6 Hz, 2H), 7.29 (dd, J = 7.6, 7.3 Hz, 2H), 7.19 (t, J = 7.3 Hz, 1H), 6.36 (d, 
J = 15.8 Hz, 1H), 6.21 (dt, J = 15.4, 7.1 Hz, 1H), 2.14 (t, J = 7.0 Hz, 2H), 1.79-1.73 (m, 2H), 1.68-
1.57 (m, 5H), 1.52-1.39 (m, 4H), 1.26-1.19 (m, 2H). 13C NMR (126 MHz, CDCl3) δ
 
138.1, 130.9, 
130.4, 128.6, 126.9, 126.0, 41.9, 39.9, 34.6, 28.6, 26.7. IR (neat, cm-1): 3025, 2917, 2851, 1650, 
1620, 1599, 1495, 1459, 1444, 1360, 1325, 1269, 1213, 1086, 963, 820, 769, 743, 691, 497. HRMS 
(EI) calcd for C16H22 [M]
+ 214.1722, found 214.1724. 
(E)-(4-(Benzyloxy)but-1-en-1-yl)benzene (10): Prepared 
following General Procedure GP1 using cinnamyl methyl carbonate (57.7 mg, 0.3 mmol, 1.0 
equiv), diethyl 4-((benzyloxy)methyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate (186.7 
mg, 0.45 mmol, 1.5 equiv), (phen)NiCl2 (4.7 mg, 5 mol %), and 4CzIPN (7.1 mg, 3 mol %) in DMF 
(3 mL, 0.1 M). The reaction was stirred under blue LEDs at rt for 16 h. Silica gel purification using 
an automated system (hexanes/EtOAc, 0 to 10%) gave the product as a colorless oil (50.6 mg, 0.21 
mmol, 71%). 1H NMR (500 MHz, CDCl3) δ 7.38 – 7.33 (m, 6H), 7.32 – 7.27 (m, 3H), 7.24 – 7.17 
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(m, 1H), 6.47 (d, J = 15.6 Hz, 1H), 6.25 (dt, J = 15.9, 7.0 Hz, 1H), 4.56 (s, 2H), 3.61 (t, J = 6.7 Hz, 
2H), 2.55 (ddd, J = 6.8, 6.7, 1.5 Hz, 2H). 13C NMR (126 MHz, CDCl3) δ
 
138.3, 137.5, 131.5, 128.4, 
128.3, 127.6, 127.5, 126.9, 125.9, 72.9, 69.7, 33.4. IR (neat, cm-1): 3061, 3027, 2854, 1598, 1495, 
1453, 1362, 1308, 1205, 1095, 1028, 964, 910, 844, 792, 734, 693, 606, 495.6, 460.3. HRMS (EI) 
calcd for C17H18O [M]
+ 238.1385, found 238.1387. 
(E)-2-Cinnamylbicyclo[2.2.1]heptane30 (12): Prepared following General 
Procedure GP1 using cinnamyl methyl carbonate (57.7 mg, 0.3 mmol, 1.0 equiv), diethyl 4-
((1R*,4S*)-bicyclo[2.2.1]heptan-2-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate (172.7 
mg, 0.45 mmol, 1.5 equiv), (phen)NiCl2 (4.7 mg, 5 mol %), and 4CzIPN (7.1 mg, 3 mol %) in DMF 
(3 mL, 0.1 M). The reaction was stirred under blue LEDs at rt for 16 h. Silica gel purification using 
an automated system (hexanes/EtOAc, 0 to 10%) gave the product as a colorless oil (47.0 mg, 0.22 
mmol, 74%). 1H NMR (500 MHz, CDCl3) δ 7.38 – 7.33 (m, 2H), 7.29 (dd, J = 7.7, 7.1 Hz, 2H), 
7.19 (td, J = 7.1, 1.5 Hz, 1H), 6.36 (d, J = 15.7 Hz, 1H), 6.19 (dt, J = 15.7, 7.0 Hz, 1H), 2.24 (s, 
1H), 2.21-2.15 (m, 1H), 2.06-2.01 (m, 2H), 1.60-1.43 (m, 4H), 1.36 (dt, J = 9.7, 2.0 Hz, 1H), 1.21 
– 1.10 (m, 4H). 13C NMR (126 MHz, CDCl3) δ
 
137.9, 130.2, 130.0, 128.4, 126.6, 125.8, 42.0, 40.6, 
40.2, 37.8, 36.6, 35.1, 30.0, 28.8. IR (neat, cm-1): 3059, 3025, 2947, 2912, 2868, 1651, 1599, 1493, 
1450, 1434, 1313, 1139, 1072, 1029, 964, 791, 748, 726, 691, 522. HRMS (EI) calcd for C16H20 
[M]+ 212.1565, found 212.1567. 
 
(E)-1-(3-Cyclohexylprop-1-en-1-yl)-3,5-difluorobenzene (13): 
Prepared following General Procedure GP2 using (E)-3-(3,5-difluorophenyl)prop-2-en-1-ol (51.1 
mg, 0.3 mmol, 1.0 equiv), diethyl 4-cyclohexyl-2,6-dimethyl-1,4-dihydropyridine-3,5-
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dicarboxylate (150.9 mg, 0.45 mmol, 1.5 equiv), DMDC (127 mg, 0.9 mmol, 3.0 equiv), 
(phen)NiCl2 (4.7 mg, 5 mol %), and 4CzIPN (7.1 mg, 3 mol %) in DMF (3 mL, 0.1 M). The reaction 
was stirred under blue LEDs at rt for 16 h. Silica gel purification using an automated system 
(hexanes/EtOAc, 0 to 10%) gave the product as a colorless oil (29.3 mg, 0.12 mmol, 41%). 1H 
NMR (500 MHz, CDCl3) δ 7.40 – 7.36 (m, 1H), 6.82 – 6.74 (m, 2H), 6.42 (d, J = 15.9 Hz, 1H), 
6.21 (dt, J = 15.4, 7.3 Hz, 1H), 2.11 (t, J = 7.0 Hz, 2H), 1.79 – 1.68 (m, 4H), 1.68 – 1.62 (m, 1H), 
1.43 – 1.36 (m, 1H), 1.25 – 1.14 (m, 3H), 0.99 – 0.92 (m, 2H). 13C NMR (126 MHz, CDCl3) δ 
160.8, 132.3 (d, J = 4.1 Hz), 127.9 (dd, J = 9.3, 5.7 Hz), 122.2, 111.4 (d, J = 24.8 Hz), 104.0 (t, J 
= 25.7 Hz), 41.3, 38.0, 33.1, 26.4, 26.2. 19F NMR (471MHz, CDCl3) δ -112.68 (d, J = 6.7 Hz), -
114.88 (d, J = 6.8 Hz). IR (neat, cm-1): 2922, 2852, 1613, 1593, 1500, 1449, 1428, 1274, 1138, 
1090, 965, 941, 848, 807, 728, 608, 535, 528, 505, 498. HRMS (EI) calcd for C15H18F2 [M]
+ 
236.1377, found 236.1368. 
 (E)-1-Chloro-4-(4-methylpent-1-en-1-yl)benzene (14): Prepared 
following General Procedure GP2 using (E)-3-(4-chlorophenyl)prop-2-en-1-ol (50.6 mg, 0.3 
mmol, 1.0 equiv), diethyl 4-isopropyl-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate (146.3 
mg, 0.45 mmol, 1.5 equiv), DMDC (127 mg, 0.9 mmol, 3.0 equiv), (phen)NiCl2 (4.7 mg, 5 mol 
%), and 4CzIPN (7.1 mg, 3 mol %) in DMF (3 mL, 0.1 M). The reaction was stirred under blue 
LEDs at rt for 16 h. Silica gel purification using an automated system (hexanes/EtOAc, 0 to 10%) 
gave the product as a colorless oil (40.9 mg, 0.21 mmol, 70%). 1H NMR (500 MHz, CDCl3) δ 7.29 
– 7.25 (m, 4H), 6.33 (d, J = 15.5 Hz, 1H), 6.20 (dt, J = 15.3, 7.1 Hz, 1H), 2.10 (ddd, J = 7.1, 7.1, 
1.2 Hz, 2H), 1.77 – 1.72 (m, 1H), 0.95 (d, J = 6.7 Hz, 6H). 13C NMR (126 MHz, CDCl3) δ 136.3, 
132.2, 130.6, 129.5, 128.5, 127.0, 42.3, 28.5, 22.3. IR (neat, cm-1): 2955, 2927, 2869, 1711, 1491, 
1464, 1404 1384, 1366, 1220, 1091, 1012, 966, 856, 827, 799, 777, 679, 528, 502. HRMS (EI) 
calcd for C12H15Cl [M]
+ 194.0862, found 194.0861. 
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(E)-1-(4-Methylpent-1-en-1-yl)-4-phenoxybenzene (15): Prepared 
following General Procedure GP2 using (E)-3-(4-phenoxyphenyl)prop-2-en-1-ol (67.9 mg, 0.3 
mmol, 1.0 equiv), diethyl 4-isopropyl-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate (146.3 
mg, 0.45 mmol, 1.5 equiv), DMDC (127 mg, 0.9 mmol, 3.0 equiv), (phen)NiCl2 (4.7 mg, 5 mol 
%), and 4CzIPN (7.1 mg, 3 mol %) in DMF (3 mL, 0.1 M). The reaction was stirred under blue 
LEDs at rt for 16 h. Silica gel purification using an automated system (hexanes/EtOAc, 0 to 10%) 
gave the product as a colorless oil (48.4 mg, 0.19 mmol, 64%). 1H NMR (500 MHz, CDCl3) δ 7.35 
– 7.32 (m, 4H), 7.10 (t, J = 6.8 Hz, 1H), 7.01 (d, J = 8.6 Hz, 2H), 6.96 (d, J = 8.6 Hz, 2H), 6.35 (d, 
J = 15.5 Hz, 1H), 6.15 (dt, J = 15.1, 7.0 Hz, 1H), 2.10 (ddd, J = 6.9, 6.8, 1.2 Hz, 2H), 1.76 – 1.71 
(m, 1H), 0.95 (d, J = 6.5 Hz, 6H). 13C NMR (126 MHz, CDCl3) δ 156.1, 133.5, 130.1, 129.8, 129.2, 
127.3, 123.2, 119.2, 118.8, 118.6, 42.5, 28.8, 22.5. IR (neat, cm-1): 2981, 2254, 1710, 1419, 1361, 
1222, 1091, 910, 727, 648, 530. HRMS (EI) calcd for C18H20O [M]
+ 252.1519, found 252.1506. 
(E)-6-(4-Methylpent-1-en-1-yl)-2,3-dihydrobenzo[b][1,4]dioxin (16): 
Prepared following General Procedure GP2 using (E)-3-(2,3-dihydrobenzo[b][1,4]dioxin-6-
yl)prop-2-en-1-ol (57.7 mg, 0.3 mmol, 1.0 equiv), diethyl 4-isopropyl-2,6-dimethyl-1,4-
dihydropyridine-3,5-dicarboxylate (146.3 mg, 0.45 mmol, 1.5 equiv), DMDC (127 mg, 0.9 mmol, 
3.0 equiv), (phen)NiCl2 (4.7 mg, 5 mol %), and 4CzIPN (7.1 mg, 3 mol %) in DMF (3 mL, 0.1 M). 
The reaction was stirred under blue LEDs at rt for 16 h. Silica gel purification using an automated 
system (hexanes/EtOAc, 0 to 10%) gave the product as a colorless oil (46.9 mg, 0.22 mmol, 72%). 
1H NMR (500 MHz, CDCl3) δ 6.88 (d, J = 2.0 Hz, 1H), 6.84 (dd, J = 8.3, 2.1 Hz, 1H), 6.79 (d, J = 
8.4 Hz, 1H), 6.25 (d, J = 15.6 Hz, 1H), 6.07 (dt, J = 15.6, 7.3 Hz, 1H), 4.26 (s, 4H), 2.07 (ddd, J = 
7.4, 7.0, 1.1 Hz, 2H), 1.75 – 1.67 (m, 1H), 0.93 (d, J = 6.6 Hz, 6H). 13C NMR (126 MHz, CDCl3) 
δ 143.3, 142.5, 131.8, 129.9, 128.2, 119.2, 117.1, 114.3, 64.3, 64.3 42.2, 28.5, 22.3. IR (neat, cm-
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1): 3416, 3004, 1710, 1583, 1508, 1421, 1359, 1307, 1286, 1258, 1220, 1092, 1069, 970, 890, 818, 
784, 529. HRMS (EI) calcd for C14H18O2 [M]
+ 218.1307, found 218.1298. 
(E)-1-Methoxy-4-(4-methylpent-1-en-1-yl)benzene (17): Prepared 
following General Procedure GP2 using (E)-3-(4-methoxyphenyl)prop-2-en-1-ol (49.3 mg, 0.3 
mmol, 1.0 equiv), diethyl 4-isopropyl-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate (146.3 
mg, 0.45 mmol, 1.5 equiv), DMDC (127 mg, 0.9 mmol, 3.0 equiv), (phen)NiCl2 (4.7 mg, 5 mol 
%), and 4CzIPN (7.1 mg, 3 mol %) in DMF (3 mL, 0.1 M). The reaction was stirred under blue 
LEDs at rt for 16 h. Silica gel purification using an automated system (hexanes/EtOAc, 0 to 10%) 
gave the product as a colorless oil (43.5 mg, 0.23 mmol, 76%). 1H NMR (500 MHz, CDCl3) δ 7.30 
(d, J = 8.7 Hz, 2H), 6.85 (d, J = 8.6 Hz, 2H), 6.33 (d, J = 15.9 Hz, 1H), 6.09 (dt, J = 15.4, 7.3 Hz, 
1H), 3.82 (s, 3H), 2.09 (dd, J = 6.9, 6.8 Hz, 2H), 1.78 – 1.69 (m, 1H), 0.95 (d, J = 6.5Hz, 6H). 13C 
NMR (126 MHz, CDCl3) δ 158.5, 130.7, 130.0, 127.6, 126.9, 113.8, 55.2, 42.3, 28.6, 22.3. IR (neat, 
cm-1): 2969, 2930, 1530, 1511, 1454, 1411, 1377, 1357, 1328, 1273, 1236, 1216, 1140, 1110, 1076, 
1048, 971, 815, 783, 583. HRMS (EI) calcd for C13H18O [M]
+ 190.1358, found 190.1346. 
 (E)-(3-(Cyclohex-3-en-1-yl)prop-1-en-1-yl)benzene (18): Prepared 
following General Procedure GP2 using (E)-3-phenylprop-2-en-1-ol (40.3 mg, 0.3 mmol, 1.0 
equiv), diethyl 4-(cyclohex-3-en-1-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate (150.0 
mg, 0.45 mmol, 1.5 equiv), DMDC (127 mg, 0.9 mmol, 3.0 equiv), (phen)NiCl2 (4.7 mg, 5 mol 
%), and 4CzIPN (7.1 mg, 3 mol %) in DMF (3 mL, 0.1 M). The reaction was stirred under blue 
LEDs at rt for 16 h. Silica gel purification using an automated system (hexanes/EtOAc, 0 to 10%) 
gave the product as a colorless oil (35.5 mg, 0.18 mmol, 60%). 1H NMR (500 MHz, CDCl3) δ 7.38 
– 7.34 (m, 2H), 7.29 (dd, J = 7.7, 7.7 Hz, 2H), 7.20 (td, J = 7.0, 1.5 Hz, 1H), 6.40 (dd, J = 15.9, 4.2 
Hz, 1H), 6.24 (dt, J = 15.7, 7.2 Hz, 1H), 5.73 – 5.64 (m, 2H), 2.25 – 2.19 (m, 2H), 2.18 – 2.11 (m, 
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1H), 2.09 – 1.99 (m, 2H), 1.84 – 1.80 (m, 1H), 1.78 – 1.70 (m, 2H), 1.34 – 1.26 (m, 1H). 13C NMR 
(126 MHz, CDCl3) δ 137.7, 130.9, 129.2, 128.4, 126.9, 126.7, 126.3, 125.8, 39.9, 33.8, 31.6, 28.4, 
25.0. IR (neat, cm-1): 2969, 2930, 1530, 1511, 1454, 1411, 1377, 1357, 1328, 1273, 1236, 1216, 
1140, 1110, 1076, 1048, 971, 815, 783, 583. HRMS (EI) calcd for C15H18 [M]
+ 198.1409, found 
198.1403. 
4-Cinnamyltetrahydro-2H-pyran (19): Prepared following General 
Procedure GP2 using (E)-3-phenylprop-2-en-1-ol (40.3 mg, 0.3 mmol, 1.0 equiv), diethyl 2,6-
dimethyl-4-(tetrahydro-2H-pyran-4-yl)-1,4-dihydropyridine-3,5-dicarboxylate (151.8 mg, 0.45 
mmol, 1.5 equiv), DMDC (127 mg, 0.9 mmol, 3.0 equiv), (phen)NiCl2 (4.7 mg, 5 mol %), and 
4CzIPN (7.1 mg, 3 mol %) in DMF (3 mL, 0.1 M). The reaction was stirred under blue LEDs at rt 
for 16 h. Silica gel purification using an automated system (hexanes/EtOAc, 0 to 10%) gave the 
product as a colorless oil (31.6 mg, 0.16 mmol, 52%). 1H NMR (500 MHz, CDCl3) δ 7.34 (d, J = 
7.1 Hz, 2H), 7.30 (dd, J = 7.6, 7.6 Hz, 2H), 7.20 (t, J = 7.2 Hz, 1H), 6.39 (d, J = 15.8 Hz, 1H), 6.20 
(dt, J = 15.4, 7.3 Hz, 1H), 3.99 (dd, J = 11.5, 4.5 Hz, 2H), 3.39 (td, J = 11.9, 1.9 Hz, 2H), 2.20 – 
2.14 (m, 2H), 1.68 – 1.62 (m, 3H), 1.40 – 1.32 (m, 2H). 13C NMR (126 MHz, CDCl3) δ 137.5, 
131.4, 128.4, 128.2, 126.9, 125.9, 68.0, 40.3, 35.4, 32.9. IR (neat, cm-1): 3025, 2951, 2912, 2838, 
1494, 1443, 1386, 1364, 1231, 1135, 1092, 1073, 1012, 982, 965, 891, 859, 742, 693. HRMS (EI) 
calcd for C14H18O [M]
+ 202.1358, found 202.1359. 
 (E)-(4-Methylhex-1-en-1-yl)benzene (20): Prepared following 
General Procedure GP2 using (E)-3-phenylprop-2-en-1-ol (40.3 mg, 0.3 mmol, 1.0 equiv), diethyl 
4-(sec-butyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate (139.2 mg, 0.45 mmol, 1.5 
equiv), DMDC (127 mg, 0.9 mmol, 3.0 equiv), (phen)NiCl2 (4.7 mg, 5 mol %), and 4CzIPN (7.1 
mg, 3 mol %) in DMF (3 mL, 0.1 M). The reaction was stirred under blue LEDs at rt for 16 h. Silica 
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gel purification using an automated system (hexanes/EtOAc, 0 to 10%) gave the product as a 
colorless oil (41.8 mg, 0.24 mmol, 80%). 1H NMR (500 MHz, CDCl3) δ 7.37 – 7.32 (m, 2H), 7.29 
(t, J = 7.7 Hz, 2H), 7.21 – 7.16 (m, 1H), 6.37 (d, J = 15.8 Hz, 1H), 6.21 (dt, J = 15.7, 7.3 Hz, 1H), 
2.26 (m, 1H), 2.09 – 2.03 (m, 1H), 1.53 – 1.49 (m, 1H), 1.46 – 1.39 (m, 1H), 1.24 – 1.67 (m, 1H), 
0.94 – 0.90 (m, 6H). 13C NMR (126 MHz, CDCl3) δ 137.9, 130.7, 129.7, 128.3, 126.6, 125.8, 40.1, 
34.9, 29.1, 19.1, 11.4. IR (neat, cm-1): 2968, 2920, 1654, 1530, 1511, 1457, 1401, 1329, 1273, 1236, 




carboxylate (21): Prepared following General Procedure GP2 using (E)-3-(4-methoxyphenyl)prop-
2-en-1-ol (49.3 mg, 0.3 mmol, 1.0 equiv), diethyl 4-isopropyl-2,6-dimethyl-1,4-dihydropyridine-
3,5-dicarboxylate (211.8 mg, 0.45 mmol, 1.5 equiv), DMDC (127 mg, 0.9 mmol, 3.0 equiv), 
(phen)NiCl2 (4.7 mg, 5 mol %), and 4CzIPN (7.1 mg, 3 mol %) in DMF (3 mL, 0.1 M). The reaction 
was stirred under blue LEDs at rt for 16 h. Silica gel purification using an automated system 
(hexanes/EtOAc, 0 to 10%) gave the product as a colorless oil (72.4 mg, 0.20 mmol, 66%). 1H 
NMR (500 MHz, CDCl3) δ 7.38 – 7.33 (m, 4H), 7.31 (dd, J = 8.8, 4.3 Hz, 1H), 7.29 – 7.27 (m, 
2H), 6.84 (d, J = 8.7 Hz, 2H), 6.32 (d, J = 15.7 Hz, 1H), 6.03 (dt, J = 15.4, 7.3 Hz, 1H), 5.13 (s, 
2H), 4.18 – 4.10 (m, 2H), 3.80 (s, 3H), 2.77 (s, 2H), 2.14 (dd, J = 7.0, 6.9 Hz, 2H), 1.72 (s, 2H), 
1.28 – 1.25 (m, 1H), 1.22 – 1.20 (m, 2H). 13C NMR (126 MHz, CDCl3) δ 159.0, 155.5, 137.2, 
131.1, 130.5, 128.6, 128.0, 128.0, 127.2, 126.1, 114.1, 67.1, 55.5, 44.4, 40.1, 36.6, 14.4. IR (neat, 
cm-1): 2929, 2852, 1694, 1606, 1511, 1466, 1364, 1276, 1244, 1175, 1128, 1108, 1087, 1030, 966, 
830, 764, 698, 599. HRMS (EI) calcd for C23H27NO3[M]
+ 365.1991, found 365.1987. 
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(E)-4-Phenylbut-3-en-1-ol (22): Prepared following General Procedure 
GP2 using (E)-3-phenylprop-2-en-1-ol (40.3 mg, 0.3 mmol, 1.0 equiv), diethyl 4-(hydroxymethyl)-
2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate (141.0 mg, 0.45 mmol, 1.5 equiv), DMDC 
(127 mg, 0.9 mmol, 3.0 equiv), (phen)NiCl2 (4.7 mg, 5 mol %), and 4CzIPN (7.1 mg, 3 mol %) in 
DMF (3 mL, 0.1 M). The reaction was stirred under blue LEDs at rt for 16 h. Silica gel purification 
using an automated system (hexanes/EtOAc, 0 to 10%) gave the product as a colorless oil (25.3 
mg, 0.17 mmol, 57%). 1H NMR (500 MHz, CDCl3) δ 7.36 (d, J = 7.5 Hz, 2H), 7.31 (dd, J = 8.4, 
6.9 Hz, 2H), 7.25 – 7.19 (m, 1H), 6.51 (d, J = 15.8 Hz, 1H), 6.21 (dt, J = 16.0, 7.1 Hz, 1H), 3.80 – 
3.70 (m, 2H), 2.50 (td, J = 6.3, 1.5 Hz, 2H), 1.47 (s, 1H). 13C NMR (126 MHz, CDCl3) δ 137.4, 
133.0,128.7, 127.4, 126.4, 126.2, 62.2, 36.6. IR (neat, cm-1): 3375, 2923, 2853, 1768, 1727, 1598, 
1492, 1450, 1371, 1336, 1312, 1272, 1227, 1197, 1089, 1043, 1029, 966, 747, 726, 700. HRMS 
(EI) calcd for C10H12O [M]
+ 148.0889, found 148.0879. 
(3aR,4R,6R,6aR)-4-Cinnamyl-6-methoxy-2,2-
dimethyltetrahydrofuro[3,4-d][1,3]dioxole (23): Prepared following General Procedure GP2 using 
(E)-3-phenylprop-2-en-1-ol (40.3 mg, 0.3 mmol, 1.0 equiv), diethyl 4-((3aR,6R,6aR)-6-methoxy-
2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-
dicarboxylate (191.5 mg, 0.45 mmol, 1.5 equiv), DMDC (127 mg, 0.9 mmol, 3.0 equiv), 
(phen)NiCl2 (4.7 mg, 5 mol %), and 4CzIPN (7.1 mg, 3 mol %) in DMF (3 mL, 0.1 M). The reaction 
was stirred under blue LEDs at rt for 16 h. Silica gel purification using an automated system 
(hexanes/EtOAc, 0 to 10%) gave the product as a colorless oil (46.2 mg, 0.16 mmol, 53%). 1H 
NMR (500 MHz, CDCl3) δ 7.37 (d, J = 7.2 Hz, 2H), 7.31 (t, J = 7.6 Hz, 2H), 7.25 – 7.20 (m, 1H), 
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6.49 (d, J = 15.9 Hz, 1H), 6.22 (ddd, J = 15.9, 7.7, 6.4 Hz, 1H), 4.99 (s, 1H), 4.66 – 4.62 (m, 2H), 
4.34 (t, J = 7.7 Hz, 1H), 3.38 (s, 3H), 2.62-2.56 (m, 1H), 2.50 – 2.44 (m, 1H), 1.50 (s, 3H), 1.33 (s, 
3H). 13C NMR (126 MHz, CDCl3) δ 132.5, 128.4, 127.2, 126.0, 125.8, 114.5, 109.5, 107.0, 86.5, 
85.5, 83.4, 54.8, 38.6, 26.4, 24.9. IR (neat, cm-1): 2989, 2935, 1496, 1449, 1373, 1272, 1239, 1210, 
1193, 1161, 1106, 1092, 1060, 1026, 965, 871, 743, 694, 514, 493. HRMS (EI) calcd for C17H22O4 
[M]+ 290.1518, found 290.1509. 
(3aR,5aS,8bR)-5-Cinnamyl-2,2,7,7-tetramethyltetrahydro-
5H-bis([1,3]dioxolo)[4,5-b:4',5'-d]pyran (24): Prepared following General Procedure GP2 
using (E)-3-phenylprop-2-en-1-ol (40.3 mg, 0.3 mmol, 1.0 equiv), diethyl 2,6-dimethyl-4-
((3aR,5aS,8aS,8bR)-2,2,7,7-tetramethyltetrahydro-5H-bis([1,3]dioxolo)[4,5-b:4',5'-d]pyran-5-yl)-
1,4-dihydropyridine-3,5-dicarboxylate (216.7 mg, 0.45 mmol, 1.5 equiv), DMDC (127.0 mg, 0.9 
mmol, 3.0 equiv), (phen)NiCl2 (4.7 mg, 5 mol %), and 4CzIPN (127 mg, 7.1 mg, 3 mmol %) in 
DMF (3 mL, 0.1 M). The reaction was stirred under blue LEDs at rt for 16 h. Silica gel purification 
using an automated system (hexanes/EtOAc, 0 to 10%) gave the product as a colorless oil (54.8 
mg, 0.16 mmol, 53%). 1H NMR (500 MHz, CDCl3) δ 7.36 (d, J = 7.5 Hz, 2H), 7.29 (dd, J = 7.5, 
7.3 Hz, 2H), 7.20 (t, J = 7.3 Hz, 1H), 6.54 (d, J = 15.9 Hz, 1H), 6.25 (dt, J = 15.7, 7.0 Hz, 1H), 
5.56 (d, J = 5.1 Hz, 1H), 4.60 (dd, J = 7.9, 2.3 Hz, 1H), 4.31 (dd, J = 5.1, 2.3 Hz, 1H), 4.20 (dd, J 
= 8.0, 1.9 Hz, 1H), 3.86 (t, J = 6.7 Hz, 1H), 2.56 (m, 2H), 1.55 (s, 3H), 1.49 (s, 3H), 1.37 (s, 3H), 
1.34 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 137.7, 132.4, 128.6, 127.2, 126.3, 126.1, 109.3, 108.6, 
96.8, 72.4, 71.0, 70.7, 67.7, 33.9, 26.2, 26.2, 25.1, 24.6. IR (neat, cm-1): 2981, 2919, 1381, 1372, 
1255, 1210, 1166, 1142, 1102, 1067, 1035, 997, 966, 916, 901, 887, 864, 804, 743, 693. HRMS 
(EI) calcd for C19H23O5 [M-CH3]
+ 331.1545, found 331.1537. 
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(Cinnamylsulfonyl)benzene (25): Prepared following General Procedure 
GP3 using cinnamyl methyl carbonate (57.7 mg, 0.3 mmol, 1.0 equiv), sodium benzenesulfinate 
(98.5 mg, 0.6 mmol, 2.0 equiv), (phen)NiCl2 (4.7 mg, 5 mol %), and 4CzIPN (7.1 mg, 3 mol %) in 
DMF (3 mL, 0.1 M). The reaction was stirred under blue LEDs at rt for 16 h. Silica gel purification 
using an automated system (hexanes/EtOAc, 10 to 30%) gave the product as a white solid (57.6 
mg, 0.22 mmol, 74%). mp = 67 – 72 ℃. 1H NMR (500 MHz, CDCl3) δ 7.88 (ddd, J = 8.4, 8.4, 1.1 
Hz, 2H), 7.67 – 7.58 (m, 1H), 7.54 (t, J = 7.7 Hz, 2H), 7.34 – 7.28 (m, 5H), 6.37 (d, J = 15.8 Hz, 
1H), 6.10 (dt, J = 15.6, 7.6 Hz, 1H), 3.95 (ddd, J = 7.6, 7.6, 1.1 Hz, 2H). 13C NMR (126 MHz, 
CDCl3) δ
 
139.1, 138.2, 135.7, 133.7, 129.0, 128.6 (2C), 128.4,126.5, 115.0, 60.4. IR (neat, cm-1): 
2975, 2903, 1317, 1306, 1295, 1234, 1149, 1084, 1025, 967, 903, 770, 751, 688, 619, 595, 564, 
530, 495. HRMS (EI) calcd for C15H14O2S [M]
+ 258.0715, found 258.0722. 
1-(Cinnamylsulfonyl)-4-methylbenzene (26): Prepared following 
General Procedure GP3 using cinnamyl methyl carbonate (57.7 mg, 0.3 mmol, 1.0 equiv), sodium 
4-methylbenzenesulfinate (106.9 mg, 0.6 mmol, 2.0 equiv), (phen)NiCl2 (4.7 mg, 5 mol %), and 
4CzIPN (7.1 mg, 3 mol %) in DMF (3 mL, 0.1 M). The reaction was stirred under blue LEDs at rt 
for 16 h. Silica gel purification using an automated system (hexanes/EtOAc, 10 to 30%) gave the 
product as a white solid (67.2 mg, 0.25 mmol, 82%). mp = 113 – 116 ℃.  1H NMR (500 MHz, 
CDCl3) δ 7.82 – 7.66 (m, 2H), 7.38 – 7.28 (m, 7H), 6.40 (d, J = 15.8 Hz, 1H), 6.11 (dt, J = 15.5, 
7.5 Hz, 1H), 3.94 (d, J = 7.7 Hz, 2H), 2.45 (s, 3H). 13C NMR (126 MHz, CDCl3) δ
 
144.6, 138.9, 
135.7, 135.5, 129.6, 128.6, 128.4, 128.4, 126.5, 115.3, 60.5, 21.5. IR (neat, cm-1): 3025, 2925, 1479, 
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1458, 1447, 1397, 1225, 1205, 1135, 1084, 967, 819, 749, 727, 616, 599, 557, 530, 478. HRMS 
(EI) calcd for C16H16O2S [M]
+ 272.0871, found 272.0869. 
 (E)-1-Fluoro-4-(3-(phenylsulfonyl)prop-1-en-1-yl)benzene (27): 
Prepared following General Procedure GP3 using (E)-3-(4-fluorophenyl)allyl methyl carbonate 
(63.1 mg, 0.3 mmol, 1.0 equiv), sodium benzenesulfinate (98.5 mg, 0.6 mmol, 2.0 equiv), 
(phen)NiCl2 (4.7 mg, 5 mol %), and 4CzIPN (7.1 mg, 3 mol %) in DMF (3 mL, 0.1 M). The reaction 
was stirred under blue LEDs at rt for 16 h. Silica gel purification using an automated system 
(hexanes/EtOAc, 10 to 30%) gave the product as a white solid (43.0 mg, 0.16 mmol, 52%). mp = 
89 – 92 ℃.  1H NMR (500 MHz, CDCl3) δ 7.89 (dd, J = 8.3, 1.3 Hz, 2H), 7.69 – 7.64 (m, 1H), 7.56 
(dd, J = 7.7, 7.7 Hz, 2H), 7.29 – 7.24 (m, 2H), 7.01 (dd, J = 8.7, 8.7 Hz, 2H), 6.36 (d, J = 15.8 Hz, 
1H), 6.03 (dt, J = 15.5, 7.6 Hz, 1H), 3.95 (dd, J = 7.5, 1.1 Hz, 2H). 13C NMR (126 MHz, CDCl3) δ
 
162.0, 138.6, 138.2, 134.0, 132.1, 129.3, 128.6, 128.4 (d, J = 8.2 Hz), 115.8 (d, J = 21.7 Hz), 115.0 
(d, J = 2.3 Hz), 60.6. 19F (471 MHz, CDCl3) δ 112.7. IR (neat, cm
-1): 3082, 2963, 1508, 1447, 1306, 
1226, 1148, 1085, 968, 904, 842, 821, 765, 708, 688, 601, 577, 556, 528, 509. HRMS (EI) calcd 
for C15H13FO2S [M]
+ 276.0620, found 276.0621. 
(E)-2-(3-(Phenylsulfonyl)prop-1-en-1-yl)naphthalene (28): 
Prepared following General Procedure GP3 using (E)-methyl (3-(naphthalen-2-yl)allyl) carbonate 
(72.7 mg, 0.3 mmol, 1.0 equiv), sodium benzenesulfinate (98.5 mg, 0.6 mmol, 2.0 equiv), 
(phen)NiCl2 (4.7 mg, 5 mol %), and 4CzIPN (7.1 mg, 3 mol %) in DMF (3 mL, 0.1 M). The reaction 
was stirred under blue LEDs at rt for 16 h. Silica gel purification using an automated system 
(hexanes/EtOAc, 10 to 30%) gave the product as a white solid (43.5 mg, 0.14 mmol, 47%). mp = 
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96 – 99 ℃.  1H NMR (500 MHz, CDCl3) δ 7.90 (d, J = 7.9 Hz, 2H), 7.82 – 7.75 (m, 3H), 7.67 – 
7.61 (m, 2H), 7.56 – 7.51 (m, 2H), 7.50 (dd, J = 8.6, 1.6 Hz, 1H), 7.48 – 7.44 (m, 2H), 6.52 (d, J = 
15.8 Hz, 1H), 6.23 (dt, J = 15.5, 7.6 Hz, 1H), 4.01 (d, J = 7.6 Hz, 2H). 13C NMR (126 MHz, CDCl3) 
δ 139.4 (2C), 138.6, 133.9, 133.5, 133.3, 129.2, 128.7, 128.6, 128.2, 127.8, 127.2, 126.6, 126.6, 
123.4, 115.5, 60.8. IR (neat, cm-1): 3051, 2962, 1446, 1307, 1291, 1150, 1085, 964, 909, 861, 813, 
774, 749, 704, 687, 598, 568, 556, 527, 475. HRMS (EI) calcd for C19H16O2S [M]
+ 308.0871, found 
308.0867. 
(E)-1-Methoxy-4-(3-(phenylsulfonyl)prop-1-en-1-yl)benzene (29): 
Prepared following General Procedure GP3 using (E)-3-(4-methoxyphenyl)allyl methyl carbonate 
(66.7 mg, 0.3 mmol, 1.0 equiv), sodium benzenesulfinate (98.5 mg, 0.6 mmol, 2.0 equiv), 
(phen)NiCl2 (4.7 mg, 5 mol %), and 4CzIPN (7.1 mg, 3 mol %) in DMF (3 mL, 0.1 M). The reaction 
was stirred under blue LEDs at rt for 16 h. Silica gel purification using an automated system 
(hexanes/EtOAc, 10 to 30%) gave the product as a white solid (59.6 mg, 0.21 mmol, 69%). mp > 
230 ℃ (decomp.).  1H NMR (500 MHz, CDCl3) δ 7.88 (dd, J = 8.2, 1.3 Hz, 2H), 7.66 – 7.61 (m, 
1H), 7.53 (dd, J = 7.8, 7.8 Hz, 2H), 7.24 – 7.20 (m, 2H), 6.84 (dd, J = 9.1, 2.5 Hz, 2H), 6.30 (d, J 
= 15.9 Hz, 1H), 5.95 (dt, J = 15.7, 7.7 Hz, 1H), 3.93 (dd, J = 7.8, 1.1 Hz, 2H), 3.81 (s, 3H). 13C 
NMR (126 MHz, CDCl3) δ
 
160.0, 138.8, 138.6, 133.8, 129.2, 129.2, 128.7, 128.1, 114.2, 112.7, 
60.8, 55.4. IR (neat, cm-1): 3003, 2981, 1709, 1607, 1511, 1458, 1446, 1304, 1223, 1176, 1146, 






(30): Prepared following General Procedure GP3 using (E)-5,9-dimethyldeca-2,8-dien-1-yl methyl 
carbonate (72.1 mg, 0.3 mmol, 1.0 equiv), sodium benzenesulfinate (98.5 mg, 0.6 mmol, 2.0 equiv), 
(phen)NiCl2 (4.7 mg, 5 mol %), and 4CzIPN (7.1 mg, 3 mol %) in DMF (3 mL, 0.1 M). The reaction 
was stirred under blue LEDs at rt for 16 h. Silica gel purification using an automated system 
(hexanes/EtOAc, 10 to 30%) gave the product as a colorless, sticky oil (51.5 mg, 0.17 mmol, 56%). 
1H NMR (500 MHz, CDCl3) δ 7.90-7.86 (m, 2H), 7.66 – 7.60 (m, 1H), 7.55 (dd, J = 7.7, 7.7 Hz, 
2H), 5.55 – 5.50 (m, 1H), 5.42 – 5.36 (m, 1H), 5.07 – 5.03 (m, 1H), 3.77 (d, J = 7.5 Hz, 2H), 2.05-
2.00 (m, 1H), 1.97-1.81 (m, 3H), 1.69 (s, 3H), 1.60 (s, 3H), 1.44 – 1.38 (m, 1H), 1.25 – 1.19 (m, 
1H), 1.10 – 1.03 (m, 1H), 0.76 (d, J = 6.7 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ
 
140.3, 138.4, 
133.4, 131.2, 128.9, 128.4, 124.5, 116.9, 60.1, 39.8, 36.4, 32.2, 25.6, 25.4, 19.1, 17.5. IR (neat, cm-
1): 2961, 2914, 1745, 1586, 1447, 137, 1319, 1307, 1237, 1144, 1086, 1025, 999, 971, 793, 731, 
689, 600, 555, 530. HRMS (EI) calcd for C18H26O2S [M]
+ 306.1654, found 306.1650. 
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Figure A4.1. 1H-NMR (500 MHz, CDCl3) and 13C-NMR (126 MHz, CDCl3) of (E)-(3-Cyclohexylprop-1-
































































































Figure A4.8.  13C-NMR (126 MHz, CDCl3) of (E)-1-Fluoro-4-(4-methylpent-1-en-1-yl)benzene (4)  
 




































































































































































Figure A4.21.  1H-NMR (500 MHz, CDCl3) and 13C-NMR (126 MHz, CDCl3) of (E)-2-































Figure A4.23.  13C-NMR (126 MHz, CDCl3) of (E)-1-(3-Cyclohexylprop-1-en-1-yl)-3,5-difluorobenzene 
(13)  
 



































































Figure A4.29.  1H-NMR (500 MHz, CDCl3) of (E)-6-(4-Methylpent-1-en-1-yl)-2,3-





Figure A4.30. 13C-NMR (126 MHz, CDCl3) of (E)-6-(4-Methylpent-1-en-1-yl)-2,3-





























































Figure A4.34.  1H-NMR (500 MHz, CDCl3) and 13C-NMR (126 MHz, CDCl3) of (E)-(3-(Cyclohex-3-en-1-




















































































































































Figure A4.43. 1H-NMR (500 MHz, CDCl3) of (3aR,4R,6R,6aR)-4-Cinnamyl-6-methoxy-2,2-





Figure A4.44. 13C-NMR (126 MHz, CDCl3) of (3aR,4R,6R,6aR)-4-Cinnamyl-6-methoxy-2,2-























Figure A4.45. 1H-NMR (500 MHz, CDCl3) of (3aR,5aS,8bR)-5-Cinnamyl-2,2,7,7-tetramethyltetrahydro-





Figure A4.46. 13C-NMR (126 MHz, CDCl3) of (3aR,5aS,8bR)-5-Cinnamyl-2,2,7,7-tetramethyltetrahydro-































































































Figure A4.52. 13C-NMR (126 MHz, CDCl3) of (E)-1-Fluoro-4-(3-(phenylsulfonyl)prop-1-en-1-yl)benzene 
(27)  
 








































Figure A4.57. 13C-NMR (126 MHz, CDCl3) of (E)-1-Methoxy-4-(3-(phenylsulfonyl)prop-1-en-1-
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